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Abstract 
 
PcrA is a DNA helicase involved in unwinding plasmids as a part of a 
complex in asymmetric rolling-circle replication of certain plasmids carrying 
antibiotic resistance genes. PcrA translocates on single stranded DNA by 
coupling ATP hydrolysis to movement on DNA. Initiator protein, RepD is 
required to nick supercoiled plasmid site-specifically and open an ssDNA 
stretch that PcrA can bind. The presence of RepD is needed throughout 
plasmid unwinding to maintain processivity. 
 
Using fluorescent-based techniques, PcrA helicase mechanistic 
functions and interactions with different components of the replication 
complex were examined at the ensemble and single molecule level. The 
development of ensemble techniques included labelling of PcrA with 
environment sensitive fluorophores such as the coumarin derivative, MDCC. 
Using MDCC-PcrA(K138C) a translocation assay was developed, which 
determined that PcrA translocates two times faster on dC (500 bases s-1) 
than on dT oligos (240 bases s-1). MDCC-PcrA(E449C) was used to 
investigate the PcrA and RepD interaction. The signal observed with this and 
other labelled PcrA mutants indicated that the 2B subdomain of PcrA is likely 
to be interaction site between PcrA and RepD. MDCC-PcrA(E449C) enabled 
the determination of PcrA  kinetics with the initiation complex and showed 
that ATP-PcrA binds differently to PcrA to RepD-DNA complex as compared 
to apo PcrA, possibly indicating that ATP binding stabilises PcrA in a specific 
conformation when binding to RepD-DNA. 
 
A single-molecule assay was developed to study individual surface-
bound PcrA helicases unwinding full length plasmids by total internal 
reflection fluorescence microscopy. PcrA unwinds plasmid with the average 
rate of 40-50 bp s-1 showing 10-fold variation between the individual 
helicases. The experiments indicated that the unwinding starts almost 
immediately after addition of ATP. The single molecule experiments with 
fluorophore-labelled biotinylated PcrA so clear indication that PcrA unwinds 
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plasmids as a monomer with processivity over 3000 base pairs. The 
comparison of the ssDNA translocation rate and dsDNA unwinding rates 
showed a significant difference between the two forms of translocation, 
which indicated PcrA to be a passive helicase. This means that PcrA is not 
actively destabilising the hydrogen bonding between DNA bases but taking 
advantage of the thermal fluctuation between the base pairs and so leading 
to separation of component DNA strands.  
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AAA+   ATPases Associated with various cellular Activities 
ADP   Adenosine disphosphate 
ASPT   Automatic Single Particle Tracking 
ATP   Adenosine triphosphate 
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bp   Base pair 
Cy3B-bioPcrA Cy3B-labelled biotinylated PcrA(E449C)  
Cy3B-SSB  Cy3B-labelled SSB(W88C) 
Da   Dalton 
dAx   Deoxyadenosine oligo of x number of dA bases 
dCx   Deoxycytodine oligo of x number of dC bases 
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DCC-SSB  IDCC-labelled SSB(G26C) 
dGx   Deoxyguanosine oligo of x number of dG bases 
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dTx   Deoxythymidine oligo of x number of dT bases 
DTNB   Dithionitrobenzoic acid, Ellman’s reagent 
dsDNA   Double stranded DNA 
EDTA   Ethylenediaminetetraacetic acid 
EMCCD Electron multiplying charge coupled device  
FPLC   Fast protein liquid chromatography 
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HPLC   High performance liquid chromatography 
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MS photobleaching Multiple step photobleaching 
NA   Numerical aperture 
NHS   N-hydroxysuccimide ester 
nt   Nucleotide 
NTP   Nucleotide triphosphate 
Pi   Inorganic phosphate 
PBP   Phosphate binding protein 
PCR   Polymerase chain reaction 
PcrA   Plasmid copy number reduction A (a helicase) 
PEG   Polyethylene glycol 
RNA   Ribonucleic acid 
SEC-MALS Size exclusion chromatography- multi angle light 
scattering 
SEM Standard error of the mean 
SFDA Single Fluorophore Detection Algorithm 
SS photobleaching Single step photobleaching 
ssDNA   Single stranded DNA 
SSB   Single stranded DNA binding protein 
ssiA/B Single stranded origin of replication of RSF1010 plasmid 
SSO   Single stranded origin of replication 
TIRFM   Total internal reflection fluorescence microscopy 
 
 
 7 
 
Table of Contents 
Acknowledgements ....................................................................................... 3 
Abstract ......................................................................................................... 4 
Abbreviations ................................................................................................. 6 
Table of Figures ........................................................................................... 12 
Table of Tables ............................................................................................ 16 
Introduction .................................................................................................. 17 
1.1. DNA replication .............................................................................. 17 
1.2. DNA and RNA helicases ................................................................... 20 
1.2.1. Structural similarities between the six helicase superfamilies .... 21 
1.2.2. Superfamily 1 and 2 helicases and PcrA-SF 1 helicase ............. 23 
1.2.3. PcrA DNA translocation model ................................................... 27 
1.2.4. Helicase superfamilies 3 to 6 ...................................................... 28 
1.2.5. Helicase movement on DNA ...................................................... 31 
1.3. Replication of circular bacterial plasmids .......................................... 33 
1.4. PcrA function ..................................................................................... 38 
1.4.1. Asymmetric rolling circle plasmid replication and PcrA ............... 38 
1.4.2. In vitro studies of the molecular motor PcrA and initiator protein 
RepD .................................................................................................... 41 
1.4.3. PcrA function in DNA repair and RecA filament removal ............ 43 
1.5. Fluorescence .................................................................................... 46 
1.5.1. Förster resonance energy transfer ............................................. 48 
1.5.2. Anisotropy .................................................................................. 50 
1.5.3. Utilisation of fluorescence to study protein function .................... 51 
1.5.4. Attachment of extrinsic fluorescent probes to biomolecules ....... 52 
1.5.5. Fluorescent biosensors .............................................................. 54 
1.6. Rapid reaction techniques ................................................................. 55 
1.6.1. Stopped-flow spectrometry ......................................................... 58 
1.7. Rapid reaction kinetics with fluorophore labelled enzyme ................. 59 
1.8. Single molecule assays..................................................................... 62 
1.8.1. Total internal reflection microscopy ............................................ 67 
1.8.2. Optical and magnetic trapping of molecules ............................... 68 
1.9. Purpose of the investigation .............................................................. 71 
2. Materials and Methods ............................................................................ 73 
2.1. Chemicals and reagents ................................................................... 73 
2.2. Buffers and media ............................................................................. 73 
 8 
 
2.3. Transformation of Escherichia coli .................................................... 73 
2.3.1. Expression cell lines ................................................................... 74 
2.3.2. Small, medium and large scale plasmid purification ................... 74 
2.4. Site-directed mutagenesis ................................................................. 75 
2.4.1. Primers used for site-directed mutagenesis of RepD ................. 76 
2.4.2. Primers used for site-directed mutagenesis of PcrA ................... 76 
2.5. Agarose gel electrophoresis .............................................................. 77 
2.6. DNA structures and sequences ........................................................ 78 
2.7. Protein expression and purification ................................................... 79 
2.7.1 SDS-PAGE analysis of expressed proteins ................................. 79 
2.7.2. Bacillus Stearothermophilus PcrA wild type and mutant 
preparations ......................................................................................... 80 
2.7.3. Staphylococcus aureus RepD preparations ............................... 81 
2.7.4. Biotinylated Bacillus Stearothermophilus PcrA expression and 
purifications .......................................................................................... 83 
2.8. Labelling of PcrA and Rep with maleimide-fluorophores ................... 84 
2.9. PcrA and PcrA mutant steady-state ATPase hydrolysis assay using 
fluorescent spectrophotometer ................................................................. 85 
2.10. DNA junction unwinding assay using stopped-flow apparatus ........ 86 
2.11. Plasmid unwinding assay on stopped-flow apparatus ..................... 87 
2.12. RepD nicking assay ........................................................................ 87 
2.13. Tests for fluorescent signals of labelled PcrAs ................................ 88 
2.14. DTNB assay .................................................................................... 88 
2.15. Size exclusion chromatography – multi angle light scattering (SEC-
MALS) ...................................................................................................... 89 
2.16. Stopped-flow apparatus set-up for fluorescence measurements .... 89 
2.17. Single molecule experiments .......................................................... 90 
2.17.1. Flow-cell preparation for TIRFM assays ................................... 90 
2.17.2. Total internal reflection microscope set-up ............................... 90 
2.17.3. Photobleaching and PcrA density measurements on the glass 
surface using TIRFM ............................................................................ 91 
2.17.4. Single molecule plasmid unwinding assay ............................... 93 
3. Results-Fluorescent species of PcrA and RepD ...................................... 95 
3.1. Introduction ....................................................................................... 95 
3.2. Fluorescent labelling of PcrA ............................................................ 98 
3.2.1. Fluorophore-labelled PcrA .......................................................... 98 
3.2.2. The effect of mutations and labelling on PcrA activity .............. 103 
3.2.3. MDCC-PcrA(K138C) activity in plasmid unwinding .................. 108 
 9 
 
3.3. Fluorescent labelling of RepD ......................................................... 112 
3.3.1. Fluorophore-labelled RepD wild type........................................ 112 
3.3.2. RepD N- and C-terminal cysteine mutants ............................... 114 
3.4. Discussion ....................................................................................... 116 
3.4.1. Fluorophore-PcrA adducts ........................................................ 116 
3.4.2. Fluorescently labelled RepD ..................................................... 117 
4. Results- PcrA binding and translocation on ssDNA ............................... 118 
4.1. Introduction ..................................................................................... 118 
4.2. MDCC-PcrA(K138C) binding to ssDNA .......................................... 119 
4.2.1. MDCC-PcrA(K138C) has different affinities and fluorescent states 
when binding to the middle or to the ends of ssDNA .......................... 119 
4.2.2. PcrA binding kinetics to ssDNA (kon) ........................................ 126 
4.2.3. PcrA dissociation kinetics from ssDNA ..................................... 131 
4.2.4. PcrA dissociation constant (Kd) for ssDNA ............................... 134 
4.3. PcrA translocation on ssDNA using MDCC-PcrA(K138C) .............. 136 
4.3.1. MDCC-PcrA(K138C) signal when translocating on ssDNA ...... 136 
4.3.2. PcrA translocates at different speeds on different deoxynucleotide 
sequences .......................................................................................... 141 
4.4. Discussion ....................................................................................... 147 
4.4.1. PcrA has different modes of binding to different parts of ssDNA
 ........................................................................................................... 147 
4.4.2. PcrA affinity to ssDNA using MDCC-PcrA(K138C) ................... 148 
4.4.3. PcrA translocation on ssDNA reported by MDCC-PcrA(K138C)
 ........................................................................................................... 150 
4.4.4. Summary .................................................................................. 153 
5. Results- PcrA interaction with the initiator protein RepD during plasmid 
unwinding .................................................................................................. 154 
5.1. Introduction ..................................................................................... 154 
5.2. MDCC-labelled PcrA(E449C) and signal on interaction with RepD, 
complexed with DNA .............................................................................. 155 
5.2.1. RepD interaction site on PcrA is on the top of the 2B domain .. 155 
5.3. The effect of ATP on PcrA binding to RepD-DNA complex ............. 166 
5.3.1. MDCC-PcrA(E449C)·ATP binding signal with RepD-DNA junction 
complexes .......................................................................................... 166 
5.3.2. MDCC-PcrA(E449C) binding signal to RepD-DNA junction 
complex when bound to non-hydrolysable ATP analogues ................ 171 
5.4. PcrA dissociation kinetics from RepD-DNA junction complex ......... 174 
5.5. Association kinetics of PcrA and RepD-plasmid complex ............... 176 
 10 
 
5.5.1. MDCC-PcrA(E449C)·ATP binding to the RepD-plasmid complex
 ........................................................................................................... 180 
5.6. PcrA dissociation kinetics from RepD-plasmid complex ................. 182 
5.7. PcrA affinity to RepD-DNA complex ................................................ 184 
5.8. MDCC-PcrA(E449C) and DNA unwinding ...................................... 185 
5.8.1. MDCC-PcrA(E449C) and DNA junction unwinding .................. 185 
5.8.2. PcrA DNA junction unwinding is processive ............................. 188 
5.8.3. MDCC-PcrA(E449C) and plasmid unwinding ........................... 189 
5.9. FRET signal with fluorophore labelled PcrA(E449C) and 
RepD(C225A, W310C) .......................................................................... 194 
5.10. Discussion ..................................................................................... 196 
5.10.1. RepD interacts with PcrA at the 2B domain ............................ 197 
5.10.2. MDCC-PcrA(E449C) biphasic signal when binding to RepD-DNA
 ........................................................................................................... 197 
5.10.3. PcrA·ATP binding to RepD-DNA complex in one conformation
 ........................................................................................................... 198 
5.10.4. PcrA affinity to RepD-DNA ..................................................... 199 
5.10.5. Investigation of PcrA unwinding DNA using MDCC-PcrA(E449C)
 ........................................................................................................... 201 
5.10.6. PcrA and RepD FRET pair ..................................................... 203 
5.11. Summary ....................................................................................... 203 
6. Results – Individual PcrA molecules unwinding plasmid DNA ............... 205 
6.1. Introduction ..................................................................................... 205 
6.2. Immobilisation of biotinylated PcrA for single molecule assays ...... 207 
6.2.1. Biotinylated PcrA and Cy3B-PcrA(E449C) ............................... 207 
6.2.2. PcrA and biotinylated PcrA are monomers in solution when 
applied to surface of PEGylated TIRFM flow cells .............................. 209 
6.2.3. Biotinylated PcrA surface density on PEGylated and streptavidin 
treated surface ................................................................................... 211 
6.2.4. Biotinylated PcrA is a monomer on the surface of the glass 
coverslip ............................................................................................. 216 
6.3. Individual PcrA helicases unwinding plasmid DNA, detected by TIRFM
 ............................................................................................................... 220 
6.3.1. Unwinding assay on TIRFM with pCERoriD 3094bp plasmid ... 220 
6.3.2. The plasmid unwinding assay enables observation of unwinding 
of plasmids short than 3 kb ................................................................. 228 
6.3.3. The 6642 bp plasmid unwinding cannot be observed in the 
plasmid unwinding assay on TIRFM ................................................... 233 
6.3.4. Amplitude dispersion of plasmid unwinding events is not affected 
by the Cy3B-bioPcrA(E449C) concentration ...................................... 236 
 11 
 
6.3.5. The addition of ATP to PcrA-RepD-plasmid complex initiates the 
unwinding instantly ............................................................................. 237 
6.3.6. Fate of plasmid complexes after completion of unwinding ....... 239 
6.4. Discussion ....................................................................................... 242 
6.4.1. PcrA is a monomeric helicase .................................................. 243 
6.4.2. Individual PcrA helicases unwinding complete plasmids .......... 244 
6.4.3. PcrA processivity ...................................................................... 246 
6.4.4. Fate of the plasmid after unwinding .......................................... 248 
6.4.5. Limitations of the single molecule plasmid unwinding assay .... 248 
6.4.6. Summary .................................................................................. 250 
7. Overall discussion ................................................................................. 252 
7.1. Production of fluorescently labelled PcrA and RepD to investigate 
their function in plasmid replication ........................................................ 252 
7.2. PcrA binding and translocation on ssDNA shows site and sequence 
specificity ............................................................................................... 253 
7.3. PcrA-RepD-DNA complex formation at the initiation of plasmid 
unwinding ............................................................................................... 255 
7.4. PcrA function in plasmid unwinding ................................................ 258 
7.4.1. In ensemble plasmid unwinding assays ................................... 258 
7.4.2. Plasmid unwinding at the single molecule level ........................ 259 
7.5. PcrA helicase – a passive helicase ................................................. 262 
7.6. Project continuation ........................................................................ 264 
8. References ............................................................................................ 267 
9. Appendix ............................................................................................... 278 
9.1. Chapter 4 Appendix ........................................................................ 278 
9.2. Chapter 5 Appendix ........................................................................ 286 
9.3. Chapter 6 Appendix ........................................................................ 295 
 
 
  
 12 
 
Table of Figures 
 
Figure 1. Cartoon representation of one of the replication forks of replication 
bubble during DNA replication. .................................................................... 19 
Figure 2. The RecA-like/AAA+ subdomains in monomeric and hexameric 
helicases. .................................................................................................... 22 
Figure 3. SF1 family helicase motifs. ........................................................... 24 
Figure 4. PcrA crystal structure with and without DNA and ATP-analogue. 26 
Figure 5. Model of PcrA translocation on DNA. ........................................... 28 
Figure 6. ATP hydrolysis models for hexameric helicases (SF3-SF6). ........ 30 
Figure 7. The different forms of plasmid replication. .................................... 34 
Figure 8. Initiation of ColE1 and RSF1010 plasmids. .................................. 37 
Figure 9. Asymmetric rolling circle replication of T181-family plasmids. ...... 40 
Figure 10. Initiation of plasmid unwinding at the origin of replication by RepD.
 .................................................................................................................... 41 
Figure 11. Jablonski diagram of absorbance, fluorescence and 
phosphorescence. ....................................................................................... 48 
Figure 12. Jablonski diagram for Förster resonance energy transfer. ......... 49 
Figure 13. Fluorescence anisotropy. ........................................................... 51 
Figure 14. Rapid mixing techniques. ........................................................... 57 
Figure 15. Protein binding kinetics measured using different concentration of 
the ligand. .................................................................................................... 62 
Figure 16. Single molecule paradigm. ......................................................... 64 
Figure 17. Single molecule assay methods. ................................................ 66 
Figure 18. DNA structures for MDCC-PcrA(K138C) ssDNA binding studies.
 .................................................................................................................... 78 
Figure 19. DNA junction structures and sequences for dsDNA unwinding and 
PcrA-RepD interaction studies. .................................................................... 79 
Figure 20. Stopped-flow set-up. ................................................................... 89 
Figure 21. Set-up of objective type lens TIRFM. .......................................... 91 
Figure 22. PcrA cysteine mutations on substrate bound PcrA structure. ..... 99 
Figure 23. 12% SDS-PAGE gel analysis of the fluorophore-labelled PcrA and 
RepD wild type. ......................................................................................... 100 
Figure 24. DNA junction unwinding assay. ................................................ 104 
Figure 25. PcrA steady-state ATP hydrolysis on ssDNA translocation 
measured using Pi biosensor. ................................................................... 107 
Figure 26. DCC-SSB plasmid unwinding assay......................................... 109 
Figure 27. PcrA wild type DCC-SSB plasmid unwinding assay. ................ 110 
Figure 28. MDCC-PcrA(K138C) DCC-SSB plasmid unwinding. ................ 111 
Figure 29. Thiol reactivity on wild type RepD dimer. .................................. 113 
Figure 30. SDS-PAGE gel of RepD nicking assay. .................................... 115 
Figure 31. Cartoon representation of PcrA structures showing the K138C 
location. ..................................................................................................... 119 
 13 
 
Figure 32. MDCC-PcrA(K138C) binding to ssDNA has different fluorescent 
states whether binding to the middle or the end of ssDNA. ....................... 121 
Figure 33. MDCC-PcrA(K138C) end binding signal is removed when ssDNA 
has no single stranded ends. ..................................................................... 123 
Figure 34. Binding kinetics of MDCC-PcrA(K138C) to dTmiddle DNA structures 
are dependent on the ssDNA length. ......................................................... 125 
Figure 35. MDCC-PcrA(K138C) binding to dT20 ssDNA. ........................... 127 
Figure 36. MDCC-PcrA(K138C) binding to dT6 ssDNA. ............................ 129 
Figure 37. MDCC-PcrA(K138C) binding to dT10 and dT50 ssDNA. ............ 130 
Figure 38. PcrA dissociation kinetics from ssDNA. .................................... 133 
Figure 39. MDCC-PcrA(K138C) signal in ssDNA translocation. ................ 137 
Figure 40. PcrA translocation rate on ssDNA. ........................................... 139 
Figure 41. MDCC-PcrA(K138C) translocation reaction is not affected by the 
ATP concentration in the range used. ....................................................... 140 
Figure 42. PcrA translocates faster on dC oligos than on dT oligos. ......... 142 
Figure 43. MDCC-PcrA(K138C) translocation on oligonucleotides with 
different base composition. ........................................................................ 144 
Figure 44. The location of E449C mutation on PcrA. ................................. 155 
Figure 45. MDCC-PcrA(E449C) signal when binding to RepD-DNA junction 
1. ............................................................................................................... 157 
Figure 46. MDCC-PcrA(E449C) binding to RepD-DNA junction/RepD/DNA 
junction. ..................................................................................................... 158 
Figure 47. MDCC-PcrA(E449C) signal with RepD-DNA junction 1 complex is 
observing its binding to the complex. ......................................................... 160 
Figure 48. MDCC-PcrA(E449C) binding signal to varying lengths of dT-arm 
on DNA junction 1. ..................................................................................... 162 
Figure 49. MDCC-PcrA(E449C) binding and unwinding a DNA junction 
lacking RepD nick sequence. .................................................................... 164 
Figure 50. MDCC-PcrA(E449C) binding to RepD-DNA junction 1 with ATP.
 .................................................................................................................. 168 
Figure 51. MDCC-PcrA(E449C)·ATP binding to RepD-DNA junction. ....... 170 
Figure 52. MDCC-PcrA(E449C) binding signal RepD-DNA junctions with 
non-hydrolysable ATP analogues. ............................................................. 173 
Figure 53. Displacement of MDCC-PcrA(E449C) from RepD-DNA junction 1 
to measure dissociation kinetics. ............................................................... 175 
Figure 54. PcrA binding to RepD-pCERoriD 3094bp complex. ................. 177 
Figure 55. PcrA binding to RepD-pCERoriD 2437bp complex. ................. 179 
Figure 56. ATP bound MDCC-PcrA(E449C) binding to RepD-plasmid 
complex. .................................................................................................... 181 
Figure 57. PcrA the dissociation rate constant (koff) from RepD-plasmid 
complex using MDCC-PcrA(E449C). ......................................................... 183 
Figure 58. MDCC-PcrA(E449C) and DNA junction unwinding of DNA 
junctions without ICRIII. ............................................................................. 187 
 14 
 
Figure 59. MDCC-PcrA(E449C) does not get displaced by unlabelled PcrA 
while unwinding DNA junction structures. .................................................. 188 
Figure 60. MDCC-PcrA(E449C) enables determination of PcrA unwinding 
rate on plasmid DNA. ................................................................................ 191 
Figure 61. MDCC-PcrA(E449C) and plasmid unwinding signal. ................ 193 
Figure 62. Emission spectra of MDCC-PcrA(E449C) and Cy3-RepD. ....... 195 
Figure 63. FRET signal on the stopped-flow with MDCC-PcrA(E449C) and 
Cy3-RepD. ................................................................................................. 196 
Figure 64. DCC-SSB plasmid unwinding assay of bioPcrA and wt PcrA. .. 208 
Figure 65. SEC-MALS of bioPcrA and wild type PcrA. .............................. 211 
Figure 66. Observation of individual Cy3B-bioPcrA(E449) on TIRFM. ...... 212 
Figure 67. Linear increase of Cy3B-bioPcrA(E449C) object numbers at 
loading concentration up to 0.2 nM. ........................................................... 213 
Figure 68. Cy3B-bioPcrA(E449C) on the flow cell surface. ....................... 214 
Figure 69. The relationship between ASPT objects count and fluorescence 
intensity. .................................................................................................... 215 
Figure 70. Cy3B-bioPcrA(E449C) photobleaching at constant laser power.
 .................................................................................................................. 218 
Figure 71. Cy3B-bioPcrA(E449C) is a monomer on the surface of the flow 
cell. ............................................................................................................ 219 
Figure 72. Plasmid unwinding assay visualised on TIRFM. ....................... 222 
Figure 73. Cy3B-SSB visualised plasmid unwinding of pCERoriD 3094bp 
plasmid under TIRFM. ............................................................................... 223 
Figure 74. Cy3B-SSB visualised plasmid unwinding of pCERoriD 3094bp 
plasmid using TIRFM. ................................................................................ 224 
Figure 75. Distribution of pCERoriD 3094 bp unwinding events. ............... 227 
Figure 76. Distribution of pCERoriD 2437 bp unwinding events. ............... 230 
Figure 77. Distribution of pCERoriD 3650bp unwinding events. ................ 232 
Figure 78. Distribution of pCERoriD 6642 bp unwinding events. ............... 235 
Figure 79. Distribution of plasmid unwinding start times (t0) with pCERoriD 
3094 with complete oriD sequence. ........................................................... 238 
Figure 80. Four major populations of different types of unwinding events 
used for clustering. .................................................................................... 241 
Figure 81. Model of PcrA conformation “locking” by ATP. ......................... 257 
Figure 82. Fits of MDCC-PcrA(K138C) binding to dT20. ............................ 278 
Figure 83. Fits of MDCC-PcrA(K138C) binding to dT6. .............................. 279 
Figure 84. Fits of MDCC-PcrA(K138C) binding to dT10. ............................ 280 
Figure 85. Fits of MDCC-PcrA(K138C) binding to dT50. ............................ 281 
Figure 86. Fits of MDCC-PcrA(K138C) displacement by wild type PcrA. .. 282 
Figure 87. Fits to wild type PcrA binding phase in MDCC-PcrA(K138C) 
displacement assay. .................................................................................. 283 
Figure 88. PcrA translocation rate at single molecule assay conditions. ... 284 
Figure 89. Fitting of MDCC-PcrA(K138C) translocation on random sequence 
oligos. ........................................................................................................ 285 
 15 
 
Figure 90. MDCC-PcrA(E449C) binding to RepD-DNA junction with varying 
dTarm lengths. ............................................................................................. 286 
Figure 91. MDCC-PcrA(E449C) binding kinetics to DNA junctions with dT6 
and dT10-arm without RepD. ...................................................................... 287 
Figure 92. MDCC-PcrA(E449C) binding to varying concentration of RepD-
DNA junction with and without ATP. .......................................................... 288 
Figure 93.  DNA junction (No ICRIII) bound to RepD. ............................... 289 
Figure 94. MDCC-PcrA(E449C) binding signal to DNA junctions without 
RepD-nicking site. ..................................................................................... 290 
Figure 95. Fits of MDCC-PcrA(E449C) displacement from RepD-DNA 
junction 1. .................................................................................................. 291 
Figure 96.Fits for MDCC-PcrA(E449C) and Cy3-RepD/Cy3-PcrA(E449C) 
and MDCC-RepD FRET measurements with DNA junction 1 (bound to 
RepD). ....................................................................................................... 292 
Figure 97. MDCC-PcrA(E449C) displacement assay traces from  RepD-
pCERoriD 3094 complex by wild type PcrA. .............................................. 293 
Figure 98. Photobleaching measurements of MDCC-PcrA(E449C) on 
stopped-flow instrument. ........................................................................... 294 
Figure 99. Extrapolation of Cy3B-bioPcrA(E449C) density on the flow cell 
surface. ...................................................................................................... 295 
Figure 100. Individual unwinding events of pCERoriD 3094 bp. ................ 296 
Figure 101. Absolute intensity change of the field of view during the 
recording. .................................................................................................. 298 
Figure 102. Distribution of unwinding events with 3094 bp plasmid with 
unlabelled bioPcrA. .................................................................................... 299 
Figure 103. ∆I and ∆t distributions of 3094 bp plasmid unwinding events with 
reduced Cy3B-bioPcrA(E449C) loading concentration. ............................. 300 
  
 16 
 
Table of Tables 
 
Table 1. PcrA cysteine mutations and their closest interactors according to 
substrate bound PcrA crystal structure. ..................................................... 100 
Table 2. The analysis of the quality of new fluorophore labelled PcrA 
mutants. ..................................................................................................... 102 
Table 3. DNA unwinding rates of labelled PcrA cysteine mutants and 
bioPcrA. ..................................................................................................... 105 
Table 4. Reaction rates of fluorophore labelled PcrAE449C, PcrAK138C and 
wild type PcrA. ........................................................................................... 107 
Table 5. DNA junction unwinding is not affected by labelling and mutations 
on RepD. ................................................................................................... 115 
Table 6. Rate constants and equilibrium binding constants for the interaction 
of PcrA with different lengths of ssDNA. .................................................... 135 
Table 7. Summary of PcrA translocation rate on different oligonucleotide 
sequences. ................................................................................................ 146 
Table 8. MDCC-PcrA(E449C) binding to DNA junction 1 and RepD. ........ 159 
Table 9. MDCC-PcrA(E449C) binding to DNA junction 1 with varying dT-arm 
lengths. ...................................................................................................... 163 
Table 10. MDCC-PcrA(E449C) binding signal to DNA junction +/- ICRIII and 
+/- CT*A. .................................................................................................... 165 
Table 11. PcrA binding rate constants (kon) for different DNA junctions and 
Rep-DNA junctions complexes, determined using MDCC-PcrA(E449C). .. 166 
Table 12. MDCC-PcrA(E449C) binding to RepD-DNA junction complex with 
ATP. .......................................................................................................... 169 
Table 13. MDCC-PcrA(E449C) binding to RepD-DNA junction complex and 
ATP and analogues. .................................................................................. 174 
Table 14. ATP bound MDCC-PcrA(E449C) binding to RepD-plasmid 
complex. .................................................................................................... 181 
Table 15. Summary of PcrA binding and dissociation kinetics with RepD-
DNA. .......................................................................................................... 184 
Table 16.Cy3B-bioPcrA(E449C) object density at saturating concentrations.
 .................................................................................................................. 216 
Table 17. Summary of photobleaching results of Cy3B-bioPcrA(E449C) on 
TIRFM. ...................................................................................................... 220 
Table 18. Single molecule plasmid unwinding assay with 3094 bp plasmid.
 .................................................................................................................. 228 
Table 19. Single molecule plasmid unwinding of 2437 bp, 3650 bp and 6642 
bp plasmids. .............................................................................................. 233 
Table 20. The mean t0 for different pCERoriD plasmids. ........................... 239 
Table 21. Clustering of single molecule plasmid unwinding events. .......... 242 
Table 22. Summary of PcrA translocation rates at different conditions and on 
different DNA. ............................................................................................ 263 
Table 23. Summary of single molecule plasmid unwinding event density 
analysis. .................................................................................................... 297 
1. Introduction 
 
17 
 
Introduction 
 
1.1. DNA replication 
 
 
All genetic material required for inheritance of any one character of an 
organism is carried as genes, which are made of deoxyribonucleic acid 
(DNA). DNA is formed of two polynucleotide chains made from four bases: 
thymine (T), adenine (A), cytosine (C) and guanine (G). These are paired 
with each other by hydrogen bonding to form a double helical structure. The 
A bases pair with T bases through two hydrogen bonds and the G bases pair 
with C bases through three hydrogen bonds (A·T and G·C base pairs). The 
structure of DNA was discovered by Watson and Crick in the 1950s [1, 2]. 
The base-pairing principle of DNA itself suggested how genetic material may 
be duplicated from one generation to the next by possible synthesis of the 
new strands from the two old strands [3]. Since the discovery of the DNA 
structure, the DNA replication was shown to be semiconservative, whereby 
the new DNA is formed from one old and one newly replicated DNA strand, 
in which the new strand has been copied from the old.  
 
DNA replication can be divided into three distinct phases, which are 
initiation, DNA synthesis and termination. All three steps require the 
replication machinery formed of specific proteins and enzymes (Figure 1). In 
bacteria, where the genomic DNA replication is best understood, DNA 
replication is initiated by multimeric origin-binding proteins that recognise a 
unique DNA sequence called the origin of replication. They bind to it and 
melt the double-stranded DNA (dsDNA). Most genomic DNA has multiple 
origins of replication, where the replication can be initiated simultaneously. 
Typically, the origins of replication are AT rich. This is thought to be a 
requirement for initiation to be energy efficient as the A·T base pairing has 
two hydrogen bonds whereas the G·C base pairs have three. Melting of DNA 
allows a helicase and other replication complex proteins to bind, unwind 
DNA, and start the synthesis of new complementary strands. In Escherichia 
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coli, the origin of replication is DNA segment of ~240 bp called oriC.  The 
oriC is recognised by DnaA protein, which facilitates the initial melting of 
dsDNA. The further separation of dsDNA is performed by a hexameric ring 
helicase, DnaB. DnaB helicase utilises ATP to move on DNA in a 5’-to-3’ 
direction. The replication starts on both strands’ in 5’-to-3’ direction forming a 
replication bubble. Figure 1 shows one side of the replication bubble. Similar 
process takes places on the other side of replication bubble. This means that 
the genomic DNA replication is bidirectional. A topoisomerase enzyme 
moves in front of the replication fork removing the supercoiling of the DNA. 
Single-stranded DNA binding protein (SSB) binds the single-stranded DNA 
(ssDNA), produced by the helicase, to prevent them from reannealing or 
forming secondary structures. RNA polymerases called primases synthesise 
~10 nucleotide RNA primers of for DNA polymerases.  All DNA polymerases 
are able to only synthesise DNA in 5’-to-3’ direction and require a primer with 
a free 3’ end of DNA to begin the synthesis of the new daughter strands. The 
leading strand synthesis requires only one primer. The replication of lagging 
strand runs in an opposite direction (Figure 1) and is synthesised 
discontinuously in segments due to DNA polymerase property of 
synthesising DNA only 5’-to-3’ direction. Hence, lagging strand synthesis 
requires many primers. The DNA segments produced in lagging strand 
synthesises are called Okazaki fragments. The Okazaki fragments are 
between 1000 to 2000 bases long in E. coli and in comparison to eukaryotes 
these are longer as the Okazaki fragments are 100 to 200 bases long in 
eukaryotes [4, 5]. In E. coli, the leading and lagging strands are primarily 
synthesised by DNA polymerase III. The RNA primers are removed and the 
gaps are filled by the DNA polymerase I as it also has 5’-to-3’ exonuclease 
activity. The Okazaki fragments are then joined together by DNA ligase.  
 
Most of the early information of DNA replication comes from work 
done in bacteria such as E. coli and the eukaryotic DNA replication, which is 
significantly more complex, contains all the components mentioned here for 
bacterial replication. For example, the eukaryotic DNA polymerases α and δ 
correspond to bacterial DNA polymerases I and III. The unravelling of DNA 
replication machinery through research is a great example of how bacterial 
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work has simplified the study of an essential process taking place in all 
organisms.  
 
 
Figure 1. Cartoon representation of one of the replication forks of 
replication bubble during DNA replication. 
Cartoon shows one of the replication forks in replication bubble during DNA 
replication. The DNA polymerase III (turquoise sphere) is the main 
replicative polymerase moving in 3’-to-5’ direction. The components ssDNA 
strands of the dsDNA are separated by DNA helicase (blue hexamer), which 
moves in 5’-to- 3’ direction on the ssDNA. Primase (orange oval shape) 
synthesises RNA primers that enable the DNA polymerase III to synthesise 
the leading and the lagging strand. Lagging strand synthesis requires 
multiple primers and is replicated in sequences called Okazaki fragments. 
The RNA primers are removed by DNA polymerase I using its endonuclease 
activity and the gap is filled by the 5-to-3’ polymerase activity of the same 
enzyme. The fragments produced are ligated together by DNA ligase. 
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1.2. DNA and RNA helicases  
 
 
This thesis investigates and discusses the function and biochemical 
characteristics of a bacterial DNA helicase, PcrA, belonging to superfamily I. 
Helicases are ubiquitous enzymes found in bacteria to multicellular 
eukaryotes, and are also encoded by viral genomes. They are involved in 
most of the cellular functions involving nucleic acid processing such as DNA 
replication, recombination, repair and transcription. Helicases are NTP-
driven enzymes, able to separate dsDNA into single strands. Helicases are 
divided into six superfamilies (SF1 to SF6) according to their sequence 
similarity, structure and function [6]. More broadly, helicases are divided in 
are to two groups based on their structure. These are the monomeric (albeit 
some active as dimers) or hexameric helicases. Helicases can also be 
classed depending on whether they translocate on ssDNA or dsDNA. Most 
helicases function as part of larger molecular machines such as the DNA 
replication machinery, which includes initiator proteins, DNA polymerases 
and SSB [6, 7]. These proteins may interact directly with the helicase or the 
interaction may be facilitated or stabilised by DNA or other accessory 
proteins, which may also affect the activity or functionality of the helicase.  
 
  In humans, helicases have been found to be involved in many 
disorders such as Werner syndrome, Bloom’s syndrome and Rothmund-
Thomson syndrome [8-10]. These disorders are caused by faults in the 
function of the RecQ family helicases (belonging to SF2) that are vital in 
genome stability from microorganisms to higher eukaryotes [10-12]. Many of 
the diseases involving helicases show increased cancer rates, which can be 
expected as many of the helicases function in DNA replication and repair 
[13, 14]. This is the case with Werner and Bloom’s syndromes patients, who 
have a predisposition to sarcomas and premature aging. 
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1.2.1. Structural similarities between the six helicase superfamilies 
 
  
The mechanisms of DNA translocation and unwinding may vary 
considerably between the different helicase superfamilies. However, there 
are several fundamental features shared by all helicases [6], the main 
requirement being the actual ability to unwind DNA. The structural 
similarities are mainly contained in their ATPase core structure and 
sequence, which resemble the RecA ATPase core that has RecA-like/AAA+ 
domain, which plays an important role in energy transduction of converting 
ATP hydrolysis to movement [6, 15]. RecA protein is a DNA translocase 
protein, which couples ATP hydrolysis to binding and formation of filaments 
on ssDNA [16]. Many enzymes with DNA translocation activity have high 
structural resemblance to RecA and so are named RecA-like. AAA+ stands 
for the ATPases Associated with various cellular Activities domain, which 
also include the classical Walker A (motif I) and B (motif II) motifs involved in 
ATP hydrolysis. These motifs interact with the Mg·ATP/ADP. The Walker A 
motif is classically defined as a GxxxxGKT/S [17], whereby the amino group 
of lysine interacts with phosphates of Mg·ATP/ADP and the hydroxyl group 
of threonine ligates the Mg2+ ion. 
 
The RecA central ATPase domain consists of twisted beta sheet with 
several β-strands joined by α-helices [18].The number of ATP-hydrolysing 
domains varies between the monomeric/dimeric and hexameric helicases. 
Figure 2 shows a cartoon presentation of the structures of monomeric and 
hexameric helicases and gives examples of individual helicases belonging to 
each type. Monomeric/dimeric helicase have two RecA-like/AAA+ 
subdomains in each monomer/subunit (SF1 and SF2 helicases) [19-28], 
whereas hexameric helicases have one RecA-like/AAA+ subdomain per 
subunit (SF3 to SF6 helicases) [6, 29-35].  
The presence of a RecA-like/AAA+ subdomain in an enzyme is not 
the only requirement for correct classification of a DNA binding enzyme as a 
helicase. Initially, many DNA translocases containing RecA-like/AAA+ motifs 
were grouped as helicases. However, these enzymes lack the DNA 
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unwinding function and are not true helicases [6]. Many of the known 
helicases also contain the ‘arginine finger’ on one of the RecA-like 
subdomains (motif IV) [15]. PcrA helicase has been used as to demonstrate 
how this arginine finger plays an important role in the ATP hydrolysis by 
interacting with γ phosphate of the ATP [21, 36]. The release of the γ 
phosphate from the arginine after the hydrolysis leads to separation of the 
motor domains (1A and 2A domains). This is vital step for the PcrA 
movement and for the DNA strand displacement or DNA duplex 
destabilisation. 
 
Figure 2. The RecA-like/AAA+ subdomains in monomeric and 
hexameric helicases.  
The RecA-like/AAA+ domains couple the nucleotide hydrolysis to movement 
on DNA in all helicases and DNA translocases The monomeric/dimeric 
helicases have two RecA-like/AAA+ subdomains per subunit, whereas the 
hexameric helicases have one RecA-like/AAA+ subdomain per subunit. The 
direction of the DNA translocation isn’t shown in this diagram as this varies 
between helicases. *1, indicates the approximate location of the Walker A 
(motif I) and the Walker B (motif II) motifs on the AAA+ domains. The Walker 
B motif interacts with the Mg2+ ion required for ATP hydrolysis. *2, indicates 
the location of the motif IV (arginine finger). [6, 19-23, 25-34] 
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1.2.2. Superfamily 1 and 2 helicases and PcrA-SF 1 helicase 
  
The superfamily 1 helicases together with those from superfamily 2 
are the largest and the most extensively studied groups of helicases. The 
oligomeric state of SF1 and SF2 helicases has been disputed in the past but 
generally they are considered to be monomeric or dimeric and all have some 
form of DNA translocation functionality as a monomer [6, 37-41]. The large 
number of known SF2 helicases reflects the large number of cellular 
processes they are involved in. A well characterised example of SF2 
helicases is the non-structural protein 3 (NS3) helicase of the hepatitis C 
virus that unwinds RNA-DNA duplexes. The crystal structure of the NS3 
helicase showed a three domain structure with two RecA-like domains, 
equivalent to the 1A and 2A domains of SF1 helicases, which form a 
nucleotide binding pocket between them and function as motor domains [23, 
24]. The two RecA-like domains and the third core domain together form a 
groove for ssDNA binding. The NS3 has also been crystallised in complex 
with SSB protein on a ssDNA template indicating possible direct interaction 
of the two proteins [23].  
 
E. coli helicases UvrD and Rep also belong to SF1 and share high 
structural and functional similarity with PcrA. Due to their sequence and 
structural similarity, they are often used as a comparison for PcrA. UvrD and 
Rep both have the same domains as PcrA and go through similar structural 
changes when binding to DNA (Figure 3) [19, 20]. The sequence similarity 
between PcrA and UvrD is 42% and 37% between PcrA and Rep [19] SF1 
family helicases share many defined motifs that are not found in other 
superfamily helicases [19, 20, 42-45]. They can translocate unidirectionally 
either in the 3-to-5’ or 5-to-3’ direction. Figure 3 shows the conserved 
sequence motifs of SF1 helicases and the alignments of these motifs on the 
substrate bound ‘closed’ conformation of UvrD. This figure also includes the 
closest known eukaryotic helicase to PcrA, the Srs2 helicase from 
Saccharomyces cerevisiae [43]. Most of the conserved sequence motifs are 
in domains 1A and 2A, which are the motor domains of SF1 and many other 
helicases. They facilitate the conversion of energy from ATP hydrolysis into 
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movement on ssDNA and unwinding of dsDNA. These include the already 
mentioned Walker A and B domains and the motif IV, the ‘arginine-finger’ in 
the Section 1.2.1. Also, further conserved motifs are found in dsDNA and 
ssDNA binding sites in domains 2B and 1B. The motif IVa is unique to SF1 
helicases and contains conserved binding sites for ssDNA [44]. 
 
 
Figure 3. SF1 family helicase motifs. 
Sequence alignment displaying motifs of the most studied SF1 helicases, 
and motifs displayed on UvrD 3D structure (The sequence colours match the 
colours on the structure). ATP is highlighted by a square around it. Motif I is 
the Walker A motif and motif II is the Walker B motif, which interacts with the 
Mg2+ ion (black sphere). The motif IV contains the highly conserved “arginine 
finger” required for ATP hydrolysis. Adapted from Lee et al. (2006) Cell 
127(7):1349-1360. [19]. 
 
PcrA (plasmid copy number reduction A), a member of the SF1 
helicases, is the main focus of this project. PcrA is an essential protein found 
in Gram-positive bacteria [46-50]. PcrA and other SF1 helicases were 
determined to have a four subdomain structure by X-ray crystallography [19, 
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21, 22, 44]. The domains are named 1A, 2A, 1B and 2B and are shown in 
Figure 4 [22, 36]. Similarly to other helicases, PcrA uses ATP to translocate 
on ssDNA and unwind dsDNA [51]. The binding site for ATP is in a cleft 
between domains 1A and 2A. The crystal structures of PcrA bound to a non-
hydrolysable ATP analogue, AMP PNP, and apo PcrA indicate a ~30° 
conformational change where the 1A and 2A domains come together, thus 
“trapping” the nucleotide. The 1A and 2A domains are responsible for ATP 
hydrolysis and coupling of the hydrolysis to movement on DNA. They are 
often called the motor domains and share structural similarity with RecA-like 
proteins and functional similarity with other ATPases [52] as discussed in the 
previous section.  
 
 The PcrA binding to DNA leads to ~140° rotation of the 2B domain 
over the 1B domain (Figure 4). Often the apo PcrA state in the crystal 
structure is called the “open” form and the folded state in the substrate 
bound crystal structure is called the “closed” form. The ssDNA interacts with 
PcrA at the surfaces on 1A, 2A and 1B domains, and 2B subdomain also 
has a possible dsDNA interface.  
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Figure 4. PcrA crystal structure with and without DNA and ATP-
analogue. 
A) PcrA at the ‘open’ conformation without substrates. B) PcrA structure 
when bound to ATP and DNA, ‘closed’ conformation. The DNA duplex (red) 
has 3’ ssDNA overhang for PcrA binding. When the PcrA binds the DNA 
duplex, the 2B domain folds over 1B domain causing a ~140° rotation 
change. The ATP analogue is AMP PNP. The coordinates for the image 
were taken from PDB files 1PJR and 3PJR and visualised using PyMol 
(http://www.pymol.org/). 
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1.2.3. PcrA DNA translocation model 
 
 
PcrA translocates in 3’-to-5’ direction on ssDNA by the model shown 
in Figure 5, which was deduced from the available crystal structures for PcrA 
[36, 53, 54]. The model proposes that a monomer of PcrA moves along DNA 
by changes in a series of base-binding pockets across the protein, using one 
ATP per base moved/unwound. ATP hydrolysis and the movement on 
ssDNA are facilitated by the 1A and 2A domains closing and opening 
(tightening and loosening the grip) on ssDNA (Figure 5B). The movement of 
the PcrA destabilises the DNA fork junction and so separates the dsDNA 
(The active and passive movement of helicases is introduced in Section 
1.2.5).  Before ATP binding the 1A domain has tighter binding to ssDNA and 
1A and 2A domains are further apart. The ATP binding to PcrA causes the 
1A and 2A subdomains becoming closer together and 2A subdomain tighter 
binding to ssDNA. ATP hydrolysis to ADP leads to separation of 1A and 2A 
domains apart and PcrA is held on the DNA by the tighter binding by 1A 
domain. This leads to PcrA moving one base forward in 3’-to-5’ direction on 
ssDNA [55, 56].   
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Figure 5. Model of PcrA translocation on DNA. 
A) Crystal structure of substrate bound PcrA. B) PcrA 1A and 2A subdomain 
structural movements coupled to movement on ssDNA. In this model, one 
ATP is hydrolysed per base moved/unwound. The eclipses represent the 
tightening and loosening of the grip of PcrA 1A and 2A domains on ssDNA. 
C) Individual residues indicated to interact with the bases of the ssDNA. [36] 
 
1.2.4. Helicase superfamilies 3 to 6 
 
All SF3 to SF6 helicases are ring-shaped hexamers or double-
hexamers (12 subunits) [6]. Each subunit contains one RecA-like/AAA+ 
containing domain with one ATP binding pockets. The individual subunits 
have negative co-operativity in binding and hydrolysing ATP. Several models 
have been suggested for the ATP hydrolysis from highly ordered to 
stochastic or random ATP hydrolysis [6]. Figure 6 shows several suggested 
ATP hydrolysis models for hexameric helicases.  Generally, the hexameric 
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helicases translocate and unwind DNA faster than monomeric helicases. SF3 
helicases have four conserved motifs and all translocate in 3’-to-5’ direction.  
An example of a SF3 helicase is the human papilloma virus E1 that has been 
crystallised in complex with DNA and ADP [57].  This structure has given 
clues to how ring-shaped helicases may couple ATP hydrolysis with the 
translocation on DNA, as all six subunits had a nucleotide bound, but three 
different conformations were present. This indicated a possible sequential-
block ATP hydrolysis model, where the ATP bound subunits are adjacent to 
each other forming “a block”. This block then moves sequentially around the 
hexamer ring as the ATP hydrolysis is coupled to movement on ssDNA 
resulting in unwinding of dsDNA.  
  
1. Introduction 
 
30 
 
 
Figure 6. ATP hydrolysis models for hexameric helicases (SF3-SF6).  
A) Sequential-alternating model, where opposite subunits are hydrolysing 
ATP synchronously to each other whereas B) Sequential-block, where the 
subunits are synchronised in block in terms of their ATP hydrolysis cycle. C) 
Concerted model, where all subunits are hydrolysing ATP synchronously. D) 
Stochastic where the subunits hydrolyse ATP random order. E) F1-ATPase 
like where only every second subunit is hydrolysis ATP. 
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SF4 helicases all translocate in 5’-to-3’ direction and share five 
conserved sequence motifs (H1, H1a, H2, H3 and H4) of which H3 and H4 
are SF4 specific [6]. The H1 and H2 motifs are equivalent to the Walker A 
and B motifs also found in SF3 helicases. These motifs are vital for 
interaction with the nucleotide. The most extensively studied SF4 helicase is 
the bacteriophage T7 gp4 helicase for which an atomic-resolution structure 
exists [58]. T7 gp4 has primase and helicase domains connected by a linker. 
T7 gp4 has been suggested to hydrolyse ATP sequentially by alternating the 
subunits with ATP, ADP and empty [32]. SF5 helicases are closely related to 
SF4 helicases. Example of superfamily 5 helicases is the Rho helicase that is 
responsible for transcription termination in bacteria by unwinding the RNA 
from RNA-DNA duplexes.  
 
 SF6 helicases include the minichromosome maintenance (MCM) 
protein complex that is thought to be the main replicative helicase in 
eukaryotes. The MCM2-7 complex has been shown to be essential for 
replication initiation and elongation [6, 59]. Crystal structures of the 
eukaryotic MCM helicase domain have not been obtained and most structural 
information is from archaeal MCM that differs from the eukaryotic MCM by 
being a homohexamer. Eukaryotic MCM is formed of heterohexamers made 
up of related, but not identical polypeptides.  
 
1.2.5. Helicase movement on DNA 
 
When studying a helicase at biochemical level several aspects of its 
movement on DNA are important [6]. These include rate, directionality, 
processivity, step size and whether helicase unwinds DNA actively or 
passively. The rate is a measurement of the speed the helicase moves on 
ssDNA, which is called translocation on ssDNA (bases s-1) or the 
measurement of the rate of DNA strand separation (base pairs s-1). These 
rates may vary for different helicase and can be affected by interaction with 
accessory factors. Both, translocation and unwinding rates may be tightly 
coupled to the ATPase rate. Helicase movement on DNA is usually 
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unidirectional, proceeding in either the 3΄-to-5΄ or 5΄-to-3΄ directions. The 
directionality of helicase can be changed or restricted by the interaction with 
accessory factors such as other proteins. Helicase step size is a measure of 
the number of base pairs the helicase moves during single catalytic cycle. 
This is often seen as the movement during single ATP hydrolysis cycle. 
Processivity of helicases is a measure of how many bases helicase can 
unwind before stalling or dissociating from DNA. This can vary greatly 
between helicases from few base pairs to thousands of base pairs. 
Processivity can also be improved by helicase interaction with other proteins 
or specific DNA sequences. 
 
 
Another fundamental question concerning a helicase mechanism is 
whether it separates dsDNA into ssDNA by actively or passively breaking the 
base pairing. In an active mechanism, helicase movement forces the two 
strands apart, for example, using a wedge domain coupled to ATP hydrolysis 
that produces a combination of force and movement [60]. In a passive 
mechanism, thermal fluctuations in the degree of pairing at of the dsDNA 
fork allow the helicase to translocate; hence, the helicase must await 
fortuitous separation, which may slow its progress. Comparison of helicase 
properties when moving along dsDNA compared with those when it moves 
along ssDNA have been proposed [61] as a way to determine to what extent 
unwinding is an active process or a passive ‘by-product’ of the translocation 
mechanism [60]. According to this model, helicases that have similar rates of 
unwinding dsDNA and translocation on ssDNA are considered active, 
whereas those with slower unwinding rates on dsDNA than ssDNA 
translocation rates are termed passive. In practice, it would be expected that 
a range of intermediate levels is also likely. An example of a helicase that 
has been considered essentially optimally active is Dda belonging to the SF2 
helicases [62]. Dda has been shown to have the rate of unwinding (Vun) of 
257 +/- 42 bp s-1 and the rate of ssDNA translocation (Vtrans) of 267 +/- 
15 nt s-1. These give a value of 0.96 for the Vun/Vtrans. For optimally active 
helicases the Vun/Vtrans value is close to 1, whereas helicases with the 
Vun/Vtrans value close to 0 are seen as passive helicases.  
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1.3. Replication of circular bacterial plasmids 
 
Plasmid replication and control of its frequency are important for 
maintaining a stable copy number of plasmids in the host cell [63, 64]. If 
plasmids are replicated too frequently, the high requirement of substrates 
and energy will become a burden and result in a slower growing and weaker 
host cell. If the plasmid replication is infrequent and slow, the plasmids may 
be lost entirely from the host or its daughter cells at cell division. This may 
result in plasmid-containing cells being be outgrown by plasmid-free 
bacteria, leading to loss of often beneficial genetic properties such as 
antibiotic resistance genes [63]. The plasmid replication processes have 
been divided into three main types, which are theta replication, strand 
displacement and rolling circle plasmid replication [64]. Irrespective of the 
exact mechanism, replication occurs in three stages - initiation, extension 
and termination. Theta and strand displacement replication initiations involve 
opening of the strands, followed by RNA priming and can be uni- or 
bidirectional, but both form a replication bubble, which is visible under 
electron microscopy as theta-like structures [65]. The rolling circle replication 
is asynchronous and the initiation of replication involves cleavage of one of 
the DNA strands to generate a 3′-OH end typically resulting in a 
unidirectional replication (Figure 7). 
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Figure 7. The different forms of plasmid replication. 
A) Bidirectional plasmid replication. Theta replication may be unidirectional 
or bidirectional depending on the plasmid in question. B) Unidirectional 
rolling circle plasmid replication. The nicked strand is the (+)-strand.  
 
 
Theta plasmid replication mechanism involves melting of the 
complementary strands at the origin of replication, synthesis of RNA primer 
and initiation of the DNA synthesis covalently from the primer [64]. It is 
common in Gram-negative bacteria but has also been found in Gram-
positive bacteria. The synthesis by theta mechanism can be bidirectional, but 
in most cases it is unidirectional. When In unidirectional replication, the 
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leading strand is replicated continuously without the discontinuous 
replication of the lagging strand. Opening of the strands is catalysed by 
specific initiators (Rep and DnaA proteins) and/or by transcription by RNA 
primer. The plasmid unwinding is performed by the main replicative helicase 
such as DnaB in E. coli. Termination of theta replication is often achieved by 
sequences specific DNA-protein complexes. One of the most extensively 
studied examples of the theta replication is the ColE1 replication in E. coli 
(Figure 8A). ColE1 replication requires melting of the ori sequence, which 
requires DNA polymerase I, RNA polymerase and RNAse H and synthesis of 
a RNA primer DNA gyrase and topoisomerase (Figure 8A)[64, 66-68]. ColE1 
plasmid has a copy number control mechanism (~20 copies per cell), which 
involves two RNA substrates, RNAI and RNAII, and Rop (or Rom) protein. 
RNAII is a primer RNA (over 500 bases), which is nicked by the RNase H to 
generate the free 3’-OH group required by the DNA polymerase for the 
synthesis of a new complementary strand. The RNAI is shorter (~108 bases) 
with complementary sequence with RNAII. Its binding to RNAII prevents the 
initiation of replication by prevention of RNAII binding to ori. The RNAI-RNAII 
complex is further stabilised by Rop protein binding. Many other plasmids 
are also known to replicative by theta mechanism including the R1, pAMβ1, 
ColE2 and ColE3 plasmids [64, 69, 70]. They all require a Rep initiator 
protein encoded from the plasmid, but may also use many of the 
components of the genomic DNA replication. 
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Figure 8. Initiation of ColE1 and RSF1010 plasmids.   
A) Initiation of ColE1 plasmid replication and control of plasmid copy 
number. ColE1 plasmid number is tightly controlled by the presence of RNAI 
and RNAII and their interaction. If RNAII is transcribed and cleaved by 
RNase H, it can initiate the replication by providing a primer for the DNA 
polymerase I.  If RNAI is transcribed at high concentrations it will bind to 
RNAII, forming an RNAI-RNAII complex. This complex is stabilised by Rop 
protein, preventing the RNAII from initiating the replication. If RNAI 
concentration is low, RNAII is free to initiate plasmid replication. B) Initiation 
of RSF1010 plasmid replication. This requires three plasmid encoded 
proteins, RepA, RepB and RepC. RepC melts the dsDNA at the iterons. 
RepA unwinds the dsDNA throughout the process of plasmid replication. The 
exposure of ssiA and ssiB elements as ssDNA enables RepB priming for 
processive plasmid replication. 
 
Strand displacement plasmid replication has been mostly studied in 
IncQ (incompatibility group Q) plasmids such as the RSF1010 plasmid in E. 
coli [64]. The replication requires three plasmid encoded proteins, RepA 
helicase, RepB primase and RepC initiator protein (Figure 8B) [64, 65, 71]. 
The origin of replication of the RSF1010 plasmid contains iterons with self-
complementary sequences, AT-rich sequence, GC-rich sequence and ssiA 
and ssiB elements. The initiation of replication of RSF1010 starts by the 
RepC binding to the iterons and AT-rich sequences preceding the iterons. 
RepC together with RepA melt the dsDNA. The ssiA and ssiB function as a 
priming region and once exposed as ssDNA are primed by the RepB. These 
primers are then used by DNA polymerase III to bidirectionally synthesise 
the complementary DNA strands. The RepA helicase is responsible for the 
unwinding of the entire plasmid and functions in the 5’-to-3’ direction. The 5’-
to-3’ direction movement by RepA implies that it unwinds while being bound 
to the displaced strand. As the three initiator proteins are plasmid encoded, 
the host RNA polymerase and other components of the DNA replication 
machinery are not required. This makes the RSF1010 a rather promiscuous 
plasmid and enables it to possess a broad host range. The termination of 
strand displacement replication is achieved by specific DNA-protein 
interactions. 
 
The third type of plasmid replication is the rolling circle replication, 
which is the subject of study in this thesis [64, 72]. Rolling circle replication is 
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asymmetric, whereby the leading and lagging strand are synthesised one 
after the other. The rolling circle replication was discovered as the replication 
mechanism of ssDNA phage genomes of ϕX174 and M13, which are both 
native to E. coli [73]. The significant differences for the rolling circle 
replication as compared to theta and strand displacement replication are the 
RNA priming requirement for the latter two and the strictly unidirectional DNA 
synthesis of rolling circle replication. In rolling circle replication, the DNA 
unwinding is performed by a helicase that is not the primary replicative 
helicase. For example, the replicative helicase in Bacillus subtilis is DnaC 
helicase and the T181-family plasmids are unwound by the PcrA helicase 
[50, 74]. Rolling circle replication has been identified in various Gram-
positive and Gram-negative bacteria as well as Archaea [75-77]. In E. coli for 
example, UvrD helicase dependent plasmid replication applies the rolling 
circle mechanism [78], which uses the nicked free 3’-OH end of the lagging 
strand for DNA polymerase III synthesis of the leading strand of T181-family 
plasmids. The termination is not well understood, but requires sequence 
specific DNA-protein complex formation. The focus of this work is the 
function of PcrA helicase in the replication of pT181 and pC221 plasmids 
through asymmetric rolling circle replication (discussed further in the next 
section). 
 
1.4. PcrA function 
 
1.4.1. Asymmetric rolling circle plasmid replication and PcrA 
 
PcrA helicase is responsible for DNA unwinding in asymmetric rolling 
circle plasmid replication of T181-family plasmids that carry antibiotic 
resistance genes in Gram-positive bacteria [47, 64]. Figure 9 summarises 
this replication by PcrA and initiator protein Rep. Asymmetric replication 
means that the (+)-strand and the (-)-strand of the plasmid are not copied 
simultaneously. Here, the leading strand refers to the strand that is 
replicated first using the parental (-)-strand as a template. The lagging strand 
synthesis refers to replication second strand using the parental (+)-strand as 
a template. PcrA was discovered in Staphylococcus aureus where a 
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conditional mutation of the pcrA gene led to a reduction in plasmid copy 
number [79, 80]. Plasmid replication by PcrA requires a dimeric initiator 
protein Rep encoded by the plasmid DNA. In these studies the Rep initiator 
protein is the RepD from S. aureus carried by the pC221 plasmid in vivo [72]. 
Rep nicks dsDNA at a specific sequence in the double stranded origin (DSO) 
called ori [81-83] (Step 1, Figure 9). The origin of replication for RepD, OriD, 
is formed of three inverted complementary repeats (ICRI-III) (Figure 10A). 
Rep makes a single-stranded nick on the (+)-strand and binds the nicked 5’ 
end of the DNA strand by forming covalent bond at the tyrosine residue of 
one of the monomers of the dimer (Figure 10B). The nicking reaction and 
bond formation is achieved by a series of transesterifications, where the 
phosphodiester bond between bases is broken and another is formed 
between the 5’end of DNA and the active tyrosine on Rep. This releases 
supercoiling and opens a section of ssDNA to which PcrA can bind and 
begin unwinding the dsDNA (Step 2 and 3, Figure 9). Rep binding and 
nicking is highly sequence specific and Rep is only able to initiate one round 
of plasmid replication as it dissociates in an inactive form at the end of 
plasmid replication [84, 85]. Rep remains part of the replication complex until 
the whole plasmid is unwound [82]. While PcrA unwinds the plasmid, the 
leading strand is simultaneously replicated by a DNA polymerase III reading 
the (-)-strand (Step 4, Figure 9). Once the replication machinery reaches the 
DSO, Rep recognises it and terminates leading strand elongation. This leads 
to dissociation of PcrA and DNA polymerase III (Step 5, Figure 9). Rep 
performs strand exchange through a series of transesterifications that result 
in a complete plasmid, which is supercoiled by DNA gyrase [86](Step 6, 
Figure 9). Rep dissociates in an inactive form with a covalently bound small 
ssDNA left from the strand exchange [84].  
 
The lagging strand is replicated by DNA polymerase from the SSO 
using the (+)-strand as a template (single strand origin of replication). During 
leading strand synthesis (template (-)-strand), the (+)-strand is protected by 
SSB proteins. This project uses the S. aureus Rep protein called RepD and 
Bacillus stearothermophilus PcrA, which are able unwind plasmid lengths of 
DNA in vitro [87]. 
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Figure 9. Asymmetric rolling circle replication of T181-family plasmids. 
1. RepD sequence specific loading onto the DSO of the supercoiled plasmid. 
2. RepD nicks the oriD sequence releasing the super coiling and forms a 
covalent bond to the 5’ end of the (+)-lagging strand. 3. PcrA and DNA 
polymerase III are recruited to the replication complex. They both bind to, 
and translocate on, the (-)-strand. 4. Leading replication: PcrA unwinds 
dsDNA followed by DNA polymerase III. The single stranded (+)-strand is 
covered by SSB proteins (small cyan spheres). 5. Once the replication 
complex reaches the DSO it replicates a few bases over the DSO and RepD 
performs the strands exchange. PcrA and DNA polymerase III dissociate 
from the complex. The leading (-)-strand replication is completed and 
inactive RepD is released.  6. The lagging (+)-strand is synthesised from a 
SSO by a DNA polymerase I. The complete daughter plasmids are 
supercoiled by DNA gyrase. 
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Figure 10. Initiation of plasmid unwinding at the origin of replication by 
RepD.  
A) OriD sequence and its postulated secondary structure. B) RepD nicking 
reaction and covalent bond formation with DNA. RepD nicking includes a 
transesterification where on phosphodiester bond is broken between the 
DNA bases and another one is formed between the 5’end of nicked DNA 
and reactive tyrosine (Tyr-188) of the RepD. [85, 86] 
 
1.4.2. In vitro studies of the molecular motor PcrA and initiator protein 
RepD 
 
PcrA is one of the most studied helicases and its function has been 
investigated in detail, but a proven model for DNA unwinding has been hard 
to produce [6, 7, 36, 49]. Most evidence supports the idea that PcrA is 
functional as a monomer, but it has been suggested that it may function as 
dimer [37]. The main mechanistic functions of PcrA are ATP hydrolysis, 
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translocation on ssDNA and unwinding of dsDNA [51, 54]. PcrA is not known 
to bind dsDNA without a ssDNA overhang and is only able to translocate on 
ssDNA. The in vitro ssDNA translocation rate has been shown to be 
~80 bases s-1 at 20°C and it hydrolyses 1 ATP per base translocated [51]. 
 
In vitro experiments show that PcrA cannot unwind even short DNA 
duplexes on its own and requires the presence of initiator protein RepD for 
processive DNA unwinding [83, 87, 88]. The compatibility of RepD and PcrA 
has been suggested as one of the regulating factors for the spread of 
antibiotic resistance carrying plasmids between bacterial species. Hence, 
probing this interaction may further our understanding of plasmid replication 
and the spread of antibiotic resistance in bacteria. The interaction surfaces 
between PcrA and RepD is not known. As has been shown using the 
plasmid unwinding assay developed in the Webb lab, PcrA and RepD are 
able to unwind plasmid lengths of dsDNA as long as ATP is present [87, 89]. 
The rate of plasmid unwinding in these experiments is ~30 bp s-1 at 30°C. 
The rate of genomic DNA synthesis for S. aureus DNA polymerase III 
holoenzyme has been measured as ~700 bp s-1 in vitro [90], hence implying 
that the rate of plasmid unwinding could be increased or DNA polymerase 
synthesis may be decreased to synchronise the speed of DNA unwinding 
and DNA synthesis. This has been shown to be the case in E. coli, where 
the DnaB helicase speed has been shown to be reduced by the interaction 
with DNA polymerases to allow enough time for the maintenance of the 
replication fork [91].   
 
Once RepD nicks oriD, it remains as a part of the 
unwinding/replication complex until the (-)-strand is fully unwound/replicated 
[85]. RepD has been shown to bind all the ICRI-III sequences, but nicks it 
only at ICRII [92]. The rate of RepD nicking of pCERoriD plasmid has been 
determined as > 25 s-1 [93]. Fluorescence based assays have been 
developed to study RepD dependent DNA unwinding by PcrA on DNA 
structures that mimic the oriD .This assay has shown that RepD does not 
need to be covalently bound to the DNA to facilitate the RepD dependent 
unwinding as the nicking deficient RepD was able to induce processive DNA 
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unwinding [93]. Of course, RepD nicking is a requirement for plasmid 
unwinding as it enables PcrA binding to ssDNA. The RepD nicking rate of 
oriD-mimic DNA junctions has been determined as ~1 s-1 indicating the 
supercoiled plasmid is significantly better substrate for RepD nicking than 
linear DNA [93]. 
 
 
1.4.3. PcrA function in DNA repair and RecA filament removal 
 
PcrA functions in the replication of a certain family of plasmids 
carrying initiator protein and antibiotic resistance genes. This function itself is 
important in the transfer of DNA between individual bacteria and between 
different bacterial species, thus the ability to recruit an endogenous helicase 
during the replication of plasmid DNA is beneficial for the organism. In other 
words, an organism having a helicase able to unwind exogenous DNA has 
been positively selected through natural selection. This is unlikely to be PcrA 
helicases’ only function as the replication of plasmids isn’t essential for 
survival of the organism but the presence of PcrA is [50]. There have been 
several publications with experimental evidence suggesting a possible role 
for PcrA in DNA repair [50, 94, 95]. This could involve removing “road 
blocks” from DNA that may introduce DNA abnormalities and stall DNA 
replication, for example DNA-binding proteins or secondary DNA structures 
formed on ssDNA. 
 
PcrA E. coli orthologue UvrD and homologous Rep helicases have 
been used to compare their possible functions in DNA repair. All three 
helicases, PcrA, UvrD and Rep, share a function of replicating exogenous 
DNA; UvrD unwinds Gram-negative rolling circle plasmids, Rep unwinds 
bacteriophage M13 and ΦΧ174 DNA and PcrA replicates Gram-positive 
rolling circle plasmids [47, 78, 96], but most have also been shown to have 
function in other endogenous cellular processes. Several points from 
previous work, which indicate this, are discussed here. As mentioned before, 
Gram-negative bacteria E. coli helicases Rep and UvrD share high 
sequence similarity with PcrA and are also structurally and functionally very 
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much alike (Figure 3). However, PcrA deletion is lethal to an organism, 
whereas deletion of Rep or UvrD is not lethal [50]. Deletion of both Rep and 
UvrD simultaneously is detrimental for the E. coli, thus it has been suggested 
that they are together functionally equivalent to PcrA [97]. It has also been 
shown that the Rep helicase and UvrD are not functionally equivalent to 
each other. UvrD is known for its function in UV damage repair and 
mismatch repair by activation of MutL [98]. UvrD E. coli mutants have been 
shown to be hyper-recombinogenic, indicating a function in DNA repair [99]. 
The UV repair in E. coli ΔuvrD can be rescued by expression of PcrA. Rep 
helicase has been shown to take part in genome replication in E. coli and 
interact with the replicative helicase DnaB [100].  
 
In vitro UvrD has been shown to perform RecA filament removal 
[101]. RecA filaments are an important part of homologous recombination 
mediated DNA repair as they bind to ssDNA after double stranded DNA 
break and scan for homologous sequences to enable the break to be 
repaired [102-105]. The control of RecA filament formation and removal is 
vital for the cell and an organisms’ survival, requiring a control step that is 
able to remove unwanted RecA filaments and prevent unnecessary 
recombination. Similarly to the E. coli UvrD, the closest eukaryotic PcrA 
orthologue, the S. cerevisiae Srs2 helicase, is involved in Rad51 filament 
removal, which is functionally equivalent to E. coli RecA filaments [43, 106]. 
PcrA deletion has been shown to lead to hyper-recombinogenic cells and the 
lethality of the prcA deletion can be overcome by deletion of recFOR genes 
[50, 97]. RecFOR genes express proteins that mediate the loading of RecA 
on to ssDNA during recombination [107]. In vitro evidence also showed that 
PcrA was able to remove toxic RecA filament structures [95]. These mutants 
were unable to unwind the DNA, but were able to remove RecA proteins 
either by translocating on ssDNA or possibly reeling it. In the experiments by 
Anand et al. (2007) ATP hydrolysis also seems unnecessary for PcrA-
mediated removal of RecA from DNA. This is quite surprising as 
translocation on ssDNA requires ATP. Further, experiments by the same 
group also state that DNA unwinding and ATP hydrolysis may take part in 
RecA removal [95]. 
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A single molecule assay by Park et al. (2010) using FRET showed 
PcrA removing RecA filaments [94]. In these experiments, the PcrA was 
shown preferentially to bind to the DNA junction.  An oscillating FRET signal 
was observed in the presence of ATP. This was thought to correspond to the 
PcrA being adhered to the fork junction and reeling the ssDNA in a 3’-to-
5’direction, hereby removing RecA filaments.  
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1.5. Fluorescence 
 
 
Many fluorescent-based techniques have been developed for 
studying cellular structure and function, as well as interactions of molecules 
in biological systems. Fluorescence is also important in the detection and 
quantitation of nucleic acids and proteins in gel electrophoresis, microarrays 
and fluorescence spectroscopy. Understanding how fluorescence takes 
place is vital for the development of these techniques. Many aspects of 
fluorescence and its uses were reviewed in Lakowicz J.R. (2006) [108]. 
Fluorescence is a process where a fluorophore absorbs light at a certain 
wavelength, which forms an energetically excited state that is released as 
emission at a different wavelength. The electron in its excited state has 
different paths to return back to the unexcited state that depend upon the 
exact nature of the fluorophore and its surroundings. If the deactivation of 
the excited state takes place by loss of energy by emission of photons, the 
process is known as fluorescence. This is schematically illustrated in a 
Jablonski diagram (Figure 11), proposed by Alexander Jablonski in 1930s 
[109]. The other main deactivation process that may occur is internal 
conversion followed by vibrational relaxation, which is also non-radiative loss 
of energy to surroundings as heat or intersystem crossing to the triplet state 
and it is known as phosphorescence.  Before excitation by absorption of light 
the molecule is in the ground state (S0). The absorption of energy leads to 
excitation of electrons to higher energy and vibrational states (S1). This 
occurs on a time scale of 10-15 seconds. Before returning to ground state the 
electrons move to lower vibrational states, which occur on a time scale of 
10-14 to 10-11 seconds. The relaxation through fluorescence is on a time scale 
of 10-9 to 10-7 seconds. For many of the fluorescence based methods used in 
experiments, such as presented in this thesis, the triplet state emitted as 
phosphorescence is undesirable as it doesn’t contribute to the fluorescent 
signal and occurs on a longer time scale of 10-3 to 102 seconds, which may 
be too slow for detection of enzyme mechanics.  
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Fluorophores absorb light at a specific range of wavelengths with a 
characteristic peak at a maximum excitation and emit light at the specific 
range of wavelengths with a peak of emission maximum. For example, Cy3B 
maleimide has an absorption maximum of 549 nm and emission maximum of 
570 nm. The absorbed light has higher energy than the emitted light, as 
some of the absorbed energy is lost to the system and by other non-radiative 
relaxation pathways. This phenomenon is known as the Stokes shift. 
Structurally, fluorophores are usually aromatic compounds with one or 
multiple carbon rings containing conjugated double bonds. Aromatic 
fluorophores are small in size ranging from a few hundred Daltons to a 
maximum of ~1000 Daltons (MDDC – 382 Da and Cy-dyes ~800 Da) when 
compared to fluorescent proteins like GFP, which is ~26 kDa. 
 
The efficiency of fluorescence emission can be expressed through the 
quantum yield (ϕ), which defines quantitatively the probability of the excited 
state being deactivated by fluorescence rather than any other mechanism. 
This can be calculated by: ϕ = number of photons emitted/number of 
photons absorbed. The quantum yield always has a value below 1. Other 
factors that affect the fluorescence characteristics are the extinction 
coefficient, which determines how much light the fluorophore is able to 
absorb, and the fluorescence lifetime of the fluorophore (duration of the 
excited state). These factors can be affected by most environmental factors, 
which include the type of solvent, ionic strength, temperature and pH of an 
aqueous solution. The change in quantum yield of a fluorophore due to a 
change in its environment can be used as a probe of conformational 
changes near the fluorophore attachment point. 
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Figure 11. Jablonski diagram of absorbance, fluorescence and 
phosphorescence. 
 
1.5.1. Förster resonance energy transfer 
 
  
If two fluorophores are in close proximity and at a correct angle to 
each other energy transfer can take place, if the donor fluorophore has an 
emission spectrum that overlaps with the excitation spectrum of another 
fluorophore (acceptor). The energy is transferred in a non-radiative manner 
to the acceptor [110-112], which is then excited and emits the energy 
transferred as fluorescence. This is called Förster or fluorescence resonance 
energy transfer (FRET) and the efficiency of the energy transfer (EFRET) is 
dependent on the distance and the orientation of the donor and acceptor 
fluorophores. The EFRET can be written as shown in Equation 1. 
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Equation 1: 
 
In Equation 1, R is the inter-dye distance and R0 is the Förster radius at 
which EFRET is 0.5. The EFRET has a value between 0 and 1. The Jablonski 
diagram for FRET is shown in Figure 12. For Cy3 and Cy5 dyes the R0 is 
~5.5 nm and typically FRET is seen to observable up to distance of 10 nm 
between acceptor and donor, but often in experimental set ups it is 
significantly less than 10 nm. Following distance changes between two 
molecules using FRET is possible by labelling the molecules with 
fluorophores suitable for FRET. It is often enough to determine the 
intensities of donor and acceptor fluorophores at different reaction states for 
correct measurement of FRET efficiency and its variation due to changes in 
the reaction.  
 
  
Figure 12. Jablonski diagram for Förster resonance energy transfer. 
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1.5.2. Anisotropy 
 
Fluorescence anisotropy is the property of a fluorophore to absorb 
polarised light (photons) at a particular range of angles. If the fluorophore 
does not move/rotate, the photons emitted are also polarised. In 
biochemistry, anisotropy uses fluorophores such as fluorescein attached to 
the ligand or protein and relies on the existence of transition dipoles for 
absorption and emission lying along the specific direction of the fluorophore 
(Figure 13). These transition dipoles are used to excite randomly oriented 
molecules in the solution with polarised light. The emission of the molecules 
is measured and some of the excited molecules become depolarised as the 
molecules “tumble” in solution. This depolarisation can be calculated by 
measuring the intensity of parallel and perpendicular light and is expressed 
as anisotropy (r). Equation 2 can be used to calculate anisotropy, where I‖ is 
the intensity of parallel light and I┴ is the intensity of perpendicular light. The 
rate of “tumbling” is dependent on the size of the molecule or complex and 
so, when a ligand is bound by protein its tumbling is slowed down, which can 
be observed as a change in anisotropy. The rate of tumbling is not only 
dependent on the size of the molecule, but is also affected by the linker that 
connects the reactive group to the fluorophore. If the linker allows for a larger 
movement of the fluorophore, larger tumbling can be expected, which is 
observed as low anisotropy. 
 
Equation 2: 
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Figure 13. Fluorescence anisotropy.  
Vertical polarisation (║) of excited light is achieved by passing the excitation 
light through a calcite prism. Only fluorophores with the excitation transition 
dipoles parallel to the excitation plane are excited in a process called 
‘photoselection’.  Fluorophores in the excited state are able to tumble in 
solution within their fluorescence lifetime.  Emission is measured at the 
appropriate wavelength for the fluorophore through polarizers that are 
parallel (║) and perpendicular (┴) to the plane of the excitation.  
Fluorescence anisotropy is calculated using Equation 2. The observed rate 
of tumbling is dependent on the size of the macromolecule and the linker on 
the fluorophore. If tumbling is fast, low anisotropy is observed and vice 
versa.  
 
1.5.3. Utilisation of fluorescence to study protein function 
 
  
Fluorescence is used in many assays and applications. It can be used 
in vitro to investigate enzyme binding to its ligand or to fluorescently label 
molecules in a cell. To study protein interactions and enzyme kinetics, the 
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use of fluorophores as reporters of the reaction is advantageous due to their 
sensitivity and rapid response. The time scale of the main steps of excitation 
and emission of fluorophores are given in Figure 11 and often occur at a 
nanosecond timescale, making them fast enough to investigate biological 
processes that are often significantly slower. Fluorescent labelling can be 
highly sensitive and enables the observation of reaction components at 
nanomolar concentration and individual fluorophores can be observed in 
single molecule assays. 
 
The three of the main fluorescent properties of fluorophores used in 
assays to study biological processes are fluorescence intensity, fluorescence 
anisotropy/polarisation and FRET. The fluorescence intensity can be used 
by labelling the ligand or protein in question with fluorophores that respond 
to environmental changes via their quantum yield. The change in quantum 
yield can be observed as either decreased or increased fluorescent signal 
when two molecules interact. FRET can be used by measuring the FRET 
efficiency of FRET labelled molecules as discussed in the previous Section 
1.5.1.  
    
1.5.4. Attachment of extrinsic fluorescent probes to biomolecules 
 
The use of fluorophores for in vitro assays requires a form of 
attachment of the fluorophore to the desired molecule. Molecules like DNA 
and nucleotides like ATP with fluorophore modification can be obtained 
relatively easily as many can be purchased commercially. Attaching a 
fluorophore to the molecule may affect the native form of binding and 
processing of these molecules by sterically hindering binding or enhancing 
the binding by increasing the substrate affinity. When experiments are 
designed using fluorophores this is something that is to be taken into 
account.  
 
Another option is the fluorescent labelling of the enzyme. Depending 
on the function of the enzyme this can make the signals harder to 
understand, as enzymes are often able to perform several chemical 
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functions and may interact with multiple components in the reaction. The 
fluorescent labelling of proteins can be achieved by several methods, but 
typically requires modifications to be made in vitro and rely on expression 
and purification of mutant protein. Many methods have been published for 
attaching a fluorophore onto a protein. The NHS-ester attached fluorophores 
react with amine groups. There may be many amine groups in one protein 
molecule. Another method is the use of maleimide/iodoacetamide chemistry. 
These groups can be attached to the desired fluorophore and sometimes 
bought commercially. Iodoacetamide and maleimide are selectively reactive 
with the –SH groups of cysteine residues. Many other forms of labelling of 
peptides and proteins have been and are being developed, for example 
inteins [113] and bromomaleimides [114].  
 
Orthogonal nonsense suppressor tRNA labelling strategies involve 
introduction of unnatural amino acids into proteins, which can then be used 
to attach modifications site specifically [115]. This method is called unnatural 
amino acid mutagenesis (UAAM) and over 100 different unnatural amino 
acids have been introduced into proteins using this method [115]. UAAM 
uses engineered aminoacyl-tRNA synthetase that incorporates an unnatural 
amino acid at an amber (nonsense) codon. For example, this can be the p-
azido-L-phenylalanine, which is sensitive to UV light and at exposure to 
wavelengths below 310 nm, photo crosslinks with amines [116]. This method 
can be used for in vivo and in vitro labelling.  
 
Maleimide/iodoacetamide coupling chemistry is often seen as the 
most well established and highly selective method of protein labelling. For 
coupling with maleimides, cysteine residues must be located at the surface 
of the protein to allow accessibility. If environment sensitive fluorophores are 
used, the conformational change in protein must change the environment of 
the fluorophore, hence the cysteine often has to be located close to the 
interaction or reaction site to have an effect on the environment of the 
fluorophore when the molecule interacts or catalyses a reaction. 
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1.5.5. Fluorescent biosensors 
 
Many fluorescence based biosensors have been developed to study 
enzyme function and kinetics and protein-ligand/protein-protein interactions 
due to their advantageous properties. These include the fluorescent signal 
that does not affect the system being studied, user safety and ease of 
disposal as compared to radioactive labels and most importantly real time 
measurement of the reaction [117, 118]. Examples of such biosensors 
include genetically encoded biosensors that contain the GFP or its 
derivatives coupled to a target protein [117]. These enable the observation of 
protein localisation and possible interaction in vivo. This method requires the 
production of a construct with GFP and its successful transfection and 
expression in the cell. Another, relatively common group of biosensor 
constructs are the aptamers [119]. These are peptide or nucleic acid based 
molecules that have highly specific binding to a molecule of interest such as 
ATP.   
 
Another type are the reagentless biosensors [118]. They are protein-
based, sometimes enzymes, with site-specific fluorophore modification to 
report on specific reaction or interaction. They can be produced to high purity 
and in high amount in E. coli and labelled with suitable fluorophore(s) after 
purification in vitro. Good examples of reagentless protein-based biosensors 
are the Pi biosensor MDCC-PBP/6ATR-PBP (fluorophore-labelled phosphate 
binding protein) [120], ssDNA biosensor DCC-SSB [89] and ADP biosensor 
MDCC-ParM [121]. These biosensors can be applied to many biological 
systems in vitro and some in vivo, but the main use has been in vitro. The 
introduction of reagentless biosensors into cells is complicated and often 
requires techniques such as microinjection that can be time consuming and 
cause damage to the cell. Typically, the fluorescent biosensors are made 
from enzymes that have a high affinity to the ligand of interest. For labelling, 
environment sensitive fluorophores, such as the coumarins, are used and 
introduced through genetic modification of the enzyme. The native residue is 
mutated into a cysteine residue that is reactive with a maleimide or 
iodoacetamide attached through a linker to the fluorophore. Genetic 
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modification is often required for enhancing the selectivity of the biosensor, 
where an amino acid is changed site-specifically at the reaction site of 
enzyme so that it changes the affinity of the enzyme to its substrate or 
substrate-type, for example ADP over ATP in case of the Rhodamine-ParM 
[122, 123].  
1.6. Rapid reaction techniques 
 
  
 Rapid reaction techniques are biochemical in vitro techniques that 
include methods which can be used to observe biological processes in real 
time. This is required as many biological processes occur on the millisecond 
time scale. The observation of a reaction that is at steady-state only allows 
the rate constant of the rate limiting step to be measured. Rapid reaction 
techniques enable the analysis of chemical steps of reactions, enabling 
determination of individual rate constants, which can be highly informative of 
the biological process in question [124, 125]. Several methods have been 
developed for the measurement of rapid kinetics and they can be divided 
broadly into rapid mixing and relaxation based techniques.  
 
The rapid mixing techniques include methods that use specially 
designed apparatuses, which use the flow of solutions to push and rapidly 
mix the reaction in the observation chamber. These include methods such as 
stopped-flow (discussed individually in the next section), quenched flow and 
photolysis of caged compounds (Figure 14). Photolysis uses caged 
compounds that can be photo activated by a fast pulse of light. For the 
helicase assay a caged form of ATP can be used, which is released by a 
light pulse. Once the ATP is available the helicase can start to unwind the 
DNA.  
 
The quenched flow is built so that two reactants are rapidly mixed 
together and pushed into “aging tube”. The aging tube length can be varied 
to enable measurements of reactions at specific time points after mixing. The 
reaction is then quenched to stop the reaction using stop solutions of acid or 
quenchers like EGTA and EDTA that remove the metal ions from the 
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enzymes. The reactions are collected and run on HPLC or analysed by other 
suitable methods to separate the reactants and the products. For example, 
running samples on 1% agarose gel was used to separate nicked and un-
nicked plasmid to measure RepD plasmid nicking rate [93]. Quenched flow 
can be seen as more labour intensive than stopped-flow, but it is highly 
valuable when no signal can be observed or interpreted using other methods 
and enables measurement of the formation or breakage of covalent bonds.  
 
 Reactions that take place faster than what can be measured using 
rapid mixing techniques can be measured using relaxation techniques. Here 
a rapid change to the equilibrium of a system is induced and the effect of this 
change is observed. This can be achieved by rapidly changing the 
temperature or pressure of the reaction [124, 126, 127].  
 
All the above techniques require a suitable optical signal to be 
produced, which can be based on radioactivity or fluorescence. Sometimes, 
intrinsic chromophores can be used and these include the tryptophans and 
tyrosines of proteins. Often, extrinsic chromophores such as environmentally 
sensitive fluorophores are the preferred choice, as they offer a larger range 
of excitation and emission wavelengths with better fluorescence quantum 
yields [128]. 
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Figure 14. Rapid mixing techniques. 
A) Stopped-flow apparatus with single-mixing set-up. The reactants are 
placed into syringes A and B and mixed together in the mixing chamber. The 
reaction is observed in the observation chamber. The drives and stop plate 
have tight control over the volumes pushed out from the syringes. B) 
Stopped-flow apparatus with double-mixing set-up. The first reactants are 
mixed from syringe A and B in mixing chamber 1. The delay or duration of 
the first mixing can be controlled before this solution is mixed with a third 
reactant from syringe C. The entire reaction is then pushed into the 
observation chamber by buffer/reaction mixture from syringe D. C) 
Quenched flow set-up. In quenched flow experiments two reacts are mixed 
together similarly to stopped-flow, but the reaction is stopped by a quencher 
from a third syringe Q. The reactions are performed with different aging 
times and the reaction components can be analysed with a suitable method, 
e.g. by HPLC. D) Photolysis set-up. In photolysis, the start of the reaction 
can be controlled tightly by use of a caged compound that is released by a 
pulse of light. The same optical set-up is used in stopped-flow and photolysis 
set-ups to observe the reaction. 
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1.6.1. Stopped-flow spectrometry  
 
 
Current stopped-flow methods were developed from continuous flow 
methods by Gibson et al. 1952 [129] and are often the preferred choice for 
measurement of reactions where tightly controlled rapid mixing is required 
[124, 130]. In the preceding continuous flow techniques the reaction was 
studied under constant flow by measuring an optical signal at different 
locations along the flow path. These data reference different time points 
along the reaction trajectory. One of the main disadvantages of constant flow 
methods is the requirement of large volumes of the reactants. In a single-
mixing experiment on stopped-flow the total volumes required are small and 
for one reaction ~20 µl can be enough [124, 130]. In single-mixing 
experiments a pneumatic pump is used to mix and rapidly push two 
reactants from the syringes into the mixing tube and from there directly into 
an observation chamber (Figure 14A and Figure 20 in Methods). The 
reaction mix flow is stopped by the “stop” syringe.  The need to achieve 
complete mixing before the reaction is pushed into the observation chamber 
causes a dead time of typically 1-2 milliseconds. The optical signal can be 
achieved by using fluorophores, whose difference in excitation and emission 
wavelengths offers a useful way to limit the noise from excitation light 
through the use of cut off filters [128]. The excitation is achieved using a 
lamp, for example xenon-mercury lamp, and the photons of the emission 
signal are collected through photo-multiplying tubes at a 90° angle to the 
path of the exciting light.  
 
Stopped-flow can also be used for double-mixing experiments (Figure 
14B), where the two reactants are mixed in an aging loop and then a third 
reactant is mixed after a delayed time with the already initiated reaction 
before being pushed into the observation chamber. This can be used to 
follow the formation of short-lived intermediates followed by their 
degradation. The mixing of the first reactants is not observable in the typical 
stopped-flow set-up. Other possible measurements on the stopped-flow are 
fluorescence anisotropy measurements using polarised light. The stopped-
flow is set to ‘T-format’ that allows the detection of both the parallel and 
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perpendicular polarised light emitted. The values from the detectors can be 
analysed using Equation 2 (Section 1.5.2) to determine the anisotropy 
change in the reaction.  
 
In this thesis, the ensemble methods performed on the stopped-flow 
are single-mixing experiments with use of fluorescently labelled substrates. 
Ensemble methods rely on synchronisation. In these experiments, the 
synchronisation of PcrA helicase in the ensemble measurements is mostly 
achieved by controlled mixing with ATP. In this way the signal observed can 
be explained and understood, as long as or while the synchronisation is 
maintained in the majority of the population.  
 
1.7. Rapid reaction kinetics with fluorophore labelled enzyme 
 
A change in fluorescence when a labelled molecule binds to another 
molecule, such as a labelled protein binding to its ligand, can be used to 
determine the equilibrium constant as well as the association and 
dissociation rate constants of the ligand and the protein in question [124]. 
Here, the equations used are for fluorescently-labelled enzyme and they are 
used to demonstrate how the equations can be used to analyse the rapid 
reaction kinetics data. If the fluorescence signal is large enough, a simple 
titration experiment on a spectrofluorometer can be carried out to determine 
the protein’s affinity to its ligand. This is expressed as equilibrium 
dissociation constant (Kd). If the signal is too small for titrations, it is often 
large enough to measure binding and dissociation kinetics using a stopped-
flow instrument. In these experiments the association rate constant (kon) and 
dissociation rate constant (koff) are obtained and from the ratio of koff/kon the 
equilibrium dissociation constant can be calculated (Equation 4).  
 
 In a typical association experiment the fluorescently labelled binding 
partner is mixed with a large (> 10-fold) excess of the unlabelled species, 
providing pseudo-first-order conditions. In this case the kinetics can be 
described by a single exponential function with apparent first order rate 
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constant, kobs. When the signal is due to protein binding to the ligand, the 
observed rate constant (kobs) increases linearly with increasing ligand 
concentration (Scheme 1, Equation 3).  
 
See Figure 15A for an example of a hypothetical ligand binding 
measurements with a fluorophore-labelled protein. As shown in Equation 3 
the association rate constant (kon) can be determined from the slope and the 
dissociation rate constant (koff) from the y-intercept value of a linear fit to kobs 
versus ligand concentration. In some cases the koff is too close to zero. For 
these reasons the estimation of koff from the y-intercept of binding 
measurements is often not accurate.  
 
A displacement assay is more accurate way to determine koff, if the 
binding is fast and high concentration of the unlabelled protein is available. 
This can be done by loading the labelled protein with ligand and then rapidly 
mixing with a large excess of unlabelled protein (Scheme 2). If dissociation 
is a single step process (first order reaction) and the unlabelled protein is in 
large enough excess, the observed rate constant does not vary with the 
unlabelled protein concentration represents the dissociation rate constant. 
The dissociation constant Kd can be calculated using Equation 4 if the 
values for kon and koff are known.  
 
Some binding measurements show hyperbolic dependence of the 
observed rate constant with increasing concentration of the ligand. This 
indicates a two-step binding process, where one of the steps is the binding 
and the other is a conformational change associated with the change in 
fluorescence (Scheme 3). See Figure 15B for an example of hypothetic 
labelled protein binding measurements to ligand indicating a two-step 
binding process. In this situation the observed rate constant can be 
calculated by Equation 5, Kd1 is the dissociation constant of  the first step, k+2  
is the association rate constant and k-2 the dissociation rate constants of the 
second step.  The y-intercept corresponds to k-2. At very high [D] the value 
of kobs is k+2 + k-2. The dissociation constant for the overall reaction, Kd (overall), 
can be calculated using Equation 6.  
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Scheme 1: 
 
P is the labelled protein. P* is the labelled protein with a fluorescent signal 
change. D is the ligand.  
 
Equation 3:  
 
Scheme 2:  
 
 
Equation 4: 
 
Scheme 3: 
 
Equation 5: 
 
Equation 6: 
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Figure 15. Protein binding kinetics measured using different 
concentration of the ligand. 
A) kobs follows the ligand concentration dependence according to Scheme 1 
and Equation 3. B) kobs follows the ligand concentration dependence 
according to Scheme 3 and Equation 5. 
 
1.8. Single molecule assays 
  
Single molecule assays are biophysical techniques that allow 
investigation of properties of individual molecules. This is very different to 
ensemble methods that look at how vast number of molecules function at the 
same time, where the signal observed is an average of those multiple 
processes taking place simultaneously. Since the first single molecule 
experiment was performed in the 1970s on ion channels, the number of 
studies and their importance in answering biological questions has 
increased. Often they are used to complement and offer an alternative 
perspective to the ensemble experiments. The most obvious benefit of single 
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molecules assays is their ability to measure individual molecules. This 
removes the effect of averaging applied to ensemble assays and enables the 
measurement of possible multiple chemical states, macromolecular 
conformations or kinetics steps present in a reaction. Observation of 
individual molecules may also show different populations of biomolecules. 
These properties of single molecule experiments are represented in Figure 
16, which shows a diagram of the “single molecule paradigm”. The diagram 
depicts three types of traffic, where the cars represent individual 
biomolecules such as motor proteins. All the traffic in all three scenarios has 
the same average speed, which represents the signal observed in ensemble 
experiments. In scenario 1 all cars are moving in a uniform manner at the 
same speed. In setting 2 the cars are moving at different speeds, but in a 
uniform manner in the separate lanes, with some of the cars stalling. The 
third case shows cars moving in a random manner, changing lanes, stalling 
and re-starting. Single molecule assays can overcome the drawbacks of 
averaging the speed of the cars, in other words the behaviour of 
biomolecules in large populations. They also enable measurements of the 
dynamics of enzymes at equilibrium conditions and other conditions that 
cannot be easily synchronised. Ensemble methods rely on synchronisation, 
which may not always be achievable.  
 
Single molecule measurements, such as those using magnetic 
tweezers, enable the measurement of direct molecular forces and as single 
molecules are observed the variation between the molecules and possible 
populations within the sample can be determined. In some systems, single 
molecule assays may enable the observation of only active enzymes as 
inactive enzymes do not show a signal and are excluded from the analysis. 
Co-operative activity of enzymes is often not detectable at single molecule 
level, but specific assays have been developed at single molecule level, 
which in fact look at the co-operativity of an enzyme. An example of this are 
the ATP binding and hydrolysis studies of 16 subunit chaperonin TriC [131], 
where Cy3-labelled ADP photobleaching was measured on TIRFM. This 
showed distinct steps of individual Cy3-ADP/ATPs photobleaching, which 
gave clues as to the number of ATPs bound to chaperonin. 
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Figure 16. Single molecule paradigm. 
The image shows a cartoon representation of three different ensemble 
assays using traffic flow as an analogy. All three scenarios have the same 
average speed, which represents the signal observed in ensemble 
experiments, which is an average of all events in a reaction. In single 
molecule assays one can observe individual molecules, here represented by 
cars, and possibly determine different behaviours, conformations and 
kinetics of the individual macromolecules. For example, in scenario 1 all the 
cars are moving at a uniform speed and manner. In scenario 2, some of the 
cars are stalled and others are travelling at various speeds, but moving in a 
uniform manner. The cars in scenario 3 are moving at various speeds and 
manners, with some of them stalling and re-initiating.      
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Single molecule work can be divided into structure-, force- and 
fluorescence-based techniques. Examples of the structure-based methods 
include single particle tomography using electron microscopy (EM) and 
atomic force microscopy (AFM).  Both of these methods look at “snap shot” 
images of molecules once the reaction has been stopped and can be used 
to visualise protein-protein/protein-DNA interactions and different 
conformational states of biomolecule of interest. Figure 17A, shows an 
image captured using the AFM set-up. The biomolecules of interest are 
attached to a mica surface and a cantilever is dragged along the surface 
producing a surface height map using laser and diode detector.  Both, AFM 
and EM tomography have been successfully used to determine 
characteristics and functions of helicases. Cryo-EM, for example, has been 
used to show the hexameric ring structure of the Rho helicase [132] and the 
ring structure of the homohexameric archaeal MCM helicase. Analysis of the 
latter showed a channel large enough to accommodate dsDNA, indicating 
MCMs ability to translocate on dsDNA [30]. AFM has been used to take 
“snap shots” of a helicase in action by starting the reaction and stopping at a 
desired time point. With PcrA, the plasmid unwinding states of unwound, 
partially unwound and fully unwound plasmid can be observed when 
different time points are used for stopping the reaction [133] (Arbore C. et al. 
and Lynch G. et al. personal communications). Similarly, AFM has been 
used to study DNA unwinding by the DEAD box helicase [134]. 
 
Studying a biological process in an aqueous environment at single 
molecule level enables the measurement of reactions in real time. This is 
especially beneficial and important for molecular motors, such as DNA 
translocases and helicases. The most common of these types of techniques 
are the magnetic tweezers, optical tweezers and fluorescence-based 
methods on a total internal reflection microscope. These set-ups are shown 
in Figure 17B to D. 
 
1. Introduction 
 
66 
 
 
Figure 17. Single molecule assay methods. 
A) Atomic force microscopy used to observe DNA structure and interaction 
with DNA binding proteins. B) Magnetic or optical tweezers C) set up to 
study helicase unwinding. D) Model of TIRF assay set up for the observation 
of molecules in the cell or on the cell surface. n1 and n2 are the refractive 
indexes for the different media in the TIRF assay, ϴ is the incident angle for 
the light, which has to be larger than ϴC for TIR to take place. The ϴC is 
calculated by ϴC = arcsin
-1(n2/n1) [135]. n1 = 1.51 for glass and n2 = 1.33 for 
water. 
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1.8.1. Total internal reflection microscopy  
 
  
Total internal reflection describes the physical property of light when it 
travels from a high- to a low-refractive index medium and hits the interface of 
two media at an angle called the critical angle (ϴc). If the angle is equal to or 
higher than the ϴc, the light will be reflected from the interface and won’t 
pass through the first to the second medium. For example, in the case of 
water and glass, which have the refractive indexes of n1 = 1.33 and n2 = 
1.51, respectively, the critical angle is 62°. The critical angle for two media 
can be calculated using the equation ϴc = arcsin(n2/n1). The region where 
the light is reflected produces an evanescent field at the optical frequency 
above the cover slide. This evanescent field can be used to excite 
fluorophores at a specific wavelength and it decays exponentially in space. 
TIRFM takes advantage of this property of light and the evanescent field in 
typical TIRFM set-up is ~100 nm [136]. The restricted excitation area and 
depth provides a low background for TIRFM measurements, hence enabling 
measurements of individual fluorophores when they are present at very low 
concentration. TIR illumination can be achieved using two different methods, 
prism-coupled and optical lens-coupled. In the prism-coupled method TIR is 
produced by use of a prism. Figure 17D shows an experimental set-up for 
TIRFM experiments and Figure 21 in Methods shows a more detailed image 
of the optical lens-coupled TIRFM method used in the single molecule 
measurements in this thesis. The images are captured using an electron 
multiplying charge-coupled device camera (EMCCD).  
 
 
TIRFM single molecule measurements in cell cultures have been 
used to determine the behaviours of receptor proteins on the cell surface, 
such as the dimerisation and dissociation of muscarin receptors [137].  
Single molecule FRET (smFRET) has been used to look at several functions 
of helicases on TIRFM. One of the first smFRET experiments with helicases 
was an unwinding measurements with Rep helicase [138].This assay used 
Cy3-Cy5-labelled DNA constructs immobilised to a glass surface with a 
ssDNA overhang for Rep binding. Unwinding was initiated by addition of 
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ATP and visualised as a decrease in FRET as the Cy3-Cy5 got separated 
from one another, showing stalling and re-initiation of unwinding. Several 
other assays have been developed since to investigate helicase and other 
DNA binding protein functions, many using fluorescent labelling of the 
helicase or SSB [94, 138-144]. The single molecule FRET measurements 
may enable observation of properties undetectable by other methods. This 
was the case with the SSB sliding movement on ssDNA, which was 
demonstrated using single molecule FRET measurements [145]. Fili N. et al. 
2009 developed a fluorescence based helicase assay using Cy3B-SSB and 
biotinylated linear DNA attached to a glass surface [146]. This enabled the 
determination of the AddAB helicase rate of unwinding at the single molecule 
level. A range of unwinding rates showed AddAB pausing and re-starting 
and also allowed for the determination of the maximum length of DNA that 
can be visualised for unwinding in the TIRFM set-up (~1.5 kb). This assay 
has been further developed as part of this thesis to investigate PcrA 
unwinding of full length plasmids. 
 
1.8.2. Optical and magnetic trapping of molecules 
 
  
Optical and magnetic trapping techniques enable the trapping of 
individual molecules and observation of single reactions in real time. They 
use two very distinct mechanisms for the immobilisation of molecules in 
place. Figure 17 shows examples of magnetic tweezers and optical tweezers 
set-ups.  
 
The optical tweezers apparatus uses a focused laser beam to “trap” a 
bead covered with a suitable coating. A biomolecule such as DNA can be 
attached to this coating [147, 148], while the other end of the DNA is 
attached to another bead held in place either by another laser beam or 
attachment to a micropipette. The trapping by light enables measurements of 
force changes in the system, for example dsDNA being unwound to ssDNA. 
This method has been used successfully to look at DNA unwinding by NS3 
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helicase [149] and DNA packing by the viral packing motor φ29 [150-152]. 
The measurements using optical tweezers with NS3 helicase showed an 
interesting property of uneven step size (~1.5 nt, ~2.5 nt and ~3.5 nt) [149]. 
This indicates possible uneven release of the two component strands 
produced from unwinding that could only be seen at the single molecule 
level. 
 
Magnetic tweezers are made up of a minimum of two permanent 
magnets that are held above the sample. The magnets create a magnetic 
field that exerts torques on the magnetic particles, such as supermagnetic 
beads, and can be used to hold them in place. The beads are coated to 
enable attachment of a biomolecule on to the bead. For example, avidin 
coating can be used to attach biotin modified DNA on to the bead. The 
microscope-based tracking system is formed of an inverted microscope and 
the EMCCD camera used for capturing the image.  
 
The initial experiment using magnetic tweezers included elasticity 
measurements of DNA. These were measured by determining the tensile 
strength of the DNA before it breaks [153, 154].  For this, DNA was stretched 
between the magnetic bead and a glass slide and measurements were taken 
at known magnetic and hydrodynamic forces. The function of the ring 
shaped helicase T7 has been studied by Johnson et al. 2007 using a 
magnetic tweezers set-up, where the DNA substrate is stretched between 
the bead and the coverslide [141]. The single tethered DNA hairpin structure 
has a dsDNA section, which the T7 helicase unwinds. The unwinding results 
were compared to nonring-shaped helicases and this showed a significant 
difference between the unwinding mechanisms of the two types of helicases. 
The bacteriophage T4 helicase gp41 function has been studied in a similar 
assay using magnetic tweezers [155]. These results show that the gp42 
helicase translocates at the speed of 400 bp s-1 on ssDNA, but unwinds at 
the speed of 30 bp s-1, indicating it to be a passive helicase when unwinding 
DNA on its own. 
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The use of single molecule assays, mainly optical and magnetic 
tweezers and TIRFM, has provided scientist with invaluable information that 
cannot be determined solely from ensemble measurements. Together, with 
the ensemble methods they have become a standard for studying the 
function of molecular motors. In future, these three main single molecule 
assays may be combined to provide even more sensitive ways to measure 
helicase function [156]. 
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1.9. Purpose of the investigation  
 
  
This project aimed to further our understanding of PcrA helicase 
unwinding activity in plasmid replication.  This process is driven by PcrA 
translocation on ssDNA and its interaction with other components of the 
DNA unwinding complex such as RepD, the initiator protein, and by the 
hydrolysis of ATP.  
 
New ensemble assays were developed to study PcrA function in 
ssDNA translocation and dsDNA unwinding. These assays were based on 
labelling of PcrA helicase with environment sensitive fluorophores. Previous 
fluorescence–based work has included the investigation of PcrA ssDNA 
binding and translocation, the ATP hydrolysis cycle and linear dsDNA 
unwinding using fluorescently labelled substrates [51, 54, 87, 157, 158]. The 
labelling of PcrA has not been done before and so provides an alternative 
method for previous fluorescence based assays, but ultimately this should 
provide us with more detailed information of how PcrA functions and 
interacts with the plasmid unwinding complex that has not been observed in 
previous experiments. For example, these will include the studies of PcrA 
translocation rate on different ssDNA substrates and its dependence on the 
DNA sequence. 
 
The interaction between PcrA and RepD is vital for processive 
plasmid and linear DNA unwinding [87]. The location and nature of the 
interaction of these two proteins remains unsolved. One of the main aims is 
to label PcrA at multiple locations to find a signal that indicates the 
interaction site on PcrA and enables the investigation of the interaction 
between the two proteins and how this interaction may change during 
plasmid unwinding. PcrA plasmid unwinding has been shown to be 
processive only in presence of RepD.  The loading of PcrA is the initial step 
of unwinding. This will be looked at using the fluorophore-labelled PcrAs in 
terms of the biochemistry of PcrA binding to ssDNA, but more importantly 
the binding of PcrA to RepD-DNA/plasmid complex. ATP binding has been 
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shown to affect PcrA structure [21] and the impact of ATP presence on PcrA 
binding kinetics will also be tested, as ATP is present under in vivo 
conditions. 
 
PcrA plasmid unwinding was also the aim of investigation at single 
molecule level. Single molecule measurements remove the averaging of the 
signal observed in ensemble assays and can provide more detailed 
information of the biological process in question and highlight possible 
intermediate states and different populations of the molecules that are lost 
by averaging. Single molecule plasmid unwinding measurements can be 
used, not only to determine the speed and processivity of PcrA on individual 
DNA molecules, but to determine possible stalling and re-initiation properties 
of PcrA while unwinding plasmid DNA. These are the first measurements 
where complete plasmids are unwound and investigated at the single 
molecule level. PcrA has been applied in a similar single molecule assay 
using linear DNA substrate [146]. Using full length plasmid provides a more 
natural substrate for PcrA. Also, the circular nature of the plasmid may cause 
force changes within the PcrA-RepD-plasmid complex not present with linear 
DNA.  
 
The ensemble plasmid unwinding assays also used in this thesis will 
provide a comparison to the newly developed single molecule plasmid 
unwinding assay. The determination of the rate of translocation on ssDNA 
and the rate of dsDNA unwinding at the same conditions by PcrA enable the 
comparison of these rates, which in turn can be used to determine whether 
the PcrA unwinds DNA actively or passively [61].  This function of PcrA has 
not been determined before and may be an important characteristic to be 
discovered to unravel the function of PcrA. 
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2. Materials and Methods  
 
2.1. Chemicals and reagents  
 
The chemicals and reagents were primarily purchased from Sigma-
Aldrich Ltd with exceptions stated in the protocols. 
2.2. Buffers and media 
 
PcrA assay buffer: 50 mM Tris·HCl pH 7.5, 150 mM NaCl and 3 mM MgCl2. 
K100 buffer: 50 mM Tris·HCl pH 7.5, 100 mM KCl, 1 mM EDTA, 10 mM 
MgCl2 and 10%(v/v) ethanediol. 
K200 buffer: 50 mM Tris·HCl pH 7.5, 200 mM KCl, 1 mM EDTA, 10 mM 
MgCl2 and 10% (v/v) ethanediol. 
TIRF buffer: of 50 mM Tris·HCl pH 7.5, 100 mM KCl, 1 mM EDTA and 10 
mM MgCl2. 
2YT broth: 1.6% Tryptone, 1% Yeast extract, 0.5% NaCl, pH 7.5. 
Luria-Bertani media/broth: 1.0% (w/v) Tryptone, 0.5% (w/v) Yeast Extract, 
1.0% (w/v) NaCl, pH 7.0. 
NZY+ media: 1% (w/v) NZ amine (casein hydrosylate), 0.5% (w/v) NaCl, 
0.5% (w/v) Yeast Extract, 0.2% (w/v) MgSO4·7H2O, pH 7.5. 
SOC media: 2% (w/v) Tryptone, 0.5% (w/v)  Yeast Extract, 0.05% (w/v) NaCl, 
1mM MgCl2,1 mM MgSO4 and 0.2% (w/v) glucose. 
 
2.3. Transformation of Escherichia coli 
 
Plasmids containing the gene of interest were transformed to E. coli 
XL-1 Blue cells (Stratagene) for amplification and B834 (DE3), B834 (DE3) 
pLysS or BL21 (DE3) pLysS cells for expression. This was done by addition 
of 10-20 ng of plasmid to 50 µl of cells in 1.5 ml Eppendorf tubes and 
incubating for 30 min on ice. After incubation, cells were heat shocked at 
42 ºC for 45 s and incubated 2 min on ice, followed by addition of 800 µl of 
pre-warmed NZY+ or SOC media. Cells were then incubated for 1 h at 37 ºC 
on rotary shaker at 225 rpm. 200 µl of culture was plated on LB agar plates 
containing ampicillin (100 µg ml-1) when no pLysS was present and when 
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pLysS or pBirAmc was present plated on LB plates containing ampicillin (50 
µg ml-1) and chloramphenicol (10 µg ml-1). 
2.3.1. Expression cell lines 
 
Strain Genotype Protein 
B834(DE3) F- ompT hsdSB(rB
- mB
-) gal dcm met (DE3) PcrA 
B834(DE3) pLysS F- ompT hsdSB(rB
- mB
-) gal dcm met (DE3)  
pLysS (CamR) 
RepD 
BL21(DE3) F- ompT hsdSB(rB
- mB
-) gal dcm met (DE3) bioPcrA 
 
2.3.2. Small, medium and large scale plasmid purification 
Small scale plasmid preparations were done using QIAGEN quick 
mini preparation kit and protocol (maximum yield 20 µg), whereas medium 
and large scale preparations were done using QIAGEN maxi (maximum 
yield 500 µg) and giga (maximum yield 10 mg) preparation kits, respectively. 
The main difference between the kits is the starting volume of bacterial 
cultured used resulting in larger yield of purified plasmid. The QIAGEN 
plasmid purification kits are based on Birnboim and Doly alkaline lysis 
method developed to extract high purity plasmid DNA from E. coli [159]. By 
this method, the E. coli cells, containing the wanted plasmid, were grown in 
LB media overnight. The cells were then centrifuged into a pellet and 
resuspended P1 buffer (50 mM Tris·HCl pH 8.0, 10 mM EDTA and 100 μg 
ml-1 RNase A). The cells were lysed by alkaline solution, P2 solution (200 
mM NaOH and 1% SDS).  The lysis reaction was neutralised by addition of 
N3 buffer (4.2 M guanidinium hydrochloride, 0.9M potassium acetate, pH 
4.8) in case of mini preparation kit and by P3 buffer (3M acetic acid, pH 5.5) 
in case of maxi and giga preparation kits. The neutralised mixture was spun 
using centrifuge to separate the crude cell debris from DNA. The plasmid 
DNA was further purified from RNA and other cellular components by 
optimised buffers and QIAGEN columns provided as a part of the kits. These 
columns contain a silica membrane, which is selective in adsorption of 
plasmid in high-salt conditions and elution in low-salt conditions. The 
supernatant containing the extracted plasmid was applied to the QIAGEN 
column equilibrated with QBT buffer (750 mM NaCl, 50 mM MOPS, pH 7.0, 
2. Materials and Methods 
 
75 
 
15% (v/v) isopropanol, 0.15% Triton X-100). The plasmid DNA was washed 
on the column membrane using PB buffer (5 M Guanidine-HCl and 30% (v/v) 
isopropanol) and PE buffer (10 mM Tris-HCl pH 7.5 and 80% ethanol) in 
case of mini preparation kit and with QC buffer (1.0M NaCl, 50 mM MOPS 
pH 7.0 and 15% isopropanol) in case of maxi and giga preparation kits. The 
plasmid DNA was eluted with EB buffer (10 mM Tris·HCl, pH 8.5) (mini 
preparation kit) or with QF buffer (25 M NaCl, 50 mM Tris·HCl pH 8.5 and 
15% isopropanol) (maxi and giga preparation kits). The plasmid DNA purified 
using maxi and giga kits were also washed with 70% ethanol after elution 
and resuspended in EB buffer. The plasmid DNA was stored at -20 °C.  
 
2.4. Site-directed mutagenesis 
 
Site-directed mutagenesis of PcrA and RepD were done using 
QuikChange II site-directed mutagenesis kit and protocol from Stratagene. 
The protocol is based on the use of primers with mismatch sequence, which 
enables the introduction of an amino acid change site-specifically using the 
polymerase chain reaction (PCR). The primers were designed to have single 
stranded DNA overhangs and the primer sequences used are stated in 
Sections 2.4.1 and 2.4.2 and were obtained from Sigma-Aldrich Ltd. The 
PCR reactions had 50 ng template plasmid, 125 ng of forward and reverse 
primers, 1 µl dNTP mix, and 2.5 U PfuTurbo DNA polymerase with 5 µl of 10 
x reaction buffer that was provided with the enzyme. The reactions were 
made to 50 µl with distilled H2O. The PCR was done using programme of 
preheating the reactions for 30 seconds at 95 °C, followed by 16 cycles of 
denaturing at 95 °C for 30 seconds, primer annealing at 55 °C for 1 minute 
and DNA synthesis for 6 minutes (1 minute/1 kb of template DNA) at 68 °C, 
which was followed by final 5 minute extension at 68 °C to ensure completion 
of DNA synthesis. The PCR reactions were then digested with Dpn I 
restriction endonuclease for 1 hour at 37 °C to remove the template plasmid 
DNA (10 U of enzyme per 50 µl of reaction). The plasmids created by PCR 
were then transformed into XL-1 Blue E. coli cells using protocol stated in 
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Section 2.3. The mutated gene sequences were checked by sequencing 
(Cogenics Ltd or GATC Ltd).  
 
2.4.1. Primers used for site-directed mutagenesis of RepD 
 
Mutation Primer sequence 
RepD(C225A) 
5’-TAC TGG AAT GAT GCC TTT GAT GAT TTA CAC ATT 
T-3’ 
 
5’-ATC ATC AAA GGC ATC ATT CCA GTA ATC AAC CAT 
A-3’ 
RepD(W310C) 
5’-CGT GAA TTT AGA TTT TGT AAG TAG AAT TCA AGC 
TTG GCT G-3’ 
 
5’-GAA TTC TAC TTA CAA AAT CTA AAT TCA CGT TGC 
CAA AA-3’ 
RepD(S2C) 
5’-GGA GAT ATA CAT ATG TGT ACA GAA AAT CAT TCA 
AAT T-3’ 
 
5’-GAT TTT CTG TAC ACA TAT GTA TAT CTC CTT CTT 
AAA GTT-3’ 
 
RepD(W310C) and RepD(S2C) were done on a RepD construct to which the 
C225A mutation was introduced before. 
 
2.4.2. Primers used for site-directed mutagenesis of PcrA 
 
Mutation Primer sequence 
PcrA(H53C) 5’-TGG CGG AAA AGT GTG TGG CGC CGT GGA ACA 
TTT-3’ 
 5’-ACG GCG CCA CAC ACT TTT CCG CCA TCA AAT A-3’ 
PcrA(K138C) 5’-ATA GAC CCG AAA TGT TTT GAG CCG CGG ACG ATT 
TTA-3’ 
 5’-TCC GCG GCT CAA AAC ATT TCG GGT CTA TGT TTT 
TTT-3’ 
PcrA(T167C) 5’-CGC CAA GCG GGC CTC GTG CTA TTA CGA AAA 
AGT CGT CAG CG-3’ 
 5’-CTG AAA AAG CAT TAT CGT GCT CCG GGC GTT 
CCG CTT AAC GAG G-3’ 
PcrA(E314) 5’-GCT TTG GAC GTG CAA CCC GGA AGG AAA GCC 
GAT TC-3’ 
 5’-CCT TCC GGG TTG CAC GTC CAA AGC CGT TTC 
GGC TTC CG-3’ 
PcrA(E347C) 5’-GCG GTG GAG CGC TGC GAA CGC CGC TAC CGT 
GAT TTT GC-3’ 
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 5’-GGT AGC GGC GTT CGC AGC GCT CCA CCG CCT 
CGC GGA TGC-3’ 
PcrA(E447C) 5’-GCG CTC GGC TGC CTA GAG ATG ATC GGG CTT 
GGC G-3’ 
 5’-CGA TCA TCT CTA GGC AGC CGA GCG CCT CAA 
ACA AGG-3’ 
PcrA(E449C) 5’-TCG GCG AGC TAT GTA TGA TCG GGC TTG GCG 
CCA-3’ 
 5’-AGC CCG ATC ATA CAT AGC TCG CCG AGC GCC 
TCA AA-3’ 
PcrA(M450C) 5’-GCG AGC TAG AGT GCA TCG GGC TTG GCG CCA 
AAG CGG-3’ 
 5’-GCC AAG CCC GAT GCA CTC TAG CTC GCC GAG 
CGC CTC-3’ 
PcrA(L453C) 5’-GAG ATG ATC GGG TGT GGC GCC AAA GCG GCC 
GGG-3’ 
 5’-CTT TCG CGC CAC ACC CGA TCA TCT CTA GCT CGC 
CG-3’ 
PcrA(Y477C) 5’-AGC TGC AAG AAT GCG TCT CCG TCA CCG AAC 
TCG T-3’ 
 5’-TGA CGG AGA CGC ATT CTT GCA GCT CAC AGG 
TAA-3’ 
PcrA(R501C) 5’-AAG GCG GAG TGT ACG ATT GAA GCA CAA AGC 
CGC CT-3’ 
 5’-TGC TTC AAT CGT ACA CTC CGC CTT GAG CAT CT-
3’ 
 
 
2.5. Agarose gel electrophoresis 
 
Mini-prep plasmids and plasmids used in site-directed mutagenesis 
were run on 1% (w/v) agarose gels prepared using 0.5 g of agarose (Bio-
Rad) to 50 ml of TAE (40 mM Tris-acetate and 1 mM EDTA). 1 µg/ml 
ethidium bromide was added to melted agarose. This was then poured to 
cast and allowed to set. DNA samples were run with 1 x loading buffer (made 
of 30% (v/v) glycerol, 0.25% (w/v) bromophenol blue) with TAE at 100 volts 
for 45 min. 
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2.6. DNA structures and sequences 
 
 
 
 
Figure 18. DNA structures for MDCC-PcrA(K138C) ssDNA binding 
studies. 
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Figure 19. DNA junction structures and sequences for dsDNA 
unwinding and PcrA-RepD interaction studies.  
DNA junctions for unwinding assay have dabcyl-Cy3 or dabcyl-
AlexaFluor350 pair depending on the fluorophore on the PcrA or RepD to 
prevent overlap of excitation and emission spectra of the DNA junctions and 
labelled protein. The unmodified DNA junctions for MDCC-PcrA(E449C) 
binding and unwinding assays without ICRIII sequence had the identical 
sequences to 20 to 40 bp DNA junctions. *, designates the site of RepD 
nicking. 
 
2.7. Protein expression and purification 
2.7.1 SDS-PAGE analysis of expressed proteins 
 
SDS-PAGE was done to analyse and check for presence of PcrA, 
RepD and bioPcrA. 12% SDS-PAGE running gels were prepared using 7.5 
ml of 30% (w/v) acrylamide and bis-acrylamide min (37.5:1), 3.8 ml of 1.5 M 
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Tris pH 8.8, 3.4 ml of distilled di-ionised water with the conductivity of 5.4 
(SEM 1.3) µS/cm, 150 µl 10% SDS (w/v) and setting with 100 µl of 
ammonium persulfate and 5 µl of TEMED (makes total of 4 gels). 5% 
stacking gels were prepared using 1.7 ml of 30% (w/v) acrylamide and bis-
acrylamide (37.5:1), 1.25 ml of 1 M Tris pH 6.8, 6.8 ml of distilled di-ionised 
water. Distilled di-ionised water had a conductivity of 5.4 (SEM 1.3) µS/cm, 
150 µl 10% SDS (w/v) and set using 100 µl of 10% (w/v) ammonium 
persulfate and 5 µl of TEMED (BioRad #161-0801).  
 
15 µl of samples were mixed with 15 µl of 2 x sample buffer (125 mM 
Tris·HCl pH 6.8, 4% SDS, 20% (v/v) glycerol, 10% (v/v) 2-mercaptoethanol 
and 0.25 mg/ml bromophenol blue)   and boiled 5 min at 95 ºC. Gels were 
run with buffer made of 25 mM Tris, 1.44% (w/v) glycine and 0.1% SDS at 
200 volts for 60 min. Gels were stained with coomassie brilliant blue R-250 
(BioRad) for approximately 15 min at room temperature and destained with 
mix of 10% (v/v) acetic acid and 50% (v/v) methanol for 2-3 h. 
2.7.2. Bacillus Stearothermophilus PcrA wild type and mutant 
preparations 
 
100 ml of LB broth with ampicillin (100 µg/ml) was inoculated with E. 
coli strain B834 (DE3) that carries plasmid pET22-BstPcrA (a gift from Dale 
Wigley, CR UK) and grown overnight at 37 ºC on shaker at 225 rpm. 4 x 5 ml 
of this was used to inoculate 4 x 500 ml of LB with ampicillin in 2 litre flasks 
and grown to OD595 0.5.  PcrA expression was induced with 1 mM IPTG 
(CALBIOCHEM # 420322) and grown 3 h at 37 ºC on rotary shaker at 225 
rpm. After incubation cells were centrifuged at 4 ºC at 4000 rpm in JS 4.2 
swing bucket rotor (Beckman Coulter) for 30 min. 2 x 500 ml culture pellets 
were resuspended into 20 ml of buffer containing  50 mM Tris·HCl pH 7.5, 2 
mM, EDTA, 1 mM DTT, 200 mM NaCl and 10% (w/v) sucrose. Cells were 
then stored at -80 ºC until PcrA extraction and purification. 
 
To extract PcrA from E. coli, the cells were thawed and PMSF was 
added to final concentration of 0.1 mM. Cells were lysed using probe 
sonicator at bursts of 4 x 30 s on ice (nominally 360 W Vibra-Cell from Sonics 
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& Materials Inc.) and spun at 13200 rpm at 4 ºC for 20 min using 45 Ti rotor 
(Beckman Coulter). Supernatant containing proteins was removed and 
measured.  To this volume 0.7 times of saturated (NH4)2SO4 was added 
gradually over 5 min period, whilst stirring at room temperature. Mix was then 
centrifuged at 13 200 rpm at 4 ºC for 20 min using 45 Ti rotor (Beckman 
Coulter). Supernatant was thrown away and the pellet was resuspended into 
20 ml of buffer (50 mM Tris·HCl pH 7.5, 2 mM EDTA, 1 mM DTT and 100 
mM NaCl).  
 
Fast protein liquid chromatography (FPLC) purification of PcrA was 
done on an AKTA FPLC (GE Healthcare) using a 20 ml heparin Sepharose 
column (GE Healthcare). First, the conductivity of the protein mixture was 
matched to the conductivity of re-suspension buffer used in FPLC by adding 
buffer containing 50 mM Tris·HCl pH 7.5, 2 mM EDTA and 1 mM DTT. The 
sample was then loaded on to the column and equilibrated using 50 mM 
Tris·HCl pH 7.5, 2 mM, EDTA, 1 mM DTT and 100mM NaCl at 1 ml/min flow 
rate at 4 ºC. PcrA was eluted on linear gradient of NaCl starting from 100 mM 
NaCl and finishing at 700 mM NaCl over a volume of 150 ml. Normally, PcrA 
elutes at ~350-400 mM NaCl and was confirmed using SDS-PAGE.  
 
The fractions from FPLC were pooled and concentrated using 20 ml 
10 000 MWCO Vivaspin concentrator (Millipore) by spinning at 4000 rpm at 
4 ºC in JS 4.2 swing bucket rotor. Quantification of PcrA was done using the 
molar extinction coefficient of 75 875 M-1 cm-1 at 280 nm (calculated from the 
amino acid sequence). PcrA was stored in aliquots with 10% glycerol (v/v) at 
-80 ºC. Figure 18A shows a wild type PcrA preparation on a 12% SDS-PAGE 
gel. 
2.7.3. Staphylococcus aureus RepD preparations 
 
RepD wild type was expressed from pET11a vector (given as a gift to 
the lab by Christopher D. Thomas, University of Leeds) transformed into E. 
coli strain B834 (DE3) pLysS.  100 ml of 2YT broth with 1% glucose (w/v), 50 
μg/ml ampicillin and 10 μg/ml chloramphenicol were inoculated with the E. 
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coli and grown overnight at 30 ºC in orbital shaker at 225 rpm. 5 ml of the 
overnight cultures was used to inoculate each 500 ml of 2YT media (typically 
total of 2 l) with 50 μg/ml ampicillin and 10 μg/ml chloramphenicol and grown 
at 30 ºC in orbital shaker at 225 rpm until the cell density reached 0.5 at 
OD595. RepD expression was induced with 0.1 mM IPTG and cells were 
grown for a further 6 h. Cells were centrifuged at 4 ºC, at 4000 rpm in a JS 
4.2 swing bucket rotor for 30 min. The pellets were resuspended to 40 ml of 
50 mM Tris·HCl pH 7.5, 1 mM EDTA, 10% (v/v) ethanediol, 500 mM KCl, 
1mM DTT and 10% sucrose and stored at -20 ºC until purification. 
 
Resuspended cells were thawed and to each 50 ml of cells, 1 tablet of 
protease inhibitor (Complete, Santa Cruz biotechnology) was added.  Cells 
were sonicated 2 x 15 s on ice using probe sonicator (nominally 360 W, 
Vibra-Cell from Sonics & Materials Inc.). The lysate was then centrifuged at 
15 ºC, at 12 000 rpm for 30 min using 45 Ti rotor (Beckman Coulter). 
Supernatant containing the protein was removed and measured. To this two 
times the volume of a buffer containing 50 mM Tris·HCl pH 7.5, 1 mM EDTA, 
10% (v/v) ethanediol and 3 M (NH4)2SO4 was added. Cell debris was 
precipitated by incubating on ice for 30 min and centrifuged at 4 ºC, at 12 000 
rpm for 30 min using 45 Ti rotor (Beckman Coulter). Pellets were then 
resuspended into of 50 mM Tris·HCl pH 7.5, 1 mM EDTA, 10% (v/v) 
ethanediol and 500 mM KCl, and pooled. Conductivity of the lysate was 
matched to buffer containing 50 mM Tris·HCl pH 7.5, 1 mM EDTA, 10% (v/v) 
ethanediol and 200 mM KCl, using buffer 50 mM Tris·HCl pH 7.5, 1 mM 
EDTA and 10% (v/v) ethanediol. The sample was then further centrifuged at 
15 ˚C, at 12 000 rpm for 30 min using 45 Ti rotor (Beckman Coulter).The 
supernatant was purified using two columns. First, on 6 ml Q-Sepharose 
column (GE healthcare), and second on 20 ml heparin Sepharose column 
(GE healthcare), that had been equilibrated in 50 mM Tris·HCl pH 7.5, 1 mM 
EDTA, 10% (v/v) ethanediol and 200 mM KCl at 1 ml/min using AKTA FPLC 
(GE healthcare). After application of sample, a gradient of KCl was run from 
200 mM to 700 mM over 200 ml to elute RepD. Elution fractions were 
analysed by SDS-PAGE and the absorbance at 260 and 280 nm was 
monitored. Fractions with A280/A260 ratio higher than 1.5 were pooled and 
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concentrated using 20 ml 10 000 MWCO Vivaspin concentrator (Millipore) in 
centrifuge at 3000 rpm at 4˚C in a JS 4.2 swing bucket rotor. RepD was 
quantified using absorbance at 280 nm and an extinction coefficient of 119 
514 M-1 cm-1 for the dimer. 
 
2.7.4. Biotinylated Bacillus Stearothermophilus PcrA expression and 
purifications 
 
The pET22b-bioPcrA construct (a gift from Mark Dillingham, University 
of Bristol) was transformed into BL21 (DE3) E. coli (Novagen) together with 
pBirAMc vector expressing the biotin ligase (Avidity) and plated on LB agar 
plates with 10 µg/ml of chloramphenicol and 50 µg/ml of ampicillin and 
incubated overnight at 37 ºC.  This was used to inoculate 100 ml overnight 
culture of liquid LB containing 10 µg/ml of chloramphenicol and 50 µg/ml of 
ampicillin.  The overnight liquid media (1/100 dilution) was used inoculate 2 L 
of LB with above antibiotics and concentrations. Cells were grown to OD595 1 
at 37˚C with shaking 225 rpm and the expression was induced with 1 mM 
IPTG. Also, biotin (Sigma) was added to final concentration of 100 µM. The 
cells were grown 3 h after which they were harvested by spinning at 4000 
rpm in JS 4.2 swing bucket rotor at 4 ˚C.  The pellets were resuspended into 
40 ml of buffer 50 mM Tris·HCl pH 7.5, 100 mM NaCl, 1 mM EDTA, 1 mM 
DTT, 10% (w/v) sucrose and protease inhibitor tablet (Complete, Santa Cruz 
biotechnology).  
 
The bioPcrA was purified by lysing the cell by sonication of four times 
for 30 s as for PcrA. The lysate was spun at 13 200 rpm in Beckman Coulter 
45 Ti rotor for 20 min. The protein was precipitated using solid ammonium 
sulphate to 50% saturation stirring at room temperature.  The precipitated 
bioPcrA was spun at 13 200 rpm using Sorvall 45 Ti rotor for 20 min and 
pellet was resuspended in buffer A (50 mM Tris·HCl pH 7.5, 100 mM NaCl, 1 
mM EDTA and 1 mM DTT). The protein was then loaded onto Softlink Avidin 
column (Promega) equilibrated in buffer A. The column was then washed 10 
column volumes. The bioPcrA was eluted with same buffer containing 5 mM 
biotin. The flow was stopped after one column volume and incubated for 30 
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minutes to allow biotin to exchange with biotinylated protein. After this the 
protein was eluted and highest absorbing fractions were pooled and loaded 
onto 5 ml HiTrap heparin column (GE healthcare #17-0407-01) equilibrated 
with buffer A.  The column was washed overnight with 300-400 ml of buffer 
A. The bioPcrA was eluted with a gradient of NaCl (100 mM to 1 M). The 
bioPcrA was concentrated using Vivaspin 10 000 MW CO column and buffer 
exchanged to buffer Tris·HCl pH 7.5, 200 mM NaCl, 1 mM EDTA , 1 mM DTT 
and 10% glycerol by overnight dialysis. The bioPcrA was then aliquoted and 
stored at -80˚C.  
2.8. Labelling of PcrA and Rep with maleimide-fluorophores 
 
The purified protein was stored in elution buffer (from FPLC 
purification) containing DTT and this was separated from protein by loading 
onto PD-10 gel filtration column (GE healthcare).  First, the column was 
equilibrated using buffer K200 (50 mM Tris·HCl pH 7.5, 200 mM KCl, 1 mM 
EDTA, 10 mM MgCl2 and 10%  (v/v) ethanediol) for RepD labelling and with 
PcrA labelling buffer (50 mM Tris·HCl pH 7.5, 300 mM NaCl and 3 mM 
MgCl2) for PcrA. The protein was applied to column and eluted using 
equilibration buffer in order to remove DTT. Fractions were collected, and 
analysed using absorbance at 280 nm for the presence of the protein. The 
fractions with the protein were then pooled and suitable labelling reagent 
was added at two times the protein concentration.  All fluorophores were 
used as solutions in dimethylformamide and Cy-derivative maleimides were 
from GE Healthcare; IDCC (N-[2-(iodoacetamido)ethyl] -7-
 diethylaminocoumarin -3-carboxamide) and MDCC (N-[2-(1-
maleimidyl)ethyl]-7-diethylaminocoumarin-3-carboxamide) were synthesized 
by J. E. T. Corrie (MRC NIMR, UK). The microcentrifuge tubes containing 
the protein and fluorophore were protected from light and incubated for 45 
minutes on a rotary mixer. Unbound fluorophore was removed using a PD-
10 column and eluted using K200 buffer (RepD) or PcrA labelling buffer 
(PcrA).  
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The fractions were analysed for the level of labelling by measuring an 
absorbance spectrum between 240-600 nm. The fluorophore concentration 
was determined first using its molar extinction coefficient at the absorbance 
maximum (MDCC ε430 - 44800 M
-1 cm-1, IDCC ε430 - 44800 M
-1 cm-1, Cy3 
ε547 - 150000 M
-1 cm-1, Cy3B ε559 -130000 M
1 cm-1 and Cy5 ε649 -250000 M
-
1 cm-1). This was used to determine the fluorophore absorbance at 280 nm 
(MDCC and IDCC ε280 - 7470 M
-1 cm-1, Cy3 ε280 – 11730 M
-1 cm-1, Cy3B ε280 
– 9450 M-1 cm-1 and ε280 - 7270 M
-1 cm-1). The fluorophore absorbance at 
280 nm was then deducted from the protein absorbance to enable accurate 
determination of protein concentration. The molar extinction coefficient used 
for PcrA was 75 875 M-1 cm-1 and 119 514 M-1 cm-1 for RepD. The labelling 
efficiency could then be expressed as a percentage. The labelling and 
quality of the new modified protein was also determined using electrospray 
mass spectrometry provided as a service by MRC NIMR, UK and done by S. 
Howell. The labelled protein was stored in 300 mM NaCl PcrA labelling 
buffer at -80 °C (PcrA) and in K200 buffer at -20 °C (RepD).  
 
2.9. PcrA and PcrA mutant steady-state ATPase hydrolysis assay 
using fluorescent spectrophotometer 
 
Wild type PcrA and mutant PcrA ATPase activities were determined 
using inorganic phosphate (Pi) biosensor, 6ATR-PBP which detects inorganic 
(Pi) production from hydrolysis of ATP by PcrA. This was measured using 
CARY Eclipse spectrofluorometer at 20ºC. 5 nm slits were used for excitation 
and 5 nm slit for emission and measurements were averaged over 1 s.  The 
excitation wavelength for 6ATR-PBP was 553 nm and emission wavelength 
of 577 nm.   
 
Each reaction had 10 nM of PcrA, 500 nM of dT30/50 (ssDNA) 
(Eurogentec Ltd), 10 µM of MDCC-PBP made in assay buffer containing 50 
mM Tris·HCl pH 7.5, 3 mM MgCl2 and 150 mM NaCl. The total of reaction 
volume in the cuvette was 60 µl. ATP was added to solution at different 
concentrations and the fluorescence change was followed over time. The 
same reaction mix was used to calibrate the fluorescence intensity using a Pi 
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titration. This enables the determination of the PcrA affinity to ATP measured 
as Km (µM) and the maximum velocity of the reaction catalysed by PcrA 
expressed as Vmax (M s
-1) by fitting the results to the Michaelis-Menten 
equation shown below (Equation 7) on GraFit 7 software (Erithacus software 
Ltd). The enzyme turnover number by PcrA expressed as kcat (s
-1) was 
calculated by dividing the Vmax by the PcrA concentration. S is the substrate 
concentration, which is the ATP concentration in these experiments. 
 
Equation 7: 
 
2.10. DNA junction unwinding assay using stopped-flow 
apparatus  
 
 
Wild type and mutant/labelled PcrA helicases were tested with wild 
type RepD for their ability to unwind dsDNA junctions. A HI-TECH scientific 
SF61MX stopped-flow (TgK Scientific Ltd) with xenon-mercury lamp was 
used. See Figure 20 for the stopped-flow set-up. Each reaction had 100 nM 
PcrA, 2.5 μM RepD (wild type), 200 μM ATP, 500 nM DNA substrate (10 bp, 
20 bp, 30 bp or 40 bp junctions labelled with Cy3 and dabcyl or with 
AlexaFluor350 and Dabcyl were from Eurogentec Ltd, Eurofins MGW Operon 
or Sigma-Aldrich Ltd) mixed in assay buffer K200. First, the RepD was mixed 
with DNA junction and incubated 5 min at 30 °C to allow the RepD loading 
and nicking of the DNA junctions. To this PcrA was added and the solution 
was incubated again for 5 min at 30 °C, after which the unwinding reaction 
was initiated by mixing with ATP in the stopped-flow apparatus. The 
reactions were measured at 30 °C. In each reaction, the PcrA and RepD are 
mixed together with ATP and excited at 548 nm and emission recorded 
through a 570 nm cut-off filter for Cy3-Dabcyl paired junctions. For 
AlexaFluor350-Dabcyl DNA junctions the excitation was at 346 nm and 
400 nm cut-off filter was used. Data from the stopped-flow experiments were 
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recorded using Kinetic Studio software (TgK Scientific Ltd). The fitting and 
analysis of traces was done using GraFit 7 software (Erithacus software Ltd).  
2.11. Plasmid unwinding assay on stopped-flow apparatus 
 
Plasmid unwinding was measured on a stopped flow apparatus at 
30 °C. A HI-TECH scientific SF61MX stopped-flow (TgK Scientific Ltd) with 
xenon-mercury lamp was used.  At typical reaction contained 0.5 nM 
pCERoriD plasmid, 190 nM PcrA, 2 nM RepD, 200 nM DCC-SSB(G26C) and 
1 mM ATP. In syringe A, plasmid was mixed with DCC-SSB and to this RepD 
was added and reaction was incubated for 30 seconds to allow RepD 
nicking. Then PcrA was added to syringe A and reaction was incubated 
further 30 s. Then the reaction was mixed with ATP in syringe B, which also 
contained 200 nM DCC-SSB. The excitation is done at 436 nm and emission 
is measured using 455 nm cut-off-filter.  
 
pCERoriD plasmids other than 3094 bp plasmid were constructed by 
Andy Slatter, MRC NIMR, UK [87]. The original pCERoriD plasmid 3094 bp 
was initially constructed to study PcrA-RepD plasmid unwinding from pUC19 
plasmid with insertion of oriD and hence most of the experiment here were 
performed with this plasmid [85, 88]. 
 
2.12. RepD nicking assay 
 
Each nicking reaction contained 1 µM RepD (10 µl of 2 uM RepD 
stock) and 10 µM of ICRII oligo (5’-CT*AATAGCCGGTT-3’, containing the 
RepD nicking sequence) made to total reaction volume of 20 µl using K200 
buffer. The reaction was incubated 5 min at 30 °C. One of the monomers of 
an active RepD dimer will nick and covalently bind the ICRII oligo. This runs 
slower on SDS-PAGE gel than the monomer unbound by ICRII oligo. The 
reactions were stopped by adding 20 µl of 2 x sample buffer (125 mM 
Tris·HCl pH 6.8, 4% SDS, 20% (v/v) glycerol, 10% (v/v) 2-mercaptoethanol 
and 0.25 mg/ml bromophenol blue) and boiled 5 min at 95 ºC. 10 µl of the 
reaction mix with the sample buffer were loaded onto 12% SDS-PAGE gels. 
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Gels were run with buffer made of 25 mM Tris, 1.44% (w/v) glycine and 0.1% 
SDS at 200 volts for 60 min. Gels were stained with coomassie brilliant blue 
R-250 (BioRad) for approximately 15 min at room temperature and destained 
with mix of 10% (v/v) acetic acid and 50% (v/v) methanol for 2-3 hours. The 
band sizes were quantified using UVIpro software. 
2.13. Tests for fluorescent signals of labelled PcrAs  
 
The labelled PcrA were tested for signal change on Cary 
spectrofluorometer by measuring excitation and emission spectrum and 
titrating in the substrate. For example, 200 nM MDCC-PcrA(E449C) was 
titrated with 1 µM RepD-DNA junction 1 complex with 2-fold excess of RepD. 
The emission maximum was determined by measuring the fluorescence 
spectrum (varying the excitation from 350 to 450 nm) with and without 
substrate. Similarly, the excitation maximum was determined by measuring 
the fluorescence spectrum (varying the emission from 450 to 550 nm). 
 
The newly labelled PcrA/RepD species were tested for fluorescent 
signals on a stopped-flow apparatus by mixing the labelled PcrA/RepD with 
high excess of PcrA/RepD ligand/substrate. For coumarin (MDCC/IDCC) 
labelled species a 436 nm wavelength excitation was used with a 455 nm 
cut-off filter. The signals were fitted using Kinetic Studio programme (TgK 
Scientific Ltd) and further analysed using GraFit 7 (Erithacus software Ltd). 
The fitting equations were chosen according to the mechanistic model best 
represented by the equation. The equations used were single, double 
exponential or single/double exponential with straight line and are stated with 
the results for individual measurements.  
2.14. DTNB assay 
 
The DTNB (Dithionitrobenzoic acid, Ellman’s reagent) assay was done 
to determine the accessibility/reactivity of the thiols on cysteine residues. 
This was done by dissolving 10 mM DTNB (# D8451 Invitrogen) into K200 
buffer. RepD was added to this at 5 or 10 µM final concentration. The 
absorbance change was measured on spectrophotometer at 412 nm 
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wavelength at room temperature. DTNB reacts with the thiol(s) in proteins 
cleaving the disulfide bond in DTNB resulting in an absorbance change. 
2.15. Size exclusion chromatography – multi angle light scattering 
(SEC-MALS) 
 
The oligomeric states of wild type PcrA and bioPcrA were determined 
on JASCO PU-1580 HPLC connected to Optilab rex (Wyatt) light scattering 
detector and a differential refractometer (dRI) (dn/dc = 0.186) (Dawn Helios, 
Wyatt). Possible different oligomer states were separated using a Superdex 
200 HR 10/30 column in 50 mM Tris·HCl pH 7.5, 100 mM KCl, 1 mM EDTA 
and 10 mM MgCl2 at a flow rate of 0.5 ml/min. 100 µl of samples were 
injected at the concentration of 0.5 mg/ml. The data were recorded using 
JASCO Chrompass Chromatography data system and ASTRA software. 
 
2.16. Stopped-flow apparatus set-up for fluorescence 
measurements 
 
 
Figure 20. Stopped-flow set-up. 
Reactants in the syringe A and B are mixed by pneumatic pump and 
obeserved in the observation chamber. The reaction flow is stopped by 
stopper block. Xenon-mercury lamp is the source for the white light that is 
passed through a monochromator enabling the excitation at specific 
wavelength. The emiting light is observed at 90° angle and passed through a 
cut-off filter at chosen wavelength. The intensity is measured using 
photomultiplier tube and converted to fluorescence units using Kinetic Studio 
software. 
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2.17. Single molecule experiments 
2.17.1. Flow-cell preparation for TIRFM assays 
 
The quartz slides were plasma cleaned and treated with Vectabond to 
obtain aminosilanisation of surfaces that were then PEGylated with a mixture 
of N-hydroxysuccinimide (NHS) ester- modified PEG with and without biotin. 
The flow cells were constructed by gluing three glass cover slips of 3 x 40 
mm on to a coverslip using UV glue. The PEGylated coverslip was glued on 
the three slips on the cover slip forming a chamber of volume of 15 µl with 
two open ends. 
 
2.17.2. Total internal reflection microscope set-up 
 
Total internal reflection fluorescence microscopy (TIRFM) was used to 
visualise the fluorescent objects (Figure 21). Excitation was via a totally 
internally reflected (TIR) green laser ( = 532 nm). A shutter was used to 
control the laser exposure time and enable time lapse imaging that allowed 
increased the overall observation time of the sample before photobleaching. 
Initially, the laser beam travels through set of lenses and mirrors, which 
expand the laser beam and then focus it at the back aperture of the objective 
lens; by moving one of the lenses (lense III) the incident TIR angle could be 
adjusted. Before hitting the glass-water interface, the laser travels through a 
high-numerical aperture objective lens (Fluar, 100x, 1.45 NA), which focuses 
the light beam. TIR light is used to excite the fluorophores at the evanescent 
field (~100 nm depth from glass cover slip). After passing through an 
emission filter (560 nm-590 nm), the emitted light is captured using a high 
sensitivity Andor digital, electron multiplying, charge-coupled device, camera 
(EMCCD camera) at 20 frames per second.  
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Figure 21. Set-up of objective type lens TIRFM. 
 
2.17.3. Photobleaching and PcrA density measurements on the glass 
surface using TIRFM 
  
The rate of photobleaching and measurement of the Cy3B-
bioPcrA(E449C) density on the flow-cell surface was measured under 
identical conditions used in the experiments using the same TIRF 
microscope.  Flow-cells constructed with the PEGylated coverslips (as 
described earlier) were incubated with 20 µg ml-1 of streptavidin for 15 
minutes and washed 5 times to remove excess streptavidin with buffer K100. 
The required concentration of Cy3B-bioPcrA(E449C) was added into the 
flow-cells and incubated at room temperature, in the dark, for 30 minutes 
after which they were washed 5 times with K100 buffer. PEGylated surfaces 
were “blocked” with biotin by incubation of Cy3B-bioPcrA(E449C) together 
with 9 µM of free biotin.  
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The flow-cells were then visualised using TIRFM with the laser power 
adjusted to 2.5 mW, measured at the sample plane (i.e. after passing through 
the objective lens).  This laser power causes the sample to photobleach fairly 
rapidly so that step-wise photobleaching events could be measured. The 
video records were analysed using the “Single Fluorophore Detection 
Algorithm” (SFDA) within the GMimPro software (GMimPro, freely available 
at http://www.nimr.mrc.ac.uk/gmimpro/). The computer algorithm searches 
the video data for sudden decreases in intensity at each pixel position over 
time, corresponding to Cy3B photobleaching events [160]. When the loading 
concentration of Cy3B-bioPcrA(E449C) was too high (0.5 nM and above) to 
visualise individual spots at the beginning of record, the number of objects on 
the first frame was determined by extrapolation. The extrapolation was done 
by averaging 5 frames and counting the objects at each time point using the 
“Automatic Single Particle Tracking” (ASPT) algorithm within the GMimPro 
programme [160] and by plotting the number of objects against time and 
fitting a single exponential with the rate constant determined from the 
exponential fitting of the photobleaching decay (measured from the change in 
integrated intensity across the entire field-of-view over time). The y-intercept 
(i.e. the amplitude) of the fit gives the total number of objects at the start of 
the records (See Figure 99 in the Appendix for the fits).  
 
Analysis of experimental measurements made using protein 
concentrations below 0.5 nM was done by averaging the first three video 
frames and performing ASPT detection followed by SFDA detection on the 
entire record. For spot density and photobleaching measurements the SFDA 
and ASPT analysis were done with the default settings (see GMimPRO 
helpfile for details): The ASPT default settings are Max.(R)adius of 5 pixels, 
Track(L)en of 20 steps, Q-threshold of 10, (C)last Thr of 300 counts/pixel and 
FWHM of 250 nm. Max.(R)adius is a parameter that determines the 
maximum radius used to link objects between frames. In another words, this 
is the maximum movement allowed between two frames for individual spot 
detected. Q-threshold is the estimate of how well the shape of the detected 
objects matches the ideal shape of a single fluorophore (Ideal shape of the 
single fluorophore is the 2D Gaussian distribution of fluorescence). 
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(C)lastThr, the clustering threshold, is the maximum intensity limit for the 
tracked object. This was selected as very high to include all the fluorescent 
objects with multiple fluorophores clustered together. Track(L)en selects for 
objects that last for certain number of frames. If the tracked object is 
terminated before a minimal number of data points then the track is 
discarded. FWHM is the full width at half maximum, which determines the 
size of single particle in nanometres. This is selected to the point spread 
function of the image system, which is close to the diffraction limit (For 
example for 500 nm light the FWHM is ~250 nm.) 
2.17.4. Single molecule plasmid unwinding assay 
 
The flow-cells constructed using the PEGylated coverslip (see above) 
were incubated with 20 µg/ml of streptavidin for 15 minutes and washed 5 
times to remove excess streptavidin with K100 buffer. The required 
concentration, typically 0.2 or 0.5 nM, of Cy3B-bioPcrA(E449C) or unlabelled 
bioPcrA was added into the flow-cell and incubated at room temperature in 
the dark for 30 minutes before washing 5 times with K100 buffer. The RepD-
plasmid complex of 8 nM pCERoriD plasmid and 250 nM RepD was 
prepared on a heat block by incubation at 30 °C for 10 minutes. The RepD-
plasmid complex was then incubated in the flow-cell for 10 minutes to allow 
bioPcrA binding to the RepD-plasmid. The reaction was started after the flow-
cell has been mounted onto the TIRF microscope using 1 mM ATP and 25 
nM Cy3B-SSB in buffer containing the oxygen scavenger and ATP 
regenerator system consisting of 10 mg ml-1 glucose, 50 µg ml-1 glucose 
oxidase, 400 µg ml-1, catalase, 500 µg ml-1 BSA, 1 mM DTT, 1 mM ascorbic 
acid and 1 mM methyl viologen. 15 µl of the ATP mix was flowed into cell by 
placing the pipette at one end of the flow cell and pipetting in the mix and 
simultaneously, drawing out the buffer already present in the flow-cell from 
the other end using a small piece of blotting paper. The experiments were 
done at room temperature (22 °C).  
 
Data analysis for single molecule plasmid unwinding was performed using 
GMimPro computer software, which is freely available at 
2. Materials and Methods 
 
94 
 
http://www.nimr.mrc.ac.uk/gmimpro/ [160]. Intensity changes due to 
accumulation or loss of fluorescent material at different positions on the 
coverslip surface (“spots” or “events”) were measured using the ASPT 
algorithm within GMimPro software with setting Max.(R)adius – 2 pixels , Q-
threshold - 10, (C)lastThr -30 000 counts/pixel, Track(L)en>100 steps and 
FWHM-250 nm. The ASPT parameters are explained above in Section 
2.17.3. 
 
The tracked events were then analysed using another piece of custom-
software called “Motility”, which can be considered as a satellite programme 
of GMimPro that allows one to remove erroneous events such as “spot 
landings” (where an aggregate of material suddenly arrives at the surface) or 
duplicate events and events with intensity change over 500 (often due to 
overlap when two neighbouring events are closer than the diffraction limit). 
The plasmid unwinding events were then fitted to a single exponential 
process using Igor Pro 6.0.1.0 (Wave Metrics, Inc.). The fitting of the plasmid 
unwinding traces to a single exponential (N(t) = No e
-t/tau ) gives a value for 
tau, which was multiplied by four to give the best estimate of ∆t (See Figure 
100 in the Appendix for example fits). This method was used as a semi-
automated analysis method to allow objective analysis of a large number of 
data traces. The single exponential fit was found to match the form of the 
data obtained from a large number of individual plasmid unwinding events. 
The fluorescence amplitude of the events, ∆I, is given by the amplitude of the 
single exponential fit. The onset of plasmid unwinding varied between 
individual events within a field of view and it was determined independently 
for each event by fitting a straight line to the intensity data around the time at 
which the first sudden increase in fluorescence intensity occurred and then 
finding the time at which that line cut the zero axis (the fluorescence 
background level before the start of the unwinding event). This fitted line also 
gave an estimate of the initial rate of unwinding. To test whether the 
maximum intensity was a function of unwinding rate ∆I was plotted against 
∆t. Also to investigate the dispersion in unwinding rates and final signal 
amplitudes the ∆t and ∆I distributions were plotted in histograms and fitted to 
Gaussian distribution on GraFit 7 (Erithacus software Ltd).
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3. Results-Fluorescent species of PcrA and RepD 
 
3.1. Introduction 
 
 
PcrA is a relatively well characterised helicase and many of its 
enzymatic processes have been determined in ensemble assays using 
fluorescently labelled substrates. For example, mantATP has been used to 
study ATP cycle of PcrA and 2-aminopurine/fluorescein labelled DNA 
structures have been used to investigate the ssDNA translocation and PcrA 
binding to DNA [51, 54, 87, 157, 158].  Fluorescent labelling of PcrA itself 
has not been used in the previously published work to study PcrA function 
in ensemble. The labelling of PcrA with environmentally sensitive 
fluorophores opens up another way to look at the known PcrA functions, but 
also may enable investigation of traits that cannot be determined solely by 
fluorescent labelling of its substrates and interactors. Previous work has 
included the fluorescent labelling of PcrA with fluorophores suitable for 
single molecule assays, mainly for FRET pairing with either DNA or by 
doubly labelling the PcrA (typically with Cy3 and Cy5 fluorophores) [94].  
 
Here, PcrA has been site-specifically labelled with the 
environmentally sensitive fluorophores using cysteine-maleimide chemistry 
together with fluorophores suitable for single molecule assays using TIRFM 
and FRET pairs. The method of designing the positions for labelling and 
their effect on PcrA and RepD are discussed in this Chapter. PcrA cysteine 
mutants were produced using site-directed mutagenesis and expressed and 
purified using the same method as wild type PcrA (Methods, Sections 2.4 
and 2.7.2.). The aim was to develop probes for several processes such as 
the ss/dsDNA binding with and without RepD, the PcrA interaction with 
replication/unwinding complex, PcrA translocation on ssDNA and while 
unwinding linear and plasmid DNA, which are both coupled to ATP 
hydrolysis. Similarly, RepD has been a target of site-specific labelling and 
together, the labelled PcrA and RepD with the use of suitable fluorophores 
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enabled the development of a FRET signal between PcrA and RepD and 
also the labelling of RepD with environmentally sensitive fluorophores. 
 
Site-specific labelling of PcrA has been achieved by the use of site-
directed mutagenesis, whereby 1 to 3 nucleotides are changed to code for 
cysteine residue at the desired location (see Methods for more detailed 
protocol for mutagenesis). Cysteine residues are required as they contain 
thiol groups (-SH), which are reactive and form covalent non-reversible 
bonds with maleimide or iodoacetamide groups [120, 161, 162]. The 
fluorophores attached through the maleimide or iodoacetamide group in 
them. Each site of labelling was chosen close to the interaction site of the 
process in question, as determined from the PcrA crystal structures at apo 
and substrate bound form. Since RepD does not have a crystal structure or 
a highly compatible homology model, the selection of RepD labelling sites 
has been more complicated, but the labelling was achieved by same 
method as PcrA labelling. The process of site selection is discussed in 
Section 3.3. 
 
An important consideration of site selection is the accessibility of the 
label to the site of modification. This means that all the sites chosen for 
labelling are on the PcrA surface and the amino acid residues orientated out 
from the core of PcrA. The sites are chosen so that they should not disrupt 
the native interaction and function of PcrA and its substrate, but close 
enough to cause an environmental or distance change on the fluorophore(s) 
when the two interact. To ensure a minimal effect on the enzymatic function 
of the PcrA, the labelled mutants have been tested using several assays, 
which measure the ATP hydrolysis rate during ssDNA translocation, the 
rate of linear dsDNA unwinding and the rate of full length plasmid unwinding 
[87, 93, 157]. 
   
The PcrA and RepD mutations done as a part of previously 
published work were also taken into account to ensure a minimal disruption 
of the wild type enzyme activity. Another factor to be considered is the 
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presence of wild type cysteines. These either need to be mutated out or 
should not be accessible to labelling.  
 
 The 2B subdomain of PcrA has been postulated as the RepD 
interaction site, as this domain is the closest to ICRIII sequence at the 
initiation complex and has no other indicated functions [21]. Seven 
mutations were introduced on the 2B domain; E447C, E449C, M450C, 
L453C, R501C and Y477C, of which four are on the top of 2B domain 
(Figure 22 and Table 1). All four mutations on the top of 2B domain E447C, 
E449C, M450C and L435C showed a RepD-specific signal. The results with 
these mutants are discussed in Chapter 5. Most of the work done here is 
with the labelled PcrA(E449C) as it showed the largest and the most RepD-
specific signal when tested with the RepD-DNA.  
 
The other sites chosen for cysteine mutation locations were sites for 
possible interaction signals with ss/dsDNA (H53C, K138C and also includes 
the Y477C and R501C) and ATP (E314C and G347C). The T167C is on 1B 
domain and together with other labelled PcrA mutants serves as a control 
for signals showing specificity to certain ligand binding, especially for 
possible RepD interaction site.  
 
PcrA(E449C) mutation was also successfully used for the 
development of FRET pair labelled PcrA and RepD (with fluorophore pairs 
MDCC-Cy3 and Cy3-Cy5) and so the E449C mutation was introduced to 
bioPcrA to be used in the single molecule assays and for the possible 
development of the single molecule FRET assays on TIRFM.   
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3.2. Fluorescent labelling of PcrA 
 
3.2.1. Fluorophore-labelled PcrA 
 
Eleven single cysteine mutations were designed on PcrA surface 
covering all four subdomains (Figure 22). All the purified PcrA cysteine 
mutants have been labelled with several fluorophores, but the first choice 
for environmentally sensitive fluorophores were the coumarin derivatives, 
MDCC and IDCC. These fluorophores have been successfully used in the 
past for development of highly specific and stable fluorescent biosensors 
with large signal changes [89, 118, 120, 121].  Several other 
environmentally sensitive fluorophores (CPM and MIANS) were also tested 
but none showed improvement to signals observed with MDCC. The other 
fluorophores included Cy3-derivatives suitable for FRET pairing and single 
molecule assays. Table 1 lists the location of mutation and the target of 
interaction and signals observed. The actual results with labelled PcrAs are 
discussed on in the following Chapters. Figure 23 shows the SDS-PAGE 
gel of the most significant labelled PcrA mutants. The expression, 
purification and labelling method clearly produce stable and pure labelled 
PcrA species. 
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Figure 22. PcrA cysteine mutations on substrate bound PcrA structure. 
PcrA(K138C) mutation is at the back of PcrA on the 1B domain loop and not 
visible in this figure. Yellow spheres indicate the mutation sites. Blue, 2B 
domain. Yellow, 1B domain. Red, 2A domain. Green, 1A domain. 
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PcrA mutation Domain Closest interaction site Signal observed with 
H53C 1A ATP, ssDNA ATP, ssDNA 
K138C 1B ss/dsDNA ss/dsDNA, ATP 
T167C 1B dsDNA No signal 
E314C 2A ATP, ssDNA ATP, ssDNA 
G347C 2A ATP, ssDNA ATP, ssDNA 
E447C 2B ss/dsDNA dsDNA, RepD 
E449C 2B ss/dsDNA dsDNA, RepD 
M450C 2B ss/dsDNA ss/dsDNA, RepD 
L453C 2B ss/dsDNA dsDNA, RepD 
Y477C 2B ssDNA ssDNA 
R501C 2B ss/dsDNA ss/dsDNA 
Table 1. PcrA cysteine mutations and their closest interactors 
according to substrate bound PcrA crystal structure.  
 
Figure 23. 12% SDS-PAGE gel analysis of the fluorophore-labelled PcrA 
and RepD wild type.  
A) 12% SDS-PAGE gel of wild type PcrA, labelled PcrA, bioPcrA(E449C) and 
labelled bioPcrA(E449C). The gel shows that new mutant PcrA are similar in 
size and contain no degradation of the protein. B)  12% SDS-PAGE gel of 
wild type RepD. The prepared wild type RepD has the ability to nick DNA 
with ICRIII sequence. 
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The efficiency of PcrA labelling was determined by calculating the 
protein and fluorophore concentrations using absorbance measurements. 
These were obtained by measuring the absorbance at 280 nm (mainly 
protein, but partly also fluorophore) and at the maximum absorbance of the 
fluorophore (MDCC/IDCC – 430 nm, Cy3 – 550 nm, Cy3B – 559 nm and 
Cy5 – 649 nm). The protein and fluorophore concentrations could then be 
expressed as a ratio of fluorophore per protein or as labelling percentage, 
where 100% labelling means one to one ratio of fluorophore to protein. This 
is a quantitative way to determine labelling efficiency, but does not enable 
distinction between free and bound fluorophore and can falsely indicate 
higher levels of labelling or multiple labelling of the protein. For this reason 
and to determine the correct expression and purification of the mutant, all 
labelled samples were also tested using electron-spray mass spectrometry. 
Mass spectrometry is not quantitative method to determine the ratio of the 
unlabelled versus labelled species, but can clearly indicate if some 
unlabelled protein is present. Mass spectrometry shows the molecular 
weights present to accuracy of +/- 2 Da.  
 
An important point before labelling any protein is the determination 
whether wild type cysteines exist in the protein and can these be labelled at 
conditions used for site-specific labelling. PcrA wild type has two cysteines, 
C247 and C96, which are buried in the PcrA and so are expected to be 
poorly reactive. This was tested by using same labelling protocol and 
conditions used for PcrA cysteine mutants labelling. The electron-spray 
mass spectrometry of labelled wild type PcrA showed a single 
macromolecule of molecular weight of 82,470.6 +/-2 Da. This corresponds 
well with the expected molecular weight of unlabelled wild type PcrA, 
82,472 Da. This indicated that the labelling conditions for PcrA modification 
do not cause significant labelling of the native cysteines and the labelling 
percentage determined are for site-specific labelling of PcrA. 
 
The labelling of cysteine mutants was highly specific. Table 2 
summarises the molecular weight of the fluorophore labelled PcrA mutant, 
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the labelling percentage and the protein yield per 0.5 L of bacterial culture. 
All the mutants expressed indicated similar levels of expression, apart from 
PcrA(T167C), which had half of the expression levels compared to other 
mutants. No clear reason has been found for this as on crystal structures 
the mutation of T167 doesn’t indicate an obstruction to the PcrA activity. 
Also, once the PcrA(T167C) mutant was labelled and tested for helicase 
activity, it was shown to have wild type-like activity. PcrA(R501C) is the only 
mutant that showed high precipitation during labelling with MDCC (not 
quantified). This is most likely due to the close proximity of the cysteine to 
the dsDNA interaction site on 2B domains (Figure 22). Even this mutant 
was shown to have wild type-like helicase activity (Table 3). 
 
Labelled PcrA mutant 
Molecular weight 
(Da) 
Labelling 
percentage 
Protein yield 
(mg/0.5 L) 
MDCC-PcrA(E449C) 82 828.5 100.2% 15.7 
Cy3-PcrA(E449C) 83 200.3 101.2% 15.7 
Cy5-PcrA(E449C) 83 226.2 106.2% 15.7 
MDCC-PcrA(H53C) 82 820.8 99.4% 10.5 
MDCC-PcrA(K138C) 82 830.0 99.6% 11.9 
MDCC-PcrA(T167C) 82 894.3 102.6% 7.1 
MDCC-PcrA(E447C) 82 829.6 96.4% 15.6 
MDCC-PcrA(M450C) 82 824.8 103.0% 17.9 
MDCC-PcrA(L453C) n/a 101.7% 14.8 
MDCC-PcrA(Y477C) 82 791.1 106.1% 13.6 
MDCC-PcrA(R501C) 82 908.2 97.8% 13.4 
bioPcrA 84 767.1 n/a 2.6 
Cy3B-bioPcrA(E449C) 85 425.0 91.0% 2.2 
 
Table 2. The analysis of the quality of new fluorophore labelled PcrA 
mutants.  
As a standard the final product, PcrA with fluorophore, was analysed using 
absorbance and mass spectrometry measurements. The labelling 
percentage was determined from the absorbance spectra. The protein yield 
was measured to confirm similar levels of expression and purification 
expressed here as total protein per 0.5 L of bacterial culture used.   
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3.2.2. The effect of mutations and labelling on PcrA activity 
 
A dsDNA junction unwinding assay was used to test the modified 
PcrA. This assay was developed to study the rate of DNA unwinding using 
DNA junctions modified with a quencher-fluorophore pair (at the distal end) 
on the stopped-flow [163]. Processive unwinding of DNA junctions by PcrA 
requires the presence of RepD [87] (Figure 24). In the assay PcrA was 
loaded on to the RepD-DNA before the unwinding was initiated by mixing 
with ATP. Once the helicase reached the end of the DNA junction, 
separation of the quencher from the fluorophore was detected as a 
fluorescence increase. The time that the helicase took to reach quencher-
fluorophore pair was observed as a lag, which is dependent on the number 
of base pairs unwound (Figure 24). The lag phase duration for each junction 
was then plotted against the number of base pairs unwound to obtain the 
value for rate of unwinding. This assay is an efficient way to look at the 
effect of the modification on PcrA, as it tests all the functions required for 
PcrA to be a processive helicase such as interaction with RepD, ssDNA 
translocation, dsDNA unwinding and ATP hydrolysis.  
 
When the DNA unwinding assay was done with coumarin-derivative 
labelled PcrA, Cy3-Dabcyl fluorophore-quencher pair labelled DNA 
junctions were used as the excitation and emission spectrum of Cy3 do not 
overlap with the coumarin excitation and emission spectrum. However, 
when Cy-dye labelled PcrA/RepD was tested, DNA junctions with an 
AlexaFluor350-Dabcyl pair were used to avoid the overlap of excitation and 
emission of the Cy-dyes. 
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Figure 24. DNA junction unwinding assay.  
Top image is a cartoon representation of DNA junction unwinding 
assay showing the structure of the DNA junctions. A) An example trace for 
20 bp DNA junction with linear fits to the lag phase and the increasing 
phase. The intercept of two linear fit is used as the time point for end of 
unwinding, which is 0.2 s for the example. B) Normalised traces for three 
lengths of DNA junctions. C) The linear fit of lag phase durations against 
number of base pairs for four DNA junctions. The gradient is 0.018 (SEM 
0.0013) and gives rate of unwinding of 56.6 bp s-1 (+/- 4.0). The 
experiments were done with 100 nM PcrA, 500 nM DNA, 2.5 µM RepD and 
200 µM ATP in K200 buffer at 30 °C. See Figure 18 for the DNA junction 
sequences. Typically, three DNA junction lengths were used in the assay. 
This has been shown to measure PcrA unwinding accurately as the same 
assay was carried out using four lengths of DNA junctions (10, 20, 30 and 
40 bp) with wild type PcrA and this had unwinding rate of 48 bp s-1. 
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The rate of unwinding on DNA junctions was measured for all PcrA 
mutants labelled with MDCC and for many labelled with other fluorophores 
and modification with biotin. They all showed similar unwinding rates to wild 
type PcrA with the rate varying between ~46-57 bp s-1. The average of all 
experiments was 51.5 bp s-1 (Table 3). The published rate for unwinding of 
DNA junctions is ~50 bp s-1 [87]. This shows that PcrA can be successfully 
mutated and labelled without affecting its helicase activity and the sites 
chosen here have no significant effect on PcrA helicase function. The 
unwinding rate of Cy3B-bioPcrA(E449C) was 52 bp s-1 showing that the 
biotinylation peptide on the N-terminal end, the biotin and the Cy3B do not 
disrupt its ability to interact with RepD and unwind DNA.  
 
 
Table 3. DNA unwinding rates of labelled PcrA cysteine mutants and 
bioPcrA. 
The assay was repeated for three times for MDCC-PcrA(E449C) and 
MDCC-PcrA(K138C). Between the different mutants and labels, the ~20% 
variation in rate of unwinding is generally observed.  
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The ATPase activity of the PcrA labelled mutants was surveyed to 
show any effect of cysteine mutation and the label. This was done by a 
steady-state, ssDNA-dependent ATP hydrolysis assay. Measurements were 
done using the Pi biosensor, 6ATR-PBP, as a fluorescent signal increase 
caused by the production of Pi from ATP hydrolysis by PcrA translocating 
on ssDNA (dT30/35) [120, 164]. The assay was repeated at various ATP 
concentrations and Figure 25 shows the Pi production rates against ATP 
concentration for MDCC-PcrA(E449C) on dT30 oligo and MDCC-
PcrA(K138C) on dT35. These rates were then compared to wild type PcrA 
ATP hydrolysis rate. Table 4 shows the values for Km and kcat for the 
reactions determined by Michaelis-Menten equation (Equation 7, Methods) 
for a variety of labelled PcrA. Km for the MDCC-PcrA(K138C) dT30 
translocation varies between 2.2 and 4 µM and is just over 4 µM for the dT35 
translocation. This further demonstrates that the mutations and the labelling 
do not change the PcrA activity. 
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Figure 25. PcrA steady-state ATP hydrolysis on ssDNA translocation 
measured using Pi biosensor.  
Measurements done at 20 °C in buffer 50 mM Tris·HCl pH 7.5, 3 mM MgCl2 
and 150 mM NaCl with 10 nM of PcrA, 500 nM of dT35 (A) or dT30 (B) and 10 
µM of 6ATR-PBP in Cary spectrofluorometer (Varian). ATP concentration 
was varied in each reaction. Pi biosensor was calibrated in same reaction 
mix using known concentration of Pi. The Km and kcat were determined by 
fitting the data to the Michaelis-Menten equation (Equation 7, Methods). 
 
PcrA   K
M
 (µM) k
cat
 (ATP s
-1
) ssDNA 
PcrA wt 3.1 (SEM 0.7) 6.5 (+/-0.4) dT
30
 
MDCC-PcrA(E449C) 2.2 (SEM 0.3) 7.9 (+/-0.3) dT
30
 
DCC- PcrA(E449C) 4.0 (SEM 0.7) 8.8  (+/-0.4) dT
30
 
Cy3B- PcrA(E449C) 3.1 (SEM 0.4) 7.9 (+/-0.3) dT
30
 
MDCC-PcrA(T167C) 3.1 (SEM 0.8) 10.5 (+/-0.7) dT
30
 
PcrA wt 4.0 (SEM 0.4) 22.8 (+/-0.5) dT
35
 
MDCC-PcrA(K138C) 4.5 (SEM 0.6) 22.1 (+/-0.8) dT
35
 
 
Table 4. Reaction rates of fluorophore labelled PcrAE449C, PcrAK138C 
and wild type PcrA. 
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3.2.3. MDCC-PcrA(K138C) activity in plasmid unwinding 
 
 
The MDCC-PcrA(K138C) helicase unwinding activity was further 
tested by measuring plasmid unwinding on the stopped-flow apparatus. The 
cartoon representation of the assay is shown in Figure 26. The assay uses 
the ssDNA biosensor DCC-SSB(G26C), which has high affinity and high 
fluorescence change when binding to ssDNA [89]. Once PcrA-RepD-plasmid 
complex is mixed with ATP, PcrA starts to unwind the plasmid releasing 
increased amounts of ssDNA to which DCC-SSB binds. DCC-SSB has high 
affinity to ssDNA (Kd = 28 nM for dT35) and at concentrations the free ssDNA 
will be bound by DCC-SSBs [121]. The traces observed are biphasic with a 
~25 s lag phase (Figure 27A). The first increasing phase is faster and is the 
actual plasmid unwinding and its duration varies with the length of the 
plasmid. The second slower increasing phase is most likely to be caused by 
the RepD nicking and re-ligation activity, which leads to some of the 
plasmids being relaxed but closed. Relaxed plasmids are poor substrates for 
RepD. This means that some of the plasmid unwinding is initiated later and 
observed as the second slower increasing phase. The breakpoint of the fast 
and slow phase is the end of single turn over unwinding, which is determined 
as the intercept of two linear fits, one to each phase. The assay was done 
with several lengths of plasmids and the plasmid unwinding durations were 
plotted against the number of base pairs of the plasmid to determine the rate 
of unwinding.  
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Figure 26. DCC-SSB plasmid unwinding assay.  
The assay was done on the stopped-flow apparatus by mixing the pre-
incubated PcrA-RepD-plasmid complex with ATP in presence of ssDNA 
biosensor DCC-SSB. 
 
 The plasmid unwinding rate by wild type PcrA and MDCC-
PcrA(K138C) are very similar, both ~30 bp s-1, showing that the plasmid 
unwinding is not affected by the MDCC-labelling or the K138C mutation of 
PcrA (Figures 27 and 28).  
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Figure 27. PcrA wild type DCC-SSB plasmid unwinding assay.  
A) Individual traces for five lengths of plasmid. The two phases were fitted 
with linear fits and the intercept of the fits was used as the end point of 
unwinding. B) Plasmid unwinding duration is dependent on the length of the 
plasmid. The linear fit of unwinding duration as a function of length of the 
plasmid has a gradient of 0.0323 (SEM 0.0022).The reciprocal of this gives 
an unwinding rate of 30.95 +/- 2.1 bp s-1. The experimental conditions were 
100 nM PcrA, 0.5 nM pCERoriD plasmid, 2 nM RepD, 200 nM DCC-SSB 
and 1 mM ATP in K200 buffer at 30 °C.  
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Figure 28. MDCC-PcrA(K138C) DCC-SSB plasmid unwinding. 
A) Individual traces of four lengths of plasmid. B) Plasmid unwinding duration 
dependence on length of the plasmid. The linear fit of unwinding duration 
against the length of the plasmid has a gradient of 0.0357 (SEM 0.0042). 
This gives an unwinding rate of 28.0 +/- 3.3 bp s-1. Experimental conditions 
were same as Figure 27. MDCC-PcrA(K138C) traces show higher noise due 
to high background  fluorescence from the coumarin label on the protein. 
This is also the most likely reason for the overlapping or crossing of traces 
shown in graph in Figure 28A and the small difference in total fluorescence 
change between the plasmids. 
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3.3. Fluorescent labelling of RepD 
 
3.3.1. Fluorophore-labelled RepD wild type 
 
   
RepD wild-type and cysteine mutants were labelled to enable 
development of a FRET assay with labelled PcrA. The FRET paired PcrA 
and RepD might be used in measurements in ensemble and at single 
molecule level. The same cysteine mutant locations were also used for 
labelling with environment sensitive fluorophores and tested for a 
fluorescent signal when RepD interacts with ss/dsDNA and PcrA. RepD wild 
type and RepD cysteine mutants were expressed and purified according to 
protocol stated in the Methods, Section 2.7.3.  
 
RepD is a 311 amino acid protein without a known crystal structure 
or a close homology based structural model. RepD wild type has one 
cysteine residue (residue 225). To test the thiol accessibility on RepD wild 
type, DTNB (Ellman’s reagent) assay was used. Figure 29 shows a 
measurement of DTNB reaction with the RepD. The traces have two 
phases, a faster phase and slower phase. The faster phase can be 
calculated to correspond to 10.8 µM TNB by converting the absorbance at 
412 nm to TNB concentration (The molar extinction coefficient of 14 150 M-1 
cm-1).  In the reaction there are 20 µM of monomers (10 µM of RepD 
dimers) and each monomer has single thiol (equals to 20 µM of thiols). The 
assay indicates that both the thiols on RepD dimer are accessible and 
slowly reactive. There may be a difference between the two thiols as two 
phases are observed. Possibly once one of the monomers (thiols) has 
reacted, the second thiol on the other monomer is poorly accessible or 
reactive. This may be due to physical change in the RepD dimer structure 
or the first fluorophore blocking the accessibility to the second thiol.  
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Figure 29. Thiol reactivity on wild type RepD dimer.  
RepD shows two phases of increased absorbance at 412 nm. Here, the 
absorbance has been converted to concentration of TNB. First phase has 
been fitted to a single exponential fit and the second to linear fit.  First phase 
has a rate constant of 8.1 x 10-3 is equivalent of 10.8 µM TNB.  The gradient 
of the linear phase is 2.8 x 10-6 µM s-1.  
   
As the C225 on RepD was shown to be reactive, the aim was to use 
it for labelling. The RepD labelling was carried out with MDCC, Cy3-, Cy3B- 
and Cy5-maleimide. The labelling of wild type RepD varied between ~30 to 
50% with two occasions reaching to ~70% of labelling but never achieving 
100% labelling. To simplify and provide comparison between different 
labelling attempts Cy3-maleimide was used for multiple testes of RepD 
labelling. These showed varying labelling percentages that rarely resulted 
over 50% labelling of monomers. This suggests only one of the RepD 
subunits is labelled. This kind of labelling is not common but could take 
place for example if the cysteines are located in the cleft of the dimerisation 
surface proving very limited space for fluorophore entry. In another words, if 
one monomer has covalently bound fluorophore on, there would be no more 
room for second one to react with the thiol of the second monomer. Due to 
large variation between labelling efficiency and not clear labelling of single 
RepD subunit, the wild type RepD proved not to be a good candidate for 
labelled RepD. 
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3.3.2. RepD N- and C-terminal cysteine mutants 
 
Another approach to label RepD was also used, in which the N- and 
C- terminal ends of the RepD were target for site-directed mutagenesis to 
produce cysteine residues. The N- and C- terminal ends of proteins are 
often on the surface of the proteins and as the structure of RepD is not 
known and no high sequence similarity homologue model exist/have been 
able to produce, the N- and C- terminals ends were the most preferable 
target for cysteine mutations. Wild type RepD has a single cysteine on its 
sequence and as shown here, this can be labelled to certain extent. For this 
reason it was necessary to mutate C225 to alanine. This mutation was 
confirmed by sequencing. RepD(C225A) was expressed and tested for 
activity (Figure 30).  
 
The construct containing the RepD(C225A) was then mutated using 
site-directed mutagenesis to have a cysteine mutation at N- or C- terminal 
ends (S2C and W310C). The RepD cysteine mutants were expressed and 
purified. Both RepD mutants, S2C and W310C, were labelled with Cy3-
maleimide. The absorbance spectrum of RepD(C225A, S2C) showed no 
maximum at 550 nm indicating that the S2C cysteine is not labelled with 
Cy3 and is inaccessible for the maleimide reaction. RepD(C225A, W310C) 
in contrast showed high labelling percentage (>80%) and electron-spray 
mass spectrometry showed only labelled species of the RepD mutant with 
molecular weight of 37 985.4 +/- 2 Da as expected. RepD mutants and the 
final labelled RepD were tested for wild type-like activity by RepD nicking 
assay on SDS-PAGE and by DNA junction unwinding assay (Figure 30 and 
Table 5). The RepD nicking assay is based on RepD function of only 
nicking and binding to DNA (here an ICRII oligo) using one of its subunits 
(often expressed as RepD/D*) [84]. On SDS-PAGE the monomer with DNA 
(RepD*) will run differently to the monomer without DNA (RepD) as was 
seen in on the gel in Figure 30. All the RepD mutants and Cy3-
RepD(C225A,W310C) were able to nick DNA as shown by SDS-PAGE. 
Cy3-RepD(C225A,W310C)  was also shown to initiate the dsDNA 
unwinding and make PcrA processive helicase similarly to wild type RepD 
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by DNA junction unwinding assay on the stopped-flow apparatus (Table 5). 
The nicking assay on SDS-PAGE shows an extra band on lane 9 in Figure 
30. This is possibly unlabelled RepD(C225A,W310C), but mass 
spectrometry analysis of the sample showed only labelled RepD species. 
Together the experiments provided enough evidence to say that the 
unlabelled species were in very low concentration compared to labelled 
species and they should have little effect on the overall results in the further 
experiments. 
 
 
Figure 30. SDS-PAGE gel of RepD nicking assay.  
M, protein standard marker. Wild type RepD with ICII oligo (1) and without 
oligo (2). Unlabelled RepD(C225A, S2C) with ICRII oligo (3) and without 
oligo (4). RepD(C225A) with ICRII oligo (5) and without oligo (6). Unlabelled 
RepD(C225A, W310C) with ICRII oligo (7) and without oligo (8). Cy3-
RepD(C225A, W310C) with ICRII oligo (9) and without oligo (10). The 
nicking assay was done by 5 minute incubation of 1 µM RepD with 5 µM 
DNA in K200 buffer at 30 °C. The monomers of RepD/D* dimer run 
differently on SDS-PAGE.  
RepD (wt PcrA)  Unwinding rate (bp s-1) 
RepD(C225A,W310C) 51 
Cy3-RepD(C225A, W310C) 50 
wt RepD  54 
 
Table 5. DNA junction unwinding is not affected by labelling and 
mutations on RepD.  
Wild type PcrA was used in all unwinding experiments. Experimental 
conditions were same as in Figure 24. 
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3.4. Discussion 
 
3.4.1. Fluorophore-PcrA adducts  
 
 
The labelling of PcrA was achieved to high level of specificity using 
thiol-maleimide chemistry. This has proven to be relatively simple and fast 
methods to produce fluorescently labelled PcrA. For example, once the 
wanted cysteine mutant has been purified, preparation of 100% labelled 
PcrA can be achieved in less than three hours and several labelling 
preparations can be done simultaneously (Table 2). The selection method 
of residues for site-directed mutagenesis by estimation of possible signal 
and accessibility has been successful for all expressed and purified 
proteins. 
  
 The activity of labelled PcrA has been tested mainly by the DNA 
junction unwinding assay, which measures PcrA unwinding rate. For PcrA 
to unwind DNA junctions successfully it must interact with RepD, bind and 
translocate on ssDNA, unwind DNA and turn over ATP [87]. By itself the 
assay provides a good indication of the activity of PcrA and the effect the 
mutations and labelling have had on it. All labelled PcrAs unwind DNA 
similarly to wild type at approximately 50 bp s-1. Steady-state ATP 
hydrolysis assay was carried to test the PcrA ssDNA translocation coupled 
ATP hydrolysis. This demonstrated that the labelled PcrA mutants have no 
significant change in Km or kcat of ATP turn over while it translocates on 
ssDNA. The assay was done to labelled PcrAs with most significant results 
which are used for results in Chapters 4 and 5 (MDCC-PcrA(K138C) and 
MDCC-PcrA(E449C)). 
 
MDCC-PcrA(K138C) was further tested in plasmid unwinding assay 
that uses full length plasmids. This was done as previous mutational work 
on PcrA has indicated in different helicase assay without RepD that 
mutating K138 to alanine, reduces PcrAs ability to unwind dsDNA without 
significant effect on ssDNA translocation activity [165]. The assay was done 
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in comparison to wild type PcrA and both showed a similar unwinding rate 
confirming that the RepD dependent unwinding is not affect by the mutation 
of K138 to cysteine and labelling this with MDCC.  
 
3.4.2. Fluorescently labelled RepD  
 
 
 RepD labelling was attempted using two methods. The first approach 
was to label the cysteine in RepD wild type (C225), and the second, was to 
introduce cysteine to N- or C-terminal ends of RepD. The labelling of wild 
type is beneficial for the obvious reason of not having to change the wild 
type RepD as introduction of mutations is more time consuming and may 
affect the actual function of the protein. The C225 did react with maleimide 
linked fluorophores but not to 100% labelling. The accessibility of the C225 
was tested using DTNB that indicated slow reactivity and possibly to mainly 
one of the subunits on the RepD dimer. This could indicate that the dimers 
bind in orientation that positions the thiols close together and once one thiol 
is labelled, the other is poorly reactive. Having a single fluorophore on 
RepD dimer would have been advantageous for future experiments. It could 
have caused less disruption the wild type activity of RepD but also 
simplified the interpretation of the results. 
 
As the full labelling of the C225 RepD was not achieved, the C225 
was mutated into alanine and site-directed mutagenesis was used to 
introduce cysteines to the N- and C- terminus of RepD. The C- and N-
terminal ends of proteins are often located on the protein surface and may 
be accessible for labelling. This method was successful as highly labelled 
RepD(C225A, W310C) was achieved with Cy3 and MDCC. RepD(C225A, 
S2C) showed no labelling implying that the orientation or the C-terminal end 
is buried in the RepD. MDCC-labelled RepD did not show a signal indicating 
that it is located or orientated far from interaction sites. Other possible 
explanation could that the RepD structural changes are too minor to cause 
environmental change in the MDCC fluorescent properties. The successful 
labelling of RepD enabled the development of FRET pair with labelled PcrA.
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4. Results- PcrA binding and translocation on ssDNA 
4.1. Introduction 
 
PcrA has an important function in replication of certain plasmids by 
separating the dsDNA into ssDNA, which is then replicated by DNA 
polymerase III [79]. The single stranded DNA that PcrA requires for loading 
onto DNA is opened by RepD nicking the dsDNA [85, 88]. PcrA translocates 
on ssDNA destabilising actively or passively the DNA base pairing. 
Therefore, the PcrA plasmid unwinding function is dependent on the ability 
of PcrA to bind and translocate on ssDNA, which is driven by the energy 
derived from ATP hydrolysis. Hence, understanding the PcrA characteristics 
of binding and translocating on ssDNA is vital for fully understanding how 
PcrA functions during plasmid unwinding. PcrA may also have other 
endogenous function(s) in bacteria that do not require PcrA helicase activity 
but rely on its ability to translocate ssDNA. This function could be in DNA 
repair. For these reasons developing assays to investigate the interaction of 
PcrA with ssDNA and translocation on ssDNA are beneficial for 
understanding the function of PcrA. 
 
PcrA K138 was chosen for site-directed mutagenesis and fluorophore 
labelling as it is located close to the ssDNA interaction site on PcrA (Figure 
31). The PcrA(K138C) mutant has been labelled with several fluorophores, 
but a signal specific for ssDNA binding and translocation was observed with 
MDCC-maleimide labelling. This signal has been characterised and MDCC-
PcrA(K138C) has been used to study PcrA binding and dissociation from 
ssDNA, PcrA translocation on ssDNA and how the DNA sequence affects 
the rate of translocation. 
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Figure 31. Cartoon representation of PcrA structures showing the 
K138C location.  
The yellow spheres indicate the location of cysteine residues introduced site- 
specifically on the surface of PcrA. The coordinates for the images were 
taken from PDB files 1PJR (open, apo) and 3PJR (closed, substrate bound) 
and visualised using PyMol (http://www.pymol.org/). 
 
4.2. MDCC-PcrA(K138C) binding to ssDNA  
 
4.2.1. MDCC-PcrA(K138C) has different affinities and fluorescent states 
when binding to the middle or to the ends of ssDNA 
 
When MDCC-PcrA(K138C) was mixed with ssDNA on the stopped-
flow instrument a fluorescent signal was observed. This signal was further 
characterised by mixing the MDCC-PcrA(K138C) with the varying length of 
the ssDNA, as the number of binding sites changes with the length of 
ssDNA (Figure 32). The signal varied according to the length of ssDNA. A 
very short oligo dT10 showed a decreasing signal, whereas the oligos longer 
than 35 bases had an increasing signal. Interestingly, the dT20 had two 
phases, which were a decreasing phase followed by an increasing phase. 
These results can be explained by MDCC-PcrA(K138C) having two different 
fluorescent states and affinities when binding to different parts of the ssDNA. 
The simplest explanation would that PcrA binds to the middle of ssDNA 
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differently than to the ends of ssDNA. As the short ssDNA dT10 with the 
largest end to middle ratio, has only a decreasing signal, PcrA bound to 
ssDNA ends must have lower fluorescence than free MDCC-PcrA(K138C) in 
solution. dT50 and poly dT with small end to middle ratios, showed only 
increasing signals. The primary form of binding is to the middle of ssDNA, 
which has higher fluorescence than MDCC-PcrA(K138C) free in solution. 
Together, the experiments with the different lengths of ssDNA confirm the 
end to middle binding-hypothesis suggested before [51], where the binding 
to the ends of ssDNA is faster than to the middle, but the middle state is 
thermodynamically more stable. The strongest evidence for this is the dT20 
ssDNA signal, which shows signals for both forms of binding. Initially the 
fluorescence decreases due to fast binding to the ends followed by an 
increase due to slow equilibration towards the more stable, middle-bound 
state. 
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Figure 32. MDCC-PcrA(K138C) binding to ssDNA has different 
fluorescent states whether binding to the middle or the end of ssDNA.  
A) Cartoon  representation of the reaction on the stopped-flow apparatus. 
B) PcrA binding to four lengths (dT10, dT20, dT50 and poly dT ~500 bases) of 
ssDNA. The experimental conditions were 100 nM MDCC-PcrA(K138C) 
mixed with 1 µM of ssDNA at 30 °C in K200 buffer. The excitation was done 
at 436 nm and the emission was measured using a cut-off filter at 455 nm. 
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To test the model further, the measurements were repeated with DNA 
structures lacking the ssDNA ends (Figure 33). These structures had a 
defined number of ssDNA (dT 10, 20, 30 or 50) between 10 bp double 
stranded structures at the 5’-and-3’ ends. They were called dTmiddle with a 
number indicating the length of the ssDNA middle. The different lengths of 
“no ends”-ssDNA structures were tested by mixing with MDCC-PcrA(K138C) 
on the stopped-flow apparatus. Regardless of the length of the ssDNA, all 
the DNA structures showed only an increasing phase. The signals obtained 
from ssDNA with and without ends were qualitatively and quantitatively more 
alike when longer ssDNA was used as they have the largest middle to end 
ratio. These measurements confirmed that the MDCC-PcrA(K138C) binding 
to the middle of ssDNA adopts a higher fluorescent state than when it binds 
to the ends of ssDNA.  
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Figure 33. MDCC-PcrA(K138C) end binding signal is removed when 
ssDNA has no single stranded ends. 
 A) Cartoon representation of the reaction and the DNA structures used for 
measurements. B) Normalised traces for dT10 and dT10middle. C) 
Normalised traces for dT20 and dT20middle. D) Normalised traces for dT50 
and dT50middle.  The experimental conditions were the same as in 
Figure 32. Figure 18 in the Methods shows the DNA oligonucleotides used. 
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MDCC-PcrA(K138C) binding to no ends-ssDNA traces were fitted 
with double exponentials. The first phase had an increase in the rate 
constant and the signal amplitude with increasing length of the middle 
ssDNA (Figure 34), while the rate constant and amplitude of the second 
phase were independent of ssDNA length. The biphasic nature of the signal 
indicates that two different processes are observed. These could be two 
binding modes even though ssDNA has “no ends”. PcrA may have a 
different conformation and affinity when it binds to a ssDNA/dsDNA junction 
than when it binds to the middle of ssDNA. However, the second phase 
does not show concentration dependence, which is normally observed with 
binding measurements (Scheme 1, Equation 3). This indicates the second 
phase to be something else than binding. It could be the conformational 
change in PcrA or the PcrA-DNA complex after binding to ss/dsDNA 
junction, which may be specifically induced by the DNA junction; hence it is 
not observed when binding to ssDNA with ssDNA ends.  
 
The rate constant kobs1 and the fluorescence change of the first phase 
have been plotted against the number of ssDNA bases and the data were 
analysed by a linear fit. The gradient of the fit is 0.46 s-1 nt-1 (SEM 0.06). 
Increasing the length of the ssDNA increases the number of PcrA binding 
sites (Figure 34). 
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Figure 34. Binding kinetics of MDCC-PcrA(K138C) to dTmiddle DNA 
structures are dependent on the ssDNA length.  
A) Cartoon representation of the reaction. B) Normalised traces for each 
length of dTmiddle ssDNA, which were analysed using a double exponential 
curve fit. C) The observed rate constant of the first phase (kobs1) from the 
double exponential fit plotted against the number of dTmiddle bases together 
with the linear fit. D) Relative intensities of the first phase (A1) plotted 
against the number of dTmiddle bases. Data were analysed by linear 
regression. The calculation for relative A1 was done by (absolute 
A1/(absolute A1+ absolute A2))*(C/Astart), where A2 is the phase 2 relative 
intensity and C the end fluorescence.  The observed rate constant of the 
second phase (E) and relative intensity (F) plotted against the number of 
dTmiddle bases. The normalisation of amplitude was done analogous to 
phase1.  
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4.2.2. PcrA binding kinetics to ssDNA (kon) 
 
Rapid mixing of MDCC-PcrA(K138C) with a dT20 oligonucleotide in 
the stopped-flow apparatus showed two phases with different fluorescence 
properties and rate constants. The two phases observed included a fast 
decreasing phase (binding to the ends of ssDNA called the end phase)  with 
~2% signal change, followed by a slower increasing phase with ~4% signal 
change (binding to the middle of ssDNA called the middle phase). The 
second phase is a mixture of binding processes to ends and to the middle of 
ssDNA (Figure 35).  
 
Varying the dT20 concentration showed that both phases have 
observed rate constants that are dependent on the concentration of dT20 
(Figure 35C and E). Figure 82 in the Appendix shows examples of the fits. 
The data for kobs at different dT20 concentrations were analysed by linear 
regression. The average of two measurements had a second order binding 
rate constant, kon, of 29.9 µM
-1 s-1 for the end binding mode and 1.1 µM-1 s-1 
for the second phase corresponding mainly to the middle binding mode.  
 
The two phases of dT20 binding indicate two different processes or 
two forms of the same process that are the binding to the end and to the 
middle of ssDNA, as discussed and shown before. The end and middle 
phase amplitudes do not increase with dT20 concentration, but this is not 
surprising as the concentration of dT20 in the experiments is above the Kd 
value for the dT20 binding, which means that the fluorescence signal is 
saturated at concentrations used (Table 6). Analysis of dT20 oligo results 
was complicated due to nature of processes and the signal observed, hence 
more emphasis were placed on the results with dT10 (shorter) and dT50 
(longer) binding measurements. 
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Figure 35. MDCC-PcrA(K138C) binding to dT20 ssDNA.  
A) Schematic illustration of MDCC-PcrA(K138C) binding to ssDNA 
measured using a stopped-flow apparatus. B) Normalised traces of MDCC-
PcrA(K138C) binding to different concentrations of dT20 ssDNA. The traces 
were analysed using double exponential curve fitting. As described in 
Section 4.2.1. the fast fluorescence decrease likely corresponds to binding of 
PcrA to the ssDNA ends, while the following increase reflects equilibration 
towards the more stable middle position. C) The observed rate constant of 
PcrA binding to the ends of ssDNA (1st phase) show concentration 
dependence. Fitting the kobs versus [dT20] data with a linear function gives 
the k+1 as the slope, which is 29.9 µM
-1 s-1 (SEM 4.9) (Equation 3, Scheme 
1). D) Plot of the amplitude of the first phase against the concentration of 
dT20. E) The observed rate constant of the second phase (final binding to 
the middle) is concentration dependent. Fitting the kobs to linear fit gives the 
k+1 as the slope, which is 1.1 µM
-1 s-1(SEM 0.2). The measurements were 
done on the stopped-flow apparatus with 100 nM MDCC-PcrA(K138C) and 
varying concentrations (0.5 to 4 µM) of dT20 oligo (only containing 
thymidines) in K200 buffer at 30 °C. The excitation was done at 436 nm and 
emission measured using a cut-off filter at 455 nm. 
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The binding kinetics of PcrA to other lengths of ssDNA were also 
measured using MDCC-PcrA(K138C). Figure 36 shows the individual traces 
and the fitting of the results for the binding of PcrA to varying concentrations 
of dT6 oligonucleotide. The dT6 binding traces were fitted to single 
exponentials. The amplitude and the kobs was dependent on the dT6 
concentration. Observation of a single phase indicated that the signal 
represents a single biochemical process. This could be expected as the dT6 
is approximately the minimum binding length of PcrA binding “footprint” on 
ssDNA (estimated to be ~7 bases) [21, 51]. This means that dT6 oligo has 
room to bind only a single PcrA molecule as when ssDNA is longer multiple 
binding sites may exist. MDCC-PcrA(K138C) binding to a dT6 
oligonucleotide is the only one tested not having two phases for binding, 
which can also be explained by its short length. Binding to dT6 most likely 
reflects only the end binding mode for PcrA. 
 
 The kinetics of binding of PcrA to dT6 showed hyperbolic 
dependence on dT6 concentration. Hyperbolic concentration dependence 
indicates two step binding, where the first phase is the actual binding and 
the second is a conformational change that causes the fluorescence signal 
(Scheme 3). The results from the fit are Kd1 of 4.96 µM (SEM 0.55) with k-2 
of 0.66 s-1 and k+2 of 3.72 µM
-1 s-1 (k+2 + k-2 of 4. 38, SEM 0.15). These were 
then used to calculate the Kd(overall)  using Equation 6. The Kd(overall)  was 
determined to be 880 nM. 
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Figure 36. MDCC-PcrA(K138C) binding to dT6 ssDNA.  
A) Cartoon representation of the reaction. B) Normalised traces for varying 
concentration of dT6. The traces were fitted to single exponential curves. C) 
Plot of the observed rate constant versus dT6 concentration. Data are well 
described by a hyperbolic fit. Results are average of a minimum of three 
traces. D) The fluorescence change plotted against the concentration of dT6. 
The experimental conditions were the same as in Figure 35 except the dT6 
concentration was varied from 0.5 to 10 µM. Example fits are shown in the 
Appendix, Figure 83. 
 
 
The concentration dependence of the observed rate constants was 
also measured with dT10 and dT50 oligonucleotides (Figure 37 and for the 
example fits, see Appendix, Figures 84 and 85). The signal of MDCC-
PcrA(K138C) binding to dT10 was decreasing. The second order rate 
constant for the first phase was 4.65 µM-1 s-1 (SEM 0.47). 
  
Mixing MDCC-PcrA(K138C) with dT50 showed an increasing 
fluorescence signal from which the binding rate constant of 10.8 µM-1 s-1  
was obtained (an average of two measurements). This was determined by 
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fitting the traces to a single exponential. This phase corresponds primarily to 
binding to the middle of ssDNA due to the large ratio of binding sites in the 
middle to binding sites at the end of longer ssDNA oligos. The signal had a 
slower second phase with small amplitude that did not show concentration 
dependence and hence has not been used for the analysis of the data. The 
amplitude of the first phase did not increase with the concentration of dT50. 
This is due to the high affinity of PcrA to dT50 (low Kd), which means that 
measurements were done in conditions where the PcrA binding was 
saturated at all dT50 concentrations used.  
 
 
Figure 37. MDCC-PcrA(K138C) binding to dT10 and dT50 ssDNA.  
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A) Normalised data traces for MDCC-PcrA(K138C) binding to varying dT10 
concentrations. The traces showed a second increasing phase after 2 µM of 
dT10.The signal was too low for accurate fitting to determine the kobs for the 
phase. B) The observed rate constants and C) the amplitudes from fitting of 
the decreasing phase (end binding) to single exponentials. kobs and 
amplitude were plotted against the dT10 concentration and fitted to a linear 
function. The results are averages of three traces. The gradient of the linear 
fit of kobs is 3.81 µM
-1 s-1 (SEM 0.24) The gradient of the linear fit of the 
amplitude is 0.98 per intensity µM-1 (SEM 0.09) D) Normalised data traces 
for MDCC-PcrA(K138C) binding to varying dT50 concentrations. These were 
fitted to double exponentials for the analysis. E) The observed rate constants 
and F) the amplitudes for the first phase (end binding) plotted against the 
dT50 concentration. Fitting the kobs values to a linear function yields the 
second order rate constant 9.73 µM-1 s-1 (SEM 1.21). The results are 
averages of three traces. The experimental conditions were the same as in 
Figure 35 except the dT10 and dT50 concentrations were varied from 
1 to 3 µM.  
 
4.2.3. PcrA dissociation kinetics from ssDNA  
 
To determine the dissociation rate constant, koff, for PcrA dissociation 
from ssDNA, a displacement assay was carried out on the stopped-flow 
apparatus. This was done by pre-loading the MDCC-PcrA(K138C) with 
ssDNA and mixing the complex with high concentration of unlabelled wild 
type PcrA (Scheme 2, Section 1.7).  
 
The displacement assay with dT6 had only a single phase with 
increasing fluorescence, understandably as it can be bound only by one 
PcrA. Data were well described by a single exponential. Having a single the 
dissociation rate constant was determined to be 0.71 s-1 (SEM 0.1 x 10-2) for 
primary dissociation from ssDNA ends (average of three traces at two 
different concentration of wild type PcrA). The rate of dissociation did not 
vary significantly between the two concentrations of wild type PcrA (12.5 and 
25 µM). An example trace is shown in Figure 38A.  
 
The displacement assay of MDCC-PcrA(K138C) from dT10 with wild 
type PcrA showed two phases (Figure 38B). The first phase was a fast 
fluorescence increase corresponding to wild type PcrA binding, and the 
second phase had a rate constant that was independent of wild type PcrA 
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concentration indicating displacement (Figure 87, Appendix). The second 
phase (dissociation phase) also had an increase in fluorescence. From 
these measurements a koff of 0.6 s
-1 (SEM 0.01) was obtained. The main 
form of PcrA dissociation from dT10 was expected to be from the ssDNA 
ends. The koff value of dT10 dissociation indicates this to be so as it is similar 
to the dT6 dissociation rate constant. With longer ssDNA oligos the 
dissociation was more complicated to interpret due to possibility of several 
PcrAs binding along one ssDNA oligo. 
 
 The displacement reaction with dT20 had three phases (Figure 38C 
and D). As with dT10, the first phase was a fast increase in fluorescence with 
a rate constant, which was dependent on the concentration of wild type 
PcrA. This indicated it to be informative of wild type PcrA binding in close 
proximity of MDCC-PcrA(K138C) on dT20 (Figure 87, Appendix) and not 
actual displacement. The two other phases were a fast increasing phase 
with a rate constant, koff of 11.98 s
-1 (SEM 0.44) corresponding to 
dissociation from the ends of ssDNA and a slower decreasing phase with  
koff of 0.14 s
-1 (SEM 0.7 x 10-3) corresponding to dissociation from the middle 
of ssDNA.  
 
The displacement assay to measure MDCC-PcrA(K138C) 
dissociation from dT50 had two primary phases, one for PcrA wild type 
binding (fast, increasing in fluorescence) and another for displacement from 
the middle of dT50 (slower decreasing phase) (Figure 38E). The fitting of the 
decreasing phase had a koff of 0.14 s
-1 (SEM 0.002). This is similar to the koff 
value observed for the second phase of dT20 dissociation which indicates the 
same process being observed, most likely dissociation from the middle of 
ssDNA.  
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Figure 38. PcrA dissociation kinetics from ssDNA.  
The dissociation was measured using a displacement assay where the 
MDCC-PcrA(K138C) is first bound to ssDNA and mixed with high excess of 
wild type PcrA. A) Displacement trace of MDCC-PcrA(K138C) from dT6 
oligonucleotide. This was fitted to a single exponential. B) Displacement 
trace of MDCC-PcrA(K138C) from dT10, which was fitted to a single 
exponential. C) Displacement trace of MDCC-PcrA(K138C) from dT20 on a 
short time scale. Data in this range were fitted to a double exponential. This 
trace shows the fast phase of wild type PcrA binding and the dissociation 
phase from ends of ssDNA. Displacement trace of MDCC-PcrA(K138C) from 
dT20 (D) and from dT50 oligonucleotide (E) on a longer time scale (100 
seconds) representing dissociation from the middle of the DNA. This was 
fitted to a single exponential plus a slope. The experiment was done by 
mixing 100 nM MDCC-PcrA(K138C) and 0.3 µM of dT50 or 0.5 µM dT6/10/20 
with 6 and 12.5 µM of wild type PcrA for dT6 and dT10, 12.5  and 25 µM for 
dT20 and 25 and 50 µM of wild type PcrA for dT50 at 30 °C. 
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4.2.4. PcrA dissociation constant (Kd) for ssDNA  
 
The comparison and understanding of these rate constants and 
values for the affinities are complicated by the fact that when the length of 
the ssDNA is increased, the number of PcrA binding sites increases. The 
size of the PcrA binding site has been estimated to be approximately 7 
bases [21]. This makes the exact determination of binding site concentration 
complicated. The above experiments indicate that the signals are from the 
MDCC-PcrA(K138C) binding to different lengths of the ssDNA (Section 
4.2.2.) and from the dissociation of MDCC-PcrA(K138C) by displacement 
with wild type PcrA (Section 4.2.3.). The dT6 oligo is the only one to show 
binding kinetics that fit well to a single exponential and the only one to show 
one phase in dissociation measurements without a second phase for PcrA 
binding. This is expected as dT6 should be too short to bind two PcrA 
helicases and these results indicate it to be so. In displacement assays 
using other tested oligos, dT10, dT20 and dT50, a fast phase for binding of a 
second (or more?) wild type PcrA close to MDCC-PcrA(K138C) proceeds 
the dissociation phase. This does not necessarily mean that two or more 
PcrAs are directly interacting forming an oligomeric helicase as the 
fluorophores are relatively large and have long linkers, so their environment 
might change when two or more proteins bind close to each other on the 
same ssDNA. The increasing phase is fast followed by the displacement 
signal, which should be little affected by the binding signal. The 
measurements of kon and koff for different lengths of ssDNA are summarised 
in Table 6. The dissociation constants Kd were calculated according to 
Equation 6 (Section 1.7) and are also shown in Table 6. 
 
PcrA dissociation constant to dT10 was calculated as 130 nM using 
Equation 4 and the measured kon and koff values. The MDCC-PcrA(K138C) 
affinity to dT50 had a Kd of 13.9 nM. These two results are the most accurate 
measurement of PcrA affinity to ends of ssDNA (dT10 Kd) and to the middle 
of ssDNA (dT50 Kd). PcrA binding to the middle of ssDNA, has a tighter 
affinity than PcrA binding to the end of ssDNA as expected, as most of the 
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PcrA finally ends up there in binding measurements after an initial fast 
binding-dissociation from the ends of ssDNA. 
 
 For dT20, determining accurately the Kd is complicated. Even it can 
be expected that the two phases of binding and dissociation were 
corresponding primarily to one of the process, binding to the ends or to the 
middle of the ssDNA. The second phase of binding and the first phase of 
dissociation are unlikely to be reporting of a single process due to very 
probable re-arrangement caused PcrA binding and dissociation from all the 
parts of ssDNA. For dT6, the binding measurements showed a two step 
process and enabled determination of Kd (overall) from a hyperbolic fit to the 
binding data and yielding an affinity of 880 nM. The koff was measured in a 
displacement assay and was 0.71 s-1 for dT6.  This is very similar to koff 
observed for dT10 and for k-2 calculated from the hyperbolic dependence of 
the MDCC-PcrA(K138C) binding to dT6 (Table 6).  
Binding with linear dependence 
dT (bases) 
kon end 
(µM-1s-1) 
kon middle 
(µM-1s-1) 
koff end (s
-1) koff middle (s
-1) 
Kd_end 
(nM) 
Kd_middle 
(nM) 
6 n/a* n/a 0.71 n/a n/a* n/a 
10 4.65 n/a 0.61 n/a 130.1 n/a 
50 n/a 9.73 n/a 0.14 n/a 13.9 
Binding with hyperbolic dependence 
dT (bases) 
Kd1 (µM) k+2 end (µM
-1s-1) k-2 end (s
-1) Kd (overall) end (nM) 
6 4.96 3.72 0.66 880.0 
Table 6. Rate constants and equilibrium binding constants for the 
interaction of PcrA with different lengths of ssDNA.  
The kon and koff values for dT oligonucleotides were obtained from binding 
and dissociation measurements using MDCC-PcrA(K138C). Binding kinetics 
of dT10 and dT50 showed a linear dependence of kobs on ssDNA 
concentration, whereas the dT6 results are from PcrA binding to dT6 
measurements, where hyperbolic dependence of rate constant was 
observed with increasing dT6 concentration. The Kd(overall) for dT6 is 
significantly higher than what was measured for dT10. This most probably 
caused by its short length, which makes it poorer binding substrate for PcrA 
than longer oligo nucleotides. 
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4.3. PcrA translocation on ssDNA using MDCC-PcrA(K138C) 
  
4.3.1. MDCC-PcrA(K138C) signal when translocating on ssDNA 
 
Making the use of the different signals of MDCC-PcrA(K138C) 
binding to ssDNA, a ssDNA translocation assay was developed on the 
stopped-flow apparatus. When MDCC-PcrA(K138C) was pre-bound to 
ssDNA and then mixed with ATP, a signal was observed for rapid MDCC-
PcrA(K138C) translocation to the 5’ end of the ssDNA that enabled the 
measurement of the duration of translocation on the ssDNA (reaction 1, 
Figure 39A). PcrA, ssDNA and ATP are all that is required for translocation 
and fast ATP hydrolysis by PcrA.  
 
The reactions in Figure 39A vary in what component is premixed with 
PcrA. When MDCC-PcrA(K138C) is pre-bound to ssDNA (reaction 1) it 
starts from a higher fluorescence state than ATP bound PcrA (reaction 3). In 
reaction 2, where MDCC-PcrA(K138C) is mixed with ATP and ssDNA at the 
same time, a fast decreasing phase is observed corresponding to ATP 
binding shown in graph B as reaction 4 (Figure 39B). The reactions with 
PcrA, ssDNA and ATP all end in the same steady-state, where PcrA 
repeatedly binds, translocates and dissociates from ssDNA (Figure 39A). 
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Figure 39. MDCC-PcrA(K138C) signal in ssDNA translocation.  
Reactions 1 - 4. 1. Green trace, MDCC-PcrA(K138C) was pre-bound to 
ssDNA and then mixed with ATP. 2. MDCC-PcrA(K138C) was mixed with 
ATP and ssDNA. 3. MDCC-PcrA(K138C) was pre-bound to ATP and then 
mixed with ssDNA. 4. MDCC-PcrA(K138C) was mixed with ATP only. In 
graph A, in all experiments the same steady-state of PcrA binding, 
translocating and dissociating from ssDNA should be reached. Therefore, 
the traces were normalised to the fluorescence value at the end of the trace. 
In Graph B, the traces were normalised to the beginning of the trace, since 
they should start from the same fluorescence level (only MDCC-PcrA). 
Graph B shows that the initial phase in reaction 2 is the ATP binding. The 
experimental conditions for the reactions were 100 nM MDCC-PcrA(K138C), 
1 µM dT20, 200 µM ATP in K200 buffer at 30 °C, except reaction 4 did not 
include dT20. 
 
The signal observed when MDCC-PcrA(K138C) was pre-bound to 
ssDNA and then mixed with ATP (Figure 39, reaction 1) was further 
analysed and used to develop an assay for determination of the 
translocation rate of PcrA on ssDNA. Out of the three reactions this reaction 
represents the simplest system for observation of PcrA ssDNA translocation. 
Figure 40A shows the three different phases of the signal. This is observed 
as a constant decrease in fluorescence. The duration of the decreasing 
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phase is dependent on the length of the ssDNA. Using various lengths of 
ssDNA has enabled the determination of the translocation rate of PcrA on 
ssDNA under different conditions. The reciprocal of the gradient of a linear fit 
to the translocation end points against the number of bases gave a 
translocation rate of 99 +/- 2.0 bases s-1 at 20 °C (Figure 40). These 
measurements were done in the same conditions as previously published for 
PcrA translocation on ssDNA to validate the assay [51]. The previously 
published assay used 2-aminopurine labelled oligos and the rate observed 
here (99 bases s-1) is similar to what had been observed previously (>80 
bases s-1) taking into account the possible difference between preparations 
of PcrA, and oligonucleotides and fluorophores used. The comparison of the 
two assays confirms the functionality of the MDCC-PcrA(K138C) based 
assay to study the PcrA translocation rate on ssDNA.  
 
Often in translocation and unwinding assays several lengths of DNA 
are used. This is important to dissect the translocation from other processes 
such as binding, conformational changes and dissociation, which are not 
linearly dependent on DNA length. For example, if a conformational change 
of PcrA and/or DNA is required at the beginning, this should be the same for 
all the DNA lengths tested. This would be removed by measuring the 
translocation on several lengths of DNA as the rate is determined from the 
reciprocal of the gradient of a linear fit to translocation/unwinding durations 
against the number of bases for each DNA length. 
 
The assay was repeated in K200 buffer at 30 °C to provide a rate of 
translocation at the same conditions as in the DNA junction unwinding and 
plasmid unwinding assays (Figure 40). The rate of translocation was 240 +/- 
4.1 bases s-1. Similarly, the assay was repeated at single molecule assay 
conditions at 22 °C in TIRF buffer and with dT oligos varying from 10 to 70 
bases (Figure 88, Appendix). This had a translocation rate of 133.3 +/- 5.3 
bases s-1. This will be used in Chapter 6 to compare the ssDNA 
translocation rate to the plasmid unwinding rate measured at single 
molecule level using TIRFM. 
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Figure 40. PcrA translocation rate on ssDNA.  
A) Schematic illustration of MDCC-PcrA(K138C) translocating on dT20. The 
three phases of each trace are 1. PcrA translocation to the 5’ end of ssDNA, 
2. re-organisation of steady-state and 3. steady-state of PcrA binding, 
translocation and dissociation. B) Normalised traces for K138C translocation 
on four lengths of ssDNA (dT10, dT20, dT35 and dT50) at 20 °C. The time point 
with the lowest fluorescence, which is the same as the end of the first phase 
indicates the end of the first round of ssDNA translocation. C) Linear fits to 
ssDNA translocation durations for four lengths of ssDNA. The gradient at 
20 °C is 0.0101 (SEM 0.0002) and at 30 °C the gradient is 0.0041(SEM 6.0 x 
10-5). The experiments at 20 °C were done in PcrA assay buffer and at 30 °C 
in K200 buffer and had 100 nM MDCC-PcrA(K138C), 1 µM dT oligo and 
200 µM ATP. 
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The translocation signal was tested for the possible effects of varying 
the ATP concentration. In these measurements, the ATP was in high excess 
to prevent it from being the limiting factor for the rate of translocation. The 
translocation assay was done as before on the stopped-flow instrument with 
dT35 ssDNA at varying ATP concentrations (50 to 300 µM) (Figure 41). As 
the end point of translocation varied minimally between the measurements, 
it could be concluded that the ATP at concentrations used in the assay (200 
µM) does not affect the rate of translocation or the fluorescent signal. This is 
expected as the ATP is well above the known Km for PcrA ATP binding 
[157]. 
 
 
Figure 41. MDCC-PcrA(K138C) translocation reaction is not affected by 
the ATP concentration in the range used.  
The experimental conditions were as in the Figure 40 at 30 °C except that 
the ATP concentration was varied from 50 to 300 µM. 
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4.3.2. PcrA translocates at different speeds on different 
deoxynucleotide sequences 
 
The development of a simple assay to monitor PcrA translocation on 
ssDNA enabled the investigation of PcrA translocation rates on different 
types of DNA sequences. Interestingly, when the oligonucleotide sequence 
was changed the signal varied and showed that PcrA translocates at 
different rates on different deoxynucleotides. The translocation on dC oligos 
was measured to be 526 bases s-1 +/- 26.5 at 30 °C (Figure 42). This is 
double the translocation rate on dT oligos. The difference between 
translocation rates on dCs and dTs could also be observed with oligos made 
of differing proportions of dT and dC repeats. By changing the dC proportion 
from 42% to 57% in a 35 base oligonucleotide showed a faster translocation. 
With four repeats for dCs (5’-CCCCC TTTTT CCCCC TTTTT CCCCC 
TTTTT CCCCC-3’) the end of translocation was 0.097 s and with three 
repeats of dCs (5’-TTTTT CCCCC TTTTT CCCCC TTTTT CCCCC 
TTTTT-3’) it was 0.102 s.  
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Figure 42. PcrA translocates faster on dC oligos than on dT oligos.   
A) Raw data traces for MDCC-PcrA(K138C) translocation on dC 
oligonucleotides. B) Plot of translocation durations against the number of 
bases on the dC oligonucleotide. C) The PcrA translocation duration varies 
according to the composition of the ssDNA sequence. The dTC35 has 35 
bases of which 20 are dTs and 15 are dCs. dCT has 35 bases of which 15 
are dTs and 20 are dCs. Experimental conditions are the same as in the 
Figure 40 at 30 °C. 
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The ssDNA translocation experiment was repeated with 
oligonucleotides made of dA bases. The traces were qualitatively and 
quantitatively dependent on the length of ssDNA (Figure 43). The shorter 
lengths (dA10 and dA20) did not show obvious end points of translocation 
when reaching the 5’-end, but clearly were indicating shorter translocation 
duration. This was also seen with dT10 oligo at 30 °C in the same assay. 
With longer dA oligos the end point of translocation is more defined and 
using several longer dA oligo lengths (up to 70 bases), the translocation rate 
has been determined as 260.9 +/- 16.6 bases s-1 (average of two 
measurements).The dA35 and dA50 oligos have signals with more defined 
end points of translocation that are 0.14 s for dA35 and 0.20 s for dA50. 
Compared to dC and dT ssDNA translocation, these values are very similar 
to what has been observed for dT oligonucleotides (dT35 -0.15 s and dT50 – 
0.21 s). The rate of translocation on dA was shown to be similar to what was 
measured for dT (Table 7). The dA35 signal showed an unexpected shoulder 
before the decrease in signal, which could not be explained, but was 
reproducible. It could be a result of the dA35 preparation and its quality as a 
single preparation was used in all the measurements. 
 
4.Results-PcrA binding and translocation on ssDNA 
144 
 
 
Figure 43. MDCC-PcrA(K138C) translocation on oligonucleotides with 
different base composition.  
A) Normalised data traces for translocation on dA oligonucleotides. B) The 
end points of translocation plotted against the number of bases on dA oligos. 
The linear fit has a gradient of 0.0036 (SEM 0.0002). C) Raw data traces for 
MDCC-PcrA(K138C) translocation on oligonucleotides with a random 
sequence. D) The translocation durations plotted against the length of the 
oligonucleotide. The gradient of the linear fit is 0.0026 (SEM 8.5 x 10-5). The 
end point of translocation was determined as the intercept of two linear fits, 
the first fitted to the fast decreasing phase and the second to the constant or 
slowly decreasing phase. See Figure 89 in Appendix for the fitting to 
determine the duration of translocation. E) Normalised trace translocation on 
dG oligonucleotides without clear signal for end of ssDNA translocation. All 
the experiments were done as stated in Figure 40. 
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The random sequence oligonucleotides containing all four bases (C, 
T, A and G) showed traces similar to that of the dT oligonucleotides, but 
without a clear second phase, which would corresponds to re-organisation to 
steady-state (Figure 43C and D). This made the time point for the end of 
translocation more complicated to determine. However, the first phase 
corresponding to ssDNA translocation varied in steepness and in the time 
taken to reach the steady-state with the length of the oligo. The time points 
were plotted against the number of bases of each oligonucleotide. The 
reciprocal of the plot gave a translocation rate of 385 +/- 12.6 bases s-1. The 
method used to analyse the individual random sequence traces was 
significantly different to the way traces with the re-organisation phase were 
analysed. This cause some error in the actual rate of translocation, but as 
the parameter used for fitting was directly dependent on the length of oligo, 
this should be equally accurate method as used for dT, dC and dA oligos. 
The rates for PcrA translocation on different oligo sequences have been 
summarised in Table 7. 
 
Different lengths of dG oligonucleotides were obtained and tested 
(Figure 43E). These were complicated to produce and especially dG45 was 
reported to be impure (HPLC analysis done by the manufacturer). No 
difference was observed between the different lengths of oligonucleotides. 
The deoxyguanosine repeats are known to form G-quadruplexes and certain 
helicases have been shown to remove these structures [166, 167]. The 
ability of dG repeats to form secondary structures may be the reason for the 
more complicated purification and production, but also for the signals 
observed with PcrA. This could indicate that PcrA is not able to remove 
secondary structures from ssDNA. The possible secondary structure of dG 
oligos could be tested further using circular dichroism.  
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ssDNA 
Rate 
(bases s
-1
) 
Temperature (°C) Buffer 
dA 260.9 (+/- 16.6) 30 K200 
dT 238.3 (+/- 15.5) 30 K200 
dC 526.3 (+/- 26.5) 30 K200 
dG n/a 30 K200 
dRandom 384.6 (+/- 12.5) 30 K200 
dT 99.0 (+/- 2.0) 20 PcrA 
dT 133.3 (+/- 5.3) 22 TIRF 
 
Table 7. Summary of PcrA translocation rate on different 
oligonucleotide sequences.  
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4.4. Discussion 
 
4.4.1. PcrA has different modes of binding to different parts of ssDNA  
  
   
 The labelling of the PcrA cysteine mutant K138C with a coumarin 
fluorophore (MDCC) enabled the investigation of PcrA binding to ssDNA. 
The comparison of signals with different lengths of ssDNA indicated that 
MDCC-PcrA(K138C) has different fluorescent states and affinities when 
binding to the end or to the middle of ssDNA. The crucial evidence was the 
MDCC-PcrA(K138C) signal with dT20, showing a decreasing signal for 
binding the ssDNA ends followed by an increasing signal for binding to the 
middle.  Oligonucleotides shorter than dT20 had only a decreasing phase. 
The longer oligonucleotides had only an increasing fluorescent phase. This 
was further tested by removal of ssDNA ends by introducing double stranded 
DNA sequences at the 3’ and 5’ ends.  The traces obtained with these “end-
less” DNA structures did not show a decreasing fluorescent phase, 
regardless of the length of ssDNA in the middle, When one ssDNA end (3’ or 
5’) was present, the traces showed a phase for end binding with a decrease 
in fluorescence, indicating that both 3’ and 5’ –ends are bound by PcrA and 
induce a low fluorescence state. After the decreasing phase, the traces 
varied in size and shape, but no distinction could be made between binding 
to the two ends of ssDNA (3’ or 5’). 
  
 The difference in affinity for ssDNA ends versus the middle of 
ssDNA may serve a purpose in vivo in DNA reeling used for removing RecA 
off from DNA in DNA repair (without RepD) [94], as the end parts of ssDNA 
may be faster to “find” but for PcrA to perform its helicase/translocase 
activity it is better located at the middle of ssDNA for movement. In addition, 
the conformation of PcrA when bound to ssDNA ends might be different from 
the PcrA-ssDNA complex bound in the middle. The actual in vivo substrate 
for PcrA is a plasmid, which doesn’t have free ends and is a substrate with 
ssDNA/dsDNA junctions opened up by RepD, hence preferred binding to the 
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middle of ssDNA is likely to be required for the actual plasmid unwinding 
function of PcrA (Process 2 in Figure 9). 
 
 Previous experiments measuring ATP hydrolysis during ssDNA 
translocation have indicated a possible difference in PcrA association and 
dissociation from the end versus the middle of ssDNA [54]. MDCC-
PcrA(K138C) has provided the first direct evidence for this process. Another 
advantage of using labelled PcrA over assays using 2-aminopurine labelled 
oligonucleotides is the lack of DNA length limitations. 2-aminopurine labelled 
oligonucleotides show no fluorescent signal when the oligonucleotide is 30 
bases or above as in longer ssDNA PcrA binds too far from the fluorophore 
[51]. This is not a limitation with the labelled PcrA, hence MDCC-
PcrA(K138C) showed a signal for binding to long ssDNA such as poly dT 
(~500 bases) (Figure 32). 
 
4.4.2. PcrA affinity to ssDNA using MDCC-PcrA(K138C) 
 
 
 The MDCC-PcrA(K138C) enabled us to determine the affinity of 
PcrA to different lengths of ssDNA. These varied from 14 nM to 880 nM in Kd 
for oligonucleotides from dT6 to dT50 bases. The variation of the Kd values is 
relatively large, but not surprising as the experiments showed that PcrA has 
different affinity to the ends and the middle of ssDNA. In other words, with 
the different lengths of ssDNA one form of binding is preferred or dominating 
over other(s) leading to different affinities.  
 
 The dT20 oligonucleotide is the only one of the tested ssDNA 
lengths to show clearly two phases for two modes of binding in both 
association and dissociation measurements. The determination of Kd values 
for the end and middle phases from the results is complicated as there is 
likely to exist some form of rearrangement during the phases observed. The 
Kd for the end binding can most confidently be determined from dT10 
measurements, which had a Kd of 130 nM. Similarly, the PcrA affinity to the 
middle of DNA can be most confidently be determined from dT50 
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measurements. This had a Kd of 14 nM. The Kd values indicate that the 
binding to the middle is 9 times tighter than to the ends of ssDNA and 
support the hypothesis of a more thermodynamically stable binding to middle 
of ssDNA than to the ends of ssDNA. This tighter binding to the middle of 
ssDNA is likely to be a requirement for a more processive and efficient 
helicase activity in the plasmid unwinding in vivo. 
 
 With short lengths of ssDNA, such as dT6, PcrA is binding only in 
the “end binding mode”, hence PcrA has the lowest observed affinity to dT6 
(Kd (overall) = 880 nM). The Kd is higher than what was observed for all other 
lengths of ssDNA. The dT50 is the opposite of dT6 in terms of having PcrA 
bound mainly to the middle of ssDNA and therefore has the lowest Kd of 14 
nM and so the tightest PcrA binding.  
 
 The MDCC-PcrA(K138C) binding to dT10 showed binding with two 
phases at higher dT10 concentrations (from 2 µM onwards), but only the first 
phase was used for determination of the binding rate constant. The signal of 
the second phase was too small for accurate fitting but as it is increasing in 
fluorescence, it can be postulated to be the binding to the middle of dT10. 
The displacement assay showed only one phase of dissociation. The Kd 
value for PcrA binding to dT10 was calculated as 130 nM and is significantly 
lower than the Kd for dT6. This is interesting as dT10 is only 4 bases longer 
than dT6 and implies that this difference has a large effect on the PcrA 
affinity and possibly dT6 is too short for high affinity binding by PcrA.  
 
 The dissociation rate constants are summarised in Table 6. With 
shorter oligonucleotides, dT6 and dT10, the dissociation rate constants are 
faster than with the dT20 and dT50 (signal primarily due to dissociation from 
the middle). This proves that the PcrA dissociates faster from the ends of 
ssDNA than from the middle of ssDNA. The dT6 dissociation has only one 
phase showing that PcrA is primarily dissociating in one process and confirm 
that the dissociation rate constant from the intercept of a hyperbolic fit to the 
binding data (k-2  = 0.66 s
-1) (Figure 36) is describing the same as process as 
the koff = 0.71 s
-1 directly measured in the displacement assay (Figure 38). 
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4.4.3. PcrA translocation on ssDNA reported by MDCC-PcrA(K138C) 
 
 The fluorescence of MDCC-PcrA(K138C) is lower when it is bound  
signal to  the end of ssDNA than at the middle. When MDCC-PcrA(K138C) 
translocates from the middle to the end, the fluorescence of the signal 
decreases. This could be exploited to develop a translocation assay on the 
stopped-flow apparatus where PcrA is premixed with ssDNA to which it 
binds randomly. The complex is then mixed with ATP. This initiates PcrA 
translocation to the 5’ end of the ssDNA. The end of translocation is 
observed as the lowest point in fluorescence, which is followed by a phase 
with a small increase in fluorescence. This second phase represents the re-
organisation to the steady-state formed of binding, translocation and 
dissociation with constant fluorescence. The published translocation rate of 
PcrA on ssDNA is ~80 bases s-1 at 20 °C at different buffer conditions than 
the DNA junction and plasmid unwinding assays [51]. To validate the MDCC-
PcrA(K138C) translocation assay the same conditions were used with 
MDCC-PcrA(K138C) and  the rate of translocation was 99 bases s-1 
indicating that MDCC-PcrA(K138C) is able to report PcrA translocation 
accurately. The rate of translocation increases with temperature, which is 
generally expected for a function of an enzyme (at 20 °C - 99 bases s-1 and 
at 30 °C - 240 bases s-1). 
 
Previous experiments with PcrA have not looked into the dependence 
of the translocation rate on DNA sequence. This is important as DNA 
sequences in vivo are formed of all four nucleotides and vary in nucleotide 
content. The PcrA translocation rate was determined on several 
oligonucleotides with different sequences using the MDCC-PcrA(K138C) 
translocation assay. The rate of translocation changed with different 
deoxynucleotide sequences. For dT at 30 °C it was 240 bases s-1.  At the 
same conditions but with dC oligonucleotides the translocation rate was over 
500 bases s-1, which is two times faster than on dT oligonucleotides. The 
difference in the rate for dT and dC ssDNA could also be observed by just 
varying the proportion of the two bases in the oligonucleotides and the 
translocation to the 5’ end took longer the more dTs the oligonucleotide had.  
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 The translocation on dA oligonucleotides indicated a similar rate of 
translocation as on dT. This is an interesting point as dA and dT form base 
pairs with each other and the possible significance could be in the way PcrA 
interacts with the bases that are able to form different number of hydrogen 
bonds. dC bases are able to form three hydrogen bonds when base pairing 
with dG bases, whereas dT and dA only form two. These results indicate that 
the structure of the base may affect the PcrA affinity to it. For example, if the 
kon is constant and the koff is faster with dC than with dT oligos then the rate 
of translocation will be faster on dC oligos. This could be the effect of the 
structural difference between the two bases. Some indication could be 
obtained by having crystal structures of PcrA binding to dC, dT, dA and dG 
oligos, as the binding pocket interactions may show variation according to 
the bases it is binding. In the structure published by Velanker et al. 1999 
PcrA is bound to a ss/dsDNA junction with random sequence. From this, it is 
impossible to determine the PcrA interaction differences between different 
bases as they may vary according to their location in the pocket and not just 
by the base PcrA is interacting with.   
  
The PcrA translocation on ssDNA sequences made of all four 
nucleotides A, T, C and G had no clear translocation end point and lacked 
the state of slow but short lived increase in fluorescence corresponding to re-
organisation of the reaction into steady-state. The end of PcrA translocation 
on ssDNA was determined from the time point where fluorescence turns 
constant (reaches the steady-state) by linear fit to the steady-state. A 
translocation rate of 385 bases s-1 was obtained from this analysis. The 
fitting was done in different ways to the dC and dT oligos, but the time taken 
to reach steady-state was dependent on the number of bases in the 
oligonucleotide. The loss of a clear end point of the translocation with the 
random sequences could be due to PcrA having a different affinity to 
different sequences or bases that causes the asynchronisation of random 
PcrA binding or be caused by faster ATP hydrolysis when bound to certain 
bases or sequences. The translocation rate of random sequence 
oligonucleotides is faster than on dT oligos and slower than on dC oligos. 
The DNA sequences used in the assay typically had ~20% of dCs, dGs and 
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dTs and ~40% of dAs bases. The measurement of the PcrA translocation 
rate on random sequence oligonucleotides may be the most accurate 
indication of the actual speed PcrA is moving on ssDNA in vivo. 
 
These experiments show for the first time that the PcrA translocation 
rate is dependent on the ssDNA sequence it moves on. Translocation on 
deoxycytodine oligonucleotides is faster than on deoxythymidines. As the 
movement on ssDNA does not require breaking of hydrogen bonds, one 
cannot expect the translocation to be similarly slowed down on dCs and dGs 
as with unwinding of dsDNA. The faster movement on dC oligos must be 
caused by one of the following factors that include PcrA binding, ATP 
hydrolysis or dissociation from dCs being faster. The ATP hydrolysis rate 
could possibly be tested with assays measuring the ATP turnover such as 
the ATP hydrolysis assay using a Pi biosensor [87]. This would be an 
interesting addition to the results observed here. 
 
 MDCC-PcrA(K138C) could provide a tool to study PcrA involvement 
in removal of secondary structures and proteins from ssDNA. The 
importance of the PcrA translocation on ssDNA has not been fully unravelled 
and in vitro evidence indicates that PcrA is involved in removal of RecA 
filaments that is important for genomic stability in response to DNA damage 
[94]. This function requires PcrA movement or reeling of ssDNA coupled to 
ATP hydrolysis. Using coumarin labelled PcrA(K138C) one could possibly 
look at what change is observed in the signal when ssDNA is coated with 
RecA. Labelling of DNA and/or RecA with fluorophores suitable for FRET 
pairing could facilitate the development of an assay for PcrA-RecA 
interaction studies on the stopped-flow instrument and on the TIRFM. This is 
just one possibility for new assay development with fluorophore-labelled 
PcrA(K138C) as it could be used for other FRET measurements such as the 
investigation of a possible interaction of PcrA with SSB protein and other 
components of the plasmid replication complex. 
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4.4.4. Summary 
 
  
MDCC-PcrA(K138C) has a useful signal measuring for ssDNA 
binding, which shows that PcrA binding to the ends of ssDNA is faster than 
to the middle. This may be needed in certain in vivo processes other than 
plasmid replication such as PcrA involvement in DNA repair, where PcrA 
may be required to bind very short DNA overhangs, in other words, bind in 
the end binding mode. PcrA is known to unwind DNA junctions with dT-arms 
of only 4 bases (C. Toseland and M. Webb, personal communication), which 
means that PcrA is able to bind ssDNA of 4 bases and start to translocate or 
unwind from it.   
 
 These experiments show for the first time that the PcrA translocation 
rate is dependent on the ssDNA sequence it moves on. The faster 
movement on dC oligos than on dT oligos must be caused by one of the 
following factors that include PcrA binding, ATP hydrolysis or dissociation 
from dCs being faster. As the DNA in nature is formed of all the four 
nucleotides (dA, dC, dT and dG), the measurements in random sequence 
oligos may be the most accurate measurement in vitro to estimate the 
ssDNA translocation rate of PcrA in vivo, which was ~380 bases s-1.
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5. Results- PcrA interaction with the initiator protein 
RepD during plasmid unwinding  
 
5.1. Introduction 
 
 
RepD-PcrA interaction is a vital component for a successful plasmid 
unwinding. PcrA is not able to unwind even short DNA junctions without 
RepD and presence of RepD increases PcrA unwinding processivity [87, 
88]. The interaction seems to exist either directly or through DNA. The top of 
the PcrA 2B domain, which is the 2B site furthest of the ATP binding site, 
was chosen for fluorescent labelling to enable the development of a signal 
and assays, which observe the PcrA interaction with the RepD (Figure 44). 
The 2B domain was selected as the target as it has not been shown to be 
involved in other process such ATP hydrolysis or DNA binding. The E447, 
E449, M450 and L453 residues are at the top of 2B domain pointing 
outwards from PcrA core. Therefore, they are likely to be near the suggested 
PcrA-RepD interaction site. Single cysteine residues were introduced using 
site-directed mutagenesis at these sites and labelled with environmentally 
sensitive fluorophores.  
 
There are several main aims for obtaining a RepD-specific signal. 
These include evidence for the RepD interaction site on PcrA, investigation 
of PcrA affinity to RepD or RepD-DNA complex and determination of how 
their interaction changes during plasmid unwinding. The sites mutated on 
the top of the 2B domain have also been used for labelling with suitable 
fluorophores, which can be used for FRET pairing with labelled RepD. 
  
 The E449C and other cysteine mutants were labelled with 
fluorophores of coumarin-maleimide and Cy-dye derivatives (as stated in 
Methods and described in Chapter 3). The fluorescently-labelled 
PcrA(E449C) has shown a signal with RepD specificity and enabled the 
investigation of PcrA-RepD interaction. This was observed on oriD-mimic 
5.Results- PcrA interaction with the initiator protein RepD during plasmid unwinding 
155 
 
DNA junction structures similar to that used in DNA junction unwinding 
assays (Figure 19, Methods). The junctions were used to provide a simple 
model system that can be used as a comparison to RepD-plasmid complex. 
RepD-plasmid complex was also used in these experiments to look for 
signal to investigate PcrA binding to the complex, interaction with RepD and 
during unwinding DNA. 
 
 
Figure 44. The location of E449C mutation on PcrA.  
The coordinates for the image were taken from PDB files 1PJR (open, apo) 
and 3PJR (closed, substrate bound) and visualised using PyMol 
(http://www.pymol.org/). The site of E449C mutation is shown as a yellow 
sphere on “the top of the 2B domain” (circled red). 
 
5.2. MDCC-labelled PcrA(E449C) and signal on interaction 
with RepD, complexed with DNA 
 
5.2.1. RepD interaction site on PcrA is on the top of the 2B domain 
 
 
All the MDCC-labelled PcrA cysteine mutants were tested for possible 
RepD specific signal on the stopped-flow apparatus (Table 1). The RepD 
specificity was only observed with a PcrA that was labelled at the top of the 
2B domain. The highest fluorescent signal change (above 20%) was 
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observed with PcrA(E449C), labelled with MDCC-maleimide (Figure 45). 
The other mutations E447C, M450C and L453C on the 2B domain, labelled 
with the same fluorophore, showed lower fluorescence change or specificity 
to RepD-DNA than MDCC-PcrA(E449C) (Figure 46). The labelled mutations 
M450C and E447C showed only ~10% signal change when interacting with 
RepD-DNA junction complex. The labelled L453C had similar amplitude of 
signal change to E449C with RepD-DNA junction 1, but it also had a large 
signal change with DNA junction 1 without RepD. This indicated the signal to 
be specific to the DNA binding, rather than RepD, and so not useful for 
investigation of PcrA-RepD interaction. The high specificity to DNA with 
labelled L453C is understandable as the site of labelling is the closest to the 
DNA on the substrate bound crystal structure of the other 2B top domain 
mutations.  
 
All the MDCC-labelled PcrA mutants, whether on 2B, 1B, 1A or 2A 
domain, have also been tested for signal for PcrA binding to RepD-DNA 
junction complex and to the RepD by itself. None of the other labelling sites 
outside of the 2B domain top show RepD specificity. Good examples are the 
Y477C and R501C mutations, which are located on the 2B domain and the 
H53C on 1A domain (Figure 22, Chapter 3). The Y477C is at the opposite 
side of the 2B domain (compared to E449C domain), close to the ssDNA 
interaction site. R501C is on the 2B domain very close to the dsDNA 
interaction site, according to the substrate bound crystal structure. Neither 
Y447C nor R501C showed signals of RepD-specificity. Generally speaking, 
the mutations have been located on all PcrA domains and should cover 
most of the possible sites of possible RepD-PcrA interaction. Together, all 
the labelled PcrA constructs strongly indicate that RepD interacts with PcrA 
on the 2B domain.  
 
The MDCC-PcrA(E449C) fluorescent signal with RepD-DNA 
junction 1 had a signal change between 20-30% (Figure 45). DNA junction 1 
structure has part of ICRII with the RepD nicking sequence as a single 
stranded overhang (5’-CT*AATAGCCGGTT-3’, where * is the RepD nick 
site) and the whole ICRIII (23 base pair sequence) for high affinity RepD 
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binding (Figure 19). When DNA junction 1 was mixed with MDCC-
PcrA(E449C) in the absence of RepD the signal increase was ~6%. No 
signal change was observed on mixing RepD and MDCC-PcrA(E449C) in 
the absence of DNA. More precisely, none of the labelled PcrA variants in 
Table 1 showed a signal when mixed with RepD on the stopped-flow 
instrument. This implies that the PcrA and RepD do not interact strongly in 
solution and the interaction is facilitated through DNA as the interaction 
signal has been only observed with RepD-DNA complex. A small (~2%) 
signal was observed with MDCC-PcrA(E449C) binding to ssDNA and 
translocating on it. No signal is observed with MDCC-PcrE449C binding to 
ATP (data not shown here). 
 
Figure 45. MDCC-PcrA(E449C) signal when binding to RepD-DNA 
junction 1.  
Purple, MDCC-PcrA(E449C) binding to the RepD-DNA junction 1 complex. 
Blue, MDCC-PcrA(E449C) binding to the DNA junction 1. Black, MDCC-
PcrA(E449C) and RepD in solution. Experiments were done using the 
stopped-flow instrument at 30 °C. The final concentrations were 100 nM 
MDCC-PcrA(E449C), 1 µM RepD and 0.5 µM DNA junction 1 in K200 buffer. 
The DNA junction and RepD were incubated 5 minutes at 30 °C to allow 
RepD-DNA complex formation. The cartoons next to the graph represent the 
end point of reaction shown. See Figure 19 in Methods for the sequence 
structure of the DNA junction 1. * is the RepD nick site on the ICRII-arm of 
DNA junction 1. 
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Figure 46. MDCC-PcrA(E449C) binding to RepD-DNA 
junction/RepD/DNA junction. 
A) MDCC-PcrA(M450C) binding to the DNA junction 1 and the RepD-DNA 
junction 1. B) MDCC-PcrA(L453C) binding to the DNA junction 1 and the 
RepD-DNA junction 1. C) MDCC-PcrA(E447C) signals binding to the DNA 
junction 1 and the RepD-DNA junction 1. The experimental conditions were 
same as in the Figure 45.  
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The results for the fitting of the MDCC-PcrA(E449C) binding signals 
to DNA junction 1 and RepD-DNA junction 1 are summarised in the Table 8. 
The kobs for PcrA binding to DNA junction 1 was 3.5 to 4 -folds faster than 
binding to the RepD-DNA junction 1 complex. This is most likely to be 
caused by the higher number of possible binding sites, i.e. bare ssDNA, on 
DNA junction 1 than when RepD is bound to it. 
 
Reaction kobs1 (s
-1
) kobs2 (s
-1
) Amplitude 1 Amplitude 2 End F Signal 
change 
DNA junction 1 21.71 2.59 0.91 0.95 30.51 6.5% 
RepD-DNAj1 4.89 0.70 4.21 2.30 37.18 21.2% 
Table 8. MDCC-PcrA(E449C) binding to DNA junction 1 and RepD.  
The fitting was done using a double exponential fit. The reaction conditions 
were same as in Figure 45.  
 
The fluorescence time courses on PcrA binding to DNA junction 1 
and to the RepD-DNA junction 1 complex were biphasic. This indicated two 
different processes occurring. The second order rate constant (kon) for 
MDCC-PcrA(E449C) binding to RepD-DNA junction 1 was determined. This 
was done by repeating the above assay with varying RepD-DNA junction 1 
concentrations. The measurements were done similarly to previous binding 
measurements with MDCC-PcrA(K138C) (Chapter 4) where the 
concentration of the ligand was varied and its effect on kobs was investigated. 
This is based on the Scheme 1 (Section 1.7, Introduction) and the results 
were fitted using Equation 3 (Section 1.7, Introduction). Example fits are 
shown in Figure 92, Appendix). Figure 47 shows the kobs dependence on the 
RepD-DNA junction 1 concentration. The kon for the fast phase is 
6.1 µM-1 s -1 and for the slow phase it is 0.6 µM-1 s-1(average of three 
experiments). As both phases show concentration dependence it can be 
concluded that both phases are processes of binding. 
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Figure 47. MDCC-PcrA(E449C) signal with RepD-DNA junction 1 
complex is observing its binding to the complex.  
A) Normalised MDCC-PcrA(E449C) binding signals with varying 
concentration of RepD-DNA junction 1 complex. The traces were fit to 
double exponential fit and each data point is an average of three traces. B) 
The kobs and C) amplitude values plotted against the concentration of RepD-
DNA complex and fitted using linear regression (fast and slow phase of 
binding). The fast phase has kon of 6.8 µM
-1 s-1 and the slow phase 
0.8 µM-1 s-1. Experiments were done as in the Figure 45 expect the RepD-
DNA junction 1 complex concentration were varied from 0.125 – 1 µM and 
the MDCC-PcrA(E449C) concentration was 50 nM.  
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This could be explained by PcrA binding to the DNA junction 1 at two 
different sites, namely the two different ssDNA arms as shown in Figure 45.  
PcrA may have different affinities to these arms or to other parts of the 
ssDNA (ssDNA end) and to the ds/dsDNA junction.  
 
The biphasic signal of PcrA binding to the RepD-DNA junction 1 
might have a different origin as there is only one ssDNA overhang (dT10-
arm) free for PcrA binding. The other ssDNA overhang (ICRII-arm) is 
covalently bound to RepD, if nicking has been efficient. Alternative 
possibilities for the biphasic signal include two different conformations of 
PcrA, different binding sites on dT10-arm or two different RepD-DNA 
junction 1 complexes.  
 
Several assays were carried out to determine what caused the 
biphasic signal when MDCC-PcrA(E449C) bound to RepD-DNA junction. 
dT10 is long enough to more than one PcrA to bind to it and this was shown 
by the displacement assay with MDCC-PcrA(K138C) (Figure 38B, Chapter 4 
and Figure 87, Appendix).To test this DNA junctions with varying lengths of 
polyT arm were used (dT6, dT8, dT10 and dT20) (Figure 48A). The DNA 
junctions with dT6 and dT8 showed reduced amplitude, but still had the two 
phases. This indicated that the biphasic signal is not due to two PcrAs 
binding on same dT10-arm, but to do with the structure and form of the 
interaction between PcrA and RepD-DNA junction complex. MDCC-
PcrA(E449C) binding to dT20-arm DNA junction also showed a biphasic 
signal. The rate constants for the first phase of binding for the dT6, dT8 and 
dT20-arm DNA junctions are similar, but they have double the rate constant 
of the dT10-arm DNA junction binding (Table 9, No ATP). This anomalous 
and cannot fully be explained. 
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Figure 48. MDCC-PcrA(E449C) binding signal to varying lengths of dT-
arm on DNA junction 1.  
A) MDCC-PcrA(E449C) biding to the DNA junctions with varying dT-arm 
length without ATP. All the increasing phases were fitted using double 
exponential fit. B) MDCC-PcrA(E449C) biding to the DNA junctions with 
varying dT-arm length with ATP. The DNA junctions have the same 
sequence structure as DNA junction 1 except for the number of dT’s on PcrA 
binding arm. The traces without ATP were fitted to single exponential. 
Experimental conditions were same as in the Figure 45.  
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No ATP With ATP 
dT-arm kobs fast (s
-1
) kobs slow (s
-1
) 
Signal 
change, 
fast phase 
Signal 
change, 
slow phase 
kobs (s
-1
) 
Signal 
change 
6 11.29 2.59 5.0% 3.5% 45.8 13.8% 
8 9.33 1.92 4.9% 2.8% 44.5 9.3% 
10 4.89 0.7 14.7% 7.6% 31.3 13.1% 
20 11.16 3.54 7.7% 3.7% 22.9 9.6% 
Table 9. MDCC-PcrA(E449C) binding to DNA junction 1 with varying dT-
arm lengths. 
 
 Another possibility for the biphasic signal at binding by MDCC-
PcrA(E449C) is the presence of two different RepD-DNA complexes. One 
possible reason for this would be to have only partial nicking. It has been 
shown that PcrA to unwind DNA junctions processively, the RepD does not 
have to be covalently bound to DNA [93]. First, this was confirmed here by 
using the DNA junction unwinding assay (Figure 24) with DNA unwinding 
junction lacking the known RepD nicking sequence, CT*A (5’-
CT*AATAGCCGGTT-3’, the CT*A-sequence removed is highlighted and * is 
where RepD nicks) (Figure 49). In the assay, the lag phases that correspond 
to the actual dsDNA unwinding were almost identical for the two DNA 
junctions used (with and without CT*A-sequence). This meant that the 
CT*A-sequence and the covalent bond formation between RepD and DNA 
are not required for vital RepD-PcrA interaction. The RepD is still required to 
enhance the PcrA unwinding function [87]. The intensity change with the 
DNA junctions (with or without CT*A) vary by two fold and this is may be due 
to the level of purity and labelling of the DNA junctions or complications of 
concentrations determination of fluorescently-modified DNA.   
 
The MDCC-PcrA(E449C) binding signal with DNA junction lacking the 
RepD nick sequence, CT*A, was still biphasic (Figure 49B). The traces were 
fitted to a double exponential and the kobs values were similar to PcrA 
binding to DNA junction with CT*A (Table 10). To determine whether the two 
phases were actual binding, the experiments were repeated with varying 
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concentrations of RepD·DNA junction (no CT*A) (Figure 94, Appendix) 
(Scheme 1 and Equation 3 shown in Section 1.7). These measurements 
determined the binding rate constant, kon, for PcrA binding. The kon fast for 
RepD-DNA junction (with ICRIII, no CT*A) was 6.7 µM-1 s-1. The slow phase 
kobs did not follow concentration dependence. This indicated that the slow 
phase signal is not actual binding.   
 
 
Figure 49. MDCC-PcrA(E449C) binding and unwinding a DNA junction 
lacking RepD nick sequence.  
A) DNA junction unwinding assay with 20 bp DNA junction with and without 
CT*A-sequence of the ICRII (RepD nick site). The DNA junction unwinding 
was done with the same conditions and as shown in the Figure 24. B) 
MDCC-PcrA(E449C) binding to DNA junctions with and without CT*A-
sequence. The binding measurements to these junctions were done at same 
conditions as in Figure 45. 
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   DNA 
junction 
kobs fast (s
-1) kobs slow (s
-1) 
Signal 
change, 
fast phase 
Signal 
change, 
slow phase 
Total 
signal 
change 
DNAj1_with 
CT*A 
4.86 0.7 16.1% 6.6% 23.8% 
DNAj1_no 
CT*A 
6.41 0.77 17.8% 3.4% 21.8% 
DNAj30bp_ 
with CT*A 
10.70 2.43 2.6% 5.0% 7.7% 
DNAj30bp_ 
no CT*A 
7.43 2.52 4.9% 2.2% 7.2% 
 
Table 10. MDCC-PcrA(E449C) binding signal to DNA junction +/- ICRIII 
and +/- CT*A. 
 
To test the effect of ICRIII on PcrA binding, the high affinity site for 
RepD, kon was measured for PcrA binding to a RepD-DNA junction without 
ICRIII (Figure 93, Appendix). The MDCC-PcrA(E449C) binding traces were 
also biphasic and the kon was 15.1 µM
-1 s-1 for the fast phase and 
1.9 µM-1 s-1 for the slow phase. This was 2.5 times faster than the binding to 
DNA junction 1 with ICRIII (Table 11). This could be due to the change in the 
RepD-DNA complex structure caused the lack of ICRIII, but could also imply 
that less nicking of the DNA junctions has taken place when the DNA 
junction does not have the ICRIII sequence. 
 
The same measurements were also repeated with DNA junctions 
lacking the CT*A and the ICRIII sequence. The kon for PcrA binding to the 
RepD-DNA junction (no ICRIII, no CT*A) is 22.4 µM-1 s-1 for the fast phase 
and 3.4 µM-1 s-1 for the slow phase. These binding rate constants were 
similar to kon values for PcrA binding to DNA junctions without RepD 
(Table 11). This may be an indication that the PcrA binding to the RepD-
DNA complex without ICRIII or nicking is similar in some way to PcrA 
binding to the DNA junction only and this also indicates that covalent binding 
of RepD doesn’t increase the kon of PcrA binding.   
 
 
To distinguish between binding to RepD-DNA junction complex and to 
the DNA junction only, the kon was determined for two DNA junctions, the 
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DNA junction 1_dT6-arm and the DNA junction_dT10-arm (Figure 90, 
Appendix). The kon for the fast phase was 34.3 µM
-1 s-1 (dT10-arm) and 
35.2 µM-1 s-1 (dT6-arm) for the two DNA junctions. For the slow phase they 
were 2.9 µM-1 s-1 (dT10-arm) and 0.9 µM
-1 s-1 (dT6-arm). The fast phase 
binding rate constants were very similar regardless the difference in the 
length of the polyT-arm. This indicated that the binding process to these 
junctions are same or similar, which is most probably the binding to the fork 
junction. The kon for the fast phase of the PcrA binding to DNA junction 
without RepD is six times faster than to RepD-DNA junction 1 (Table 11). 
This may imply that RepD may restrict the binding of PcrA, for example 
sterically.  
          
Reaction kon fast (µM
-1
 s
-1
) kon slow (µM
-1
 s
-1
) 
DNA junction 1_dT10arm 34.3 (SEM 6.7) 2.9 (SEM 0.4) 
DNA junction 1_dT6arm 35.2 (SEM 4.0) 0.9 (SEM 1.3) 
RepD-DNA junction 1 6.1 (SEM 0.8) 0.6 (SEM 0.3) 
RepD-DNA junction (No ICRIII) 14.9 (SEM 0.7) 1.9 (SEM 0.5) 
RepD-DNAj1_no CT*A 6.7 (SEM 0.9) n/a 
RepD-DNA junction (No ICRIII)_no CT*A 22.4 (SEM 5.0) 3.4 (SEM 0.9) 
 
Table 11. PcrA binding rate constants (kon) for different DNA junctions 
and Rep-DNA junctions complexes, determined using MDCC-
PcrA(E449C). 
 
5.3. The effect of ATP on PcrA binding to RepD-DNA complex 
 
5.3.1. MDCC-PcrA(E449C)·ATP binding signal with RepD-DNA junction 
complexes  
 
The effect of ATP on PcrA binding to RepD-DNA junction 1 (with the 
high affinity RepD binding sequence, ICRIII) was investigated using MDCC-
PcrA(E449C) on the stopped-flow apparatus (Figure 50). However, in 
measurements including ATP, unwinding of the DNA junctions can be 
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expected to take place subsequent to the PcrA binding. When MDCC-
PcrA(E449C) was ATP bound, the maximum signal change was less than 
15%. This is approximately half of the signal change when 
MDCC-PcrA(E449C) is not ATP bound. The signal had three phases. Phase 
1 was increasing in fluorescence and is likely to be the MDCC-PcrA(E449C) 
binding to the RepD-DNA junction 1 complex. Phase 2 was a decrease and 
possibly corresponded to re-organisation to steady-state. The phase 3 was 
the steady-state signal of MDCC-PcrA(E449C) binding, translocating and 
dissociating from DNA junction dT10-arm or from unwound DNA junction 
sequences. The phase 1 corresponding to the PcrA·ATP binding to RepD-
DNA complex was fitted using single exponential. The kobs was 31.3 s
-1 for 
PcrA·ATP binding to the RepD-DNA complex. This is 6 times larger than the 
kobs1 without ATP (Table 12 and Figure 47).  
 
The PcrA·ATP binding kinetics to the RepD-DNA was determined 
according to Scheme 1 by varying the RepD-DNA junction complex 
concentration in presence of ATP and fitting the results using Equation 3, 
Introduction, Section 1.7.(Figure 50). The kon for PcrA binding to RepD-DNA 
junction 1 complex with ATP was 24.9 µM-1 s-1 for average of two 
experiments. This is over four times faster than when ATP is not present 
(Table 11). This implies that the binding is faster and more uniform (as only 
single phase is observed) when PcrA is bound to ATP. Both can be a result 
of conformational change on PcrA when bound to nucleotide or the actual 
translocation on ssDNA to the dsDNA junction. 
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Figure 50. MDCC-PcrA(E449C) binding to RepD-DNA junction 1 with 
ATP.  
A) Purple, MDCC-PcrA(E449C) binding to the RepD-DNA junction 1 
complex. Green, MDCC-PcrA(E449C)ATP binding to the RepD-DNA 
junction 1 complex. Black, MDCC-PcrA(E449C) and RepD in solution. 
Experiments were done on the stopped-flow instrument at 30 °C. The final 
concentrations were 100 nM MDCC-PcrA(E449C), 200 µM ATP, 1 µM RepD 
and 0.5 µM DNA junction 1 in K200 buffer. The cartoons represent the end 
point of reaction shown. See Figure 19 in Methods for sequence structure of 
DNA junction 1. * indicates the RepD nick site on the ICRII-arm of DNA 
junction 1 (13 bases). B) The breakdown of the signal of MDCC-
PcrA(E449C) binding to the 2 µM RepD-DNA junction complex. Other 
reactions components were same as in (A). 
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Reaction Fit kobs1 (s
-1) kobs2 (s
-1) 
Signal 
change 
RepD-DNAj1 Dbl 4.89  0.70 23.8% 
RepD-DNAj1 
+ ATP 
Sgl 31.28 n/a 14.9% 
RepD-DNA j. 30 bp 
(No ICRIII) 
Dbl 23.61 3.60 5.5% 
RepD-DNA j. 30 bp 
(No ICRIII) + ATP 
Sgl 58.19  n/a 3.5% 
Table 12. MDCC-PcrA(E449C) binding to RepD-DNA junction complex 
with ATP.  
Sgl, the trace has been fitted to single exponential, and Dbl, means fitting 
done using double exponential fit. 
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Figure 51. MDCC-PcrA(E449C)·ATP binding to RepD-DNA junction. 
 A) The raw data traces of MDCC-PcrA(E449C)·ATP binding to varying 
concentrations of RepD-DNA junction 1 complex. B) The three phases 
observed at higher RepD-DNA junction 1 complex concentration. 1. Binding. 
2. Re-organisation to steady-state. 3. Steady-state of translocation on 
ssDNA. C) The linear fit of kobs at different RepD-DNA junction 1 complex 
concentrations. The gradient of fit gives kon of 20. 6 µM
-1s-1 (SEM 1.0). D) 
The signal amplitude change with the concentration of RepD-DNA junction 1 
complex. The linear fit was fitted up to 1.5 µM and has a gradient of 4.6 
(SEM 0.2) of intensity per µM of complex. Experiments were done as in 
Figure 45 in presence of 200 µM ATP with 100 nM MDCC-PcrA(E449C). 
The RepD-DNA junction 1 complex concentration was varied from 0.5-2 µM. 
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MDCC-PcrA(E449C) binding signal has also been tested with oriD-
mimic DNA junction that lacks the ICRIII sequence (Table 12). This has the 
same sequence and structure as the DNA junctions used for DNA junction 
unwinding assays (Figure 24) and hence should be readily unwound by 
PcrA when RepD is present. Similarly, to DNA junction 1 (with ICRIII) the 
binding without ATP is biphasic, but with lower signal change than with DNA 
junction 1 complex (~6%) (Table 12). The kobs is increased by 4-fold when 
ATP present for the fast and slow phase. This may indicate that when PcrA 
is ATP bound, it is in different conformation compared to when it is ATP-free. 
The ATP bound PcrA conformation may have higher affinity to the RepD-
DNA. Hence, the PcrA binding is faster when ATP is present in the reaction.  
 
5.3.2. MDCC-PcrA(E449C) binding signal to RepD-DNA junction 
complex when bound to non-hydrolysable ATP analogues 
 
The MDCC-PcrA(E449C)·ATP binding signal with RepD-DNA 
complex was further investigated using non-hydrolysable ATP analogue, 
ATPγS (Figure 52). PcrA has been shown to have similar affinity to as 
ATPγS as ATP [157].This can give information how the ATP changes the 
signal without the effect of actual ATP turnover. In the measurements, the 
ATPγS was pre-mixed with MDCC-PcrA(E449C) in the stopped-flow syringe 
before mixing with the pre-incubated RepD-DNA junction complexes. With 
DNA junctions with ICRIII, the amplitude change of the fluorescent signal 
was similar to the MDCC-PcrA(E449C) binding to RepD-DNA junction when 
no ATP is present. The results are summarised in the Table 13. The 
fluorescence time course could be fitted well using single exponential. The 
kobs of PcrA·ATPγS binding was half of PcrA binding without nucleotide, and 
6- to 10-fold slower than PcrA·ATP binding (Table 13). The measurements 
were repeated with DNA junction lacking the ICRIII sequence and with this 
junction two non-hydrolysable ATP analogues were tested, ATPγS and 
AMPPNP. The results showed similar pattern of PcrA·ATP analogue 
binding, where a single phase was observed that had kobs 6- to 10-fold 
slower than PcrA·ATP binding.  
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These results indicate that the increased kobs with PcrA·ATP may be 
related to the actual ATP hydrolysis taking place. PcrA may hydrolyse 1 ATP 
before binding and this complex (PcrA·ADP) may have higher affinity to 
RepD-DNA complex. This is unlikely as PcrA affinity ADP is low [157]. But, 
of course, the structural differences between ATP and its analogues may 
affect the PcrA conformation and its affinity to RepD-DNA. Other possibility 
for increased kobs when ATP is present would be the ssDNA translocation to 
the DNA junction that directs PcrA to the junction faster than random 
binding. As single phase was observed with non-hydrolysable ATP 
analogues, this implied that PcrA·ATP analogue is binding in single 
conformation to RepD-DNA. 
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Figure 52. MDCC-PcrA(E449C) binding signal RepD-DNA junctions with 
non-hydrolysable ATP analogues. 
A) ATP/ATPγS-MDCC-PcrA(E449C) binding to RepD-DNA junction 1. B) 
AMPPNP/ATPγS-MDCC-PcrA(E449C) binding to RepD-DNA junction no 
ICRIII. (A) The experimental conditions were 70 nM MDCC-PcrA(E449C), 
500 nM DNA junction 1, 1 µM RepD and +/- 200 µM ATPγS or ATP and (B) 
conditions were 100 nM MDCC-PcrA(E449C), 500 nM DNA junction No 
ICRIII, 1 µM RepD and +/- 200 µM ATPγS or ATP or 600 µM AMPPNP. 
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Reaction Fit k
obs fast 
(s
-1
) k
obs slow
 (s
-1
) Signal change 
RepD-DNA junction (No ICRIII) 
No Nucleotide Dbl 19.84 2.72 7.3% 
ATP Sgl 59.19 n/a 3.5% 
ATPγS Sgl 10.83 n/a 6.2% 
AMPPNP Sgl 9.66 n/a 6.2% 
RepD-DNA junction (With ICRIII) 
No Nucleotide Dbl 5.95 1.07 8.5% 
ATP Sgl 31.28 n/a 14.9% 
ATPγS Sgl 2.48 n/a 7.9% 
Table 13. MDCC-PcrA(E449C) binding to RepD-DNA junction complex 
and ATP and analogues.  
The fitting was done either to single or double exponential. The experimental 
conditions for both sets of experiments are stated in Figure 52. 
 
5.4. PcrA dissociation kinetics from RepD-DNA junction 
complex 
 
To measure the PcrA dissociation kinetics from the RepD-DNA 
junction 1 complex, a displacement assay was designed using MDCC-
PcrA(E449C) (Figure 53, Scheme 2, Section 1.7). This was done on the 
stopped-flow apparatus by incubated DNA junction 1 with the RepD and 
adding MDCC-PcrAE449C to this, to the pre-form the MDCC-PcrA(E449C)-
RepD-DNA complex. This was then mixed with a high excess of wild-type 
PcrA. The time courses showed a decrease in fluorescence and the traces 
were fitted to single exponential followed by a linear slope (to take account 
of slow photobleaching) (Figure 95, Appendix). The rate constant for the 
exponential phase, koff, was 0.16 s
-1 (average of three traces at three 
different wild-type PcrA concentrations). Varying the wild type PcrA 
concentrations had no significant effect on the koff confirming that the 
displacement assay was indeed measuring the dissociation of MDCC-
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PcrA(E449C) from RepD-DNA complex. On very short time courses, an 
initial, small increase in fluorescence was seen. This could correspond to 
some wild type PcrA binding to close proximity to the MDCC-PcrA(E449C) 
before the latter dissociates.  
 
 
Figure 53. Displacement of MDCC-PcrA(E449C) from RepD-DNA 
junction 1 to measure dissociation kinetics.  
A) Cartoon representation of the reaction of MDCC-PcrA(E449C) 
displacement assay. B) Normalised data trace of MDCC-PcrA(E449C) 
displacement by 10 µM wild type PcrA. The trace was fitted to single 
exponential decay with straight line. This had a koff of 0.14 s
-1 (SEM 1.2 x 
10-3) and the linear regression has a gradient of 7.9 x 10-3 (SEM 1.8 x 10-4). 
The DNA junction 1 was incubated for 5 min with RepD at 30 °C to which 
MDCC-PcrA was added. The reaction mix was then mixed with different 
concentrations of wild type PcrA. Excitation was done at 436 nm and 
emission measured using 455 nm cut-off filter. The final reaction 
concentrations were 100 nM MDCC-PcrA(E449C), 500 nM DNA junction 1, 1 
µM RepD and 5,10 or 15 µM PcrA in buffer K200. 
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5.5. Association kinetics of PcrA and RepD-plasmid complex 
 
 PcrA binding kinetics to RepD-pCERoriD complex (full length plasmid) 
was measured using MDCC-PcrA(E449C) on the stopped-flow apparatus 
(Figure 54) (Scheme 1 and Equation 3, Section 1.7).The plasmids used for 
the assay were the same plasmids as used for the plasmid unwinding assay 
with DCC-SSB (Figure 26). The MDCC-PcrA(E449C) binding signal to 
RepD-plasmid complex at pseudo-first order conditions of 10-fold excess of 
RepD-plasmid complex over MDCC-PcrA(E449C) was ~16%. The traces 
were biphasic and the binding was similar in time scale to the PcrA binding 
to RepD-DNA junction 1. Measurements with the varying RepD-plasmid 
complex concentrations showed that the both phases were concentration 
dependent. The kon has been determined for two different lengths of plasmid, 
2437 bp and 3094 bp. 
 
 The PcrA binding to the RepD-3094bp plasmid complex had a kon of 
46.2 µM-1s-1 for the fast phase and 4.0 µM-1s-1 for the slow phase (average of 
three measurements). This showed that the binding to RepD-pCERoriD3094 
is almost 10-fold faster than the binding to the RepD-DNA junction 1 
complex. This could be indication that the RepD binding and complex 
formation isn’t optimal with DNA junctions compared to plasmid or possible 
presence of ssDNA contamination in the plasmid preparations, which PcrA 
would bind, increasing the effective binding site concentration. These ssDNA 
may be too short to be observed on agarose gel electrophoresis. The 
biphasic binding signal with the RepD-plasmid complex indicates, similarly to 
RepD-DNA junction binding signal, that two processes are taking place. 
These could be due to PcrA having two different binding modes either to 
possible multiple binding sites on the nicked oriD, two different PcrA 
conformations or different RepD-plasmid complex. Also, the slower phase 
could be a result of binding to ssDNA contamination from preparation of 
plasmid.  
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Figure 54. PcrA binding to RepD-pCERoriD 3094bp complex.  
A) Cartoon representation of the reaction. B) Raw data traces for MDCC-
PcrA(E449C) binding varying concentrations of RepD-pCERoriD 3094 
complex. Traces were fitted to double exponential. C) The observed rate 
constants for phase 1 and 2 from fitting plotted against the RepD-plasmid 
concentration. The fits are average of three traces. The linear fit has a 
gradient of 52.9 µM-1s-1 (SEM 5.7) for the fast phase 1 and 5.6 µM-1s-1 (SEM 
0.8) for the slow phase 2. D) The amplitudes for phase 1 and 2 from fitting 
plotted against the RepD-plasmid concentration. The gradient for the phase 
1 amplitude is 11.2 per µM and 1.0 per µM for the phase 2. The 
experimental conditions were 20 nM MDCC-PcrA(E449C) and 125 nM to 
225 nM RepD-plasmid complex in K200 buffer. The RepD is in 4-fold excess 
over the plasmid concentration and the complex was prepared by 5 minute 
incubation at 30 °C. The reaction mix was then mixed with different 
concentrations of wild type PcrA. Excitation was done at 436 nm and 
emission measured using 455 nm cut-off filter. 
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 The PcrA binding kinetics to RepD-pCERoriD 2437 bp plasmid 
was also measured (Figure 55). This had similar biphasic signal with larger 
signal change (~35%) when RepD-plasmid complex was at 10-fold excess 
over MDCC-PcrA(E449C) than at low excess. The fast phase for PcrA 
binding to RepD-pCERoriD 2437 bp plasmid had kon of 14.1 µM
-1s-1 and 
2.0 µM-1s-1 for the slow phase (average of three measurements). The 
amplitude of the first phase followed concentration dependence, but the 
second phase remained constant with varying the RepD-plasmid 
concentration.  
 
 The kon for PcrA binding to RepD-2437 bp plasmid and for RepD-
3094 bp plasmid complex are different (Table 15). This may be an indication 
that PcrA binds at different rates to different length plasmids, which could be 
a result of a certain form of secondary structure in the plasmid after the 
RepD-plasmid complex formation. Also, there may be a different rate of 
RepD nicking on different lengths of plasmids that has not been investigated 
before. The PcrA may also be binding to the other parts of plasmid and 
these may vary between different lengths of plasmids. Other possible reason 
for the kon variation is the difference between preparations of plasmids that 
affect the proportion of supercoiled plasmid over the nicked relaxed plasmid. 
The plasmid preparations were always run on agarose gel, but no accurate 
quantification of relaxed-nicked versus supercoiled plasmid can be done by 
gel analysis. Furthermore, RepD is known to nick supercoiled plasmid more 
efficiently than nicked-relaxed plasmid [93]. Other, likely possibility is the 
ssDNA contamination in the plasmid preparations. PcrA binds very short 
nucleotide oligos and these cannot be observed in agarose gel 
electrophoresis. This has been suggested before for similar plasmid 
preparations [87]. The amount of ssDNA contamination may vary between 
different preparations and between different plasmid lengths. Overall, both 
the 2437 and 3094 bp plasmids show that the kon is several magnitudes 
faster for PcrA binding to the RepD-plasmid complex than to the RepD-DNA 
junction complex (Table 15). 
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Figure 55. PcrA binding to RepD-pCERoriD 2437bp complex.  
A) Normalised data traces for MDCC-PcrA(E449C) binding varying 
concentrations of RepD-pCERoriD 3094 complex. Traces were fitted to 
double exponential. B) The kobs and C) The amplitudes for the phase 1 and 2 
from fitting plotted against the RepD-plasmid concentration. The fits are 
average of three traces. The linear fit has a gradient 13.6 µM-1s-1 for the fast 
phase 1 and 1.9 µM-1s-1 for the slow phase 2. The gradient for the phase 1 
amplitude is 18.5 per µM. The second phase of amplitude does not show 
linear dependence in amplitude with concentration of complex. The 
experimental conditions were 20 nM MDCC-PcrA(E449C) and 100 nM to 
250 nM RepD-plasmid complex.  
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5.5.1. MDCC-PcrA(E449C)·ATP binding to the RepD-plasmid complex  
 
 
 The effect of ATP and ATP non-hydrolysable analogues on MDCC-
PcrA(E449C) binding to the RepD-plasmid complex was investigated using 
ATP, AMPPNP and ATPγS (Figure 56 and Table 14). These measurements 
were done with 25% excess of plasmid over MDCC-PcrA(E449C) due to low 
availability of good quality plasmid and relatively high concentration MDCC-
PcrA(E449C) required for observable signal on the stopped-flow 
measurements. In other words, the conditions used were not in pseudo-first 
order conditions and the results cannot be directly compared with the PcrA 
binding measurements to RepD-DNA junction (Figure 45). The 
measurements with PcrA·ATP analogue binding to RepD-plasmid are purely 
a comparison between the different PcrA binding measurements with the 
plasmid. The fitting of traces was not done as a part of the analysis as the 
reactions were not done in pseudo-first order conditions. This means that 
many of the RepD-plasmid complexes could have more than one MDCC-
PcrA(E449C) binding to them (two processes of binding). The PcrA binding 
signal with ATP had the lowest fluorescence change of 5.8% and compared 
to 11.3 to 11.6% with the ATP analogues, ATPγS and AMPPNP, and 
especially lower than when no nucleotide is present (16.1%). This was also 
observed with the MDCC-PcrA(E449C) binding to RepD-DNA junction.  
 
 The observed binding rate constant of 5.8 s-1 is approximately three 
times faster with ATP present in the reaction than without nucleotide or with 
the non-hydrolysable ATP analogues, which have kobs of 1.6 to 1.9 s
-1 for the 
fast phase of binding. Though, it has to be noted that as the conditions were 
not pseudo-first order conditions, the observed rate constants cannot be 
accurately interpreted. The second phase of 10 second traces is slower but 
has a higher signal change. The kobs of the slow phase varied little between 
the four experiments and was between 0.2 to 0.3 s-1 (with and without 
nucleotide). The slow phase may be a second MDCC-PcrA(E449C) binding 
to the complex, rather than being another process of binding, though this 
may be possible even this was not observed with RepD-DNA junction 
binding experiments. 
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Figure 56. ATP bound MDCC-PcrA(E449C) binding to RepD-plasmid 
complex.  
The experiments were done on the stopped-flow apparatus by pre-
incubating the RepD-plasmid complex in syringe at 30 °C and mixing with 
MDCC-PcrA(E449C) and ATP/ATP analogue in the other syringe. The 
experiments were not done in pseudo-first order conditions due to low 
available quantity of plasmid. Each reaction had 30 nM MDCC-PcrA(E449C), 
37.5 nM pCERoriD 3094bp, 150 nM RepD, 1 mM ATP/ATPγS/AMPPNP. It 
should be noted that these measurements were not done in pseudo-first 
order conditions. 
Reaction 
kobs fast 
(s-1) 
kobs slow 
(s-1) 
Fluorescence 
change total 
Fluorescence 
change, 
fast phase 
Fluorescence 
change, 
slow phase 
No 
nucleotide 1.72 0.32 16.1% 4.8% 11.3% 
ATP 5.77 0.27 5.8% 1.9% 3.9% 
ATPγS 1.55 0.27 11.3% 2.1% 9.2% 
AMP PNP 1.91 0.23 11.6% 3.0% 8.6% 
 
Table 14. ATP bound MDCC-PcrA(E449C) binding to RepD-plasmid 
complex.  
The reaction conditions are the same as in the Figure 56. The fitting was 
done to 10s traces with double exponential fit and results are an average of 
three traces. 
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5.6. PcrA dissociation kinetics from RepD-plasmid complex 
 
 
 A displacement assay was carried out to determine the PcrA 
dissociation rate constant, koff, from the RepD-pCERoriD 3094 bp complex 
(Scheme 2, Introduction, Section 1.7). The MDCC-PcrA(E449C)-RepD-
plasmid complex was mixed with 50-fold excess of wild type PcrA, a signal 
with two phases was observed (Figure 57 and Figure 97, Appendix). The 
first phase was increasing and the second was decreasing in fluorescence. 
Varying the wild type PcrA concentration and fitting the increasing phase and 
part of the decreasing phase to a double exponential showed that the first 
phase rate constant increased with the increasing wild type PcrA 
concentration (Figure 57B). This indicated the phase may be due to wild type 
PcrA binding to RepD-plasmid complex at a close proximity to MDCC-
PcrA(E449C) and had a rate constant of 1.3 x 10-2 µM-1 s-1. 
  
 The second phase was fitted by single exponential decay followed 
by a slope. Increasing the wild type PcrA concentration did not increase the 
observed rate constant of the phase. This is likely to be PcrA dissociation 
from the RepD-plasmid complex. The dissociation rate constant, koff, for the 
dissociation was measured to be 0.019 s-1. This was an average for three 
traces at three different wild type PcrA concentrations. The slope had a 
gradient of 0.004 s-1 and this is most likely the rate of photobleaching as it is 
very similar to the rate of photobleaching observed with MDCC-PcrA(E449C) 
at same conditions (Figure 98, Appendix). 
 
 The displacement assay was also repeated for the pCERoriD 
2437 bp plasmid. The PcrA dissociation rate constant (koff) was 0.017 s
-1 
(average of three traces from measurements with three concentrations of 
wild type PcrA). This is similar to koff of PcrA dissociation from RepD-3094 bp 
plasmid complex (Table 15). These measurement were performed with the 
same plasmid preparations as the binding measurements and showed that 
the difference observed in PcrA binding to different lengths of plasmid-RepD 
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complex isn’t present in dissociation of MDCC-PcrA(E449C) from the same 
complexes.  
 
 
Figure 57. PcrA the dissociation rate constant (koff) from RepD-plasmid 
complex using MDCC-PcrA(E449C).  
A) Normalised traces of MDCC-PcrA(E449C) binding to the RepD-pCERoriD 
3094bp complex with 10 and 25 µM concentrations of wild type unlabelled 
PcrA. B) Linear fit of kobs for wild type PcrA binding to complex that gives a 
second order rate constant of 1.3 x 10-2 µM-1s-1 (SEM 0.01). The assay 
follows the Scheme 2 shown in Introduction. The experiments were done at 
30 °C in K200 buffer with 20 nM MDCC-PcrA(E449C), 100 nM pCERoriD 
3094/2437bp, 400 nM RepD with varying concentration of wild type PcrA.  
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5.7. PcrA affinity to RepD-DNA complex 
 
 
Together, the displacement assays and the binding of MDCC-
PcrA(E449C) to RepD-DNA provide the binding rate constants (kon) and the 
dissociation rate constants (koff). This enables the calculation of Kd values for 
PcrA affinity to RepD-DNA complex by dividing the koff with the kon 
(Equation 4, Section 1.7). The measured kon and koff values are summarised 
in Table 15. The Kd for the RepD-DNA junction 1 (with ICRIII) is 26 nM. The 
PcrA affinity to RepD-plasmid complex is 0.4 nM for the RepD-plasmid 3094 
bp complex and 1.2 nM for the RepD- plasmid 2437 bp complex. This shows 
that even with the variation in binding rate constants between the two 
lengths of plasmid, the PcrA affinity to RepD-plasmid complex is at least 20 
times tighter than to RepD-DNA junction 1 complex.  
 
Reaction kon fast (µM
-1
 s
-1
) kon slow (µM
-1
 s
-1
) koff (s
-1
) Kd (nM) 
DNA junction 1 34.3 2.9 
  
DNA junction 1_dT6arm 35.2 0.9 
  
RepD-DNA junction 1 6.1 0.6 0.16 26.2 
RepD-DNA junc. 1_dT6arm 11.2 1.1 
  
RepD-DNA j.(No ICRIII) 14.9 1.9 0.19 13.0 
RepD-DNA j. 1+ ATP 24.9 n/a 
  
RepD-DNA j.(No ICRIII) + ATP 34.9 n/a 
  
RepD-DNAj1_noCT*A 6.7 n/a 
  
RepD-DNAj(NoICRIII) noCT*A 22.4 3.4 
  
RepD-plasmid 3094 bp
§ 
46.2 4.0 0.019 0.41 
RepD-plasmid 2437 bp
§ 
14.1 2.0 0.017 1.21 
 
Table 15. Summary of PcrA binding and dissociation kinetics with 
RepD-DNA. 
§, the actual values for the PcrA association to the RepD-plasmid complex 
may not be accurate and the reasons for this are discussed in Discussion, 
Section 5.10.4. 
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5.8. MDCC-PcrA(E449C) and DNA unwinding  
 
5.8.1. MDCC-PcrA(E449C) and DNA junction unwinding 
 
 
MDCC-PcrA(E449C) signal interaction with RepD-DNA enabled the 
development of an assay to investigate the PcrA DNA unwinding on the 
stopped-flow apparatus. Firstly, an assay was designed where MDCC-
PcrA(E449C) unwinds the DNA unwinding junctions without the quencher-
fluorophore modifications (Figure 58A). In the assay, the 
MDCC-PcrA(E449C) was loaded on to the RepD-DNA junction complex and 
the unwinding was initiated by mixing with ATP on stopped-flow apparatus. 
As the fluorophore is on PcrA, the other components were in excess over 
the MDCC-PcrA(E449C) to enable single turnover measurements at 
pseudo-first order conditions. By having the PcrA at significantly lower 
concentration than the DNA meant that only single PcrA molecules could be 
expected to be unwinding individual DNA junctions.  
 
The signal first had a small decreasing phase. This phase probably 
corresponds for ATP binding to PcrA that is in complex with RepD-DNA or to 
PcrA in solution that then binds to the RepD-DNA complex. The second 
phase had an increase in fluorescence. The duration of this phase was 
dependent on the number of base pairs on the DNA junction. The increase 
was followed by a decreasing phase. The fluorescent peak (the highest point 
of fluorescence) formed between the second and third phase was used as 
the end point of DNA unwinding as it was seen as the end point of DNA 
unwinding. The fourth phase had a constant fluorescence and corresponded 
to the steady-state of PcrA binding translocating/unwinding and dissociating 
from ssDNA. The second phase for the 30 bp DNA junctions had duration of 
~0.5 s (Figure 58B). This matched well with the durations of the lag phase in 
DNA junction unwinding assay where the 30 bp DNA junction has a ~0.4 s 
lag phase (Figure 27). When the duration of unwinding was measured for 
the different lengths of DNA junctions and plotted against the number of 
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base pairs, the gradient gave an unwinding rate of 43 bp s-1. This is very 
similar to what is observed with DNA junction unwinding assay confirming 
the signal to be informative of PcrA unwinding linear DNA (Table 3). When 
the same assay was performed using DNA junction with ICRIII (DNA 
junction 1) and the number of base pairs is varied (30, 40 and 50 bp), no 
clear signal or phase corresponding to unwinding was observed (Figure 
58D).   
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Figure 58. MDCC-PcrA(E449C) and DNA junction unwinding of DNA 
junctions without ICRIII.  
A) Cartoon representation of the reaction. B) Normalised traces for three 
lengths of DNA junctions. C) Plot of duration of DNA unwinding against the 
number of bp in the DNA junction. D) DNA junction unwinding assay with 
DNA junction with ICRIII. The experiments were done at 30 °C in K200 by 
preforming the replication complex of 100 nM MDCC-PcrA(E449C), 500 nM 
DNA junction without ICRIII (20/30/40 bp) and 1 µM RepD before mixing with 
200 µM ATP. The concentrations are final reaction concentrations. See DNA 
junction structure sequences in Figure 19. DNA junctions are unmodified and 
do not have ICRIII. 
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5.8.2. PcrA DNA junction unwinding is processive  
 
 
 A question often asked with DNA translocating enzymes is how 
processive they are. This means that how far they move on DNA before they 
dissociated or falling off. Often this can be followed by binding of another 
enzyme for example in case DNA unwinding several helicases maybe 
required for full unwinding of the DNA. The possibility to observe unwinding 
by labelled-PcrA opened up an opportunity to look into how processive is the 
DNA unwinding by PcrA. To test this, a competition assay was performed on 
the stopped-flow instrument. The assay was done by forming the unwinding 
complex of MDCC-PcrA(E449C)-RepD-DNA before the initiation of 
unwinding by mixing with ATP. The ATP was added together with high 
excess of wild type unlabelled PcrA. If the MDCC-PcrA(E449C) dissociates 
from the complex before end of unwinding, the unwinding signal should have 
a change in its fluorescence. The results showed that the MDCC-
PcrA(E449C) that starts the unwinding is not replaced by wild type PcrA 
during unwinding and it continues without dissociating until the DNA junction 
is unwound (Figure 59). This could be concluded from the assay as no 
significant change was seen in MDCC-PcrA(E449C) DNA junction unwinding 
signal.  
 
Figure 59. MDCC-PcrA(E449C) does not get displaced by unlabelled 
PcrA while unwinding DNA junction structures.  
MDCC-PcrA(E449C) is pre-bound to RepD-DNA junction (no ICRIII) and 
then mixed with ATP (black), ATP and wild type PcrA (blue) or wild type 
PcrA (green). The unwinding of 30 bp DNA junction showed a peak 0.42 s in 
presence of unlabelled PcrA when it was ~0.4 s just with ATP.   
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5.8.3. MDCC-PcrA(E449C) and plasmid unwinding  
 
  
As the MDCC-PcrA(E449C) showed a signal with unwinding linear 
DNA, the next step was to test whether the MDCC-PcrA(E449C) could be 
used to observe plasmid unwinding. Indeed, the unwinding of plasmid was 
observed using MDCC-PcrA(E449C) when it was mixed with RepD-plasmid 
complex and ATP (Figure 60). The signal had a ~10 s phase of small 
decreasing fluorescence before a phase with a large fluorescence increase. 
The cause for the decrease hasn’t been determined, but it may be due to the 
PcrA binding to ATP and then to RepD-plasmid complex. The increasing 
phase duration varied with the length of the plasmid and presumably 
corresponded to the plasmid unwinding. This phase was followed by a 
decreasing phase, which may be dissociation of PcrA from DNA that is then 
bound by SSB. The end point of unwinding was determined as the time point 
of end of the second phase. This time point had the highest fluorescence. 
The time points for unwinding durations for different length plasmids were 
plotted against the length of the plasmids. The reciprocal of the linear fit 
gave an unwinding rate of 34.8 bp s-1 (average of two measurements). This 
corresponds well with the plasmid unwinding rate measured using DCC-SSB 
(Figure 27). 
 
This assay required the presence of SSB. SSB may be preventing the 
re-annealing or it may be required for possible interaction with PcrA that 
facilitates processive plasmid unwinding. The peaks used to determine the 
end point of unwinding were broad and added some uncertainty to the 
determination of the end of unwinding. The broad peaks are most likely 
caused by the small proportion of plasmids that are unwound later than 
majority of plasmids. These plasmids have been nicked and re-ligated by 
RepD (lost supercoiling). RepD nicks relaxed plasmids at slower rate than 
supercoiled plasmids. 
 
The fluorescence signal itself for the unwinding is unexpected as 
during the unwinding t the environment of the MDCC-PcrA(E499C) should 
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be relatively constant and the major changes in MDCC-PcrA(E449C) 
environment should be during initiation and termination of plasmid 
unwinding.  One explanation for the unexpected unwinding phase signal 
would be that the SSB binds to the MDCC-PcrA(E449C) and once the 
plasmid is unwound SSB starts to bind the available ssDNA, which has 
higher affinity than to PcrA. This would release MDCC-PcrA(449C) into 
solution and would be observed as a constant increase in fluorescence until 
the plasmids are fully unwound. Another possibility would be that the MDCC-
PcrA(E449C) is functioning similarly to DCC-SSB by having fluorescent 
increase when associating with ssDNA. This would require relatively large 
proportion of plasmid that is not unwound at all during the reaction as 
otherwise there would not be enough MDCC-PcrA(E449C) to cover the all 
the ssDNA produced from unwinding. This could be possible and could also 
explain the broad peaks as MDCC-PcrA(E449C) running out.  
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Figure 60. MDCC-PcrA(E449C) enables determination of PcrA 
unwinding rate on plasmid DNA.  
A) Cartoon representation of the reaction. B) Individual normalised 
unwinding traces for four lengths of pCERoriD plasmid. C) The linear fit of 
time point of the end fluorescence increase against the number of base pairs 
on the plasmid enable determination of PcrA plasmid unwinding rate. The 
gradient of the linear fit is 0.00367 s bp-1(SEM 0.0012). The experiments 
were done at 30 °C in K200 buffer with 30 nM MDCC-PcrA(E449C), 37.5 nM 
pCERoriD plasmid, 150 nM RepD and 1 mM ATP. All measurements had 
wild type SSB at 2-fold excess over the estimated number of possible SSB 
binding sites to fully unwound plasmid (SSB binding site ~65 bases and SSB 
binding to both strands). For example, fully unwound pCERoriD 3094bp 
would have maximum of 95 SSB bound to it (2.9 µM SSB in total reaction).  
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The MDCC-PcrA(E449C) plasmid unwinding assay was repeated 
without SSB with different length plasmids (Figure 61A). When SSB is left 
out of the plasmid unwinding reaction, the signal changes greatly and loses 
the phase the phase corresponding to plasmid unwinding. The first phase 
increasing phase is the initial binding of MDCC-PcrA(E449C) to the RepD-
plasmid complex. The second increasing phase may be caused by more 
MDCC-PcrA(E449C) binding to ssDNA freed from plasmid unwinding 
(“functioning similarly to DCC-SSB”). This would explain why the second 
phase has same duration for all the plasmid lengths (MDCC-PcrA(E449C) 
concentration is constant). If signal would be related to the SSB binding, the 
phase duration should vary with the concentration of SSB, as it is increased 
with the plasmid length. The third phase is the MDCC-PcrA(E449C) running 
out seen as constant fluorescence. The fourth phase is likely to correspond 
to photobleaching of MDCC-PcrA(E449C).   
 
The MDCC-PcrA(E449C) binding to RepD-plasmid complex in 
presence of wild type SSB showed a 14-fold decrease in amplitude (Figure 
61B). This may be an indication that the SSB is blocking PcrA binding to 
RepD-plasmid complex or interacting with MDCC-PcrA(E449C) preventing it 
from binding to the RepD-plasmid complex.  
  
5.Results- PcrA interaction with the initiator protein RepD during plasmid unwinding 
193 
 
 
 
Figure 61. MDCC-PcrA(E449C) and plasmid unwinding signal.  
A) When no SSB present in the plasmid unwinding reaction, no signal is 
observed corresponding to length of plasmid. B) SSB and ATP are required 
for plasmid unwinding signal with MDCC-PcrA(E449C), SSB seems block 
E449C binding when no ATP is in the reaction. The experimental conditions 
for the measurements were 30 nM MDCC-PcrA(E449C), 37.5 nM pCERoriD 
2437/3094/6642bp, 150 nM RepD, +/- 1 mM ATP, +/- 200 nM SSB. 
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5.9. FRET signal with fluorophore labelled PcrA(E449C) and 
RepD(C225A, W310C) 
 
 
Development of a FRET signal between PcrA and RepD would 
enable another method to study PcrA-RepD interaction. As FRET is distance 
and orientation dependent, a FRET signal between the two could provide 
information on how they interact and how the interaction changes during the 
plasmid unwinding. Labelling the PcrA(E449C) for FRET purposes was one 
of the first choices as it had shown the RepD-specific signal and the 
production of labelled RepD, MDCC-/Cy3-RepD(C225A, W310C) enabled 
the test for suitable FRET pairs between PcrA and RepD (Chapter 3). 
PcrA(E449C) and other PcrA mutants and RepD(W310C) have been 
labelled with several coumarin and Cy-dyes. Signals were observed with 
Cy3-PcrA(E449C) and Cy5-RepD(C225A, W310C) pair, but the highest 
signal was observed with MDCC-/Cy3-PcrA(E449C)  and Cy3-/MDCC- 
RepD(C225A, W310C) pair. Figure 62 shows the measurements of 
emissions spectra of different combinations of labelled and unlabelled PcrA 
and RepD in complex with DNA junction 1. With unlabelled PcrA and Cy3-
RepD exciting at 436 nm, a small Cy3 emission peak was observed at 570 
nm. This emission peak from Cy3-RepD was increased almost by double 
when MDCC-PcrA(E449C) was in the reaction. The control where RepD is 
unlabelled has no peak at the 570 nm. These measurements indicate FRET 
transfer of energy from MDCC-PcrA(E449C) to the Cy3-RepD. 
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Figure 62. Emission spectra of MDCC-PcrA(E449C) and Cy3-RepD.  
Black, emission spectra of MDCC-PcrA(E449C) mixed with Cy3-RepD 
bound to DNA junction 1 showing increase at 570 nm emission indicating 
FRET. Controls: Red, unlabelled PcrA and Cy3-RepD-DNA junction 1. Blue, 
MDCC-PcrA(E449C) and unlabelled RepD-DNA junction1. Conditions were 
600 nM PcrA, 0.5 µM DNA junction 1 and 1 µM RepD. The excitation was 
done at 436 nm and the emission was measured from 450 to 650 nm. 
Measurements were done at 30°C in K200 buffer. 
 
After identification of FRET signal between fluorophore-labelled PcrA 
and RepD, stopped-flow experiments were done to test PcrA binding to 
RepD-DNA junction complex with and without ATP (Figure 63). The 
fluorescent time courses were biphasic when ATP was not present. When 
ATP was added to reaction, the fluorescent time courses had a single phase 
of binding. This resembled the environmentally sensitive signal observed 
with MDCC-PcrA(E449C) (Sections 5.2. and 5.3.). The observed rate 
constants with FRET-labelled PcrA and RepD were also almost identical to 
the MDCC-PcrA(E449C) binding measurements (Figure 63 and Table 12). 
This indicated that the FRET signal was informative of same process as 
MDCC-PcrA(E449C) alone. The FRET-labelled PcrA and RepD were also 
tested on plasmid unwinding assay, but the signal was relatively weak and 
the measurements with FRET-labelled PcrA and RepD did not provide new 
evidence of PcrA function compared to environmentally labelled PcrA. 
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Figure 63. FRET signal on the stopped-flow with MDCC-PcrA(E449C) 
and Cy3-RepD.  
A) Schematic illustration of the experimental set-up with the PcrA-RepD 
FRET pair. B) Normalised 10 s data traces with and without ATP. C) 
Normalised 1 s data traces with and without ATP. The traces without ATP 
were fitted to double exponential decay. The fast phase had observed rate 
constant (kobs) of 4.2 s
-1 and the slow phase of 1.3 s-1. The traces with ATP 
were fitted single exponential and the kobs was 40.2 s
-1. The measurements 
were done with 100 nM MDCC-PcrA(E449C), 0.5 µM DNA junction, 1 µM 
Cy3-RepD(W310C, C225A) and 200 µM ATP. Measurements were 
performed at 30 °C in K200 buffer. The excitation was done at 436 nm and 
the emission was measured using a 570 nm cut-off filter. 
 
5.10. Discussion 
 
RepD interaction with PcrA is a requirement for processive unwinding 
by PcrA [88]. Details of this interaction are not understood, but PcrA isn’t 
able to unwind even short DNA duplexes by itself [87]. This improved 
unwinding does not require RepD nicking and covalent binding to DNA when 
unwinding DNA junctions (Figure 49), but its presence is still required [93]. 
The plasmid replication always requires the initiator protein RepD to make a 
single stranded nick on oriD, which opens up a single stranded stretch of 
DNA that PcrA may bind. RepD is thought to be interacting with the PcrA 
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throughout the plasmid unwinding, but how they interact and how RepD 
interacts with DNA remains unknown.  
 
5.10.1. RepD interacts with PcrA at the 2B domain 
 
 The E447C, E449C, M450C and L453C locations on PcrA were 
chosen for fluorescent labelling for their location on the top of 2B domain, 
which is expected to be the closest site to RepD when PcrA binds to oriD. 
As a part of this project, every subdomain of PcrA has been labelled, but the 
RepD-specific signal has only been observed with the coumarin-labelled 
PcrA mutants that are labelled at the top of the 2B domain (Figures 45 and 
46). This is strong evidence that RepD interaction domain on PcrA is the 2B 
subdomain. All the labelled mutants have also been tested for RepD-specific 
signal without DNA and all show no fluorescence change. This implies that 
the RepD and PcrA only interact when bound to DNA, but the fluorescent 
signals rely on environment change around the fluorophore. Therefore, the 
signals may well be dependent on the 2B subdomain rotation, which occurs 
on binding to DNA.  
 
5.10.2. MDCC-PcrA(E449C) biphasic signal when binding to RepD-DNA  
 
MDCC-PcrA(E449C) binding to RepD-DNA complex caused a 4 to 5-
fold increase in fluorescence. The MDCC-PcrA(E449C) binding signal to 
RepD-DNA junction is biphasic when no ATP is present with both phases 
have concentration dependent rate constants, indicating two processes of 
binding. The fast phase had a higher rate constant and amplitude change 
than the second phase. The first phase was postulated to be the primary 
binding signal to RepD-DNA junction complex. Several assays were done to 
test what is causing the biphasic nature of the signal. These included 
changing the dT-arm length to which PcrA binds to test to see if two PcrA 
are binding on one arm and to assess the effect of arm length (Figure 48 
and Table 9) and removal of RepD nicking site on the DNA junction (Figure 
49 and Table 10). None of these assays removed the second phase. In fact, 
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they indicated that the biphasic signal is not caused by how RepD has 
formed the complex or that the signal is little affected by whether the RepD 
is covalently bound to DNA junction or not. 
 
5.10.3. PcrA·ATP binding to RepD-DNA complex in one conformation 
 
PcrA·ATP was shown to bind six-fold faster to RepD-DNA than PcrA 
without ATP (Table 11). This was shown with DNA junctions and with 
plasmid experiments using MDCC-PcrA(E449C). When ATP or non-
hydrolysable ATP analogues were bound to PcrA to the binding to the 
RepD-DNA junction (Figures 50 and 52) had only a single phase. This has 
been the primary condition found where the biphasic signal of MDCC-
PcrA(E449C) binding to the RepD-DNA junction complex is lost (Figures 45 
and 50). There are two preferred explanations for the effect of ATP on PcrA 
binding, which are the ATP “locking” the PcrA into single conformation or the 
fast translocation to fork of RepD-DNA junction. The translocation may be so 
fast that it causes the loss of second phase. This is unlikely as the 
measurements with non-hydrolysable ATP analogues showed also a single 
phase indicating a single process of binding.  
 
This makes the PcrA “locking” by ATP most likely explanation for the 
single binding mode as the ATP/ATP analogues “lock” PcrA in one 
conformation and so one form of binding is observed. Whereas when PcrA 
isn’t bound to nucleotide, it may be in two conformations at equilibrium (open 
and closed) even when binding to DNA. The locked conformation could be 
the 2B domain folding over 1B domain (closed conformation) facilitated by 
ATP. The nucleotide binding (AMPPNP) in crystal structure has been shown 
to cause a 30° rotational change in 1A and 2A domains, whereby they come 
closer together. This hypothesis is also supported by the experiments with 
dT6-arm of DNA junction 1 that should enable only one PcrA to bind and 
have only one possible site of binding, still biphasic binding was observed 
indicating two forms of binding (Figure 48).  
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The ATP “locked” form of PcrA can also explain the increased binding 
rate with ATP to the RepD-DNA complex as it may higher affinity to RepD-
DNA than the other PcrA conformation(s). Another possibility is the fast 
translocation to fork of RepD-DNA junction. When the dT-arm length was 
varied in presence of ATP the observed rate constant reduced with length of 
dT-arm. This could be because the PcrA that binds at distal end of dT-arm 
(3’ end) take longer to translocate to the fork junctions and lead to drop in 
the observed rate constant. Of course, it is possible that the increased kobs of 
PcrA binding is due to both, as the ATP binding may lock the binding 
conformation increasing the PcrA affinity to the DNA/RepD-DNA, but at the 
same time the ATP hydrolysis enables translocation to the DNA fork 
junction.  
 
A faster rate constant was observed with MDCC-PcrA(E449C) 
binding to the DNA junction only than when RepD is in complex with DNA 
junction, possibly indicating that the RepD may have some restrictive effect 
on the binding (Table 11). Though, the rate constant of PcrA binding to DNA 
junction can be expected to be higher as they have two ssDNA arms of 10 
and 13 bases when no RepD is in the reaction. When DNA junction is 
covalently bound to RepD only one ssDNA arm is free for PcrA binding. As 
the binding to DNA junctions have binding rate constant, kon, >30 µM
-1 s-1, 
which is five times the kon of PcrA binding to RepD-DNA junction 1, this is 
unlikely to be the only factor affecting the binding. Hence, the effect must 
have something to do with the RepD. 
 
5.10.4. PcrA affinity to RepD-DNA 
 
 Development of RepD-specific signal enabled the measurement of 
association and dissociation kinetics, which in turn enabled the 
determination of PcrA affinity to the RepD-DNA junction and RepD-plasmid 
complexes. The PcrA binding rate constant, kon, to DNA junction 1 was 
6 µM 1 s-1. When the same assay was done with RepD-plasmid the kon was 
52 µM-1 s-1 for the pCERoriD 3094 bp. The kon to pCERoriD 2437 bp was 
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lower at 15 µM-1 s-1. This difference in the results could be anomalous even 
the experiments were repeated with two different plasmid preparations. But 
there are several possible explanations for the variation. First, the RepD-
plasmid complex may be affected by the length of the plasmid and this could 
affect PcrA binding. Secondly, the different lengths of plasmids vary in 
sequence and PcrA may be binding these sequences differently. Thirdly, the 
proportion of the nicked relaxed versus supercoiled plasmid may vary 
between the plasmid preparations, which is not necessarily obvious on an 
agarose gel. The relaxed plasmids have been shown to be poor substrates 
for RepD nicking [93]. Lastly and possibly most likely, a factor that may 
affect the binding measurements is the proportion of ssDNA contamination 
in the plasmid preparations. PcrA binds very short ssDNA sequences and if 
any present, it will bind to it. Determination of ssDNA of less than 100 bases 
is complicated on an agarose gel, especially when one is determining the 
quality of plasmid of several thousand base pairs.  
 
The dissociation kinetics of PcrA from RepD-DNA complexes were 
measured using the wild type PcrA displacement assay. The displacement 
assay indicated that second PcrA is able to bind to MDCC-PcrA(E449C)-
RepD-plasmid complex before the MDCC-PcrA(E449C) dissociated and 
replaced by the unlabelled PcrA (Figure 57). The second phase of the traces 
was used to determine the koff. The dissociation rate constant from RepD-
plasmid complex for PcrA was 0.019 s-1 for the 3094bp plasmid and 
0.017 s-1 for the 2437 bp plasmid. In other words, there is no significant 
difference between the dissociation rate constants between the plasmid 
lengths. This supports the idea that the kon difference between 2437 bp and 
3094 bp plasmids is caused by the quantity of RepD-plasmid complexes that 
is dependent on the quality of the plasmid preparation as the dissociation is 
independent of the RepD-plasmid complex concentration.  
 
The dissociation rate constant for PcrA from RepD-DNA junction was 
measured as 0.16 s-1 (Table 15). The kon and koff enable the determination of 
the Kd, which were 0.4 nM for PcrA binding to the RepD-plasmid complex 
(3094 bp) and 26 nM for the RepD-DNA junction 1 (Table 15). This indicated 
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that PcrA affinity to RepD-plasmid is over 60 times tighter than to RepD-
DNA junctions. This should be taken into consideration when using oriD-
mimic junctions to study PcrA function, even though the availability of DNA 
junctions make them ideal substrates for PcrA assays compared to plasmids 
as they are hard to obtain at high concentrations required for excess over 
labelled PcrA on the stopped-flow apparatus. Measuring the dissociation of 
PcrA in presence of ATP was not done as it is complicated by the 
unwinding/translocation on ssDNA that may prevent the displacement. 
 
5.10.5. Investigation of PcrA unwinding DNA using MDCC-PcrA(E449C) 
 
MDCC-PcrA(E449C) signal with RepD-DNA was used to investigate 
PcrA unwinding DNA. This was tested on DNA junctions and on plasmid. 
When MDCC-PcrA(E449C) was loaded onto the RepD-DNA junction 30 bp 
(no ICRIII) complex and this was mixed ATP, a phase corresponding to DNA 
unwinding was observed. The rate of unwinding was determined to be 
~43 bp s-1, which is similar to what is observed with DNA junctions without 
ICRIII (Figure 58 and Table 3). Using the same assay with wild type 
unlabelled PcrA, the processivity of PcrA unwinding on DNA junctions could 
be tested (Figure 59). This showed that the PcrA that starts to unwind the 
short linear DNA is not displaced by unlabelled PcrA. 
 
MDCC-PcrA(E449C) was used to develop an assay to look at PcrA 
unwinding full lengths of plasmid. The length dependent signal was only 
observed when SSB was in the reaction. The signal was more 
distinguishable when MDCC-PcrA(E449C) was mixed to complex rather 
than loaded on to the complex with before addition of ATP. The rate of 
unwinding was determined as ~30 bp s-1. This is very similar what was 
observed with plasmid unwinding assay using DCC-SSB (Figure 27).  
 
The requirement of SSB for plasmid unwinding signal with MDCC-
PcrA(E449C) may be explained by the separation of component single 
stranded DNA that can be a requirement for processive unwinding. But other 
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possibilities exist to explain the signal. The signal may indicate that the SSB 
is required for activation of PcrA processivity. No evidence exists for this and 
this would the first indication for it. This is an interesting point for future 
experiments that could not be assessed here. Other helicases have shown 
to interact with SSB. For example, the Pri helicase involved in DNA 
replication restart in E. coli has been shown to interact with SSB and require 
interaction for unwinding activity [168]. Also, the DCC-SSB plasmid 
unwinding assay developed before to investigate PcrA uses SSB. Only the 
assays on short linear DNA are done without the presence of SSB and the 
interaction with SSB may be required for the processivity that is required for 
unwinding entire plasmid lengths of DNA. 
 
The nature of the fluorescent signal in plasmid unwinding was 
unexpected as the phase of unwinding was constantly increasing in 
fluorescence. It can be expected that if the enzyme is preforming a constant 
function such unwinding a long length of DNA, the enzyme is staying at the 
same state. This in turn should mean that the environment of the fluorophore 
is not changing and so the process should be observed as constant 
fluorescence. This is not the case here. This opens a question of what is 
actually causing the signal. One possibility would be the MDCC-
PcrA(E449C) binding to SSB in solution that would have a lower 
fluorescence state than when MDCC-PcrA(E449C) is free in solution. Once, 
the MDCC-PcrA(E449C) starts to unwind plasmid DNA the SSB starts to 
bind to ssDNA to which it has very high affinity. This would lead to constant 
increase in fluorescence until plasmid is fully unwound or all MDCC-
PcrA(E449C) is free of SSB. The experiments assessing PcrA and SSB 
interaction using fluorescence such as FRET could possibly answer the 
questions raised from results observed here and could also involve use of 
assays such as analytical ultracentrifugation of PcrA and SSB with and 
without ssDNA. 
 
A second explanation for the unwinding signal observed in 
MDCC-PcrA(E449C) plasmid unwinding assay is the possibility of MDCC-
PcrA(E449C) functioning similarly to ssDNA biosensor (for example the 
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DCC-SSB). It may that when SSB is present free MDCC-PcrA(E449C) binds 
to increasing ssDNA together with the SSB. This could lead to constant 
increase in fluorescence until all the plasmid has been unwound. As the 
experiments were done with relatively high concentration of MDCC-
PcrA(E449C) (30 nM) compared to plasmid (37.5 nM), the reaction could 
have proportion of free MDCC-PcrA(E449C) in the solution ready to bind 
ssDNA until the end of plasmid unwinding.  
  
5.10.6. PcrA and RepD FRET pair  
 
 The PcrA(E449C) mutant was the first choice used to find a FRET 
pair between PcrA and RepD. The FRET signal was tested with Cy3 and C5 
labels that would be suitable for single molecule FRET on TIRFM, but higher 
signal was observed with the MDCC and Cy3 labelled PcrA(E449C) and 
RepD(C225A, W310C). The emission spectra indicated very small drop in 
the donor fluorophore MDCC on PcrA, but this can expected when taking in 
account the MDCC-PcrA(E449C) signal when interacting with RepD-DNA. 
The acceptor (Cy3) emission increased in the presence of MDCC-
PcrA(E449C), indicating FRET. MDCC-PcrA and Cy3-RepD were used on 
the stopped-flow measurements to test PcrA binding to RepD-DNA junction 
and in plasmid unwinding. The ensemble FRET measurements did not 
provide new information on PcrA function. Hence, the FRET labelled PcrA 
and RepD were not used in further experiments, but they do open up a 
possibility for development of new assays at single molecule level using 
TIRFM.  
 
5.11. Summary 
 
 The signal from MDCC-labelled PcrA cysteine mutants binding to 
RepD-DNA has provided direct evidence for the location of PcrA and RepD 
interaction on PcrA surface. The signal was only observed with PcrA 
mutants that had fluorophores on the top of the 2B domain. The signal was 
present only when RepD was attached to DNA. The signal from MDCC-
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PcrA(E449C) enabled the determination of its affinity to RepD-DNA junctions 
and RepD-plasmid complex showing that the actual PcrA affinity to RepD-
plasmid complex is significantly tighter than to oriD-mimic junctions bound 
with RepD. The ATP makes the binding faster, possibly by “locking” the 
PcrA into one conformation that has a higher affinity to the DNA/RepD-DNA.  
 
 The plasmid and DNA junction unwinding assays have been 
developed using MDCC-PcrA(E449C) and confirm the previous observed 
results for rates of unwinding on DNA junctions and plasmids. FRET pair 
between PcrA and RepD were developed using PcrA E449C and RepD 
W310C location for labelling. These showed very similar observed rate 
constants to the MDCC-PcrA(E449C) signal when PcrA was binding to 
RepD-DNA junction complex, but could prove very useful in the future in 
single molecule assays.   
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6. Results – Individual PcrA molecules unwinding 
plasmid DNA 
 
6.1. Introduction 
 
   In Chapters 4 and 5, the PcrA function and interaction with the 
plasmid unwinding complex was investigated using ensemble based 
methods. Here, a plasmid unwinding assay has been developed at single 
molecule on TIRFM to observe individual PcrA helicases unwinding full 
lengths of circular plasmids. This is important as the investigation of an 
enzyme such as PcrA at single molecule level may enable the observation 
of processes that are masked by the averaging in the ensemble assays. 
These include processes such as stalling, dissociation, re-starting and 
unwinding processivity. Single molecule assays can also show different 
populations of the enzyme or intermediate steps it takes not observable 
using other methods. For example, in vivo a helicase can be performing two 
processes that require two different rates, which are averaged in the 
ensemble unwinding assays. Also, single molecule assays can give clues to 
helicase unwinding termination and oligomeric state when unwinding DNA.  
 
   The single molecule plasmid unwinding assay on TIRFM was 
constructed very similarly to the ensemble DCC-SSB plasmid unwinding 
assay where the RepD-bound pCERoriD plasmid is unwound by PcrA 
hydrolysing ATP and detected by a ssDNA biosensor DCC-SSB [87, 89] 
(Figure 26). A similar assay has been used to measure helicases unwinding 
linear DNA [146]. Total internal reflection of light in TIRF microscope 
produces an evanescent field of ~100 nm in depth above the glass slide it is 
reflected from [148] The formation of this field is discussed in the 
Introduction, Section 1.8.1., and the TIRFM set-up used here is shown in 
Methods, Figure 21. By attaching the unwinding complex either through 
DNA or PcrA on the surface of a glass slide, the reaction occurs in the 
evanescent field, which allows the excitation of fluorophores without 
diffusion. In the single molecule plasmid unwinding assay, DCC-SSB was 
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replaced by Cy3B-SSB, which was excited with a green laser at 532 nm. 
Cy3B-SSB does not have large signal change when binding to ssDNA and 
the single molecule assay relies on the localisation of Cy3B-SSB at the fixed 
plasmid unwinding site. Synchronisation of the reactions is achieved by 
addition of ATP at the desired time. 
 
   Immobilisation of reactions to PEGylated surfaces can be achieved 
by use of biotinylated linear DNA, which is available commercially. The biotin 
can then be used to attach the DNA to avidins such as streptavidin linked to 
biotinylated polyethylene glycol (bio-PEG). The bio-PEG is added to the 
surfaces in a mixture with non-biotinylated PEG. The non-biotinylated PEG 
is used to block the surfaces for non-specific binding of molecules [143].  
When large DNA structures are required, shorter oligos/DNA duplexes with 
biotinylation can be ligated into PCR products/lambda DNA or biotinylated 
primers can be used to amplify wanted DNA sequences.  As plasmids are 
circular, the attachment of DNA is more complicated to achieve, but can be 
done by PCR amplification using primers with biotin modification (similarly to 
site-directed mutagenesis). Attaching circular DNA on a surface was not 
used here as the attachment may cause restriction to unwinding by pausing 
the complex at the site of attachment and also possibly only allow unwinding 
of the partial plasmid. Also, it is likely to prevent the natural termination and 
release of the plasmid. Hence, another option for attaching the plasmid 
unwinding reaction to the surface was used. This was done by immobilising 
the PcrA on the surface of the cover slide by making a biotin-modified PcrA 
described in Methods, Section 2.7.4. RepD was not used for immobilisation 
as it is a dimer and so would have two biotins on it, which may complicate 
the binding to the streptavidin and affect the observed plasmid unwinding. 
Using this method individual PcrAs were visualised unwinding full lengths of 
plasmid. This enabled the determination of individual PcrA unwinding rate 
and reveal new characteristics of PcrA function. 
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6.2. Immobilisation of biotinylated PcrA for single molecule 
assays 
 
6.2.1. Biotinylated PcrA and Cy3B-PcrA(E449C) 
 
 
 The biotinylated PcrA was prepared by cloning a biotinylation peptide 
sequence to N-terminal end of the pcrA gene. The PcrA was then expressed 
together with a biotin ligase in presence of high concentration of free biotin. 
During expression, the biotin ligase ligates the biotin on to the biotin peptide 
sequence on PcrA.  The expression and purification protocol is described in 
the Methods, Section 2.7.4., and checked for correct size and level of 
biotinylation using electro-spray mass spectrometry. The mass spectrometry 
showed single species at the molecular weight of 84 767.0 +/- 2 Da 
corresponding to expected molecular weight of bioPcrA. The biotinylation 
was highly specific as only singly biotinylated PcrA were observed on mass 
spectrometry without any non-biotinylated PcrA. This indicated that the 
biotinylation must have been close to 100%.  
 
 The E449C mutation was introduced to bioPcrA using site-directed 
mutagenesis to enable fluorophore labelling of bioPcrA with 
maleimide/iodoacetamide attached fluorophores. The biotinylated 
bioPcrA(E449C) was labelled with Cy3B-maleimide and checked for level of 
labelling and biotinylation by mass spectrometry and absorbance. Cy3B-
bioPcrA(E449C) had molecular weight of 85 425.0 +/- 2 Da and a Cy3B-
maleimide labelling percentage was measured using absorbance and it was 
91%. The labelling of bioPcrA was desirable as this enable the observation 
of bioPcrA on the surface and possible development of FRET paired 
bioPcrA for single molecule FRET measurements on TIRFM. The E449 
location was chosen as the coumarin-labelled PcrA(E449C) had a RepD-
specific signal in the ensemble assays and has been used for development 
of FRET pair of labelled PcrA and RepD (Chapter 5).  
 
 The unwinding activity of the biotinylated PcrA and PcrA(E449C) was 
checked using an ensemble DNA junction unwinding assay (Table 3, 
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Chapter 3) and plasmid unwinding  assay (Experimental set-up, Figure 26), 
as previously described. Figure 64 shows the traces for bioPcrA and wild 
type PcrA unwinding pCERoriD 2437 bp. The breakpoint of unwinding was 
~110 s for both, the bioPcrA and the wild type PcrA. This confirms that the 
unwinding function of PcrA is unaffected by the biotinylation.  
 
 
Figure 64. DCC-SSB plasmid unwinding assay of bioPcrA and wt PcrA.  
The experimental conditions were same as in Figure 27. 
 
 The unwinding activities of Cy3B-bioPcrA(E449C) and bioPcrA were 
confirmed by the DNA junction unwinding assay at single molecule assay 
conditions and at ensemble assay conditions (Figure 24, Chapter 3). The 
normal assay condition for DNA junction unwinding assay is 30 °C in K200 
buffer. At these conditions, the rate of unwinding of DNA junctions by 
bioPcrA and Cy3B-bioPcrA(E449C) was ~50 bp s-1. This is similar to wild 
type PcrA (Table 3, Chapter 3). Under single molecule assay conditions, the 
DNA junction unwinding was done at 22 °C in TIRF buffer and the results 
were compared to wild type PcrA activity at the same conditions. The single 
molecule conditions were used to ensure that Cy3B-bioPcrA(E449C) was 
still an active helicase. The unwinding rate at single molecule assay 
conditions was 23.5 +/-7.5 bp s-1 for the wild type PcrA and 24.4 +/-0.5 bp s-1 
for Cy3B-bioPcrA(E449C). This is half of the rate of unwinding in K200 
buffer at 30 °C, but this is not surprising as lower the temperature is 
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expected to lower the enzyme Vmax. These assays indicate that the 
biotinylation peptide, the biotin, the cysteine mutation, and the labelling do 
not significantly affect the PcrA unwinding activity of Cy3B-bioPcrA(E449C) 
when compared to the activity of the wild type PcrA. Therefore, it can be 
used reliably to investigate PcrA function in plasmid unwinding. 
 
6.2.2. PcrA and biotinylated PcrA are monomers in solution when 
applied to surface of PEGylated TIRFM flow cells 
 
 PcrA is thought to function in DNA unwinding as a monomer, but there 
is no conclusive experimental confirmation for this.  PcrA crystallises as a 
monomer in apo and DNA/substrate-bound forms and most of the 
biochemical evidence is consistent with the hypothesis that is active as a 
monomer on ssDNA [21, 22], but some suggestions of PcrA oligomerisation 
have been made [37]. Closely related helicases, UvrD and Rep from E. coli, 
require oligomerisation for processive unwinding [38, 39]. UvrD can exist as 
a monomers, dimers or tetramers in solution, but require dimerisation to 
unwind DNA, even though UvrD crystal structure with DNA junction shows 
UvrD as a monomer [19, 39]. Rep helicase is monomeric in solution and can 
bind ssDNA as a monomer, but requires dimerisation for active/processive 
unwinding [138, 169]. The definite proof of PcrA monomeric activity has 
been hard to obtain as most assays are only able to indicate 
dimerisation/oligomerisation. Some assays have been attempted such as 
the gel filtration where PcrA oligomeric state was tested with DNA and RepD 
[170]. In the assay PcrA was monomeric, but inability to observe oligomers 
in solution or without ATP does not exclusively prove that PcrA is not dimeric 
at certain conditions. For example, PcrA could dimerise when binding to 
certain length ssDNA or when coming to a fork junction and this could 
require presence of ATP. The interaction with other proteins or change in 
conditions such as salt concentration may also facilitate dimerisation.  
 
  As the subsequent plasmid unwinding experiments are done with 
surface immobilised PcrA, it is important to investigate if bioPcrA is bound to 
surface as a monomer or dimer. This also confirms whether the plasmid 
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unwinding is performed by monomeric or dimeric PcrA. Also, the correct 
interpretation of the results is dependent on the knowledge of PcrA 
oligomeric state.  
 
 First, the PcrA oligomeric state in solution was studied using size 
exclusion chromatography-multiangle light scattering (SEC-MALS). Running 
a protein on SEC-MALS provides information about the molecule weights of 
the complexes. Size exclusion chromatography is informative of protein 
oligomeric or complex state, if run in ideal buffering conditions for the protein 
or complex in question and provides evidence about the protein oligomeric 
state and possible aggregation. Figure 65 shows the results for the SEC-
MALS carried out for the wild-type PcrA and bioPcrA at the micromolar 
concentrations used, wild-type and the bioPcrA do not form dimers or 
oligomers in solution. This provides further evidence to PcrA existence as 
monomer.  
 
 In the subsequent single molecule assays, the bioPcrA is applied to 
streptavidin in solution at low concentrations without presence of DNA or 
RepD. According to SEC-MALS results PcrA should bind to streptavidin as a 
monomer and perform plasmid unwinding in the single molecule assays as a 
monomer. This in part address the question of PcrA oligomer state being a 
monomer, as the single molecule assay designed here involves bioPcrA 
immobilisation to the surface before addition of other plasmid unwinding 
components, the PcrA should be attached as a monomer on the surface and 
when unwinding is observed, this can only be by the monomeric PcrA. 
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Figure 65. SEC-MALS of bioPcrA and wild type PcrA.  
Red. bioPcrA. Blue, wild type PcrA. Solid horizontal lines indicate the molar 
masses of proteins and the dashed lines are the percentage of light 
scattering. 
6.2.3. Biotinylated PcrA surface density on PEGylated and streptavidin 
treated surface 
 
 Cy3B-bioPcrA(E449C) enabled the observation and quantitation of the 
helicase on the surface of the flow cell using TIRFM and gave information 
about the correct working concentration in subsequent unwinding 
measurements. Density measurements could show the concentration at 
which the surface is saturated and give indication on the quality of the 
surfaces. Cy3B-bioPcrA(E449C) was applied to surfaces using standardised 
method by where aminosilane treated cover slips were PEGylating with NHS 
ester–PEG to prevent any unwanted surface absorption [111, 143]. The 
PEGylation was done with mixture of PEG and biotin-PEG to enable 
attachment of biotinylated PcrA on to the surface using streptavidin, which 
binds to the biotin on surface and the biotin on PcrA.  
 
 The density of Cy3B-bioPcrA(E449C) on the surface was measured as 
a function of concentration in the applied solution. The Cy3B-
bioPcrA(E449C) was exposed to laser light until the fluorophores had 
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photobleached (the photobleaching assay). The number of spots detected 
increased with the Cy3B-bioPcrA(E449C) loading concentration (Figure 66 
from 0.01 nM to 0.2 nM). The increase was linear (Figure 67).  The results 
were analysed using the GMim Pro programme, Automatic Single Particle 
Tracking (ASPT), which tracks fluorescent objects in a xy-plane [160]. The 
analysis of spots is described in detail in Methods Section 2.17.3. When the 
fluorescent objects are detected using ASPT, they do not need to have a 
change in fluorescence to be detected. Hence, for analysis of single or 
complied frames, ASPT was used as it can detect constant still fluorophores 
and objects on individual frames. 
 
Figure 66. Observation of individual Cy3B-bioPcrA(E449) on TIRFM.  
Cy3B-bioPcrA(E449C) was applied to surfaces at 0.01 nM (A), 0.05 nM (B), 
0.1 nM (C) and 0.2 nM (D) concentrations. The application of Cy3B-
bioPcrA(E449C) at 0.2 nM was also done with 9 µM biotin as control of 
binding of biotin to streptavidin (E). The surface preparation and Cy3B-
bioPcrA(E449C) surface attachment protocols are given in Methods, Section 
2.17.3. 
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Figure 67. Linear increase of Cy3B-bioPcrA(E449C) object numbers at 
loading concentration up to 0.2 nM. 
Spots tracked by ASPT analysis was done to the sum of 3 first frames of the 
record. The gradient for ASPT density increase: 2.92 objects per µm2 per nM 
of Cy3B-bioPcrA(E449C) (SEM 0.61).  
  
 In other set of experiments, the Cy3B-bioPcrA(E449C) was loaded on 
the PEGylated streptavidin treated surfaces at concentrations from 0.1 nM to 
2 nM (Figure 68).  The background of the surfaces increased significantly 
from ~150 at 0.1 nM to ~600 at 2 nM. This indicates saturation of the 
fluorescence on the surface at higher Cy3B-bioPcrA(E449C) loading 
concentration.  
  
 The method used for the analysis at the higher Cy3B-bioPcrA(E449C) 
concentrations (>0.5 nM) was unable to detect correctly the number of 
spots. Figure 69A shows the plot of objects against time for 2 nM Cy3B-
bioPcrA(E449C) indicating clear saturation of the surface. At the beginning 
of the record the number of objects cannot be detected accurately by the 
ASPT detection. Hence, another method of spot estimation was taken into 
use, which enabled the calculation of object density at the beginning of the 
record. On the records where all the fluorophores were photobleached, the 
number of objects were detected using the ASPT at different time points. 
These object numbers were plotted against time and fitted with a single 
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exponential. This enabled the extrapolation of the curve to obtain the 
number of objects on the first frame at zero time. Figure 99 in Appendix 
shows and describes the fitting method.  Table 16 summaries the number of 
objects on the surface extrapolated from the fit and Figure 69B shows the 
linear fit done to the object density versus Cy3B-bioPcrA(E449C) loading 
concentration plot. The density of objects increases linearly with the Cy3B-
bioPcrA(E449C) loading concentration. These results indicate that at least 
up to 2 nM of Cy3B-bioPcrA(E449C) no significant saturation of streptavidin 
by the Cy3B-bioPcrA(E449C) is observed by bioPcrA even the fluorescent 
signal of the field of view has been saturated.  
 
Figure 68. Cy3B-bioPcrA(E449C) on the flow cell surface.  
The Cy3B-bioPcrA(E449C) was applied to surfaces at 0.1 nM (A), 0.5 nM 
(B), 1 nM(C) and 2 nM (D) concentrations. The application of Cy3B-
bioPcrA(E449C) at 0.1 nM was also done with biotin block as a control (E). 
Once, 9 µM biotin was incubated together with 0.1 nM, the ASPT analysis of 
field of view detected an average of 26 objects. Whereas, without biotin this 
was 1127 objects at the same Cy3B-bioPcrA(E449C) loading concentration. 
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Figure 69. The relationship between ASPT objects count and 
fluorescence intensity.  
A) Spot density of 2 nM Cy3B-bioPcA(E449C) during the photobleaching 
record. At higher concentrations ASPT was unable to detect individual 
objects due to their overlap and this was observed as saturation of number 
of events counted at the beginning of record. The single exponential fit was 
done from 30 s onwards till end record and shown as black line. The single 
exponential decay has rate constant of 0.051 s-1 for 2 nM Cy3B-
bioPcrA(E449C) and the number of objects (y-intercept) is 3180.2 (SEM 
138.7) on area of 1394 µm-2. This has a density of 2.23 objects per µm2. B) 
Cy3B-bioPcrA(E449C) density relationship with varying loading 
concentration of Cy3B-bioPcrA(E449C) determined using extrapolation of 
spots from photobleaching records. The linear fit has a gradient of 
0.75 objects µm-2 per nM (SEM 0.093). 
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[Cy3B-bioPcrA(E449C)] (nM) 
Number of 
objects Density (objects/µm
2
) 
0.1 962.5 0.53 
0.5 1817.1 1.01 
1 2592.7 1.44 
2 3607.2 2.00 
Table 16.Cy3B-bioPcrA(E449C) object density at saturating 
concentrations.  
The fit to determine the y-axis (the number of objects on the surface at 
frame 1) was done using fixed rate constant (kc) determined from intensity 
decay of whole field of view. Data is an average of two records from two 
experiments. The number of objects was calculated on area of 1800 µm2. 
The fitting is shown in Appendix, Figure 99. 
 
6.2.4. Biotinylated PcrA is a monomer on the surface of the 
glass coverslip  
 
 
 The SEC-MALS experiments showed that PcrA and bioPcrA are 
monomers in solution and when applied to the flow cell surface, but as 
streptavidin has four possible binding sites, it could in principle facilitate 
binding of up to three PcrAs when surface bound. These PcrAs might 
function together as a dimer or as a monomer on same DNA molecule. 
Hence, photobleaching experiments were designed using Cy3B-
bioPcrA(E449C). For other biological systems, photobleaching experiments 
at single molecule level on TIRFM have been successfully used to observe 
the oligomeric state of proteins in vitro and in cell cultures [137, 146, 171, 
172]. The accuracy of the measurements is dependent on the resolution of 
TIRFM (~100 nm) and the spread of molecules [173-175]. 
 
  In photobleaching measurements, the Cy3B-bioPcrA(E449C) or Cy3B-
SSB was attached to streptavidin treated surface through biotin in low 
concentration (below 0.2 nM for Cy3B-bioPcrA(E449C)) to provide individual 
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spots. These were then viewed under TIRFM and exposed to laser light long 
enough to photobleach the fluorophores. If the protein was an oligomer, 
multiple step photobleaching would be observed corresponding to number of 
fluorophores on the protein. For example, for tetrameric SSB, this was four 
photobleaching steps [146]. 
 
 Here, all the photobleaching records at <0.2 nM Cy3B-bioPcrA(E449C) 
were analysed by SFDA that looks for instant fluorescence decreases, 
caused by the photobleaching of the fluorophore and called “drops”. The 
detection of the number of photobleaching steps provides information about 
the oligomeric state of Cy3B-bioPcrA(E449C). To measure photobleaching 
steps accurately, the loading of Cy3B-bioPcrA(E449C) had to be at 
concentrations where only single fluorophores were observed.  Figure 70 
show an example of spots with multiple photobleaching steps and those with 
single photobleaching steps. Very few spots with multiple step 
photobleaching were observed with all concentrations tested from 0.01 nM 
and 0.2 nM of Cy3B-bioPcrA(E449C). The results for photobleaching Cy3B-
bioPcrA(E449C) at various concentrations are given in Table 17 and 
Figure 71. At all loading concentrations of 0.2 nM and below, over 90% of 
the spots showed only a single photobleaching step. 
  
 When the records with higher loading concentrations of Cy3B-
bioPcrA(E449C) were analysed using SFDA tracking, the density at loading 
concentration of 0.5 nM Cy3B-bioPcrA(E449C) was ~1.8 objects µm-2 for 
single step photobleaching and 0.14 spot µm-2 for objects with multiple step 
photobleaching. This means that at maximum less than 15% of the spots 
showed multiple step photobleaching. The results clearly indicate that most 
spots visualised on surfaces are single PcrA molecules and hence PcrA is 
bound to streptavidin as a monomers. This is important as the loading 
concentrations used for plasmid unwinding assay were 0.2 and 0.5 nM.  
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Figure 70. Cy3B-bioPcrA(E449C) photobleaching steps at constant 
laser power.  
A) Examples of spots with single step photobleaching. B) Examples of spots 
with double step photobleaching. The Cy3B-bioPcrA(E449C) photobleaching 
examples are from record with 0.1 nM Cy3B-bioPcrA(E449C) in TIRF buffer 
without oxygen scavenger at laser power ~2.5 mW. The loading of Cy3B-
bioPcrA(E449C) was done as described in Methods, Section 2.17.3., and the 
objects were tracked using SFDA for the entire length of the record. 
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Figure 71. Cy3B-bioPcrA(E449C) is a monomer on the surface of the 
flow cell.  
The loading of Cy3B-bioPcrA(E449C) was done as described in Methods, 
Section 2.17.3., and the objects were tracked using SFDA for entire record. 
(SS, single step photobleaching. MS, multiple step photobleaching). 
 
[Cy3B-
bioPcrAE449
C)] (nM) 
Total 
number of 
objects 
Single 
step 
Multiple 
step 
Objects 
with steps 
(average) 
Single step 
(average) 
Multiple 
step 
(average
) 
Singl
e 
step 
phot
oblea
ching 
(%) 
Objects 
with 
decreas
e/µm
2
 
Current 
(A) 
0.01 253 179 3 338.5 197.5 1.5 99.2 0.19 0.3 
0.01 424 216 0 
     
0.6 
 
0.05 985 705 35 971.7 688.3 31.7 95.6 0.54 0.3 
0.05 950 796 17 
     
0.3 
0.05 980 564 43 
     
0.6 
 
0.1 1675 954 7 1308.3 893.3 26.0 97.2 0.73 0.3 
0.1 1085 936 25 
     
0.3 
0.1 1165 790 46 
     
0.6 
 
0.2 2121 1713 115 2003.0 1343.7 99.7 93.1 1.11 0.3 
0.2 2287 1293 25 
     
0.3 
0.2 1601 1025 159 
     
0.6 
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Table 17. Summary of photobleaching results of Cy3B-bioPcrA(E449C) 
on TIRFM.  
The loading of Cy3B-bioPcrA(E449C) was done as described in Methods, 
Section 2.17.3., and the objects were tracked using SFDA for entire record. 
The area used for analysis is 1800 µm2. 
 
6.3. Individual PcrA helicases unwinding plasmid DNA, 
detected by TIRFM 
 
6.3.1. Unwinding assay on TIRFM with pCERoriD 3094bp plasmid 
 
 The surface-bound PcrA enabled the development of single molecule 
plasmid unwinding assay where individual PcrA helicases, unwinding full 
lengths of plasmid, could be measured in real time (Figure 72). As the 
bioPcrA could be visualised using Cy3B-fluorophore, prior to unwinding, a 
relatively high control over focus could be achieved. This is important as the 
addition of ATP causes slight movement of the coverslip and could cause 
loss of information if not corrected accurately. The single molecule plasmid 
unwinding assay was done by loading bioPcrA at 0.2 or 0.5 nM. To this the 
RepD-plasmid complex was added. The reaction was initiated using ATP on 
TIRFM in presence of Cy3B-SSB, oxygen scavenger and ATP regenerator.  
 
 The single molecule plasmid unwinding measurements showed a large 
difference in the number of bioPcrA on the surface compared to how many 
actual unwinding events were observed. Therefore, most of the 
measurements have been done with 0.5 nM Cy3B-bioPcrA(E449C).  
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Figure 72. Plasmid unwinding assay visualised on TIRFM.  
A) Biotinylated PcrA is bound to glass surface using streptavidin. The RepD-
plasmid complex is formed before applying on the bioPcrA. B) RepD-plasmid 
complex is then added to surfaces and will bind PcrA. C) The unwinding is 
initiated by addition of ATP. Once, PcrA unwinds the plasmid the amount of 
ssDNA increases to which Cy3B-SSB binds. This leads to gradual 
localisation of SSB on the surface that is observed as a spot with increase in 
fluorescence. 
   
 This assay was done with different length plasmids, but the starting 
point was the 3094 bp plasmid. Previous helicase unwinding assays on 
TIRFM using linear DNA had showed that the DNA lengths up to 1.5 kb 
remained in the evanescent field [146]. Therefore, the 3094 bp plasmid 
could be expected to remain in evanescent field throughout the unwinding. 
Figure 73 shows individual Cy3B-bioPcrA unwinding this plasmid over 90 s. 
The intensity of certain spots increase over time after addition of ATP and 
Cy3B-SSB, and these events are the actual plasmid unwinding events. 
Figure 74 shows control experiments without ATP and without RepD. 
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Figure 73. Cy3B-SSB visualised plasmid unwinding of pCERoriD 
3094bp plasmid under TIRFM.  
Left side panel shows 25 µm2 area of field view at state time points and right 
panel shows the matching 3D presentation of the intensity landscape of the 
field of view. The experimental set-up and conditions are described in 
Methods, Section 2.17.4. Frame 1 s, is the frame 1 s after ATP addition. 
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Figure 74. Cy3B-SSB visualised plasmid unwinding of pCERoriD 
3094bp plasmid using TIRFM.  
The 0 s frame is the frame 1 of the records before ATP is added. The 50 s 
frame is the image taken 50 s after ATP addition. The –RepD image is a 
control experiment without RepD. The experiment was carried out as 
described in Methods apart from RepD not being added to the reaction.  
 
 The plasmid unwinding event selection and analysis was done using 
ASPT and Motility (GMimPro) as described in Methods, Section 2.17.4. The 
event selection excluded those events, which 1) had instant increase as they 
were likely not be true unwinding events or were landing events of already 
unwound plasmid-SSB complexes, 2) had no clear end point, as a constant 
increase in fluorescence is not a property for unwinding of fixed length DNA 
and 3) had total intensity change above 500, as these are too high in 
intensity to be result of one plasmid unwinding event. Four main properties 
of events were analysed, which were the duration (∆t), the total intensity 
change (∆I), the start time (t0) and the density of events. The traces were 
fitted to single exponential on Igor Pro at two different time scales to enable 
selection of better fit and determination of ∆t and ∆I. Semi-automated 
analysis method using single exponential fit was chosen after comparison 
with manual analysis of the data, as no difference was observed between 
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the results and the semi-automated enabled faster determination of the ∆t 
and ∆I. Therefore, it enabled analysis of relatively large number of events. 
Examples of the fitting are shown in the Figure 100 in the Appendix.  
 
   The density of plasmid unwinding events varied from 0.12 to 
0.24 µm 2 and had an average of 0.17 events µm-2. The mean unwinding 
duration was determined from the unwinding duration (∆t) distribution 
histogram by fitting to data with Gaussian distribution (Figure 75A). This was 
76.3 s (SEM 2.4) for 3094 bp plasmid, which gave the unwinding rate of 40.6 
+/-1.3 bp s-1 assuming complete unwinding. Averaging four independent 
measurements with total of 1037 events, the average unwinding rate was 
46.3 bp s-1 (Table 18).  
 
 To test the robustness of the determination of the mean ∆t using 
Gaussian fit, the mean ∆t for all events with 3094 bp plasmid was calculated 
simply by adding the event durations together and dividing by number of 
events (average, no fitting). This was 92.1 s and the unwinding rate was 
33.6 bp s-1. This method gives a lower unwinding rate compared to results 
from Gaussian fits to ∆t distribution. This is most likely caused by the 
inclusion of unwinding events that are outliers. These events have a very 
long ∆t due, possibly due damaged PcrAs. When these long events are 
included in the mean ∆t calculation, they increase it significantly lowering the 
mean unwinding rate. When the mean ∆t is determined by fitting to 
Gaussian distribution, the outliers have less of an effect and the emphasis is 
on the major event population of the unwinding ∆t. This may be an indication 
that the observed rate constant for unwinding at ensemble assays is slower 
due to averaging of all PcrAs, including those that may be poorly functional 
helicases, which may result from the protein preparation. Hence, the mean 
∆t was determined using Gaussian fitting to the distribution histograms. 
 
 The ∆I distribution from same record is shown in the Figure 75B. The 
mean ∆I from Gaussian fit is 203.9 (SEM 11.08). The amplitude of the 
individual events showed considerable variation. This can be caused by 
multiple factors such as the variation in the distance of the events from the 
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surface, movement/fluctuation of the plasmids during unwinding, events 
going out of evanescent field, presence of partial unwinding events and 
events taking place close together and observed as a single spot. As the 
events are highly synchronised at the start of the reaction, one can expect 
that the observed ∆t of events is not affected by detection of two plasmid 
unwinding events observed as one, but these events would have double the 
total expected intensity.   
 
 Plotting the event ∆t against ∆I enables the analysis of how the two 
correlate with each other (Figure 75C). The plot shows that the overall event 
intensity increases with the event duration. A significant proportion of events 
cluster around ∆I ~200 as expected from ∆I histogram. The range of 
unwinding event durations at ∆I 200 +/-20 give a range of unwinding rates 
that vary from 15 to 150 bp s-1. The range of unwinding rates is 
unexpectedly large. This indicates that some PcrA helicases are able to 
unwind plasmids almost four times faster than the mean population of PcrA 
helicases. The plot in the Figure 75C has been fitted by linear regression 
and to straight, horizontal line. The two fits enable the determination of 
possible dependence of the event duration (∆t) with the event intensity 
change (∆I). If linear dependence between intensity change and duration are 
observed, this implies that the records have significant number of events 
with partially unwound plasmids. The linear regression fit has ~17% smaller 
reduced chi2 than when data is fitted to constant y indicating that the data 
shows some linear dependence between ∆t and ∆I.  This is the case with all 
plasmids tested for reduced chi2, which is 10 – 20% smaller for linear 
regression than for fit to horizontal line. A summary of data is in Table 16. 
The average of four records for pCERoriD 3094 bp unwinding has a gradient 
of 0.014 s per unit of intensity and reciprocal of this gives the increase of 
intensity with time which is 6.99 units of intensity s-1. This shows that the 
records have some partial unwound plasmids but the majority of events are 
fully unwound plasmids. 
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Figure 75. Distribution of pCERoriD 3094 bp unwinding events.  
A) Unwinding duration (∆t) distribution histogram. The mean ∆t from the 
Gaussian fit is 76.3 s (SEM 2.4). This gives an unwinding rate of 40.6+/- 
1.3 bp s-1. The variance of the distribution is 34.8 (SEM 2.4). B) Event 
intensity (∆I) distribution histogram. The mean ∆I from Gaussian fit is 203.9 
(SEM 11.1) and the variance of the fit is 101.0 (SEM 11.3). C) ∆t versus ∆I 
plot of 3094 bp plasmid unwinding events. The gradient for the linear 
regression is 0.145 s per unit of intensity (SEM 0.016). The y is constant is 
83.1 s (SEM 2.0). The analysis was using GraFit 7, Erithacus software Ltd. 
Record: 090212r04.  
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Table 18. Single molecule plasmid unwinding assay with 3094 bp 
plasmid.  
The plasmid unwinding assays has been measured at two Cy3B-
bioPcrA(E449C) loading concentrations A) 0.5 nM and B) 0.2 nM and with 
labelled and C) unlabelled bioPcrA (the data analysis shown in Appendix, 
Figures 102).  
 
6.3.2. The plasmid unwinding assay enables observation of unwinding 
of plasmids short than 3 kb  
  
 Other lengths of pCERoriD plasmid used in the single molecule 
measurements were the 2437 bp, 3650 bp and 6642 bp plasmids. pCERoriD 
2437bp plasmid was made by removing a sequence from the 3094 bp 
plasmid [87]. The larger plasmids, 3650 and 6642 bp have been made from 
pCERoriD 3094 bp by inserting sequences derived from λDNA.  
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 To test and to validate the plasmid unwinding assay ideally a plasmid 
of two times larger or smaller would be used in the assay. As the making of 
1.5 kb and smaller pCERoriD plasmid proved unsuccessful, the pCERoriD 
2437 bp plasmid was the shortest of plasmid used in single molecule 
plasmid unwinding assay. The event density for 2437 bp plasmid unwinding 
was uniform with density ranging from 0.14 to 0.19 µm-2 and having an 
average density of 0.16 events µm-2 for the records. Figure 76 shows the ∆I 
and ∆t distributions for the unwinding events. The unwinding rates vary with 
four measurements from 42 to 56 bp s-1 and with an average of 48.2 bp s-1 
for  1167 events from Gaussian fit. As the plasmid unwinding rate with 2437 
bp was similar to that of the 3094 bp plasmid, this showed that the plasmid 
unwinding is fully observed with the two plasmids and that PcrA has a 
processivity at least up to ~3kb. The range of unwinding rates between PcrA 
unwinding 2437 bp plasmid varied between ~18 to 120 bp s-1 (Figure 76).       
 
 The mean ∆I from a distribution fit for the 2437 bp plasmid was 168.8 
(SEM 12.5), 17% less than that for the 3094 bp plasmid unwinding events 
(∆I = 203). The expected reduction in mean ∆t would be 21% between 3094 
and 2437 bp plasmids. This shows that in experiments performed at exactly 
same optical conditions the amplitude follows the size of the plasmid.  This 
comparison can most correctly be made between experiments done on the 
same day to minimise day-to-day variation. The fluorescence at the 
beginning of the record can be used as an indicator of the actual intensity 
and laser power difference and can be used to validate the comparison. The 
start fluorescence intensity is not the only aspect affecting the ∆t and ∆I as 
the length of the record and the clustering of type events has an effect 
on the final analysis and will be discussed further in the Chapter 6 
Discussion. 
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Figure 76. Distribution of pCERoriD 2437 bp unwinding events.  
A) The histogram of ∆t distribution of events. The Gaussian fit has mean 
value of 43.6 s (SEM 13.8) that would give an unwinding rate of 45.7 +/- 0.9 
bp s-1. The variance of the fit is 20.7 (SEM 1.0). B) The histogram of ∆I 
distribution of events. The Gaussian fit has the mean of 177.1 (SEM 14.0). 
The variance of the fit is 97.0 (SEM 14.6). C) ∆t versus ∆I plot of 2437 bp 
plasmid unwinding events. The linear regression has a gradient of 0.05 
(SEM 0.01). The y equals constant fit has a value of 55.5 s (SEM 1.5) and 
rate of unwinding of 43.9 bp s-1. (Record: 090212r09)  
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 The third plasmid length tested was the pCERoriD 3650 bp plasmid.  
The results are summarised in the Table 19 and example of the data is 
shown in the Figure 77. The average of total of 886 events from two records 
had a ∆t of 68.0 s and the unwinding rate of 53.9 bp s-1. The Gaussian fit to 
∆I distribution had a mean of 123.1 +/- 10.2. The distribution showed a large 
number of events with low ∆I and short ∆t. This indicated the presence of a 
significant number of partial unwinding events.  
 
 The distribution and plot of ∆t and ∆I indicated broader clustering and 
many events with lower ∆t between 20 to 40 s compared to 3094 and 2437 
bp plasmid unwinding (Figure 77). Also, with this graph a second cluster at 
higher intensity around ~170 to 190 could be seen. These events are the 
fully unwound 3650 bp plasmid events. The possible reason for increased 
number of partial unwinding events with the 3650 bp plasmid could be its 
sequence. The plasmids, which are larger than pCERoriD 3094 bp, have 
extra lambda DNA in them. The increasing length of plasmid and the λDNA 
may reduce the PcrA processivity. This has not been directly observed with 
ensemble assays but the effect of partial unwinding events may be hidden if 
most of the plasmids are unwound fully. Also, the greater length may cause 
the plasmid partially to go out of the evanescent field. 
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Figure 77. Distribution of pCERoriD 3650bp unwinding events. 
A) The histogram of ∆t distribution of events. The Gaussian fit has a mean of 58.8 s 
(SEM 2.8) that has an unwinding rate of 62.0+/- 3.0 bp s-1. The variance of the fit is 
37.4 (SEM 3.0). B) The histogram of ∆I distribution of events. The Gaussian fit has 
the mean of 177.1 (SEM 14.0). The variance of the fit is 72.2 (SEM 9.5). C) ∆t 
versus ∆I plot of 3650 bp plasmid unwinding events. The linear regression has a 
gradient of 0.23 (SEM 0.02). The y equals horizontal line has a value of 75.3 s 
(SEM 2.7). Record: 220512r09. 
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Table 19. Single molecule plasmid unwinding of 2437 bp, 3650 bp and 
6642 bp plasmids. 
 
6.3.3. The 6642 bp plasmid unwinding cannot be observed in the 
plasmid unwinding assay on TIRFM 
 
 The assay was repeated with pCERoriD 6642bp to test if large size 
plasmid unwinding could be observed in the assay and this could also 
provide a comparison for 3094 bp plasmid by being two times larger. The ∆t 
distribution and the ∆I distributions for unwinding of 6642bp plasmid are 
shown in the Figure 78.The mean ∆t from Gaussian fit is 43.8 s (SEM 
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13.8).The data clearly does not follow Gaussian distribution and shows large 
number of short events having ∆t between 20 to 40 s.  The distribution is 
actually more similar to exponential decay than Gaussian distribution of ∆t 
values. 
  
 When the mean ∆t for all events was calculated by sum of all events 
divided by the number of events, the ∆t was 77.5 s. The large difference 
between the two ways of determining the mean ∆t values is caused by 
events that have longer unwinding duration (∆t) than expected. When these 
are added to mean ∆t calculation (no fitting), the average ∆t is significantly 
increased compared to what had been determined using the Gaussian was 
fitting.  
 
 But whichever method was used for determining the mean ∆t, the ∆t 
was shorter in duration than expected for 6642 bp plasmid if it is fully 
unwound or the unwinding is fully observed. This indicated that the 
pCERoriD 6642 bp was primarily not unwound fully and possibly the PcrA 
stalls/dissociates at quite specific time point/part of pCERoriD 6642bp 
plasmid or the plasmid is moving out of evanescent field due to its size. In 
both cases the observed event duration/processivity may have sequence 
and structural dependence and the effect may not only be caused by the 
length of plasmid. But comparison of the number of events with ∆t >200 s 
between 6642 bp and 3094 bp plasmid showed that there are more ∆t 
>200 s events with the 6642 bp plasmid than with the 3094 bp plasmid.  
 
 The Gaussian fit to ∆I distribution had a mean of 79.3 (SEM 4.30) and 
the plot of ∆t versus ∆I, shows a clustering at short events durations (Figure 
78C). The ∆I is expected to be over 440 if full unwinding is observed. The 
lower ∆I with 6642 bp plasmid than with 3094 bp plasmid doesn’t support the 
idea that 6642 bp plasmid moves out of the evanescent field. In another 
words, if short low intensity unwinding events are likely to be partial 
unwinding events. These and the 3650 bp plasmid results may indicate that 
the PcrA processivity is reduced with longer plasmids.    
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Figure 78. Distribution of pCERoriD 6642 bp unwinding events.  
A) Histogram of ∆t distribution of events. The Gaussian fit has a mean of 
43.6 s (SEM 13.8), which gives an unwinding rate of 151.6 +/- 47.7 bp s-1. 
The variance of the fit is 50.5 (SEM 14.0). B) Histogram of ∆I distribution of 
events. The Gaussian fit has mean ∆I of 79.3 (SEM 4.3). The variance of the 
fit is 39.2 (SEM 4.4). C) ∆t versus ∆I plot of 6642 bp plasmid unwinding 
events. The linear regression has a gradient of 0.23 (SEM 0.02). The y 
equals constant fit has a value of 77.5 s (SEM 3.94). Record 050412r02 and 
r03 
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6.3.4. Amplitude dispersion of plasmid unwinding events is not 
affected by the Cy3B-bioPcrA(E449C) concentration 
 
  
 The pCERoriD plasmids, which showed primarily full unwinding (2437, 
3094 and 3650bp) also showed high variation of events amplitudes (∆I). One 
possible reason for this is the observation of two events together. The 
density measurement using Cy3B-bioPcrA(E449C) indicated that at the 
0.5 nM loading concentration two helicases may be observed as one object. 
This meant that also two plasmid unwinding events could be observed as 
one event. Therefore, the single molecule plasmid unwinding experiments 
were repeated with the 2437 bp and 3094 bp plasmids with 0.2 nM Cy3B-
bioPcrA(E449C) (Figure 103, 9.3. Appendix). Table 18 and 19 summarise all 
the results for 3094 bp and 2437 bp plasmid. The results show that 
decreasing the Cy3B-bioPcrA(E449C) concentrations decreases the number 
of events observed (81 and 56 events for two individual measurements for 
3094 bp plasmid). The mean ∆t and so the rate of unwinding is similar to 
that measured at higher loading concentration (Tables 18 and 19). This 
indicates that the dispersion of event amplitudes is not caused by two events 
occurring together. Hence, there must be other reasons for the event ∆I 
variation, which include differences in the maximum height of the complex 
above the surface, plasmid fluctuation in and out of evanescent field and 
variation in the orientation of the event.    
 
 The mean of ∆I distribution from fit is 124.7 +/- 6.2. This is lower than 
mean ∆I for other measurements on other days for 3094 bp plasmid, but the 
same reduction was observed for the 2437 bp plasmid experiments done on 
the same day (See Table 18 and 19). The variation in event intensities has 
been observed on certain days and sets of experiments and as said before, 
the true comparison of intensities can be only done with the same day 
experiments. As a control Figure 101 in the Appendix shows the total field of 
view intensity change for the entire record duration. They show clear 
difference in total intensity change observed between different days. Other 
factors may also affect the overall intensity and the intensity may vary 
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between individual surfaces in one set of experiments as they are all 
individually made and can have slight tilts in the angle or difference in height 
of the flow cell. Also, slight movement of TIRF set-up can occur during 
experiments while addition of ATP causing changes in TIRF angle.  
 
6.3.5. The addition of ATP to PcrA-RepD-plasmid complex initiates the 
unwinding instantly 
 
 The ensemble plasmid unwinding has a ~25 s lag phase at the 
beginning of the reaction (Figure 27). This lag phase has remained 
unexplained, but suggestions have been made as to what may be causing it. 
These include the rearrangement of PcrA-RepD-plasmid complex after ATP 
addition, PcrA passing through the ICRIII sequence or impaired binding of 
DCC-SSB to the newly formed ssDNA at early stages.  
 
 In these single molecule assays, the majority of events started instantly 
after ATP addition and the initiation was highly synchronised. Figure 79 
shows the distribution of the observed time points (t0) for start of unwinding 
after addition of ATP for one of the pCERoriD 3094bp unwinding records. 
The mean t0 was 3.9 s (SEM 0.01) and the variance of distribution (σ) was 
1.3. The time of ATP addition could be determine to less than 0.5 s accuracy 
as the added Cy3B-SSB could be observed as an increase in the 
background intensity. This was used as frame 0. The results show that most 
events start in less than 3 s of the mean t0 (3.9 s). Table 20 shows the start 
time analysis for three 3094 bp plasmid experiments. The average mean t0 
for all three experiments was 2.92 s (756 events). The plasmid unwinding is 
highly synchronised and only 6.3 to 7% of events starting after 15 s of the 
ATP addition. 
  
 The ensemble plasmid unwinding assay on the stopped-flow apparatus 
uses same principle as the single molecule plasmid unwinding assay 
developed here [87] (Figures 26 and 72). There are four main differences 
between the two assays, which are the ssDNA biosensor (DCC- SSB(G26C) 
in the ensemble assay and Cy3B-SSB(W88C) in the single molecule assay), 
6.Results- Individual PcrA molecules unwinding plasmid DNA 
238 
 
concentration of the ssDNA biosensors are different between the assays, 
PcrA attachment in single molecule assays and use of a high excess of PcrA 
over the RepD-plasmid complex in the ensemble assay.  
 
 The experiments show that the plasmid unwinding starts either over 8 
times faster on single molecule assays than on ensemble plasmid unwinding 
assay or the lag phase in ensemble assay is not actual result of plasmid 
unwinding but caused by the biosensor DCC-SSB [176]. The latter seems 
more likely explanation when taking into account the ensemble plasmid 
unwinding assays with MDCC-PcrA(E449C), which also lacked the ~25 s lag 
phase (Figure 60, Section 5.8.3.). DCC-SSB is known to bind ssDNA in two 
modes, the ~35 and ~65 base binding mode [89, 121]. These modes have 
two different fluorescent states and affinities to ssDNA and it may be that at 
the beginning of plasmid unwinding the 35 base binding mode is preferred. 
As the 35 base binding has a lower fluorescence change, a lag phase is 
observed in ensemble plasmid unwinding assay. The single molecule 
plasmid unwinding signal is not dependent on the environmental change and 
no fluorescence difference is observed whether SSB is binding in ~35 or ~65 
base mode. Hence, no lag phase is observed with Cy3B-SSB. 
 
 
Figure 79. Distribution of plasmid unwinding start times (t0) with 
pCERoriD 3094 with complete oriD sequence. 
The mean t0 from Gaussian fit is 3.94 s (SEM 0.08). The variance of the data 
(σ) is 1.31 (SEM 0.08).  
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Table 20. The mean t0 for different pCERoriD plasmids.  
t0 (s), the start of observable unwinding. σ, the variance of the Gaussian fit. 
 
6.3.6. Fate of plasmid complexes after completion of unwinding 
  
 After the fluorescence increase during the unwinding, the fluorescence 
traces showed a variety of fluorescent behaviours that correspond to the fate 
of plasmid unwinding complex once the plasmid unwinding was completed 
or had stalled. The fate of the plasmid unwinding complex was quantified 
and investigated by clustering. This may provide information about the fate 
of plasmid unwinding/replication complex after or at the termination, even 
though at physiological conditions DNA polymerase III would be included in 
the reaction and strand exchange could take place. The plasmid unwinding 
events were grouped by their fluorescence behaviour following the end of 
plasmid unwinding. This is likely to depend on what happens to the DNA-
protein complex at this stage. The clustering was done manually using data 
from the 3094 bp plasmid. The four major groups selected were full drop, 
half a drop, no drop and partial unwinding (Figure 80). The full drop events 
have been further divided into two further groups, depending on whether the 
fluorescence decrease was instant or slow. The full drop corresponds to 
complete release of plasmid DNA out of the evanescent field. The half a 
drop in intensity most represents release of one DNA strand while other 
remains bound to bioPcrA, itself surface-bound, or possibly directly to  the 
surface. No drop in fluorescence, although there may be fluctuations in 
intensity, represents complexes that do not dissociate from the surface. The 
fluctuation is probably caused by the plasmid moving in and out of the 
evanescent field. The partial unwinding events are defined as those that do 
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not reach high enough intensity to be full unwinding events (typically events 
with ∆I<100).  
    
 Table 21 summarises the results for the clustering analysis. The most 
common type of “ending” to plasmid unwinding is the half drop and no drop 
at all, combined representing more than 50% of events. This indicates either 
that once PcrA reaches the oriD again, it stalls and remains bound to 
plasmid or that after unwinding the RepD-plasmid-SSB complex does not 
dissociates from bioPcrA but gets stuck to surface. As no DNA polymerase 
is in the reaction the plasmid cannot be synthesised into dsDNA and the 
correct termination reaction cannot occur. This can lead to tangled up 
plasmid-RepD-SSB complex that PcrA cannot dissociate from. Also the SSB 
binding to the plasmid may increase its affinity to the surface and so remain 
in the evanescent field. As the plasmid would have to move a significant 
distance to be seen as a separate spot, one cannot distinguish between 
surface binding and binding to PcrA.  
 
 The clustering results are dependent on the length of the record after 
ATP addition. This means that some full drops may not be distinguished 
from partial and no drop events, if the records are not long enough (>150 s 
after ATP addition). Therefore, the longer records have larger percentage of 
events showing full drops, which count for ~25% of all events.   
 
 The proportion of partial unwinding events with 3094 bp plasmid seems 
relatively constant between different records and represent <20% of events. 
This proportion is higher for longer plasmids as shown by distribution 
histograms of 3650 (Figure 77) and 6642 bp (Figure 78) plasmids. 
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Figure 80. Four major populations of different types of unwinding 
events used for clustering.  
A) Full drop: full unwinding followed by a decrease in intensity back to the 
zero, which corresponds to full unwinding and release of both 
complementary strands of the plasmid DNA.  B) Half a drop: full unwinding 
with an intensity drop to approximately half of the maximum. This 
corresponds to the release of one of the plasmid strands from the 
bioPcrA/surface. C) No drop: full unwinding without a decrease in intensity 
(may fluctuate) due unwound plasmid remaining on the bioPcrA/surface. 
D) Partial unwinding: events where ∆I is significantly smaller than expected 
corresponding to the partial unwinding of the plasmid. This either remains on 
bioPcrA/surface or is released fully. The events in the figure are all from 
record 050412r05 in which pCERoriD 3094 bp plasmid was unwound. 
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Table 21. Clustering of single molecule plasmid unwinding events. 
 
6.4. Discussion  
  
   PcrA function in plasmid replication, ssDNA binding and translocation 
and dsDNA unwinding has been extensively investigated previously using 
ensemble methods [51, 52, 54, 87, 88, 93, 157, 177]. With helicases such as 
PcrA, ensemble methods may miss important information due to averaging 
of the signal. These include processes such as pausing and reannealing of 
DNA and variation in the rate of unwinding between individual helicases. 
With PcrA, another interesting component of the PcrA plasmid unwinding is 
the interaction and possible changes in the interaction between PcrA and 
RepD during plasmid unwinding, which may not be observable using 
ensemble methods. The need to observe these kinds of processes has led 
to development of methods that enable observation of individual molecules. 
These methods include atomic force microscopy, electron microscopy, 
optical and magnetic trapping and fluorescence based assays on TIRFM 
[143, 178, 179]. Here, a single molecule method has been further developed 
to enable the observation of individual PcrA helicases unwinding complete 
plasmid in real time using TIRFM. The assay enabled the measurement of 
the PcrA oligomeric state during plasmid unwinding, its behaviour while 
unwinding such as the processivity and possible stalling and the rate of 
unwinding by individual PcrA helicases. 
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6.4.1. PcrA is a monomeric helicase 
 
  Most of the previous ensemble evidence suggests that PcrA is 
functional as a monomer, but requires other protein interactions for 
increased processivity. No definitive results have been produced to confirm 
the oligomeric state of PcrA while unwinding DNA. A monomer in solution 
does not discount dimers or higher oligomers being formed on binding to 
DNA. The single molecule plasmid unwinding assay used here with 
immobilised PcrA, gave an opportunity to understand the oligomeric state of 
PcrA.  If PcrA is a monomer in solution before attachment to surface, the 
likelihood of PcrA forming dimers on biotin is low. Also, as no DNA is 
present during PcrA immobilisation, it cannot have an effect on the PcrA 
oligomeric state. The SEC-MALS experiments showed that wild-type PcrA 
and biotinylated PcrA are both monomeric in solution at micromolar 
concentrations. This meant that at low loading concentrations (nanomolar) of 
bioPcrA, the PcrAs were attached to surface as monomers and the 
unwinding events observed were unwound by monomeric PcrA. 
 
 The density measurements showed saturation of the field of view was 
observed at loading concentrations higher than 0.2 nM of Cy3B-
bioPcrA(E449C) and the number of spots/objects observed had linear 
dependence with increasing loading concentrations when loading 
concentrations was varied from 0.01 nM to 0.2 nM (ASPT and SFDA 
tracking). But at loading concentrations below 0.5 nM ~90% of the spots had 
single photobleaching step (SFDA tracking). These PcrA helicases can be 
expected to monomers on the surface. This indicates that the unwinding 
events observed here are results of single monomeric PcrAs unwinding 
plasmids.  
 
 However, when comparing the plasmid unwinding event density with 
the density of Cy3B-bioPcrA(E449C) spots indicates that fraction of total 
Cy3B-bioPcrA(E449C) is unwinding plasmid DNA. In fact, the plasmid 
unwinding density is similar to density of Cy3B-bioPcrA(E449C) objects that 
have multiple step photobleaching (Section 6.2.3.). This could possibly 
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indicate that the plasmid unwinding events are result of PcrA molecules that 
are bound to streptavidin as dimer and hence have multistep 
photobleaching. This is unlikely as at the loading conditions the bioPcrA is 
monomeric. Also, to have the same density of multistep photobleaching 
objects and plasmid unwinding events, all the “dimeric” bioPcrAs would have 
to be active and this is unlikely. 
 
6.4.2. Individual PcrA helicases unwinding complete plasmids 
 
  
 The single molecule plasmid unwinding assay enabled the 
measurement of processive unwinding of plasmids by PcrA. The plasmid 
unwinding rates observed were ~40-50 bp s-1 at 22 °C (in TIRF buffer), 
determined using three different lengths of plasmid DNA (2437 bp, 3094 bp 
and 3650 bp) (Table 18 and 19). Using the ensemble plasmid unwinding 
assay, PcrA had unwinding rate of ~27 bp s-1 at the same conditions [176]. 
The single molecule plasmid unwinding measurements indicated that the 
primary PcrA population actually unwinds plasmids faster than what has 
been observed in the ensemble assays. One likely reason for this could be 
the averaging of signal in ensemble assays, which would include the slower 
PcrA molecules. In the single molecule assay, the event duration (∆t) 
distribution shows “outliers”, which unwind DNA significantly slower. These 
outliers have less of an effect when a Gaussian fit is used to determine the 
mean ∆t. The determination of the unwinding rate this way is possibly more 
accurate as the very slow events may be a result of anomalous or damaged 
PcrAs from the protein preparation. But there are other possibilities for these 
variations in rate such as there may be a small fraction of complexes 
pausing briefly when PcrA is in solution in ensemble assay. Whereas, with 
immobilised PcrA, premature dissociation of PcrA would not lead to loss of a 
fluorescent spot and might result in a short pause followed by re-association 
of a new PcrA close by to continue unwinding. This might be explained by 
the nucleotide-free PcrA having lower affinity to RepD-DNA and so it 
occasionally dissociates before binding to ATP. This would lead to longer 
unwinding times in solution PcrA in ensemble assay. The PcrA affinity 
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measurements using MDCC-PcrA(E449C) showed that PcrA·ATP has a ~6-
fold faster binding to RepD-DNA than nucleotide-free PcrA (Sections 5.3 and 
5.7).  
 
 The rate of unwinding between the individual PcrA helicases varied 
greatly, from approximately 15 to 150 bp s-1, without obvious populations of 
speeds. This means that in the assay there are helicases unwinding DNA 
with whole magnitude difference in the rate of unwinding. There are several 
possibilities for the variation, which include fraction of PcrAs being damaged 
(slow unwinding), brief pausing or dissociation and re-association of certain 
PcrAs, variation in secondary structures formed on unwound ssDNA, 
suboptimal packing of Cy3B-SSB along the ssDNA, damaged plasmid DNA 
varying between individual plasmids and missing control elements from the 
reaction that would synchronise the PcrA unwinding rates. The missing 
component of the plasmid unwinding reaction, which would synchronise the 
PcrA unwinding rates, could be the DNA polymerase III. This has been 
shown to synthesise DNA in vitro at the rate of ~700 nt s-1 and addition of 
DNA polymerase III into reaction could increase the PcrA rate of unwinding 
[90]. DNA polymerase III would also remove one of the single-strand DNAs 
reducing the amount of possible tangling of ssDNA caused by secondary 
structures and the differences caused by variation in Cy3B-SSB ssDNA 
packing. One explanation for the faster unwinding rates, other than it being 
the actual PcrA unwinding rate, could be two PcrAs unwinding the same 
plasmid and together they would remove the effects of pausing and 
dissociation caused by low affinity and damaged DNA. The effect of 
damaged or nicked DNA could be tested and removed by treating the 
plasmid preparations with DNA ligase that should repair the nicked DNA. 
This would be an important and interesting test to be done in the future 
experiments. 
 
 The analysis of the start point of plasmid unwinding showed that it 
starts highly synchronised manner after addition of ATP and most events 
start in less than 2 s of PcrA binding to ATP. This indicates that the active 
PcrA·RepD-plasmid complex must be formed correctly before addition of 
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ATP or is formed very fast after binding ATP. The measurements with 
MDCC-PcrA(E449C) indicated that the ATP binding increases the PcrA 
affinity to RepD-DNA complex (Section 5.3.). As ATP is needed to initiate 
the plasmid unwinding, no ATP is added to the reaction until the PcrA·RepD-
plasmid complex is formed. However, the addition of ATP solution may 
remove most of the unbound or weakly bound RepD-plasmid complex out 
from the flow cell. This would also explain why no events or very few fresh 
binding events are being observed.    
 
  In comparison to the almost immediate start point of plasmid 
unwinding in single molecule assay, the ensemble assay unwinding starts or 
is observed after ~25 s (Figure 27, Chapter 3). The DCC-SSB biosensor is 
known to have two ssDNA binding modes (~35 and ~65 base binding mode) 
with different fluorescent properties; it is likely that lag phase observed in the 
plasmid unwinding ensemble assay is caused partially by the DCC-SSB. 
The ~35 base binding mode is preferred at low concentration of ssDNA 
[121], which is the case at beginning of plasmid unwinding. This binding also 
has lower fluorescence change than the ~65 base binding mode. The single 
molecule plasmid unwinding signal relies on the Cy3B-SSB, for which the 
fluorescence signal is not dependent on the environment, nor whether SSB 
is binding to ssDNA in ~35 or ~65 base binding mode.. Hence, no lag phase 
is observed in single molecule plasmid unwinding assay. It should be noted 
that it can expected that when SSB is binding along ssDNA in ~35 base 
mode, larger number should be binding to the DNA reducing the 
fluorescence difference between ~35 and ~65 base binding modes.  
 
6.4.3. PcrA processivity 
 
 The single molecule experiments showed that the bioPcrA unwinding 
processivity is approximately 3 kb, as full unwinding is observed with most 
events with plasmid 3094 bp and smaller. Plasmid longer than 3 kb showed 
increased proportion of unwound plasmid and with over 6 kb plasmid, only a 
small proportion of the plasmids were fully unwound. What caused these 
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partial unwinding events and why they increased with the increasing plasmid 
length? There are many possible explanations for this apart from the actual 
PcrA processivity being <3 kb, such as the DNA sequence variation 
between the plasmid lengths and the steric hindrance caused when PcrA 
unwinds longer plasmids and increased damage to longer plasmids. Also, 
longer plasmids are more likely to move out of evanescent field due to their 
increased size. The plasmids longer than 3094 bp have been constructed by 
inserting λDNA into the 3094 bp plasmid. These sequences may affect PcrA 
processivity or cause changes into DNA secondary structure that hinder 
PcrA unwinding. The attachment of PcrA to the surface may also cause 
hindrance while plasmid is unwound and this may be more of an issue when 
longer plasmids are unwound. Addition of DNA polymerase III into the 
unwinding reaction could increase the PcrA processivity by increasing its 
affinity or rate of unwinding. It could also possibly remove or reduce the 
effects of ssDNA secondary structures and becoming stuck on the surface.   
 
 One possibility for the observed similarity between the densities of 
multiple step photobleaching spots and unwinding event density is that two 
PcrAs may be required for the processive unwinding of complete plasmids. 
The affinity of bioPcrA to RepD-plasmid complex may not be tight enough to 
facilitate unwinding of long lengths of DNA. This possibly could be improved 
by having two PcrAs binding to same plasmid, whether or not as a dimer. 
These PcrA helicases could be bound to one streptavidin or two separate 
streptavidins close together. For example, if one PcrA dissociates from the 
plasmid, the other is still bound to it. It has been suggested that the 
processive unwinding in ensemble plasmid unwinding assay is a result of 
multiple PcrAs unwinding same plasmid. In this model, multiple PcrA are 
following the PcrA that is unwinding the plasmid. As it falls off, it is replaced 
by PcrA following it and this can be repeated multiple times during 
unwinding of single plasmid (“Helicase-Train” model) [170]. The ensemble 
plasmid unwinding assay is formed at high excess of PcrA over DNA. The 
MDCC-PcrA(E449C) binding experiments show that more than one PcrA is 
able to bind to oriD once it has been nicked by RepD, supporting the idea 
that PcrAs can follow each other on ssDNA even they might not form a 
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dimer (Section 5.6.). There can be a significant difference in the affinities 
between the PcrA free in solution and the immobilised PcrA. The PcrA 
affinity when immobilised to surface could be reduced to extent that two or 
three PcrAs are required for the efficient unwinding of plasmid DNA. Having 
said that, the binding measurement indicated increased affinity or at least 
increased rate of binding when PcrA is ATP bound and the actual affinity of 
PcrA to RepD-plasmid complex while unwinding may be significantly tighter 
than what was measured for RepD-plasmid binding without ATP using 
MDCC-PcrA(E449C). 
  
6.4.4. Fate of the plasmid after unwinding  
 
 The clustering of events according to behaviour after unwinding 
showed that the most of the unwound plasmids remain in the evanescent 
field, either attached to the bioPcrA or close to it on the surface (Table 21). 
This may be caused by the plasmid unwinding stalling once reaching the 
oriD. As the reaction does not contain DNA polymerase III, no strand 
exchange can take place to terminate correctly The PcrA·RepD-plasmid-
SSB complex stalls without dissociation or attaches to the surface. Addition 
of DNA polymerase III to the assay could increase the rate of unwinding 
observed with reduction of total intensity as fewer SSBs would be binding to 
ssDNA and it could change the way plasmid unwinding ends as the strand 
exchange could take place and one complete daughter plasmid would be 
formed. This would possibly increase the proportion of plasmids that are fully 
released after unwinding. Ideally, this would be something that should be 
tested in the future. 
 
6.4.5. Limitations of the single molecule plasmid unwinding assay 
 
 The event density comparison with the density of Cy3B-
bioPcrA(E449C) showed that  only 10% of Cy3B-bioPcrA(E449C) on the 
surface is actively and processively unwinding plasmid DNA. This could be a 
result of low affinity of bioPcrA to RepD-plasmid complex, which could be 
6.Results- Individual PcrA molecules unwinding plasmid DNA 
249 
 
due to immobilisation or to PcrA and RepD being from different bacterial 
species. The effect of immobilisation could be possibly tested by 
immobilising the plasmid, but this would be successful only if the reduced 
affinity was directly caused by the immobilisation of PcrA.  
 
 The assay here was done with B. stearothermophilus PcrA and 
S. aureus RepD. Efforts have been made to produce PcrA and RepD from 
same species (S. aureus). In the future, repeating the experiments with PcrA 
and RepD from same species would be highly interesting and may give 
more accurate view of PcrA and RepD interaction. This could increase the 
PcrA affinity RepD-plasmid and so increase the number of plasmid 
unwinding events.  
 
 Another explanation for the relatively low event density, and possibly 
the most likely factor, is the washing off the RepD-plasmid complex from 
bioPcrA with the ATP buffer solution. This is also a major difference between 
the stopped-flow ensemble measurements where PcrA·RepD-plasmid 
complex is free in solution and not exposed to similar change of solution.   
 
  The event amplitude, ∆I, showed dispersion in the distribution (Figure 
75B). Several reasons for this can be suggested such as the complex height 
above the surface, or multiple unwinding events observed very closely 
spaced. Alternatively, the events may be moving in and out of the 
evanescent field that affect the excitation and emission of the fluorescence. 
The intensity of the field decays exponentially from the surface and the 
attachment distance of the complex may vary, hence this could contribute to 
the intensity dispersion, as the intensity used to excite fluorophores varies 
depending on the depth of the complex. This variation can be caused by the 
difference in the PEGylation or angle on the flow cell. Both will affect the ∆I 
without changing the event duration. Some of the events may be multiple 
unwinding events close together, but as the experiments were repeated with 
0.2 nM Cy3B-bioPcrA(E449C) loading concentration instead of 0.5 nM and 
the ∆I dispersion remained the same, this explanation does not seem likely. 
Another possibility could be the plasmids moving out of the evanescent field 
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in a manner, which affects more the ∆I than the ∆t. For instance, once 
plasmid is unwound enough it can reach to outer layers of evanescent field 
leading to lower excitation and emission distorting linearity of intensity 
increase during plasmid unwinding. Again the ∆t would not be affected by 
this as long as some increase in intensity is observed until whole plasmid is 
fully unwound. This could also explain why the events show reduction in the 
rate of intensity increase at the end of plasmid unwinding and the traces 
would fit well to single exponential increase. The amplitude of the 
fluorescence intensity may also be affected by the photobleaching and it can 
have different effect if there is variation in the excitation. The variation in 
excitation can be caused by various reasons such as the location and 
orientation of the plasmid unwinding reaction on the surface.  
 
6.4.6. Summary 
 
 Biotinylated PcrA has been successfully used to develop a single 
molecule plasmid unwinding assay, which has enabled the observation of 
individual PcrA helicases unwinding full lengths of plasmid in real time by 
TIRFM.  Fluorescent labelling of bioPcrA provided a method to determine 
the bioPcrA density on the surface and enhanced the control of focus when 
applying ATP to initiate the plasmid unwinding. The plasmid unwinding at 
single molecule level was measured on three lengths of plasmid (2437, 3094 
and 3650 bp). The unwinding rate for plasmids fully visible in the TIRFM 
(2437 and 3094 bp) was 40-50 bp s-1 at 22 °C (Table 18 and 19). This is 
slightly increased compared to ensemble unwinding rate of ~30 bp s-1 at 
same conditions in ensemble measurements and may actually be faster 
when taking in account the temperature difference between the experiments. 
The DNA junction unwinding assay implies that the PcrA unwinding rate is 
halved by temperature drop from 30 °C to 22 °C, but it should be noted that 
the ensemble DNA junction unwinding is done with short linear DNA, which 
is vastly different circular plasmid DNA used in TIRFM measurements.  
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 The single molecule plasmid unwinding experiments showed that the 
plasmid unwinding start almost immediately after ATP addition (Figure 73 
and 79). The assay has shown PcrA processivity to be high and over 80% of 
plasmid are fully unwound once the unwinding has been initiated. The assay 
also indicates that the most of the unwound plasmid remain on PcrA or close 
to the location of unwinding once plasmid has been unwound. This may 
indicate stalling of the PcrA·RepD complex after unwinding as no DNA 
polymerase III is present to synthesise the leading strand and enable the 
strand exchange that completes leading strand synthesis of plasmid 
replication.  
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7. Overall discussion 
 
 
 This Chapter summarises the main aims and results within this thesis. 
It draws together all the experiments done and where possible, relates the 
results to previous work on PcrA and to its function in the DNA translocation 
and plasmid replication. The future possibilities for continuity of the project 
are also discussed. 
 
7.1. Production of fluorescently labelled PcrA and RepD to 
investigate their function in plasmid replication 
 
 
 The role of PcrA in plasmid unwinding was investigated by creating 
several different fluorescent PcrAs, labelled with environmentally sensitive 
fluorophores. The labelling was achieved using site-directed mutagenesis to 
introduce cysteine residues at suitable locations on the surface of PcrA and 
subsequent labelling with fluorophores using maleimide chemistry. This 
proved to be a highly efficient and specific way to label PcrA and RepD, as 
the labelled species used in the experiments showed ~100 % labelling 
without significant non-specific labelling (Table 2, Chapter 3). The 
fluorescent proteins all showed ATPase activity and DNA unwinding activity 
similar to wild type PcrA (Figure 24 and Table 3, Chapter 3). 
 
In the past, PcrA function has been studied using fluorophore labelled 
substrates or radioactivity and most of the transient kinetics data with PcrA 
has used labelled substrates such as mantATP/ADP, fluorophore-labelled 
DNA or a fluorescent biosensor. The benefit of labelling the substrate can be 
a fluorescent signal, which is usually simpler to achieve and in some cases 
easier interpret. With labelled enzyme this signal may be complex, as the 
enzyme often interacts with more than one substrate and goes through 
conformational changes. This complexity can often be overcome by further 
testing in particular focussing on partial reactions, as was achieved with 
most of the assays presented in this thesis. 
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7.2. PcrA binding and translocation on ssDNA shows site 
and sequence specificity 
  
PcrA translocation on ssDNA was investigated using MDCC-
PcrA(K138C). To understand the observed signal in ssDNA translocation, 
the MDCC-PcrA(K138C) binding to varying lengths of ssDNA was 
measured. This showed that the PcrA binds tighter to the middle of the 
ssDNA with higher fluorescence than to the ends of ssDNA (Figure 32, 
Section 4.2.1.), to which PcrA binds faster. This was indicated by the 
MDCC-PcrA(K138C) binding to the dT20 oligonucleotide, which showed 
phases for both binding modes (Figure 32 and 35, Chapter 4). This may be 
caused by the different conformations of PcrA when binding different parts of 
ssDNA. The hypothesis was confirmed by repeating measurements with 
DNA structures lacking the ssDNA ends (Figure 33, Section 4.2.1.). 
‘Removal’ of ssDNA ends by making then double stranded, removed the end 
binding phase. Association and dissociation rate constant measurements 
using MDCC-PcrA(K138C) enabled the determination of PcrA affinity  to 
different length of ssDNA. The results showed that PcrA affinity to short 
lengths of ssDNA (dT10, Kd = 130 nM) is lower than to longer lengths of 
ssDNA (dT50, Kd = 14 nM) (Table 6, Section 4.2.4.). The lower PcrA affinity 
to ends of ssDNA may have a biological importance in the cell for example 
in DNA repair and especially in RecA filament removal and PcrA locating 
them [94, 95].  
 
Compared to previous ssDNA binding studies done with PcrA, a 
benefit of using labelled PcrA is the ability to observe signals with any length 
of ssDNA, as with 2-aminopurine-labelled oligos no signal was observed 
with oligos 30 bases and longer. This was because most of the PcrA binds 
too far from the fluorophore to affect its environment [51]. This is not the 
case with the MDCC-PcrA(K138C) as it shows signals with all lengths of 
ssDNA. Also, MDCC-PcrA(K138C) shows a signal with most DNA 
structures, as long as it has a ssDNA stretch on it.   
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The MDCC-PcrA(K138C) signal was used to measure PcrA 
translocation rate on ssDNA. Previous work has shown that PcrA movement 
on ssDNA is unidirectional [54], a finding which is supported by the MDCC-
PcrA(K138C) translocation measurements, as the signal seen is dependent 
on PcrA moving uniformly to the end of ssDNA. This is observed as a 
decrease in fluorescence until PcrA reaches the end of the ssDNA. The rate 
of translocation was first determined (99 bases s-1) on dT oligos (Figure 40, 
Section 4.3.1.). This is in good agreement with the previous measurements 
with labelled DNA carried out at the same conditions indicating that the 
MDCC-PcrA(K138C) is measuring ssDNA translocation accurately [51]. 
 
The advantage of using MDCC-PcrA(K138C) to measure ssDNA 
translocation was the possibility to do this with different sequences of ssDNA. 
This showed that when PcrA translocates on dA and dT oligos the rate of 
translocation is approximately ~250 bases s-1, whereas with dC oligos the 
rate of translocation was over 500 bases s-1 at 30 °C (Table 7, Section 
4.3.2.). This indicates that the PcrA rate of translocation is dependent on the 
sequence it is moving on, suggesting movement of the bases among the 
base binding pockets of PcrA limits the observed rate. Unfortunately, no 
translocation signal was observed with dG oligos. When random sequence 
oligos were used in the assay, the rate of translocation was determined as 
~380 bases s-1. This is as expected if there was a difference in the way PcrA 
translocates on dA/dT and dC/dG bases and is the first evidence showing 
that PcrA rate of translocation is sequence dependent. The reason for this 
could be PcrA having a lower affinity to dC bases that allows than faster 
movement on ssDNA. This property is most likely caused by the way the 
bases interact with base binding pocket of the PcrA. Interestingly, the speed 
of translocation on ssDNA is 5-8 times faster than the DNA unwinding rate. 
This implies that the separation of base pairs is rate limiting for PcrA 
moment, but the ATP hydrolysis remains as 1 ATP per base moved/unwound 
[87].  
 
When comparing PcrA ssDNA translocation rate to closely related 
UvrD helicase, it is relatively similar. UvrD monomer has been shown to 
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translocation at the rate of ~190 bases s-1 at 25 °C on dT bases, [40]. Also, 
the rate of ssDNA translocation by UvrD has sequence dependence in the 
order dT>dC>dA>dG [40]. With PcrA this was observed to be dC>dT=dA, 
which is relatively surprising as PcrA and UvrD are structurally and 
functionally similar, having 42 % of sequence similarity. However, Tomko et 
al. 2007 experiments varied in the buffering conditions as they were done 
with 20 mM NaCl compared PcrA measurements which were done with 
either 150 mM NaCl or 200 mM KCl [39, 40, 142] and this could explain or 
add to the observed difference between PcrA and UvrD measurements.  
 
7.3. PcrA-RepD-DNA complex formation at the initiation of 
plasmid unwinding 
 
 PcrA has been shown to be a poor helicase on its own and requires 
presence of Rep initiator protein for processive DNA unwinding [87, 88]. This 
was also shown here in the single molecule assay (Figure 74, Section 6.3.1.), 
as when RepD was not included the plasmid unwinding reaction, the 
unwinding event number was greatly reduced. The requirement of activating 
proteins emphasises the importance of having a control mechanism, as an 
unregulated helicase may have deleterious effect on the organism. Also, 
PcrA may have multiple functions in the cell, which consist of translocase and 
unwinding activities whereby binding partners can act as switches between 
these modes.  
 
 Before the work done as a part of this thesis, the interaction surface 
between PcrA and RepD had not been defined. The 2B subdomain of PcrA 
has been suggested as the most likely interaction site with the RepD [21], as 
it is not involved in the ATP hydrolysis or direct translocation on ssDNA. Also, 
this domain is known to show autoinhibition of PcrA helicase activity [180]. 
 
Here, the coumarin labelled PcrA mutants E447C, E449C, M450C and 
L453C, located on surface of the top of the 2B subdomain, showed a signal 
when binding to RepD-DNA complex on the stopped-flow measurements 
(Figure 46, Chapter 5). This supported the hypothesis that the PcrA-RepD 
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interaction surface is at the 2B domain. The fluorescent signal relating to 
RepD was only observed with the mentioned mutants on top of the 2B 
subdomain. Other labelled PcrA mutations did not show RepD-specificity and 
so are good controls for the RepD-specific signals. (Table 1, Chapter 3). This 
implies that the interaction of PcrA and RepD takes places once RepD is 
DNA bound. However, this cannot be fully confirmed by fluorescent signal 
experiments, as the possible interaction may not cause a large 
conformational change or is at a location which does not affect the 
environmentally sensitive fluorophore(s).  
 
 PcrA binding to the initiation complex was investigated using MDCC-
PcrA(E449C). The MDCC-PcrA(E449C) signal is highly RepD-specific as the 
signal change was 5 times larger with DNA junction bound by RepD than with 
DNA junction 1 only (Figure 45, Section 5.2.1.). This enabled the 
determination of the association and dissociation kinetics of PcrA to and from 
DNA and RepD-DNA complexes in the presence and absence of a 
nucleotide. PcrA binding to RepD-DNA is faster when it is ATP-bound (with 
RepD-DNA junction 1 it was 6 µM-1 s-1 without ATP and over 25 µM-1 s-1 with 
ATP) and with RepD-DNA junction 1 the rate constant of binding is increased 
by almost 5-fold (Figures 47 and 50, Chapter 5) . Experiments repeated with 
non-hydrolysable ATP analogues were performed to observe the PcrA·ATP 
complex binding when no hydrolysis of the ATP takes place (Figure 52, 
Chapter 5). This showed that PcrA binding was faster without nucleotide, but 
not as fast as with ATP, which is hydrolysed when ssDNA is present.  
 
MDCC-PcrA(E449C) binding to the RepD-DNA junction complex was 
biphasic indicating two processes of binding. The possible processes 
suggested included two conformations of PcrA (open and closed), two 
different binding sites on the dT-arm of the DNA junction or two different 
RepD-DNA complexes. These three possibilities were tested and the only 
condition where the biphasic nature of the binding signal was not observed 
was when PcrA was binding to RepD-DNA junction in presence of nucleotide 
(PcrA·ATP) (Figure 50, Section 5.3.1.). The X-ray crystal structure of PcrA 
with nucleotide (AMPPNP) shows that ATP binding causes a relatively small 
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structural change in PcrA where the 1A and 2A subdomains come closer 
together [21, 22] (Figure 2, Introduction). This change may be required for 
stabilising the structural change to one conformation (closed) when PcrA 
binds to DNA and so when PcrA is ATP bound, only one form of binding 
mode exist. When no ATP is present, the PcrA may fluctuate between these 
two modes of binding (open and closed). The structural change expected 
when PcrA binds to DNA, is the 2B domain folding over the 1B domain 
(closed conformation), as seen in the X-ray crystal structure of substrate 
bound PcrA (Figure 2B, Introduction) [21, 22] and this could be stabilised by 
the ATP. Figure 81 shows a kinetic scheme of the two PcrA conformations 
binding to RepD-DNA complex. 
 
 
 
 
Figure 81. Model of PcrA conformation “locking” by ATP. 
PcrA1, PcrA conformation 1, open. PcrA2, PcrA conformation 2, closed. k1 is 
the binding rate constant 1 of the biphasic PcrA binding signal to RepD-DNA 
junction complex (no ATP). k2 is the binding rate constant 2 of the biphasic 
PcrA binding signal to RepD-DNA junction complex (no ATP).When PcrA is 
ATP bound, it is “locked” into closed conformation. This increases the 
observed binding rate constant and removes the second binding phase 
observed when PcrA is nucleotide-free. The two conformations, open and 
closed, are shown in Figure 4, Section 1.2.2. 
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7.4. PcrA function in plasmid unwinding  
 
7.4.1. In ensemble plasmid unwinding assays 
 
 
An assay was developed using MDCC-PcrA(E449C) to measure 
PcrA activity in the plasmid unwinding using the stopped-flow apparatus. It 
measured the environmentally sensitive signal from the MDCC-maleimide. 
The assay showed rate of unwinding between 30 - 40 bp s-1 (Figure 60, 
Chapter 5). This is close to the rate of unwinding observed with the DCC-
SSB plasmid unwinding assay, indicating that the assay is truly measuring 
plasmid unwinding. The signal was only observed when SSB was present. 
This may indicate the SSB requirement for processive plasmid unwinding 
by PcrA, but also SSB may be keeping the unwound DNA separated or 
physically activates PcrA. The activation by SSB seems unlikely as the 
DNA junctions are unwound without SSB in the reaction.  
 
The signals observed with MDCC-PcrA(E449C) were different to 
those obtained with the DCC-SSB plasmid unwinding assay, as they did not 
have a lag phase at beginning of the signal (Figure 27, Chapter 3). The 
experiments suggest that the lag phase is partly a result of the DCC-SSB. 
The DCC-SSB has two main binding modes, the ~35 and ~65 base binding 
mode, where by the ~35 base binding dominates at low salt conditions and 
at a high protein to DNA ratio and the ~65 base mode dominates at high 
salt conditions [181-183]. Similarly, the DCC-SSB shows these binding 
modes and they have different fluorescent states, with the ~35 base mode 
having smaller fluorescence increase when binding to ssDNA [121]. This 
could mean that the lag phase is caused by the ~35 base mode binding, 
which may be preferred at the beginning of plasmid unwinding due to high 
SSB protein to DNA ratio. Another possible explanation is the presence of 
unlabelled SSB in the preparations which may have tighter affinity to the 
ssDNA than the labelled SSB. This would then bind to ssDNA at the start of 
plasmid unwinding and be observed as a lag phase [89]. 
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7.4.2. Plasmid unwinding at the single molecule level 
 
 
An assay to measure individual plasmid unwinding events using 
TIRFM was developed using biotinylated PcrA. Labelling of bioPcrA 
enabled visualisation of the bioPcrA on the surface of the flow cell and 
improved the control over the focus when performing the plasmid unwinding 
experiments. The determined unwinding rates varied between 40 to 
50 bp s-1 at 22 °C for three lengths of plasmids that were small enough to 
remain in the evanescent field for the entire duration of the unwinding 
(2437, 3094 and 3650 bp) (Table 18 and 19, Chapter 6).  
 
The PcrA showed a wide range of unwinding rates from 15 to 
150 bp s-1. This may be natural variation as it is possible, that PcrA function 
does not require tight control over the rate of unwinding or the control is 
introduced by other components of the plasmid replication complex that are 
missing from plasmid unwinding assay. The most likely component to have 
such an effect is the DNA polymerase III. Other possibilities for variation, 
which include fraction of PcrAs being damaged (slow unwinding), brief 
pausing or dissociation and re-association of certain PcrAs, variation in 
secondary structures formed on unwound ssDNA, suboptimal packing of 
Cy3B-SSB along the ssDNA and damaged plasmid DNA varying between 
individual plasmids. Generally, the rate of unwinding is faster than those 
observed for plasmid unwinding in ensemble experiments, which could be 
caused by the averaging of the slow unwinding PcrA helicases that may 
have been damaged during preparation.  
 
Also, the distribution of amplitude varied greatly and showed 
relatively limited relation to the different sizes of plasmid. The variation 
could be caused by many factors, such as the two plasmids being unwound 
close together and seen as one event, the distance of the event from the 
surface (lower excitation, lower amplitude), the intensity variation over the 
field of view (though TIRF was adjusted to have the most even laser 
illumination possible), partial unwinding events being observed as full 
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unwinding events and also some events moving in and out of the 
evanescent field.  
 
Full plasmid unwinding was observed with the 2437 and 3094 bp 
plasmids (Figures 83 and 84), whereas the 3650bp plasmid showed 
increased number of partial unwinding events (Figure 85) and the 6642 bp 
plasmid (Figure 86) had a high proportion of stalled unwinding events. This 
indicates majority of PcrAs unwind plasmids with a processivity ~3 kb. The 
clustering of 3094 bp plasmid unwinding showed that less than 20 % of the 
events are partial unwinding events. In other words, 80 % of the events 
were unwound to completion with a processivity above 3 kb.  
 
Cy3B-bioPcrA(E449C) density on the surfaces was significantly 
higher than the density of plasmid unwinding events. This means that once 
PcrA does start to unwind, it is unlikely to dissociate before completion of 
unwinding. The difference in the Cy3B-bioPcrA(E449C) density and 
plasmid unwinding density could be an indication of low affinity by the 
surface bound bioPcrA to the RepD-plasmid complex. The PcrA binding to 
RepD-plasmid is tight in solution, but this may be weakened by the 
immobilization of PcrA (Section 5.7.). However, the evidence here indicates 
that addition of ATP should make the binding even tighter (Section 5.3.). In 
the assay, the ATP solution is added after incubation of RepD-plasmid 
complex with the bioPcrA. This may wash away many of the complexes 
from the bioPcrA, leading to a reduced number of unwinding events 
compared to the number of bioPcrA on the surface and the concentration of 
RepD-plasmid loaded on to surface. The affinity may be increased if the 
PcrA and RepD were from the same species, as in this study the PcrA is 
from B. stearothermophilus and the RepD is from S. aureus. Repeating the 
measurements with the S. aureus PcrA and RepD in the single molecule 
assay may increase of the number of events and possibly processivity of 
PcrA.  
 
An interesting point highlighted by the single molecule plasmid 
unwinding assay was that the start of unwinding was almost instant once 
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ATP is added to the cell (Figure 79 and Table 20, Chapter 6). As with the 
MDCC-PcrA(E449C) plasmid unwinding assay, there is no lag phase in the 
plasmid unwinding.  The Cy3B-SSB(W88C) is a different cysteine mutant 
than the DCC-SSB(G26C), which could also affect the binding, but as both 
have been tested and shown not to be significantly affected by the 
mutations or labels, this is unlikely [89, 146]. The great difference between 
DCC-SSB and Cy3B-SSB is the signal, as the Cy3B is not sensitive to 
environmental changes. As discussed with the MDCC-PcrA(E449C) 
plasmid unwinding assay the difference in the ssDNA biosensor may be the 
largest contributor the difference observed at the beginning of the plasmid 
unwinding. The single molecule plasmid unwinding supports the idea that 
the lag phase in the ensemble plasmid unwinding assay with DCC-SSB is 
caused by the different fluorescent states due to the different binding 
modes of DCC-SSB(G26C). 
 
 One important question addressed by the single molecule plasmid 
unwinding measurements using Cy3B-bioPcrA(E449C) was the oligomeric 
state of PcrA while unwinding plasmids. The loading of Cy3B-
bioPcrA(E449C) at concentrations where individual objects were observed 
allowed photobleaching experiments to be used to probe the oligomeric 
state of the PcrA on the surface. This showed that over 90 % of the objects 
had a single photobleaching step only, which suggests that most of the 
Cy3B-bioPcrA(E449C) exist as monomers on the surface (Figure 71, 
Chapter 6). The loading of multiple PcrAs is possible even if PcrA is not 
forming a dimer, as the surface-bound streptavidin potentially has three free 
binding sites, but the formation of the multi-PcrA-streptavidin complexes is 
unlikely, as bioPcrA was shown to be a monomer at loading conditions 
using SEC-MALS (Figure 65, Chapter 6). This implies that the events seen 
are most likely showing unwinding by a monomeric PcrA. Hence, the single 
molecule assay using immobilised bioPcrA and plasmid-RepD complexes 
show that a single PcrA monomer is sufficient for processive plasmid 
unwinding. Although, in principle, conditions in the cell might allow multiple 
PcrA molecules to bind behind the unwinding complex, the presence of 
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both the DNA polymerase III and SSB make this much less likely and 
support the idea of a single monomeric PcrA as the functional unit in vivo. 
 
7.5. PcrA helicase – a passive helicase 
 
Helicases unwind and translocate on DNA at hugely varying rates, 
from a few to thousands of base pairs per second [6]. Helicases can be 
classified by their unwinding activity as “passive” or “active” [6, 61]. If a 
helicase is able to actively destabilize base pairs by lowering the activation 
energy of the base pairing, it can be considered as an active helicase. 
Alternatively, if a helicase is not able to lower the activation energy of base 
pairing but has to wait for the separation of base paring by the intrinsic 
thermal fluctuations before moving, it is seen as a passive helicase. With 
passive helicases, the base pair separation is a rate limiting step. The GC 
content of DNA will affect the rate of unwinding of a passive helicase, as 
more hydrogen bonds need to be broken to separate DNA. Generally, 
helicases that are unwinding fast with rates of thousands of base pairs per 
second are thought to be active helicases [184, 185]. 
 
 A simple model to determine whether a helicase is passive or active 
in DNA separation exists. The model is based on comparison of helicase 
translocation rate on ssDNA and rate of dsDNA unwinding [61]. If a 
helicase is actively unwinding DNA, its translocation rate on ssDNA may be 
similar to the rate of unwinding dsDNA. An example is the Dda helicase, 
which has an unwinding rate over ssDNA translocation ratio of 0.96 making 
it likely to be an optimally active helicase [62]. If a helicase is passive, the 
translocation rate on ssDNA is significantly faster than the rate of dsDNA 
unwinding [61].  
 
Table 22 summarises the results obtained for PcrA ssDNA 
translocation and dsDNA unwinding rates and unwinding rates.  PcrA 
translocation on ssDNA is significantly faster than unwinding of dsDNA, 
varying from 4 to 8 times when comparing different assays done at same 
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conditions. This indicates that PcrA is a passive helicase or has similar 
activity to a passive helicase while unwinding plasmid DNA. At single 
molecule assay conditions, at 22 °C in TIRF buffer, the ssDNA translocation 
is ~130 bases s-1 and the plasmid unwinding ~40 bp s-1. The Vun/Vtrans ratio 
is 0.3. (For the ensemble conditions the Vun/Vtrans ratio for PcrA is 0.13 
when ssDNA translocation is calculated only from dT oligo translocation.) 
According to the model, helicases with a Vun/Vtrans ratio >0.25 are seen as 
active and those showing Vun/Vtrans ratios of 0.25 and below are classed as 
passive helicases. By this PcrA unwinds in manner of a passive helicase, a 
proposal which could be further tested by using DNA junctions and 
plasmids with varying GC content.  
 
Type of 
DNA 
Ensemble/ 
Single 
molecule 
Rate of 
translocation 
T(°C) Buffer 
RepD-plasmid 
complex formation 
Time T (°C) 
ssDNA Ensemble 130 bases s
-1
 22 TIRF - - 
ssDNA Ensemble 240 bases s
-1
 30 K200 - - 
Linear  
dsDNA 
10-50 bp 
Ensemble 50 bp s
-1
 30 K200 5 min 30 
Linear  
dsDNA 
10-50 bp 
Ensemble 24 bp s
-1
 22 TIRF 5 min 30 
Plasmid
§
 Ensemble 30 bp s
-1
 30 
K100/ 
K200 
30 s 30 
Plasmid* Ensemble 27 bp s
-1
 22 TIRF 
10 
min 
30 
Plasmid 
Single 
molecule 
40-50 bp s
-1
 22 TIRF 
10 
min 
30 
Linear 
dsDNA 
0.5-1.5 kb 
Single 
molecule 
>40 bp s
-1
 22 TIRF 
10 
min 
30 
 
Table 22. Summary of PcrA translocation rates at different conditions 
and on different DNA. 
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 §, the DCC-SSB plasmid unwinding assay Slatter et al. 2009, TIRF paper 
2012. *, the experiments were performed at single molecule conditions by 
Toseland C.P. and Fili N.  
 
How does this relate to PcrA’s biological function? It could be that in 
plasmid unwinding the slow rate is required for correct function and correct 
replication of the plasmid. However, plasmid replication has been indicated 
to take place at a significantly faster rate than the observed plasmid 
unwinding and the DNA polymerase III holoenzyme has been shown to 
synthesise DNA in vitro at the rate of ~700 bases s-1 [90]. This could mean 
that the DNA polymerase III is the component that makes the PcrA move 
faster resulting in an active helicase. It is also possible that other protein 
partners exist for PcrA in the cell that make it behave more like an active 
helicase. 
 
7.6. Project continuation 
  
 The novel fluorescent PcrA molecules prepared by site-directed 
mutagenesis and fluorophore labelling have enabled the development of 
new methods to study PcrA function and, of the 11 made, 10 showed 
fluorescent signals with at least one component of the plasmid replication 
complex. This led to the selection of the most significant and most easily 
interpretable signals, but some properties of signals were not investigated 
further due restrictions in time and the relevance of the process to this 
thesis. As an example, these included the MDCC-PcrA(K138C) signal with 
ATP and MDCC-PcrA(H53C) FRET pair with Cy3-labelled DNA junction. 
With aid of possible crystal structure of PcrA·RepD complex, these are 
avenues that could be addressed in the future and many possibilities exist 
for the labelling of the different PcrA cysteine sites developed here for 
FRET pairing with various components of the replication complex from ATP 
to other proteins, such as SSB and DNA polymerase.  
 
 PcrA is an essential helicase in Gram-positive bacteria and it seems 
likely that plasmid unwinding is not its only function and evidence to support 
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this exists [50, 94, 95]. The MDCC-PcrA(K138C) signal in ssDNA 
translocation may become a valuable tool for testing the endogenous 
function(s) of PcrA. UvrD has been shown to be involved and required for 
the removal of RecA filaments, which are toxic to cell genomic stability if 
their levels are not controlled tightly [186-188]. Similarly, PcrA has been 
shown able to dismantle RecA filaments and even though it is not an 
essential function for the organism, it may still be playing an important part 
in genomic stability and DNA repair [94, 95]. The evidence for PcrA 
dismantling RecA filaments was obtained from smFRET measurements 
where PcrA was shown to reel the ssDNA hydrolysing ATP and removing 
the RecA from the DNA. MDCC-PcrA(K138C) generated a fluorescent 
signal which relates to ssDNA translocation. It could possibly be used for 
further studies to observe the RecA filament removal in ensemble assays 
that has not been done before. 
 
 The plasmid unwinding assays reported here are all dependent on 
the presence of SSB. This may indicate that there is an interaction between 
PcrA and SSB. The possibility of an interaction between PcrA and SSB 
should be addressed. If an interaction was discovered, this could lead to 
further importance of SSB·PcrA interaction, which could show that SSB 
may be regulating its function. The other important component of plasmid 
replication is the DNA polymerase and how it affects PcrA function. The 
plasmid replication rates in vitro have been suggested to be ~700 nt s-1 for 
DNA polymerase III holoenzyme [90]. This is almost 20 times faster than 
the unwinding rate observed for PcrA. When plasmid replication occurs, 
they are expected to function as a complex or at least follow each other. 
This means that the DNA polymerase is either slowed down by PcrA or the 
translocation rate of PcrA is increased by the DNA polymerase.  
 
 One of the main questions of the PcrA function in plasmid replication 
is its interaction with RepD. Here, the evidence supports the location of the 
interaction to be the 2B subdomain, but still leaves many questions 
unanswered. The only method for determining the true form of interaction 
would be X-ray crystallography of PcrA and RepD in complex with DNA. 
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This could answer how RepD interacts with the DNA and explain many of 
the features at initiation, as well as during translocation and at the 
termination stage of plasmid replication. 
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Figure 82. Fits of MDCC-PcrA(K138C) binding to dT20.  
The MDCC-PcrA(K138C) binding traces to dT20 fitted to double exponential 
fit. Y-axis:%, Intensity (a.u., arbitrary units). The traces were fitted using 
double exponential fit. 
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Figure 83. Fits of MDCC-PcrA(K138C) binding to dT6.  
The MDCC-PcrA(K138C) binding traces were fitted to single exponential 
decay for all the dT6 concentrations measured. Y-axis:%, Intensity (a.u., 
arbitrary units). The traces were fitted using single exponential fit. 
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Figure 84. Fits of MDCC-PcrA(K138C) binding to dT10. 
The graphs on the left are single exponential fits of the End binding phase. 
The graphs on the right are showing the double exponential fit of MDCC-
PcrA(K138C) binding to dT10. As the middle binding phase has small 
amplitude, the concentration dependence cannot be observed. Y-axis:%, 
Intensity (a.u., arbitrary units). The traces were fitted using single (left) 
double (right) exponential fit. 
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Figure 85. Fits of MDCC-PcrA(K138C) binding to dT50.  
The MDCC-PcrA(K138C) binding traces to varying dT50 concentrations fitted 
to double exponential. The second phase has not been used for analysis as 
it has does not show true concentration dependence and could be 
something like sliding on ssDNA. Y-axis:%, Intensity (a.u., arbitrary units). 
The traces were fitted using double exponential fit. 
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Figure 86. Fits of MDCC-PcrA(K138C) displacement by wild type PcrA. 
 Y-axis:%, Intensity (a.u., arbitrary units). The traces were fitted using single 
exponential fit with straight line. 
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Figure 87. Fits to wild type PcrA binding phase in MDCC-PcrA(K138C) 
displacement assay.  
Y-axis:%, Intensity (a.u., arbitrary units). The traces were fitted using double 
exponential fit. The first phase is the wild type PcrA binding to the ssDNA in 
close proximity to the MDCC-PcrA(K138C). The second phase is the actual 
dissociation of MDCC-PcrA(K138C) from dT10. 
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Figure 88. PcrA translocation rate at single molecule assay conditions. 
A) Normalised traces for MDCC-PcrA(K138C) translocation on ssDNA with 
dT10 to dT70. B) The linear fit of translocation end time points against the 
number of bases in the oligos. The gradient of the linear fit is 0.0075 (SEM 
0.0003).  The measurements were done at 22°C in TIRF buffer  with 100 nM 
MDCC-PcrA(K138C), 1 µM dTx and 200 µM ATP. 
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Figure 89. Fitting of MDCC-PcrA(K138C) translocation on random 
sequence oligos. 
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9.2. Chapter 5 Appendix 
 
 
Figure 90. MDCC-PcrA(E449C) binding to RepD-DNA junction with 
varying dTarm lengths.  
Y-axis:%, Intensity (a.u., arbitrary units). The traces were fitted using double 
exponential fit (A and C to E)and linear regression (B and F). 
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Figure 91. MDCC-PcrA(E449C) binding kinetics to DNA junctions with 
dT6 and dT10-arm without RepD.  
The kobs of PcrA binding to varying concentration of DNA junction 1_dT10arm. 
The traces fit to double exponential. The fast phase has a gradient of 
34.3 µM-1 s-1 and the slow phase 2.9 µM-1 s-1. B) The amplitude change of 
fast and slow phase with varying DNA junction 1_dT10arm concentration. C) 
The kobs of PcrA binding to varying concentration of DNA junction 1_dT10arm. 
The traces fit to double exponential. The fast phase has a gradient of 35.2 
µM-1 s-1 and the slow phase 0.9 µM-1 s-1. D) The amplitude change of fast 
and slow phase with varying DNA junction 1_dT6arm concentration. 
Experimental conditions were same as in the Figure 45.  
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Figure 92. MDCC-PcrA(E449C) binding to varying concentration of 
RepD-DNA junction with and without ATP.  
Y-axis:%, Intensity (a.u., arbitrary units). The traces were fitted using double 
exponential fit. 
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Figure 93.  DNA junction (No ICRIII) bound to RepD.  
A) PcrA binding kinetics to RepD-DNA junction (No ICRIII) complex with 
varying complex concentration. B) The signal amplitude change with 
increase concentration of RepD-DNA junction (No ICRIII) complex. 
Experimental conditions were same as in Figure 45.  
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Figure 94. MDCC-PcrA(E449C) binding signal to DNA junctions without 
RepD-nicking site.  
A) and C) are the observed rate constant dependence on the concentration 
of the RepD-DNA junction (no ICRIII, no CTA) for the fast and slow phase. 
B) and D) are the amplitude dependence on complex concentration for the 
RepD-DNA junction (no ICRIII, no CTA) fast and slow phase. E) and F) are 
the observed rate constant dependence on the concentration of the RepD-
DNA junction (with ICRIII, no CTA) for the fast and slow phase. G) and H) 
are the amplitude dependence on complex concentration for the RepD-DNA 
junction (no ICRIII, no CTA) fast and slow phase. The experimental 
conditions are stated in Figure 45. 
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Figure 95. Fits of MDCC-PcrA(E449C) displacement from RepD-DNA 
junction 1.  
A) 5 µM WT PcrA. B) 15 µM WT PcrA. C) 10 µM WT PcrA and D) 20 µM WT 
PcrA. 
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Figure 96.Fits for MDCC-PcrA(E449C) and Cy3-RepD/Cy3-PcrA(E449C) 
and MDCC-RepD FRET measurements with DNA junction 1 (bound to 
RepD).  
A) Double exponential fit to MDCC-PcrA(E449C) mixed with Cy3-RepD-DNA 
junction 1. B) Single exponential fit to MDCC-PcrA(E449C) mixed with Cy3-
RepD-DNA junction 1 with ATP. C) Single exponential fit to MDCC-
PcrA(E449C)-ATP mixed with Cy3-RepD-DNA junction 1.D) Double 
exponential fit to Cy3-PcrA mixed with MDCC-RepD-DNA junction 1. E) 
Double exponential fit to Cy3-PcrA(E449C) mixed with Cy3-RepD-DNA 
junction 1 with ATP. F) Double exponential fit to Cy3-PcrA(E449C)-ATP 
mixed with MDCC-RepD-DNA junction 1. Y-axis:%, Intensity (a.u., arbitrary 
units). The traces were fitted using double exponential fit. 
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Figure 97. MDCC-PcrA(E449C) displacement assay traces from  RepD-
pCERoriD 3094 complex by wild type PcrA.  
The fits on the left are done using double exponential and on the left by 
single exponential and slope. Y-axis:%, Intensity (a.u., arbitrary units). The 
traces were fitted using double exponential fit. 
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Figure 98. Photobleaching measurements of MDCC-PcrA(E449C) on 
stopped-flow instrument.  
A) Single exponential fit of MDCC-PcrA(E449C) photobleaching inK200 
buffer with 5 µM BSA. This has a kobs of 0.007 s
-1. B) Single exponential fit of 
MDCC-PcrA(E449C) photobleaching inK200 buffer only. This also has a kobs 
of 0.007 s-1. B) Normalised photobleaching measurements MDCC-
PcrA(E449C) in three conditions (only buffer, buffer with BSA and buffer with 
10 µM SSB). These traces have also been fitted to single exponential and 
have kobs between 0.007 and 0.011 s
-1. The experiments were done using 
the stopped-flow apparatus with 100 nM MDCC-PcrA(E449C) at 30 °C. The 
excitation was set to 436 nm and emission measured using 455 nm cut-off 
filter.  
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9.3. Chapter 6 Appendix 
 
 
 
Figure 99. Extrapolation of Cy3B-bioPcrA(E449C) density on the flow 
cell surface.  
The exponential decay of the intensity of total field of view is shown as blue 
trace and black is the fit of the intensity decay. The number of objects at 
each time point is shown as circles and the single exponential fit of object 
numbers is shown as black line. The sample preparation was done as in 
described in Methods Section 2.17.3. and the objects were tracked using 
ASPT by averaging five frames at each time point. The rate constant (kc) 
was fixed to the rate constant determined from the rate of photobleaching of 
entire field of view and it varied from 0.036 to 0.066 s-1 between different 
records (0.1 nM kc = 0.066 s
-1, 0.5 nM kc = 0.053 s
-1, 1 nM kc =0.036 s
-1 and 
2 nM kc = 0.041 s
-1). The number of spots on the surface at the frame 1 is 
the value of the intercept on y-axis. As the area of record is known the object 
density can be calculated on the first frame of the record and results are 
shown in Table 16. 
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Figure 100. Individual unwinding events of pCERoriD 3094 bp.  
The events were analysed using ASPT and the ∆t and ∆I were determined 
by fitting a single exponential fit from start of record to defined point of time 
(75s and 150s) on Igor Pro programme. Between the two fitting times the 
results fitting better to ∆t was used for final analysis. The fit produced an 
output file of Amplitude (∆I), tau (1/4 of ∆t) and start time of event /fit. These 
were used for determining the mean ∆t and ∆I and the distribution of start 
time. The actual start time of event is calculated by deducting the time when 
ATP was added. For this record ATP was added at 49.61 s. In all of the 
graphs the x-axis is time (s) and y-axis is the fluorescence intensity (a.u.) 
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Table 23. Summary of single molecule plasmid unwinding event 
density analysis. 
Event densities were determined for previous measurement done by Fili N. 
and Toseland C. with bioPcrA and linear DNA (PCR product) and to 
pCERoriD plasmid unwinding events by Chisty L.T. 
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Figure 101. Absolute intensity change of the field of view during the 
recording.  
0.5 nM Cy3B-bioPcrA(E449C): 090212r09, 130212r01 and 050412r05. 0.5 
nM unlabelled bioPcrA 050412r06 and r08. 
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Figure 102. Distribution of unwinding events with 3094 bp plasmid with 
unlabelled bioPcrA.  
The data were fitted to Gaussian distribution. C) ∆t versus ∆I plot of 3094 bp 
plasmid unwinding events with unlabelled bioPcrA. The data was fitted to 
linear regression and y=constant. 
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Figure 103. ∆I and ∆t distributions of 3094 bp plasmid unwinding 
events with reduced Cy3B-bioPcrA(E449C) loading concentration.  
A) Histogram of ∆t distribution of events. The Gaussian fit has mean value of 
74.0 s (SEM 4.3) that gives an unwinding rate of 41.8 +/- 2.4 bp s-1. The 
variance of the fit is 38.4 (SEM 4.4). B) The histogram of ∆I distribution of 
events. The Gaussian fit has the mean of 124.7 (SEM 6.2). The variance of 
the fit is 56.1 (SEM 6.2). Record:040412r04  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
